# ==============================================================================
# List of protein-ligand complexes in the PDBbind refined set v.2020
# 5316 protein-ligand complexes in total, sorted by their release year.
# Latest update: July 2021
# PDB code, resolution, release year, binding data, reference, ligand name
# ==============================================================================
2tpi  2.10  1982  Kd=49uM       // 2tpi.pdf (2-mer)
4tln  2.30  1982  Ki=190uM      // 4tln.pdf (LNO)
1rnt  1.90  1987  Kd=6.5uM      // 1rnt.pdf (2GP)
4ts1  2.50  1989  Kd=11.6uM     // 4ts1.pdf (TYR)
4tmn  1.70  1989  Ki=0.068nM    // 4tmn.pdf (0PK)
2tmn  1.60  1989  Ki=1.3uM      // 2tmn.pdf (0FA)
1tlp  2.30  1989  Ki=28nM       // 1tlp.pdf (RDF)
1tmn  1.90  1989  Ki=50nM       // 1tmn.pdf (0ZN)
5tmn  1.60  1989  Ki=9.1nM      // 5tmn.pdf (0PJ)
1rbp  2.00  1991  Kd=0.19uM     // 1rbp.pdf (RTL)
1fkf  1.70  1991  Kd=0.4nM      // 1fkf.pdf (FK5)
4er1  2.00  1991  Ki=0.242uM    // 4er1.pdf (0ZP)
5er2  1.80  1991  Ki=0.27uM     // 5er2.pdf (0EK)
4er2  2.00  1991  Ki=0.5nM      // 4er2.pdf (6-mer)
2ypi  2.50  1991  Ki=15uM       // 2ypi.pdf (PGA)
6cpa  2.00  1991  Ki=3pM        // 6cpa.pdf (ZAF)
4sga  1.80  1991  Ki=50nM       // 4sga.pdf (5-mer)
5er1  2.00  1991  Ki=960nM      // 5er1.pdf (0HT)
4tim  2.40  1992  Ki=6.9mM      // 4tim.pdf (2PG)
1igj  2.50  1993  Kd=0.1nM      // 1igj.pdf (DGX)
1fkb  1.70  1993  Kd=0.2nM      // 1fkb.pdf (RAP)
1l83  1.70  1993  Kd=0.40mM     // 1l83.pdf (BNZ)
1atr  2.34  1993  Kd=110nM      // 1atr.pdf (ADP)
6rnt  1.80  1993  Kd=4.3mM      // 6rnt.pdf (2AM)
3gst  1.90  1993  Ki=0.19uM     // 3gst.pdf (GPR)
1cps  2.25  1993  Ki=0.22uM     // 1cps.pdf (CPM)
2gst  1.80  1993  Ki=0.85uM     // 2gst.pdf (GPS)
1ppm  1.70  1993  Ki=1600nM     // 1ppm.pdf (0P1)
1hos  2.30  1993  Ki=2.8nM      // 1hos.pdf (PHP)
1ppl  1.70  1993  Ki=2.8nM      // 1ppl.pdf (1Z7)
1bcd  1.90  1993  Ki=2nM        // 1bcd.pdf (FMS)
1ivp  2.50  1993  Ki=30nM       // 1ivp.pdf (1ZK)
1trd  2.50  1993  Ki=4uM        // 1trd.pdf (PGH)
1hsl  1.89  1994  Kd=0.064uM    // 1hsl.pdf (HIS)
2drc  1.90  1994  Kd=0.13nM     // 2drc.pdf (MTX)
1lst  1.80  1994  Kd=14nM       // 1lst.pdf (LYS)
1dhj  1.80  1994  Kd=281nM      // 1dhj.pdf (MTX)
1adl  1.60  1994  Kd=4.4uM      // 1adl.pdf (ACD)
1mfd  2.10  1994  Kd=4.9uM      // 1mfd.pdf (3-mer)
2cgr  2.20  1994  Kd=53nM       // 2cgr.pdf (GAS)
1dhi  1.90  1994  Kd=55nM       // 1dhi.pdf (MTX)
1srg  1.80  1994  Kd=5uM        // 1srg.pdf (MHB)
1erb  1.90  1994  Kd=8nM        // 1erb.pdf (ETR) Kd=93nM in phosphate buffer; Kd=8nM in crystallization buffer
1mfa  1.70  1994  Kd=9.1uM      // 1mfa.pdf (3-mer)
1tni  1.90  1994  Ki=0.10mM     // 1tni.pdf (PBN)
2ctc  1.40  1994  Ki=0.13mM     // 2ctc.pdf (HFA)
1add  2.40  1994  Ki=0.18uM     // 1add.pdf (1DA)
1elc  1.75  1994  Ki=0.22uM     // 1elc.pdf (0Z3)
1wht  2.00  1994  Ki=0.2mM      // 1wht.pdf (BZS)
2sim  1.60  1994  Ki=0.38mM     // 2sim.pdf (DAN)
1tnh  1.80  1994  Ki=0.43mM     // 1tnh.pdf (FBA)
1ela  2.00  1994  Ki=0.44uM     // 1ela.pdf (0Z1)
1cbx  2.00  1994  Ki=0.45uM     // 1cbx.pdf (BZS)
1ppc  1.80  1994  Ki=0.69uM     // 1ppc.pdf (MID)
1hps  2.30  1994  Ki=0.6nM      // 1hps.pdf (RUN)
1azm  2.00  1994  Ki=0.8uM      // 1azm.pdf (AZM) ligand is compound 2
1tng  1.80  1994  Ki=1.17mM     // 1tng.pdf (AMC)
1pph  1.90  1994  Ki=1.2uM      // 1pph.pdf (0ZG)
1fki  2.20  1994  Ki=100nM      // 1fki.pdf (SB1)
1rpf  2.20  1994  Ki=103uM      // 1rpf.pdf (C3P) ligand is compound 3'-CMP
1fkg  2.00  1994  Ki=10nM       // 1fkg.pdf (SB3)
1tkb  2.30  1994  Ki=10nM       // 1tkb.pdf (N1T)
1hvl  1.80  1994  Ki=112pM      // 1hvl.pdf (A76) Ki=112pM (cryst, pH=6.2); Ki=1000pM (soln, pH=4.7)
1epo  2.00  1994  Ki=11nM       // 1epo.pdf (2Z3)
1hvk  1.80  1994  Ki=11pM       // 1hvk.pdf (A79) Ki=11pM (cryst, pH=6.2); Ki=77pM (soln, pH=4.7)
1hvi  1.80  1994  Ki=12pM       // 1hvi.pdf (A77) Ki=12pM (cryst, pH=6.2); Ki=84pM (soln, pH=4.7)
1sbg  2.30  1994  Ki=18nM       // 1sbg.pdf (IM1)
1apv  1.80  1994  Ki=1nM        // 1apv.pdf (5-mer)
1ppk  1.80  1994  Ki=22nM       // 1ppk.pdf (IVV)
1lyb  2.50  1994  Ki=3.8pM      // 1lyb.pdf (6-mer)
2cht  2.20  1994  Ki=3uM        // 2cht.pdf (BAR)
1aaq  2.50  1994  Ki=4.0nM      // 1aaq.pdf (PSI)
1hvj  2.00  1994  Ki=4pM        // 1hvj.pdf (A78) Ki=4pM (cryst, pH=6.2); Ki=35pM (soln, pH=4.7)
1elb  2.10  1994  Ki=70nM       // 1elb.pdf (0Z4)
8cpa  2.00  1994  Ki=710pM      // 8cpa.pdf (AGF)
1fkh  1.95  1994  Ki=7nM        // 1fkh.pdf (SBX)
1siv  2.50  1994  Ki=8.4nM      // 1siv.pdf (PSI)
1drj  2.50  1995  Kd=0.040uM    // 1drj.pdf (RIP)
2dri  1.60  1995  Kd=0.13uM     // 2dri.pdf (RIP)
1drk  2.00  1995  Kd=0.15uM     // 1drk.pdf (RIP)
1flr  1.85  1995  Kd=0.1nM      // 1flr.pdf (FLU)
1hmr  1.40  1995  Kd=0.28uM     // 1hmr.pdf (ELA)
1hms  1.40  1995  Kd=0.43uM     // 1hms.pdf (OLA)
1hmt  1.40  1995  Kd=1.64uM     // 1hmt.pdf (STE)
1cny  2.30  1995  Kd=14nM       // 1cny.pdf (EG3)
1laf  2.06  1995  Kd=14nM       // 1laf.pdf (ARG)
186l  1.80  1995  Kd=14uM       // 186l.pdf (N4B) ligand is compound 38
1cnw  2.00  1995  Kd=19nM       // 1cnw.pdf (EG1)
184l  1.80  1995  Kd=19uM       // 184l.pdf (I4B) ligand is compound 39
1yda  2.10  1995  Kd=280nM      // 1yda.pdf (AZM)
185l  1.80  1995  Kd=290uM      // 185l.pdf (IND) ligand is compound 15
1pgp  2.50  1995  Kd=2uM        // 1pgp.pdf (6PG)
1lah  2.06  1995  Kd=30nM       // 1lah.pdf (ORN)
187l  1.80  1995  Kd=422uM      // 187l.pdf (PXY) ligand is compound 18
1cnx  1.90  1995  Kd=43nM       // 1cnx.pdf (EG2)
188l  1.80  1995  Kd=470uM      // 188l.pdf (OXE) ligand is compound 4
1ydb  1.90  1995  Kd=5.8nM      // 1ydb.pdf (AZM)
1lag  2.06  1995  Kd=500nM      // 1lag.pdf (HIS)
1ydd  2.10  1995  Kd=86nM       // 1ydd.pdf (AZM)
2gyi  1.60  1995  Ki<=100nM     // 2gyi.pdf (HYA)
1cgl  2.40  1995  Ki=0.135uM    // 1cgl.pdf (0ED)
1ele  2.00  1995  Ki=0.14uM     // 1ele.pdf (0QN)
1fpc  2.30  1995  Ki=0.1uM      // 1fpc.pdf (0ZI)
1eld  2.00  1995  Ki=0.20uM     // 1eld.pdf (0Z0)
1lcp  1.65  1995  Ki=0.23uM     // 1lcp.pdf (PLU)
1pdz  2.20  1995  Ki=0.2mM      // 1pdz.pdf (PGA)
1hvr  1.80  1995  Ki=0.31nM     // 1hvr.pdf (XK2) IC50=0.22uM
1atl  1.80  1995  Ki=0.52uM     // 1atl.pdf (SLE-TYR)
1tpw  1.90  1995  Ki=0.5mM      // 1tpw.pdf (PGH)
1hpv  1.90  1995  Ki=0.60nM     // 1hpv.pdf (478)
1ctu  2.30  1995  Ki=1.2pM      // 1ctu.pdf (ZEB)
1gar  1.96  1995  Ki=100pM      // 1gar.pdf (U89)
1bty  1.50  1995  Ki=18.4uM     // 1bty.pdf (BEN) ligand is TPB7
1fiv  2.00  1995  Ki=260nM      // 1fiv.pdf (5-mer)
1bma  1.80  1995  Ki=26uM       // 1bma.pdf (0QH)
1ctt  2.20  1995  Ki=30uM       // 1ctt.pdf (DHZ)
1hbv  2.30  1995  Ki=430nM      // 1hbv.pdf (GAN)
1hvs  2.25  1995  Ki=50pM       // 1hvs.pdf (A77)
1hii  2.30  1995  Ki=53nM       // 1hii.pdf (C20)
1lan  1.90  1995  Ki=60nM       // 1lan.pdf (LEU)
1ppi  2.20  1995  Ki=9.7uM      // 1ppi.pdf (4-mer)
1hih  2.20  1995  Ki=9nM        // 1hih.pdf (C20)
1nja  2.50  1996  Kd=0.49uM     // 1nja.pdf (DCM)
1gaf  1.95  1996  Kd=10nM       // 1gaf.pdf (NPE)
1tsy  2.20  1996  Kd=11.0uM     // 1tsy.pdf (UMP)
1dar  2.40  1996  Kd=11uM       // 1dar.pdf (GDP)
1lkk  1.00  1996  Kd=140nM      // 1lkk.pdf (4-mer)
1lkl  1.80  1996  Kd=1540nM     // 1lkl.pdf (4-mer)
1nje  2.30  1996  Kd=160uM      // 1nje.pdf (DCM)
1str  1.80  1996  Kd=17uM       // 1str.pdf (6-mer) Kd for monomer
1ceb  2.07  1996  Kd=1uM        // 1ceb.pdf (AMH)
1njd  2.20  1996  Kd=2.7uM      // 1njd.pdf (UMP)
1njc  2.50  1996  Kd=2.8uM      // 1njc.pdf (DCM)
1mai  1.90  1996  Kd=210nM      // 1mai.pdf (I3P)
1sld  2.50  1996  Kd=270nM      // 1sld.pdf (6-mer)
2olb  1.40  1996  Kd=2900nM     // 2olb.pdf (3-mer)
1pot  1.80  1996  Kd=3.2uM      // 1pot.pdf (SPD)
1det  1.80  1996  Kd=50uM       // 1det.pdf (2GP)
1kel  1.90  1996  Kd=52nM       // 1kel.pdf (AAH)
1mmq  1.90  1996  Ki=0.03uM     // 1mmq.pdf (RRS)
1grp  2.50  1996  Ki=0.189mM    // 1grp.pdf (ICT)
1sln  2.27  1996  Ki=0.23uM     // 1sln.pdf (INH)
1hsh  1.90  1996  Ki=0.38nM     // 1hsh.pdf (MK1)
1igb  2.30  1996  Ki=0.4uM      // 1igb.pdf (IPO)
1jao  2.40  1996  Ki=1.2uM      // 1jao.pdf (0D3)
1gai  1.70  1996  Ki=10nM       // 1gai.pdf (GAC)
1tcx  2.30  1996  Ki=112nM      // 1tcx.pdf (IM1)
1dud  2.30  1996  Ki=15uM       // 1dud.pdf (DUD)
1gno  2.30  1996  Ki=20nM       // 1gno.pdf (U0E)
1gnn  2.30  1996  Ki=2100nM     // 1gnn.pdf (U0E)
1dif  1.70  1996  Ki=22pM       // 1dif.pdf (A85)
1jaq  2.40  1996  Ki=33uM       // 1jaq.pdf (01S)
2csn  2.50  1996  Ki=39uM       // 2csn.pdf (CKI)
1mmr  2.40  1996  Ki=4.0uM      // 1mmr.pdf (SRS)
1mtr  1.75  1996  Ki=4nM        // 1mtr.pdf (PI6)
1hpx  2.00  1996  Ki=5.5pM      // 1hpx.pdf (KNI)
1gnm  2.30  1996  Ki=560nM      // 1gnm.pdf (U0E)
1pro  1.80  1996  Ki=5pM        // 1pro.pdf (A88)
1rnm  2.00  1996  Ki=844.2uM    // 1rnm.pdf (C5P) ligand is compound 5'-CMP; Ki measured at pH=6.0
1fkw  2.40  1996  Ki=9uM        // 1fkw.pdf (PUR)
1avn  2.00  1997  Kd=0.125mM    // 1avn.pdf (HSM)
1drv  2.20  1997  Kd=0.29uM     // 1drv.pdf (A3D) ligand is 3-Ac-NADH; Kd=0.29+/-0.05uM
1okl  2.10  1997  Kd=0.93uM     // 1okl.pdf (MNS)
1jev  1.30  1997  Kd=130nM      // 1jev.pdf (3-mer)
1aj7  2.10  1997  Kd=135uM      // 1aj7.pdf (NPE)
1jeu  1.25  1997  Kd=150nM      // 1jeu.pdf (3-mer)
1ado  1.90  1997  Kd=1uM        // 1ado.pdf (13P)
2h4n  1.90  1997  Kd=2nM        // 2h4n.pdf (AZM)
2mas  2.30  1997  Kd=30nM       // 2mas.pdf (PIR)
1jet  1.20  1997  Kd=56nM       // 1jet.pdf (3-mer)
2aac  1.60  1997  Kd=6mM        // 2aac.pdf (FCB)
1uvt  2.50  1997  Ki=0.023uM    // 1uvt.pdf (I48)
1qbt  2.10  1997  Ki=0.024nM    // 1qbt.pdf (146)
1qbr  1.80  1997  Ki=0.027nM    // 1qbr.pdf (XV6)
1ajq  2.05  1997  Ki=0.049mM    // 1ajq.pdf (SPA)
1qbu  1.80  1997  Ki=0.058nM    // 1qbu.pdf (846)
1ai7  2.50  1997  Ki=0.082mM    // 1ai7.pdf (IPH)
1hxb  2.30  1997  Ki=0.12nM     // 1hxb.pdf (ROC)
1ai5  2.36  1997  Ki=0.189mM    // 1ai5.pdf (MNP)
1dmp  2.00  1997  Ki=0.28nM     // 1dmp.pdf (DMQ) IC50=76nM
1qbs  1.80  1997  Ki=0.34nM     // 1qbs.pdf (DMP)
1hpo  2.50  1997  Ki=0.6nM      // 1hpo.pdf (UNI)
1yds  2.20  1997  Ki=1.2uM      // 1yds.pdf (IQS)
3gss  1.90  1997  Ki=1.5uM      // 3gss.pdf (2-mer)
2gss  1.90  1997  Ki=11.5uM     // 2gss.pdf (EAA)
1ajx  2.00  1997  Ki=12.2nM     // 1ajx.pdf (AH1)
2rkm  1.80  1997  Ki=125uM      // 2rkm.pdf (2-mer)
3aid  2.50  1997  Ki=137nM      // 3aid.pdf (ARQ)
1aid  2.20  1997  Ki=15uM       // 1aid.pdf (THK)
1ajv  2.00  1997  Ki=19.1nM     // 1ajv.pdf (NMB)
1ajn  2.36  1997  Ki=2.32mM     // 1ajn.pdf (AAN)
1vfn  2.15  1997  Ki=2.5uM      // 1vfn.pdf (HPA)
1ydr  2.20  1997  Ki=3.0uM      // 1ydr.pdf (IQP)
1ai4  2.35  1997  Ki=3.13mM     // 1ai4.pdf (DHY)
7upj  2.00  1997  Ki=3.2nM      // 7upj.pdf (INU)
6upj  2.34  1997  Ki=480nM      // 6upj.pdf (NIU)
1ydt  2.30  1997  Ki=48nM       // 1ydt.pdf (IQB)
1ajp  2.31  1997  Ki=5.85mM     // 1ajp.pdf (OMD)
1amk  1.83  1997  Ki=50uM       // 1amk.pdf (PGA) Ki=0.050+/-0.003mM
1tom  1.80  1997  Ki=5nM        // 1tom.pdf (MIN)
5upj  2.30  1997  Ki=75nM       // 5upj.pdf (UIN)
2jxr  2.40  1997  Ki=90nM       // 2jxr.pdf (2Z3)
1rtf  2.30  1997  Ki=910uM      // 1rtf.pdf (BEN)
1b7h  2.00  1998  Kd=0.0095uM   // 1b7h.pdf (3-mer)
1b6h  1.80  1998  Kd=0.015uM    // 1b6h.pdf (3-mer)
1a4k  2.40  1998  Kd=0.01uM     // 1a4k.pdf (FRA)
3pcj  2.13  1998  Kd=0.06uM     // 3pcj.pdf (INO)
1b1h  1.80  1998  Kd=0.093uM    // 1b1h.pdf (3-mer)
1b0h  1.90  1998  Kd=0.20uM     // 1b0h.pdf (3-mer)
1b38  2.00  1998  Kd=0.254uM    // 1b38.pdf (ATP)
3pck  2.13  1998  Kd=0.2uM      // 3pck.pdf (NNO)
1bcu  2.00  1998  Kd=0.53mM     // 1bcu.pdf (PRL) Kd=0.53mM in crystal; Kd=10uM in solution
1wdn  1.94  1998  Kd=0.5uM      // 1wdn.pdf (GLN)
1b3h  2.00  1998  Kd=0.62uM     // 1b3h.pdf (3-mer)
1a9q  2.00  1998  Kd=0.68uM     // 1a9q.pdf (HPA) ligand is hypoxanthine
1ax0  1.90  1998  Kd=0.746mM    // 1ax0.pdf (A2G)
1jmg  2.20  1998  Kd=0.85uM     // 1jmg.pdf (UMP)
1b5h  1.90  1998  Kd=0.97uM     // 1b5h.pdf (3-mer)
1yet  1.90  1998  Kd=1.2uM      // 1yet.pdf (GDM) ligand is compound 34(geldanamycin)
1jmf  2.50  1998  Kd=1.7uM      // 1jmf.pdf (UMP)
1b3l  2.00  1998  Kd=1300nM     // 1b3l.pdf (3-mer)
1b3f  1.80  1998  Kd=130nM      // 1b3f.pdf (3-mer)
1a1e  2.20  1998  Kd=1uM        // 1a1e.pdf (4-mer)
2izl  1.48  1998  Kd=1uM        // 2izl.pdf (IMI)
1b3g  2.00  1998  Kd=200nM      // 1b3g.pdf (3-mer)
4tmk  1.98  1998  Kd=20nM       // 4tmk.pdf (T5A)
3pcn  2.40  1998  Kd=220uM      // 3pcn.pdf (DHY)
1amw  1.85  1998  Kd=29uM       // 1amw.pdf (ADP)
1b2h  1.90  1998  Kd=29uM       // 1b2h.pdf (3-mer)
1a99  2.20  1998  Kd=2uM        // 1a99.pdf (PUT)
1b4h  1.90  1998  Kd=3.44uM     // 1b4h.pdf (3-mer)
1bm7  2.00  1998  Kd=30nM       // 1bm7.pdf (FLF)
5tmp  1.98  1998  Kd=34nM       // 5tmp.pdf (Z5A)
1bhf  1.80  1998  Kd=42uM       // 1bhf.pdf (5-mer)
1swg  1.80  1998  Kd=43.9nM     // 1swg.pdf (BTN)
4rsk  2.10  1998  Kd=47.4uM     // 4rsk.pdf (U3P) Ki=47.4uM (with 0.018M Na+); Ki=153.6uM (with 0.142M Na+)
1b05  2.00  1998  Kd=75nM       // 1b05.pdf (3-mer)
1b32  1.75  1998  Kd=79nM       // 1b32.pdf (3-mer)
1usn  1.80  1998  Ki=0.018uM    // 1usn.pdf (IN9)
2qwe  2.00  1998  Ki=0.033uM    // 2qwe.pdf (GNA)
1bv7  2.00  1998  Ki=0.05nM     // 1bv7.pdf (XV6) complex between HIV-1 PR (I84V mutant) with XV638; Ki mutant/wt ratio=0.5; Ki(wt)=0.1nM
1xug  1.50  1998  Ki=0.09uM     // 1xug.pdf (BAB)
1bxo  0.95  1998  Ki=0.10nM     // 1bxo.pdf (PP7)
1bv9  2.00  1998  Ki=0.11nM     // 1bv9.pdf (XV6)
1bhx  2.30  1998  Ki=0.145uM    // 1bhx.pdf (R56)
2usn  2.20  1998  Ki=0.31uM     // 2usn.pdf (IN8)
1moq  1.57  1998  Ki=0.35mM     // 1moq.pdf (GLP)
1alw  2.03  1998  Ki=0.3uM      // 1alw.pdf (ISA)
1bdq  2.50  1998  Ki=0.46uM     // 1bdq.pdf (IM1)
1met  1.90  1998  Ki=0.4nM      // 1met.pdf (DMP)
10gs  2.20  1998  Ki=0.4uM      // 10gs.pdf (VWW)
1br6  2.30  1998  Ki=0.6mM      // 1br6.pdf (PT1)
2wed  1.50  1998  Ki=0.8uM      // 2wed.pdf (PP6)
3pcf  2.15  1998  Ki=0.9uM      // 3pcf.pdf (FHB)
1a4w  1.80  1998  Ki=1.2uM      // 1a4w.pdf (QWE)
3pce  2.06  1998  Ki=10mM       // 3pce.pdf (3HP)
2wec  1.50  1998  Ki=110uM      // 2wec.pdf (PP5)
1a9m  2.30  1998  Ki=119nM      // 1a9m.pdf (U0E)
1hvh  1.80  1998  Ki=11nM       // 1hvh.pdf (Q82)
2qwd  2.00  1998  Ki=14uM       // 2qwd.pdf (4AM)
1hxw  1.80  1998  Ki=15pM       // 1hxw.pdf (RIT)
1bju  1.80  1998  Ki=16uM       // 1bju.pdf (GP6) Ki=16+/-2.8uM for ACPU
2qwb  2.00  1998  Ki=1820uM     // 2qwb.pdf (SIA)
2qwf  1.90  1998  Ki=2.160uM    // 2qwf.pdf (G20)
1bwa  1.90  1998  Ki=2.5nM      // 1bwa.pdf (XV6)
1bjv  1.80  1998  Ki=2.9uM      // 1bju.pdf (GP8) Ki=2.9+/-0.1uM for APPU
1mes  1.90  1998  Ki=20nM       // 1mes.pdf (DMP)
1afk  1.70  1998  Ki=240nM      // 1afk.pdf (PAP)
3jdw  2.40  1998  Ki=253uM      // 3jdw.pdf (ORN)
2qwc  1.60  1998  Ki=280uM      // 2qwc.pdf (DAN)
1hfs  1.70  1998  Ki=2nM        // 1hfs.pdf (L04)
1ohr  2.10  1998  Ki=2nM        // 1ohr.pdf (1UN)
1bwb  1.80  1998  Ki=3.8nM      // 1bwb.pdf (146)
1bxq  1.41  1998  Ki=42nM       // 1bxq.pdf (PP8)
1a28  1.80  1998  Ki=5.1nM      // 1a28.pdf (STR) ligand is progesterone
1a30  2.00  1998  Ki=50uM       // 1a30.pdf (3-mer)
1afl  1.70  1998  Ki=520nM      // 1afl.pdf (ATR)
3pcg  1.96  1998  Ki=5mM        // 3pcg.pdf (4HP)
1a69  2.10  1998  Ki=5uM        // 1a69.pdf (FMB)
1bq4  2.50  1998  Ki=6uM        // 1bq4.pdf (BHC)
2web  1.50  1998  Ki=7.6uM      // 2web.pdf (PP4)
1stc  2.30  1998  Ki=8nM        // 1stc.pdf (STU)
1bnn  2.30  1999  Kd=0.10nM     // 1bnn.pdf (AL1)
1swr  1.90  1999  Kd=0.12uM     // 1swr.pdf (BTN)
1bn3  2.20  1999  Kd=0.13nM     // 1bn3.pdf (AL6)
1bnt  2.15  1999  Kd=0.16nM     // 1bnt.pdf (AL2)
1bnu  2.15  1999  Kd=0.20nM     // 1bnu.pdf (AL3)
1a4r  2.50  1999  Kd=0.22uM     // 1a4r.pdf (GNH) Kd=9.4pM for GDP
1bnq  2.40  1999  Kd=0.32nM     // 1bnq.pdf (AL4)
1rpj  1.80  1999  Kd=0.33uM     // 1rpj.pdf (ALL)
1bn1  2.10  1999  Kd=0.46nM     // 1bn1.pdf (AL5)
1bn4  2.10  1999  Kd=0.49nM     // 1bn4.pdf (AL9)
1d4p  2.07  1999  Kd=0.5uM      // 1d4p.pdf (BPP)
1bnw  2.25  1999  Kd=0.83nM     // 1bnw.pdf (TPD)
2ans  2.50  1999  Kd=1.2uM      // 2ans.pdf (2AN)
1ork  2.40  1999  Kd=1.56nM     // 1ork.pdf (ATC)
1bnv  2.40  1999  Kd=1.70nM     // 1bnv.pdf (AL7)
1b9j  1.80  1999  Kd=1100nM     // 1b9j.pdf (3-mer)
1qka  1.80  1999  Kd=1200nM     // 1qka.pdf (3-mer)
3tmk  2.00  1999  Kd=135nM      // 3tmk.pdf (T5A)
1d2e  1.94  1999  Kd=1uM        // 1d2e.pdf (GDP)
1bgq  2.50  1999  Kd=2.7nM      // 1bgq.pdf (RDC)
3kiv  1.80  1999  Kd=20uM       // 3kiv.pdf (ACA)
1d7i  1.90  1999  Kd=250uM      // 1d7i.pdf (DSS)
1b58  1.80  1999  Kd=260nM      // 1b58.pdf (3-mer)
2pcp  2.20  1999  Kd=2nM        // 2pcp.pdf (1PC)
1yei  1.90  1999  Kd=35nM       // 1yei.pdf (PGG)
1yej  1.85  1999  Kd=35nM       // 1yej.pdf (PNF)
1b5j  1.80  1999  Kd=37nM       // 1b5j.pdf (3-mer)
1bzy  2.00  1999  Kd=4.6nM      // 1bzy.pdf (IMU)
1b55  2.40  1999  Kd=40nM       // 1b55.pdf (4IP)
1b51  1.80  1999  Kd=43nM       // 1b51.pdf (3-mer)
1qkb  1.80  1999  Kd=45nM       // 1qkb.pdf (3-mer)
1d7j  1.85  1999  Kd=500uM      // 1d7j.pdf (BUQ)
1b46  1.80  1999  Kd=5200nM     // 1b46.pdf (3-mer)
1b40  2.20  1999  Kd=53nM       // 1b40.pdf (3-mer)
1b4z  1.75  1999  Kd=5900nM     // 1b4z.pdf (3-mer)
1qk4  1.90  1999  Kd=61uM       // 1qk4.pdf (IMP)
1qk3  1.65  1999  Kd=7.1uM      // 1qk3.pdf (5GP)
1qaw  2.50  1999  Kd=7.5uM      // 1qaw.pdf (TRP)
1b52  2.30  1999  Kd=76nM       // 1b52.pdf (3-mer)
1b5i  1.90  1999  Kd=90nM       // 1b5i.pdf (3-mer)
1d4y  1.97  1999  Ki=0.008nM    // 1d4y.pdf (TPV)
2std  2.10  1999  Ki=0.14nM     // 2std.pdf (CRP)
456c  2.40  1999  Ki=0.17nM     // 456c.pdf (CBP)
1bxr  2.10  1999  Ki=0.4mM      // 1bxr.pdf (ANP)
1pme  2.00  1999  Ki=0.4nM      // 1pme.pdf (SB2)
5yas  2.20  1999  Ki=0.55mM     // 5yas.pdf (FAC)
1cet  2.05  1999  Ki=1.3mM      // 1cet.pdf (CLQ)
2bza  1.90  1999  Ki=1.58mM     // 2bza.pdf (ABN)
1qin  2.00  1999  Ki=10nM       // 1qin.pdf (GIP)
1qf2  2.06  1999  Ki=1200nM     // 1qf2.pdf (TI3)
1bzc  2.35  1999  Ki=12uM       // 1bzc.pdf (TPI)
1xka  2.30  1999  Ki=131nM      // 1xka.pdf (4PP) IC50=272nM
1a94  2.00  1999  Ki=14nM       // 1a94.pdf (0Q4)
1b8y  2.00  1999  Ki=14nM       // 1b8y.pdf (IN7)
7std  1.80  1999  Ki=19pM       // 7std.pdf (CRP)
6std  1.80  1999  Ki=2.3nM      // 6std.pdf (MS2)
1mfi  1.80  1999  Ki=2.6uM      // 1mfi.pdf (FHC)
1bai  2.40  1999  Ki=20nM       // 1bai.pdf (0Q4)
2bpv  1.90  1999  Ki=21.2nM     // 2bpv.pdf (1IN)
1c3x  2.40  1999  Ki=210uM      // 1c3x.pdf (8IG)
1bzj  2.25  1999  Ki=22uM       // 1bzj.pdf (PIC)
966c  1.90  1999  Ki=23nM       // 966c.pdf (RS2)
1b8o  1.50  1999  Ki=23pM       // 1b8o.pdf (IMH)
1upf  2.30  1999  Ki=25uM       // 1upf.pdf (URF)
1qhc  1.70  1999  Ki=27nM       // 1qhc.pdf (PUA)
2fmb  1.80  1999  Ki=2nM        // 2fmb.pdf (LP1)
1b8n  2.00  1999  Ki=30pM       // 1b8n.pdf (IMG)
5std  1.95  1999  Ki=32pM       // 5std.pdf (UNN)
1ciz  1.64  1999  Ki=36nM       // 1ciz.pdf (DPS)
2bpy  1.90  1999  Ki=39.8nM     // 2bpy.pdf (3IN)
1hwr  1.80  1999  Ki=4.70nM     // 1hwr.pdf (216)
1qbv  1.80  1999  Ki=4100nM     // 1qbv.pdf (PPX)
1qf0  2.20  1999  Ki=42nM       // 1qf0.pdf (TI2)
4std  2.15  1999  Ki=47pM       // 4std.pdf (BFS)
1qf1  2.00  1999  Ki=48nM       // 1qf1.pdf (TI1)
1qbq  2.40  1999  Ki=5nM        // 1qbq.pdf (HFP)
3std  1.65  1999  Ki=7.7pM      // 3std.pdf (MQ0)
1fao  1.80  2000  Kd=0.043uM    // 1fao.pdf (4IP)
1fl3  2.45  2000  Kd=0.16uM     // 1fl3.pdf (SPB)
1df8  1.51  2000  Kd=0.20nM     // 1df8.pdf (BTN)
1g52  1.80  2000  Kd=0.29nM     // 1g52.pdf (F2B)
1dl7  2.35  2000  Kd=0.32uM     // 1dl7.pdf (NCH)
1g1d  2.04  2000  Kd=0.36nM     // 1g1d.pdf (FSB)
1fcz  1.38  2000  Kd=0.6nM      // 1fcz.pdf (156)
1d3d  2.04  2000  Kd=0.81nM     // 1d3d.pdf (BZT)
1dzk  1.48  2000  Kd=0.8uM      // 1dzk.pdf (PRZ)
1g53  1.94  2000  Kd=0.91nM     // 1g53.pdf (F6B)
1qkt  2.20  2000  Kd=0.92nM     // 1qkt.pdf (EST)
1g54  1.86  2000  Kd=1.5nM      // 1g54.pdf (FFB)
1g46  1.84  2000  Kd=1.6nM      // 1g46.pdf (F2B)
1duv  1.70  2000  Kd=1.6pM      // 1duv.pdf (PSQ)
1qft  1.25  2000  Kd=1.7nM      // 1qft.pdf (HSM)
1ql7  2.10  2000  Kd=10uM       // 1ql7.pdf (ZEN) Kd=10~20uM
1c5c  1.61  2000  Kd=110nM      // 1c5c.pdf (TK4)
1elr  1.90  2000  Kd=11uM       // 1elr.pdf (6-mer)
1g45  1.83  2000  Kd=2.3nM      // 1g45.pdf (FSB)
1f4x  2.30  2000  Kd=2.6uM      // 1f4x.pdf (MGS)
1fo0  2.50  2000  Kd=2.6uM      // 1fo0.pdf (8-mer)
1ftm  1.70  2000  Kd=24.8nM     // 1ftm.pdf (AMQ)
1fzq  1.70  2000  Kd=24nM       // 1fzq.pdf (GDP)
1e4h  1.80  2000  Kd=3.9nM      // 1e4h.pdf (PBR)
1g48  1.86  2000  Kd=3.9nM      // 1g48.pdf (F6B)
1fcy  1.30  2000  Kd=3nM        // 1fcy.pdf (564)
1bp0  2.40  2000  Kd=4.0uM      // 1bp0.pdf (UMP)
1d3p  2.10  2000  Kd=41nM       // 1d3p.pdf (BT3)
1g4o  1.96  2000  Kd=5.6nM      // 1g4o.pdf (BSB)
1fcx  1.47  2000  Kd=64nM       // 1fcx.pdf (184)
1d6v  2.00  2000  Kd=670nM      // 1d6v.pdf (HOP)
1fch  2.20  2000  Kd=70nM       // 1fch.pdf (5-mer)
1c1u  1.75  2000  Ki=0.0056uM   // 1c1u.pdf (BAI)
1b57  2.00  2000  Ki=0.01uM     // 1b57.pdf (PGH) ligand is phosphoglycolohydroxamic acid (PGH)
1c1r  1.37  2000  Ki=0.0235uM   // 1c1r.pdf (BAI)
1c1v  1.98  2000  Ki=0.023uM    // 1c1v.pdf (BAB)
1c4u  2.10  2000  Ki=0.043nM    // 1c4u.pdf (IH1)
1c70  2.50  2000  Ki=0.05nM     // 1c70.pdf (L75)
1fjs  1.92  2000  Ki=0.11nM     // 1fjs.pdf (Z34)
1fh8  1.95  2000  Ki=0.13uM     // 1fh8.pdf (2-mer) ligand is XYP-XIF
1fhd  1.90  2000  Ki=0.15uM     // 1fhd.pdf (2-mer) ligand is XYP-XIM
1c5x  1.75  2000  Ki=0.21uM     // 1c5x.pdf (ESI)
1f3e  1.85  2000  Ki=0.2uM      // 1f3e.pdf (DPZ)
1fh9  1.72  2000  Ki=0.37uM     // 1fh9.pdf (2-mer) ligand is XYP-LOX
1c5q  1.43  2000  Ki=0.44uM     // 1c5q.pdf (ESI)
1e6s  1.35  2000  Ki=0.6mM      // 1e6s.pdf (GOX)
1d4k  1.85  2000  Ki=0.6nM      // 1d4k.pdf (PI8)
1d9i  2.30  2000  Ki=0.78nM     // 1d9i.pdf (00P)
1ec9  2.00  2000  Ki=0.8mM      // 1ec9.pdf (XYH)
1f74  1.60  2000  Ki=0.9mM      // 1f74.pdf (NAY)
1ezq  2.20  2000  Ki=0.9nM      // 1ezq.pdf (RPR)
1eoc  2.25  2000  Ki=0.9uM      // 1eoc.pdf (4NC)
1ecq  2.00  2000  Ki=1.0mM      // 1ecq.pdf (DXG)
1c5s  1.36  2000  Ki=1.0uM      // 1c5s.pdf (ESX)
1f4e  1.90  2000  Ki=1.1mM      // 1f4e.pdf (TPR)
1fkn  1.90  2000  Ki=1.6nM      // 1fkn.pdf (7-mer)
1d4l  1.75  2000  Ki=1.7nM      // 1d4l.pdf (PI9)
1b6k  1.85  2000  Ki=1.8nM      // 1b6k.pdf (PI5)
1f0t  1.80  2000  Ki=1000nM     // 1f0t.pdf (PR1)
1dqn  1.75  2000  Ki=10nM       // 1dqn.pdf (IMU)
1e2k  1.70  2000  Ki=11.4uM     // 1e2k.pdf (TMC)
1d6w  2.00  2000  Ki=1100nM     // 1d6w.pdf (00R)
1b6j  1.85  2000  Ki=12nM       // 1b6j.pdf (5-mer)
1qbn  1.80  2000  Ki=1400nM     // 1qbn.pdf (688)
1c83  1.80  2000  Ki=14uM       // 1c83.pdf (OAI)
1ecv  1.95  2000  Ki=14uM       // 1ecv.pdf (878)
1qji  2.14  2000  Ki=14uM       // 1qji.pdf (PKF)
1qb1  1.80  2000  Ki=170nM      // 1qb1.pdf (974)
1f0s  2.10  2000  Ki=18nM       // 1f0s.pdf (PR2)
1qbo  1.80  2000  Ki=18nM       // 1qbo.pdf (711)
1f57  1.75  2000  Ki=2.3uM      // 1f57.pdf (DCY)
1ejn  1.80  2000  Ki=2.4uM      // 1ejn.pdf (AGB)
1c5n  1.50  2000  Ki=20uM       // 1c5n.pdf (ESI)
1c86  2.30  2000  Ki=20uM       // 1c86.pdf (OPA)
1c5p  1.43  2000  Ki=21uM       // 1c5p.pdf (BAM)
1f0r  2.10  2000  Ki=22nM       // 1f0r.pdf (815)
1f4f  2.00  2000  Ki=24uM       // 1f4f.pdf (TP3)
1d09  2.10  2000  Ki=27nM       // 1d09.pdf (PAL) ATCase in complex with PALA
1egh  2.00  2000  Ki=2uM        // 1egh.pdf (PGA)
1c5o  1.90  2000  Ki=320uM      // 1c5o.pdf (BAM)
1f4g  1.75  2000  Ki=330nM      // 1f4g.pdf (TP4)
1qan  2.40  2000  Ki=33uM       // 1qan.pdf (SAH)
1qb9  1.80  2000  Ki=36nM       // 1qb9.pdf (806)
1fq5  2.40  2000  Ki=4.0nM      // 1fq5.pdf (0GM)
1f73  1.95  2000  Ki=4.1mM      // 1f73.pdf (HMN)
1ql9  2.30  2000  Ki=4.45uM     // 1ql9.pdf (ZEN)
1dy4  1.90  2000  Ki=44uM       // 1dy4.pdf (SNP)
1c88  1.80  2000  Ki=5.1uM      // 1c88.pdf (OTA)
1fh7  1.82  2000  Ki=5.8uM      // 1fh7.pdf (2-mer) ligand is XYP-XDN
1e2l  2.40  2000  Ki=51.5uM     // 1e2l.pdf (TMC)
1b6l  1.75  2000  Ki=5nM        // 1b6l.pdf (PI4)
1ft7  2.20  2000  Ki=6.6uM      // 1ft7.pdf (PLU) Ki measured at pH=8.0
1c5y  1.65  2000  Ki=63uM       // 1c5y.pdf (ESP)
1c87  2.10  2000  Ki=63uM       // 1c87.pdf (OPA)
1f0u  1.90  2000  Ki=69nM       // 1f0u.pdf (RPR)
1gfy  2.13  2000  Ki=8.32uM     // 1gfy.pdf (COL) ligand is compound 29; -logKi=5.08
1enu  1.95  2000  Ki=8.3uM      // 1enu.pdf (APZ)
1dgm  1.80  2000  Ki=8.9uM      // 1dgm.pdf (ADN) ligand is adenosine
1c5t  1.37  2000  Ki=80uM       // 1c5t.pdf (ESP)
1qb6  1.80  2000  Ki=870nM      // 1qb6.pdf (623)
8a3h  0.97  2000  Ki=88uM       // 8a3h.pdf (IDC)
1c84  2.35  2000  Ki=9.9uM      // 1c84.pdf (761)
1ie9  1.40  2001  Kd=0.065nM    // 1ie9.pdf (VDX) ligand is 1,25(OH)2 vitamin D3
1hn4  1.50  2001  Kd=0.15mM     // 1hn4.pdf (MJI)
1ex8  1.85  2001  Kd=0.47uM     // 1ex8.pdf (A4P) Kd=0.47uM (with Mg2+); Kd=1.93uM (without Mg2+)
1g7v  2.40  2001  Kd=0.4uM      // 1g7v.pdf (PAI)
1i7z  2.30  2001  Kd=0.4uM      // 1i7z.pdf (COC)
1e3g  2.40  2001  Kd=0.99nM     // 1e3g.pdf (R18) ligand is compound 3 (RU1881)
1k1l  2.50  2001  Kd=125nM      // 1k1l.pdf (FD3)
1fzo  1.80  2001  Kd=13nM       // 1fzo.pdf (9-mer)
1k1n  2.00  2001  Kd=153nM      // 1k1n.pdf (CCR)
1i9n  1.86  2001  Kd=2.2nM      // 1i9n.pdf (IOA)
1fzm  1.80  2001  Kd=20nM       // 1fzm.pdf (8-mer)
1if8  1.94  2001  Kd=230pM      // 1if8.pdf (SBS)
1ii5  1.60  2001  Kd=240nM      // 1ii5.pdf (GLU)
1k1i  2.20  2001  Kd=264nM      // 1k1i.pdf (FD1)
1k1j  2.20  2001  Kd=28nM       // 1k1j.pdf (FD2)
1jgl  2.15  2001  Kd=2nM        // 1jgl.pdf (EST)
1i9p  1.92  2001  Kd=3.9nM      // 1i9p.pdf (IOE)
1if7  1.98  2001  Kd=30pM       // 1if7.pdf (SBR)
1ikt  1.75  2001  Kd=400uM      // 1ikt.pdf (OXN)
1k1m  2.20  2001  Kd=40nM       // 1k1m.pdf (FD4)
1e3v  2.00  2001  Kd=45.74uM    // 1e3v.pdf (DXC)
1fzk  1.70  2001  Kd=4nM        // 1fzk.pdf (9-mer)
1h6h  1.70  2001  Kd=5.0uM      // 1h6h.pdf (PIB)
1fzj  1.90  2001  Kd=8nM        // 1fzj.pdf (8-mer)
1i1e  2.50  2001  Kd=9.4uM      // 1i1e.pdf (DM2)
1j4r  1.80  2001  Ki=0.019uM    // 1j4r.pdf (001)
1f8c  1.70  2001  Ki=0.04uM     // 1f8c.pdf (4AM)
1e66  2.10  2001  Ki=0.13nM     // 1e66.pdf (HUX)
1g7g  2.20  2001  Ki=0.25uM     // 1g7g.pdf (INX)
1jzs  2.50  2001  Ki=0.25uM     // 1jzs.pdf (MRC)
1i37  2.00  2001  Ki=0.27nM     // 1i37.pdf (DHT)
1k9s  2.00  2001  Ki=0.30uM     // 1k9s.pdf (FM2)
1e6q  1.35  2001  Ki=0.7mM      // 1e6q.pdf (NTZ)
1iih  2.20  2001  Ki=1.3mM      // 1iih.pdf (3PG)
1e1x  1.85  2001  Ki=1.3uM      // 1e1x.pdf (NW1)
1hdq  2.30  2001  Ki=1.5uM      // 1hdq.pdf (INF)
1e5j  1.85  2001  Ki=100uM      // 1e5j.pdf (4-mer)
1hlk  2.50  2001  Ki=10uM       // 1hlk.pdf (113) IC50=29uM
1g2k  1.95  2001  Ki=11nM       // 1g2k.pdf (NM1)
1e1v  1.95  2001  Ki=12uM       // 1e1v.pdf (CMG)
1g30  2.00  2001  Ki=140nM      // 1g30.pdf (T87)
1f8e  1.40  2001  Ki=15uM       // 1f8e.pdf (49A)
1f5k  1.80  2001  Ki=180uM      // 1f5k.pdf (BAM)
1fm9  2.10  2001  Ki=1nM        // 1fm9.pdf (570)
1jak  1.75  2001  Ki=2.7uM      // 1jak.pdf (IFG)
1g3d  1.80  2001  Ki=2.8uM      // 1g3d.pdf (108) Ki for Cu-108
1hp5  2.10  2001  Ki=280nM      // 1hp5.pdf (NGT)
1g2o  1.75  2001  Ki=28pM       // 1g2o.pdf (IMH)
1g98  1.90  2001  Ki=2uM        // 1g98.pdf (PA5)
1jsv  1.96  2001  Ki=2uM        // 1jsv.pdf (U55)
1g7f  1.80  2001  Ki=3.4uM      // 1g7f.pdf (INZ)
1hi4  1.80  2001  Ki=32uM       // 1hi4.pdf (A3P)
1ik4  2.00  2001  Ki=39nM       // 1ik4.pdf (PGH)
1f8b  1.80  2001  Ki=4.0uM      // 1f8b.pdf (DAN)
1g3e  1.80  2001  Ki=4.2uM      // 1g3e.pdf (109) Ki for Cu-109
1hee  1.75  2001  Ki=4.6uM      // 1hee.pdf (LHY)
1f8d  1.40  2001  Ki=400uM      // 1f8d.pdf (9AM)
1f5l  2.10  2001  Ki=5.3uM      // 1f5l.pdf (AMR)
1g2l  1.90  2001  Ki=57nM       // 1g2l.pdf (T87)
1hi3  1.80  2001  Ki=64uM       // 1hi3.pdf (A2P)
1k1o  2.00  2001  Ki=675nM      // 1k1o.pdf (IGN)
1g36  1.90  2001  Ki=67nM       // 1g36.pdf (R11)
1efy  2.20  2001  Ki=6nM        // 1efy.pdf (BZC)
1g35  1.80  2001  Ki=7.3nM      // 1g35.pdf (AHF)
1g32  1.90  2001  Ki=780nM      // 1g32.pdf (R11)
1hyo  1.30  2001  Ki=84.8uM     // 1hyo.pdf (HBU)
1hi5  1.80  2001  Ki=92uM       // 1hi5.pdf (ADP)
1m7y  1.60  2002  Kd=0.011nM    // 1m7y.pdf (PPG)
1lbf  2.05  2002  Kd=0.014uM    // 1lbf.pdf (137)
1n4k  2.20  2002  Kd=0.09nM     // 1n4k.pdf (I3P)
1lrh  1.90  2002  Kd=0.15uM     // 1lrh.pdf (NLA)
1li6  2.00  2002  Kd=0.16mM     // 1li6.pdf (5MP)
1gx8  2.40  2002  Kd=0.43uM     // 1gx8.pdf (RTL) compound retinoids 1, chance of additional binding site in the cases of 1
1m83  2.20  2002  Kd=0.4mM      // 1m83.pdf (ATP)
1lgt  1.70  2002  Kd=0.8uM      // 1lgt.pdf (BP3) Ki=2.75mM is for steady-state kinetic parameter for DHBD for chlorinated DHBs
1kdk  1.70  2002  Kd=0.9nM      // 1kdk.pdf (DHT)
1kv1  2.50  2002  Kd=1.16uM     // 1kv1.pdf (BMU)
1kzn  2.30  2002  Kd=1.2nM      // 1kzn.pdf (CBN)
1kyv  2.40  2002  Kd=1.2uM      // 1kyv.pdf (RBF)
1lhu  1.80  2002  Kd=1.48nM     // 1lhu.pdf (EST) ligand is compound 20; -logKd=8.83
1lgw  1.85  2002  Kd=100uM      // 1lgw.pdf (1AN)
1k6v  2.00  2002  Kd=120nM      // 1k6v.pdf (XN2)
1h2t  2.15  2002  Kd=13nM       // 1h2t.pdf (GDP-7MG)
1k6t  2.25  2002  Kd=24nM       // 1k6t.pdf (XN1)
1jyq  2.00  2002  Kd=2nM        // 1jyq.pdf (4-mer)
1g85  1.80  2002  Kd=3.3uM      // 1g85.pdf (3OL)
1h0a  1.70  2002  Kd=3.6uM      // 1h0a.pdf (I3P)
1k6c  2.20  2002  Kd=33nM       // 1k6c.pdf (MK1)
1k6p  2.20  2002  Kd=44nM       // 1k6p.pdf (XN3)
1jlr  2.45  2002  Kd=465uM      // 1jlr.pdf (GTP)
1fd0  1.38  2002  Kd=4nM        // 1fd0.pdf (254)
1li3  1.85  2002  Kd=56uM       // 1li3.pdf (3CH)
1lbk  1.86  2002  Kd=668uM      // 1lbk.pdf (GSH)
1m48  1.95  2002  Kd=8.2uM      // 1m48.pdf (FRG)
1g7q  1.60  2002  Kd=877nM      // 1g7q.pdf (8-mer)
1ez9  1.90  2002  Kd=8uM        // 1ez9.pdf (4-mer)
1kmy  2.00  2002  Kd=8uM        // 1kmy.pdf (BPY)
1li2  2.00  2002  Kd=91uM       // 1li2.pdf (IPH)
1ghy  1.85  2002  Ki=0.008uM    // 1ghy.pdf (121) Ki for Zn-121
1izh  1.90  2002  Ki=0.02uM     // 1izh.pdf (Q50)
1gi4  1.37  2002  Ki=0.065uM    // 1gi4.pdf (122) Ki for Zn-122
1d4h  1.81  2002  Ki=0.10nM     // 1d4h.pdf (BEH)
1ec2  2.00  2002  Ki=0.10nM     // 1ec2.pdf (BEJ)
1gj6  1.50  2002  Ki=0.10uM     // 1gj6.pdf (132)
1kuk  1.45  2002  Ki=0.124mM    // 1kuk.pdf (3-mer)
1m0q  2.00  2002  Ki=0.13mM     // 1m0q.pdf (EPC)
1kug  1.37  2002  Ki=0.160mM    // 1kug.pdf (3-mer)
1kui  1.50  2002  Ki=0.169mM    // 1kui.pdf (3-mer)
1eby  2.29  2002  Ki=0.20nM     // 1eby.pdf (BEB)
1izi  2.15  2002  Ki=0.26uM     // 1izi.pdf (Q50)
1loq  1.50  2002  Ki=0.2mM      // 1loq.pdf (U)
1koj  1.90  2002  Ki=0.2uM      // 1koj.pdf (PAN)
1gpn  2.35  2002  Ki=0.334uM    // 1gpn.pdf (HUB)
1j01  2.00  2002  Ki=0.34uM     // 1j01.pdf (XIL)
1m4h  2.10  2002  Ki=0.3nM      // 1m4h.pdf (7-mer)
1ebz  2.01  2002  Ki=0.40nM     // 1ebz.pdf (BEC)
1gjc  1.73  2002  Ki=0.45uM     // 1gjc.pdf (130)
1ksn  2.10  2002  Ki=0.4nM      // 1ksn.pdf (FXV)
1ew9  2.00  2002  Ki=0.6mM      // 1ew9.pdf (MMQ)
1l8g  2.50  2002  Ki=0.6uM      // 1l8g.pdf (DBD) ligand is compound f1; protein is PTPN1
1h22  2.15  2002  Ki=0.8nM      // 1h22.pdf (E10)
1ebw  1.81  2002  Ki=0.90nM     // 1ebw.pdf (BEI)
1ec3  1.80  2002  Ki=0.92nM     // 1ec3.pdf (MS3)
1jq8  2.00  2002  Ki=1.01uM     // 1jq8.pdf (5-mer)
1fv0  1.70  2002  Ki=1.18uM     // 1fv0.pdf (9AR)
1ec1  2.10  2002  Ki=1.20nM     // 1ec1.pdf (BEE)
1h2k  2.15  2002  Ki=1.2mM      // 1h2k.pdf (OGA) ligand is compound 31
1d4i  1.81  2002  Ki=1.40nM     // 1d4i.pdf (BEG)
1k4g  1.70  2002  Ki=1.4uM      // 1k4g.pdf (AIQ)
1kpm  1.80  2002  Ki=1.59uM     // 1kpm.pdf (VIT)
1kav  2.35  2002  Ki=1.5uM      // 1kav.pdf (FEP)
1gvw  1.00  2002  Ki=110nM      // 1gvw.pdf (0EM)
1h5v  1.10  2002  Ki=117uM      // 1h5v.pdf (5-mer)
1km3  1.50  2002  Ki=12.4uM     // 1km3.pdf (UP6) ligand is compound 3
1jqy  2.14  2002  Ki=12uM       // 1jqy.pdf (A32)
1j16  1.60  2002  Ki=143uM      // 1j16.pdf (BEN)
1ghz  1.39  2002  Ki=16uM       // 1ghz.pdf (120)
1lee  1.90  2002  Ki=18nM       // 1lee.pdf (R36)
1h4w  1.70  2002  Ki=22uM       // 1h4w.pdf (BEN)
1m1b  2.25  2002  Ki=22uM       // 1m1b.pdf (SPV)
1gyy  1.35  2002  Ki=230uM      // 1gyy.pdf (FHC)
1n1m  2.50  2002  Ki=2uM        // 1n1m.pdf (A3M)
1ec0  1.79  2002  Ki=3.2nM      // 1ec0.pdf (BED)
1gyx  1.35  2002  Ki=3.3mM      // 1gyx.pdf (BEZ) Ki=13.9mM for EPE
1gi1  1.42  2002  Ki=3.4uM      // 1gi1.pdf (BMZ) Ki measured at pH=7.72
1jys  1.90  2002  Ki=300uM      // 1jys.pdf (ADE)
1lf2  1.80  2002  Ki=30nM       // 1lf2.pdf (R37)
1gi7  1.79  2002  Ki=31uM       // 1gi7.pdf (120)
1j14  2.40  2002  Ki=32.2uM     // 1j14.pdf (BEN)
1iiq  1.83  2002  Ki=33nM       // 1iiq.pdf (0ZR)
1kc7  2.20  2002  Ki=3uM        // 1kc7.pdf (PPR)
1k21  1.86  2002  Ki=4.2nM      // 1k21.pdf (IGN)
1gpk  2.10  2002  Ki=4.3uM      // 1gpk.pdf (HUP)
1d4j  1.81  2002  Ki=4.40nM     // 1d4j.pdf (MSC)
1h23  2.15  2002  Ki=4.5nM      // 1h23.pdf (E12)
1m0o  2.40  2002  Ki=4.9mM      // 1m0o.pdf (MPM) Ki=0.5mM when preincubated with DGD for 30min
1kzk  1.09  2002  Ki=41pM       // 1kzk.pdf (JE2)
1ghv  1.85  2002  Ki=45uM       // 1ghv.pdf (120)
1i2s  1.70  2002  Ki=490uM      // 1i2s.pdf (CIT) ligand is citrate
1k22  1.93  2002  Ki=4nM        // 1k22.pdf (MEL)
1ew8  2.20  2002  Ki=5.5mM      // 1ew8.pdf (PAE)
1j17  2.00  2002  Ki=6.05uM     // 1j17.pdf (ZEN)
1m0n  2.20  2002  Ki=6.0mM      // 1m0n.pdf (HCP)
1gvx  1.00  2002  Ki=60nM       // 1gvx.pdf (6-mer)
1kv5  1.65  2002  Ki=60uM       // 1kv5.pdf (PGA)
1ghw  1.75  2002  Ki=63uM       // 1ghw.pdf (BMZ)
1h1s  2.00  2002  Ki=6nM        // 1h1s.pdf (4SP)
1jcx  1.80  2002  Ki=7.0uM      // 1jcx.pdf (PAI)
1k4h  1.80  2002  Ki=7.7uM      // 1k4h.pdf (APQ)
1jvu  1.78  2002  Ki=7uM        // 1jvu.pdf (C2P) ligand is 2'-CMP
1eb2  2.00  2002  Ki=980nM      // 1eb2.pdf (BPO)
1nf8  1.60  2003  Kd=0.015uM    // 1nf8.pdf (ISC)
1o7o  1.97  2003  Kd=0.032mM    // 1o7o.pdf (UDP)
1q72  1.70  2003  Kd=0.14uM     // 1q72.pdf (COC)
1qyg  1.81  2003  Kd=0.14uM     // 1qyg.pdf (BCG)
1p1n  1.60  2003  Kd=0.16uM     // 1p1n.pdf (KAI)
1usi  1.80  2003  Kd=0.18uM     // 1usi.pdf (PHE)
1mrw  2.00  2003  Kd=0.2nM      // 1mrw.pdf (K57)
1g74  1.70  2003  Kd=0.30uM     // 1g74.pdf (OLA)
1usk  2.00  2003  Kd=0.40uM     // 1usk.pdf (LEU)
1m7d  2.30  2003  Kd=0.59uM     // 1m7d.pdf (3-mer)
1mh5  2.10  2003  Kd=0.61nM     // 1mh5.pdf (HAL)
1msn  2.00  2003  Kd=0.81nM     // 1msn.pdf (JE2)
1ogx  2.00  2003  Kd=0.81uM     // 1ogx.pdf (EQU)
1ogd  1.95  2003  Kd=0.93mM     // 1ogd.pdf (RIP)
1q8u  1.90  2003  Kd=1.1uM      // 1q8u.pdf (H52)
1ugx  1.60  2003  Kd=1.24uM     // 1ugx.pdf (GAL-MGC)
1ogz  2.30  2003  Kd=1.4uM      // 1ogz.pdf (EQU) Kd=1.4+/-0.1uM
1ols  1.85  2003  Kd=1.52uM     // 1ols.pdf (TDP)
1p1o  1.60  2003  Kd=1.74uM     // 1p1o.pdf (QUS)
1mjj  2.10  2003  Kd=1.83nM     // 1mjj.pdf (HAL)
1r0p  1.80  2003  Kd=10nM       // 1r0p.pdf (KSA)
1p1q  2.00  2003  Kd=12.8uM     // 1p1q.pdf (AMQ)
1q8t  2.00  2003  Kd=17.5uM     // 1q8t.pdf (Y27)
1oif  2.12  2003  Kd=19nM       // 1oif.pdf (IFM)
1lnm  1.90  2003  Kd=2.0nM      // 1lnm.pdf (DTX)
1gwv  2.50  2003  Kd=2.68mM     // 1gwv.pdf (LAT)
1oz0  2.50  2003  Kd=20nM       // 1oz0.pdf (MS1)
1nli  1.93  2003  Kd=260uM      // 1nli.pdf (ADE)
1oba  2.45  2003  Kd=3.6mM      // 1oba.pdf (CHT)
1lke  1.90  2003  Kd=30.2nM     // 1lke.pdf (DOG)
1msm  2.00  2003  Kd=33pM       // 1msm.pdf (JE2)
1n0s  2.00  2003  Kd=35.2nM     // 1n0s.pdf (FLU)
1olu  1.90  2003  Kd=39.3uM     // 1olu.pdf (TDP)
1oe8  1.65  2003  Kd=3uM        // 1oe8.pdf (GSH)
1m7i  2.50  2003  Kd=4.0uM      // 1m7i.pdf (5-mer)
1lvu  2.05  2003  Kd=4.8uM      // 1lvu.pdf (9PP)
1hk4  2.40  2003  Kd=4.9uM      // 1hk4.pdf (T44)
1olx  2.25  2003  Kd=47.1uM     // 1olx.pdf (TDP)
1pz5  1.80  2003  Kd=4uM        // 1pz5.pdf (8-mer)
1q8w  2.20  2003  Kd=5.7uM      // 1q8w.pdf (M77)
1m5w  1.96  2003  Kd=54uM       // 1m5w.pdf (DXP)
1mrx  2.00  2003  Kd=55nM       // 1mrx.pdf (K57)
1ucn  2.00  2003  Kd=6.0uM      // 1ucn.pdf (ADP)
1nw5  2.05  2003  Kd=6.1uM      // 1nw5.pdf (SAM)
1odi  2.40  2003  Kd=62uM       // 1odi.pdf (ADN)
1nw7  2.10  2003  Kd=8.1uM      // 1nw7.pdf (SAH)
1odj  2.40  2003  Kd=80uM       // 1odj.pdf (GMP)
1onz  2.40  2003  Kd=8uM        // 1onz.pdf (968) Ki=17uM
1o3f  1.55  2003  Ki=0.011uM    // 1o3f.pdf (696)
1o2q  1.50  2003  Ki=0.021uM    // 1o2q.pdf (991)
1lyx  1.90  2003  Ki=0.029mM    // 1lyx.pdf (PGA)
1n46  2.20  2003  Ki=0.03nM     // 1n46.pdf (PFA)
1oyt  1.67  2003  Ki=0.057uM    // 1oyt.pdf (FSN)
1o3i  1.51  2003  Ki=0.05uM     // 1o3i.pdf (907)
1o2h  1.77  2003  Ki=0.068uM    // 1o2h.pdf (CR3) Ki measured at pH=8.06
1o3d  1.33  2003  Ki=0.074uM    // 1o3d.pdf (780)
1nz7  2.40  2003  Ki=0.076uM    // 1nz7.pdf (901)
1nm6  1.80  2003  Ki=0.09nM     // 1nm6.pdf (L86)
1o2j  1.65  2003  Ki=0.12uM     // 1o2j.pdf (656)
1pvn  2.00  2003  Ki=0.15nM     // 1pvn.pdf (MZP)
1o38  1.38  2003  Ki=0.15uM     // 1o38.pdf (653)
1nq7  1.50  2003  Ki=0.16uM     // 1nq7.pdf (ARL)
1o30  1.55  2003  Ki=0.17uM     // 1o30.pdf (693)
1o3j  1.40  2003  Ki=0.17uM     // 1o3j.pdf (334)
1ony  2.15  2003  Ki=0.17uM     // 1ony.pdf (588)
1o86  2.00  2003  Ki=0.27nM     // 1o86.pdf (LPR)
1n4h  2.10  2003  Ki=0.28uM     // 1n4h.pdf (REA)
1o3l  1.40  2003  Ki=0.29uM     // 1o3l.pdf (678)
1m2r  1.70  2003  Ki=0.35uM     // 1m2r.pdf (MNY)
1o2o  1.63  2003  Ki=0.44uM     // 1o2o.pdf (950)
1pbq  1.90  2003  Ki=0.54uM     // 1pbq.pdf (DK1)
1iy7  2.00  2003  Ki=0.64uM     // 1iy7.pdf (CXA)
1k1y  2.40  2003  Ki=0.6mM      // 1k1y.pdf (ACR)
1nc1  2.00  2003  Ki=0.75uM     // 1nc1.pdf (MTH)
1m2p  2.00  2003  Ki=0.78uM     // 1m2p.pdf (HNA)
1o2z  1.65  2003  Ki=0.78uM     // 1o2z.pdf (312)
1m2q  1.79  2003  Ki=0.80uM     // 1m2q.pdf (MNX)
1o2n  1.50  2003  Ki=0.81uM     // 1o2n.pdf (762)
1nhz  2.30  2003  Ki=0.84uM     // 1nhz.pdf (486) ligand is RU486
1os0  2.10  2003  Ki=0.93uM     // 1os0.pdf (0PQ)
1k27  1.95  2003  Ki=1.0nM      // 1k27.pdf (MTM) Ki=26nM at initial rate; Ki=1.0nM at equilibrium
1j37  2.40  2003  Ki=1.1nM      // 1j37.pdf (X8Z)
1nfw  2.10  2003  Ki=1.1nM      // 1nfw.pdf (RRR)
1nl9  2.40  2003  Ki=1.1uM      // 1nl9.pdf (989)
1o36  1.70  2003  Ki=1.1uM      // 1o36.pdf (607)
1o0h  1.20  2003  Ki=1.2uM      // 1o0h.pdf (ADP)
1n3i  1.90  2003  Ki=1.3nM      // 1n3i.pdf (DIH) Ki*=42pM
1nfy  2.10  2003  Ki=1.3nM      // 1nfy.pdf (RTR)
1nt1  2.00  2003  Ki=1.3nM      // 1nt1.pdf (T76)
1o2w  1.38  2003  Ki=1.4uM      // 1o2w.pdf (847)
1q54  1.93  2003  Ki=1.4uM      // 1q54.pdf (BHI)
1o33  1.46  2003  Ki=1.8uM      // 1o33.pdf (801)
1my4  1.90  2003  Ki=105nM      // 1my4.pdf (IWD) ligand is compound (S)-2e
1nc3  2.20  2003  Ki=10uM       // 1nc3.pdf (FMC)
1o35  1.41  2003  Ki=10uM       // 1o35.pdf (802)
1jn4  1.80  2003  Ki=11.3uM     // 1jn4.pdf (139)
1oyq  1.90  2003  Ki=110nM      // 1oyq.pdf (T87)
1mrs  2.00  2003  Ki=110uM      // 1mrs.pdf (5HU)
1ndv  2.30  2003  Ki=1200nM     // 1ndv.pdf (FR0)
1pr5  2.50  2003  Ki=120uM      // 1pr5.pdf (TBN)
1n51  2.30  2003  Ki=14uM       // 1n51.pdf (4-mer)
1njs  1.98  2003  Ki=15nM       // 1njs.pdf (KEU)
1nvs  1.80  2003  Ki=15nM       // 1nvs.pdf (UCM)
1oss  1.93  2003  Ki=16.4uM     // 1oss.pdf (BEN)
1j36  2.40  2003  Ki=18nM       // 1j36.pdf (LPR)
1nfu  2.05  2003  Ki=18nM       // 1nfu.pdf (RRP)
1mq5  2.10  2003  Ki=1nM        // 1mq5.pdf (XLC)
1n5r  2.25  2003  Ki=2.2uM      // 1n5r.pdf (PRM)
1nhu  2.00  2003  Ki=2.2uM      // 1nhu.pdf (153)
1nny  2.40  2003  Ki=22nM       // 1nny.pdf (515)
1pb9  1.60  2003  Ki=241uM      // 1pb9.pdf (4AX)
1lpz  2.40  2003  Ki=25nM       // 1lpz.pdf (CMB)
1pa9  2.00  2003  Ki=25uM       // 1pa9.pdf (CSN)
1h46  1.52  2003  Ki=270uM      // 1h46.pdf (RNP)
1np0  2.50  2003  Ki=270uM      // 1np0.pdf (NGT) ligand is compound 1a (NAG-thiazoline)
1lpk  2.20  2003  Ki=28nM       // 1lpk.pdf (CBB)
1i5r  1.60  2003  Ki=3.0nM      // 1i5r.pdf (HYC)
1nfx  2.15  2003  Ki=3.0nM      // 1nfx.pdf (RDR)
1pyn  2.20  2003  Ki=3.2uM      // 1pyn.pdf (941)
1mrn  2.45  2003  Ki=30uM       // 1mrn.pdf (T5A)
1no6  2.40  2003  Ki=39uM       // 1no6.pdf (794)
1nwl  2.40  2003  Ki=4.1mM      // 1nwl.pdf (964)
1lzq  2.20  2003  Ki=4.1nM      // 1lzq.pdf (0ZQ)
1owh  1.61  2003  Ki=40nM       // 1owh.pdf (239)
1o1s  2.30  2003  Ki=49nM       // 1o1s.pdf (1NH)
1ps3  1.80  2003  Ki=5.2mM      // 1ps3.pdf (KIF)
1nvq  2.00  2003  Ki=5.6nM      // 1nvq.pdf (UCN)
1ndw  2.00  2003  Ki=5900nM     // 1ndw.pdf (FR2)
1o0f  1.50  2003  Ki=5uM        // 1o0f.pdf (A3P)
1o2r  1.45  2003  Ki=6.1uM      // 1o2r.pdf (CR9)
1ocq  1.08  2003  Ki=6.5uM      // 1ocq.pdf (IFM-BGC)
1owe  1.60  2003  Ki=631nM      // 1owe.pdf (675)
1ndy  2.00  2003  Ki=680nM      // 1ndy.pdf (FR3)
1pb8  1.45  2003  Ki=7.02uM     // 1pb8.pdf (DSN)
1o0m  1.50  2003  Ki=7.1uM      // 1o0m.pdf (U2P)
1ndz  2.00  2003  Ki=7.7nM      // 1ndz.pdf (FR5)
1nvr  1.80  2003  Ki=7.8nM      // 1nvr.pdf (STU)
1m2x  1.50  2003  Ki=70uM       // 1m2x.pdf (MCO) Ki=70~100uM
1mq6  2.10  2003  Ki=7pM        // 1mq6.pdf (XLD)
1lpg  2.00  2003  Ki=82nM       // 1lpg.pdf (IMA)
1o0n  1.50  2003  Ki=82uM       // 1o0n.pdf (U3P)
1ui0  1.50  2003  Ki=88nM       // 1ui0.pdf (URA)
1od8  1.05  2003  Ki=8uM        // 1od8.pdf (XDL-XYP)
1qxk  2.30  2003  Ki=9.0uM      // 1qxk.pdf (429)
1sr7  1.46  2004  Kd=0.08nM     // 1sr7.pdf (MOF)
1utj  1.83  2004  Kd=0.144mM    // 1utj.pdf (ABN)
1os5  2.20  2004  Kd=0.14uM     // 1os5.pdf (NH1) IC50=0.93uM
1nki  0.95  2004  Kd=0.2uM      // 1nki.pdf (PPF) Ki=0.41uM
1s19  2.10  2004  Kd=0.31nM     // 1s19.pdf (MC9) ligand is MC903(calcipotriol)
1utn  1.15  2004  Kd=0.321mM    // 1utn.pdf (ABN)
1qy1  1.70  2004  Kd=0.3uM      // 1qy1.pdf (PRZ)
1xow  1.80  2004  Kd=0.52nM     // 1xow.pdf (R18)
1tq4  1.95  2004  Kd=0.64uM     // 1tq4.pdf (GDP)
1uho  2.50  2004  Kd=0.6nM      // 1uho.pdf (VDN) Kd=0.6~0.7nM
1w9u  1.85  2004  Kd=0.81uM     // 1w9u.pdf (5-mer) IC50=0.5uM
1t7d  2.47  2004  Kd=0.94uM     // 1t7d.pdf (ARY)
1utm  1.50  2004  Kd=0.972mM    // 1utm.pdf (PEA)
1u1w  1.35  2004  Kd=1.4uM      // 1u1w.pdf (3HA)
1qy2  1.75  2004  Kd=1.8uM      // 1qy2.pdf (IPZ)
1v11  1.95  2004  Kd=104.8uM    // 1v11.pdf (TDP)
1rmz  1.34  2004  Kd=10nM       // 1rmz.pdf (NGH) Kd=8mM for AHA
1vyg  2.40  2004  Kd=10nM       // 1vyg.pdf (ACD)
1xws  1.80  2004  Kd=10nM       // 1xws.pdf (BI1)
1v1m  2.00  2004  Kd=115.0uM    // 1v1m.pdf (TDP)
1uz8  1.80  2004  Kd=11uM       // 1uz8.pdf (3-mer)
1v16  1.90  2004  Kd=134.8uM    // 1v16.pdf (TDP)
1rd4  2.40  2004  Kd=18.3nM     // 1rd4.pdf (L08)
1pfu  1.91  2004  Kd=1900uM     // 1pfu.pdf (MPJ)
1q1g  2.02  2004  Kd=2.7nM      // 1q1g.pdf (MTI)
1oau  1.80  2004  Kd=20nM       // 1oau.pdf (SER-DNF)
1szd  1.50  2004  Kd=29.16uM    // 1szd.pdf (APR)
1xap  2.10  2004  Kd=2nM        // 1xap.pdf (TTB) Kd=2~9nM
1utl  1.70  2004  Kd=3.41mM     // 1utl.pdf (PRA)
1oar  2.22  2004  Kd=40nM       // 1oar.pdf (AZN)
1td7  2.50  2004  Kd=43uM       // 1td7.pdf (NFL) Ki=1.26uM
1uw6  2.20  2004  Kd=45.2nM     // 1uw6.pdf (NCT)
1ttm  1.95  2004  Kd=45nM       // 1ttm.pdf (667)
1sv3  1.35  2004  Kd=45uM       // 1sv3.pdf (ANN) Ki=18uM
1w3j  2.00  2004  Kd=484nM      // 1w3j.pdf (OXZ)
1r9l  1.59  2004  Kd=4uM        // 1r9l.pdf (BET)
1uto  1.15  2004  Kd=5.32mM     // 1uto.pdf (PEA)
2bfr  2.50  2004  Kd=5.63uM     // 2bfr.pdf (ADP)
1oxr  1.93  2004  Kd=6.4uM      // 1oxr.pdf (AIN)
1sw2  2.10  2004  Kd=60nM       // 1sw2.pdf (BET)
1pzi  1.99  2004  Kd=60uM       // 1pzi.pdf (1DM)
1q7a  1.60  2004  Kd=64nM       // 1q7a.pdf (OPB)
1uv6  2.50  2004  Kd=7575nM     // 1uv6.pdf (CCE)
1p19  2.30  2004  Kd=76.8uM     // 1p19.pdf (IMP)
1nw4  2.20  2004  Kd=860pM      // 1nw4.pdf (IMH)
1vyf  1.85  2004  Kd=9nM        // 1vyf.pdf (OLA)
1rp7  2.09  2004  Ki=0.003uM    // 1rp7.pdf (TZD)
1v0l  0.98  2004  Ki=0.028uM    // 1v0l.pdf (XIF-XYP)
1sqo  1.84  2004  Ki=0.035uM    // 1sqo.pdf (UI2)
1ua4  1.90  2004  Ki=0.06mM     // 1ua4.pdf (AMP)
1xd0  2.00  2004  Ki=0.075uM    // 1xd0.pdf (ARE)
1pxn  2.50  2004  Ki=0.07uM     // 1pxn.pdf (CK6)
1sb1  1.90  2004  Ki=0.128uM    // 1sb1.pdf (165)
1pkx  1.90  2004  Ki=0.12uM     // 1pkx.pdf (XMP)
1om1  1.68  2004  Ki=0.17uM     // 1om1.pdf (IQA)
1nh0  1.03  2004  Ki=0.18nM     // 1nh0.pdf (5-mer)
1wc1  1.93  2004  Ki=0.1mM      // 1wc1.pdf (TAT)
1rjk  1.99  2004  Ki=0.1nM      // 1rjk.pdf (VDZ) ligand is compound 4
1pxp  2.30  2004  Ki=0.22uM     // 1pxp.pdf (CK8)
1xjd  2.00  2004  Ki=0.33nM     // 1xjd.pdf (STU)
1r5y  1.20  2004  Ki=0.35uM     // 1r5y.pdf (DQU)
1o5a  1.68  2004  Ki=0.38uM     // 1o5a.pdf (696)
1w3l  1.04  2004  Ki=0.52uM     // 1w3l.pdf (3-mer)
1px4  1.60  2004  Ki=0.59mM     // 1px4.pdf (IPT)
1phw  2.36  2004  Ki=0.5mM      // 1phw.pdf (__N)
1wm1  2.10  2004  Ki=0.5uM      // 1wm1.pdf (PTB)
1sqa  2.00  2004  Ki=0.62nM     // 1sqa.pdf (UI1)
1sqt  1.90  2004  Ki=0.63uM     // 1sqt.pdf (UI3)
1v2k  2.00  2004  Ki=0.65uM     // 1v2k.pdf (ZEN)
1ta6  1.90  2004  Ki=0.74nM     // 1ta6.pdf (177)
1u0g  1.70  2004  Ki=0.7uM      // 1u0g.pdf (E4P)
1uj5  2.00  2004  Ki=0.89mM     // 1uj5.pdf (5RP)
1xbo  2.50  2004  Ki=0.92uM     // 1xbo.pdf (IX1)
1uwu  1.95  2004  Ki=1.04uM     // 1uwu.pdf (GOX)
1uwt  1.95  2004  Ki=1.08uM     // 1uwt.pdf (GTL)
1mu8  2.00  2004  Ki=1.0nM      // 1mu8.pdf (CDB)
1v2n  1.80  2004  Ki=1.25uM     // 1v2n.pdf (BBA)
1r1h  1.95  2004  Ki=1.2nM      // 1r1h.pdf (BIR)
1sl3  1.81  2004  Ki=1.4pM      // 1sl3.pdf (170)
1m0b  2.45  2004  Ki=1.53nM     // 1m0b.pdf (0ZQ)
1w5w  1.80  2004  Ki=1.6nM      // 1w5w.pdf (BE4)
1rql  2.40  2004  Ki=1.79mM     // 1rql.pdf (VSO)
2bet  2.20  2004  Ki=1.7mM      // 2bet.pdf (DEZ)
1ur9  1.80  2004  Ki=1.7uM      // 1ur9.pdf (3-mer)
1o5e  1.75  2004  Ki=1.8uM      // 1o5e.pdf (132)
1qxl  2.25  2004  Ki=11nM       // 1qxl.pdf (FR8)
1o5g  1.75  2004  Ki=11uM       // 1o5g.pdf (CR9)
1uz1  2.00  2004  Ki=130nM      // 1uz1.pdf (IFL)
1xff  1.80  2004  Ki=15uM       // 1xff.pdf (GLU)
1v48  2.20  2004  Ki=16nM       // 1v48.pdf (HA1)
1v2o  1.62  2004  Ki=18.45uM    // 1v2o.pdf (ANH)
1sdv  1.40  2004  Ki=1810pM     // 1sdv.pdf (MK1)
1txr  2.00  2004  Ki=18nM       // 1txr.pdf (BES)
1v2t  1.90  2004  Ki=19.56uM    // 1v2t.pdf (ANH)
1ssq  1.85  2004  Ki=1uM        // 1ssq.pdf (CYS)
1pxo  1.96  2004  Ki=2.0nM      // 1pxo.pdf (CK7)
1mue  2.00  2004  Ki=2.3nM      // 1mue.pdf (CDD)
1r1j  2.35  2004  Ki=2.3nM      // 1r1j.pdf (OIR)
1s39  1.95  2004  Ki=20nM       // 1s39.pdf (AQO) Ki=20~50nM
1uou  2.11  2004  Ki=20nM       // 1uou.pdf (CMU)
1u33  1.95  2004  Ki=25uM       // 1u33.pdf (LM2)
1v2r  1.70  2004  Ki=278.96uM   // 1v2r.pdf (ANH)
1w5y  1.90  2004  Ki=3.3nM      // 1w5y.pdf (BE6)
1q65  2.10  2004  Ki=3.5uM      // 1q65.pdf (BHB)
1uml  2.50  2004  Ki=30nM       // 1uml.pdf (FR4)
1ro6  2.00  2004  Ki=350nM      // 1ro6.pdf (ROL) Ki=350~400nM
1q5k  1.94  2004  Ki=38nM       // 1q5k.pdf (TMU) IC50=104nM
1xkk  2.40  2004  Ki=3nM        // 1xkk.pdf (FMM)
1w5x  1.90  2004  Ki=4.0nM      // 1w5x.pdf (BE5)
1mu6  1.99  2004  Ki=4.2nM      // 1mu6.pdf (CDA)
1uz4  1.71  2004  Ki=400uM      // 1uz4.pdf (IFL)
1p57  1.75  2004  Ki=40uM       // 1p57.pdf (CR4)
1sgu  1.90  2004  Ki=4235nM     // 1sgu.pdf (MK1)
1v2u  1.80  2004  Ki=427uM      // 1v2u.pdf (BEN)
1pzp  1.45  2004  Ki=490uM      // 1pzp.pdf (FTA)
1s89  2.22  2004  Ki=5.8uM      // 1s89.pdf (PGA)
1w3k  1.20  2004  Ki=50uM       // 1w3k.pdf (BGC-OXZ)
1v2l  1.60  2004  Ki=51uM       // 1v2l.pdf (BEN)
1sdt  1.30  2004  Ki=540pM      // 1sdt.pdf (MK1)
1v2j  1.90  2004  Ki=566uM      // 1v2j.pdf (BEN)
2bes  2.10  2004  Ki=57uM       // 2bes.pdf (RES)
1o5c  1.63  2004  Ki=6.0uM      // 1o5c.pdf (CR9)
1ogg  1.97  2004  Ki=6.4uM      // 1ogg.pdf (3-mer)
1v2s  1.72  2004  Ki=68uM       // 1v2s.pdf (BEN)
1s38  1.81  2004  Ki=7.0uM      // 1s38.pdf (MAQ)
1w5v  1.80  2004  Ki=7.1nM      // 1w5v.pdf (BE3)
1thz  1.80  2004  Ki=7.1uM      // 1thz.pdf (326)
1o5r  2.35  2004  Ki=7.5nM      // 1o5r.pdf (FR9)
1q91  1.60  2004  Ki=70uM       // 1q91.pdf (DPB)
1sdu  1.25  2004  Ki=86pM       // 1sdu.pdf (MK1)
1q84  2.45  2004  Ki=8900fM     // 1q84.pdf (TZ4)
1v0k  1.03  2004  Ki=8uM        // 1v0k.pdf (XDN-XYP)
1v7a  2.50  2004  Ki=9.8nM      // 1v7a.pdf (FRC)
1sh9  2.50  2004  Ki=932nM      // 1sh9.pdf (RIT)
1v2w  1.75  2004  Ki=97.79uM    // 1v2w.pdf (ANH)
2bfq  1.50  2005  Kd=0.13uM     // 2bfq.pdf (AR6)
1xt8  2.00  2005  Kd=0.14uM     // 1xt8.pdf (CYS)
1uwf  1.69  2005  Kd=0.15uM     // 1uwf.pdf (DEG)
2bys  2.05  2005  Kd=0.3nM      // 2bys.pdf (LOB)
1w9v  2.00  2005  Kd=0.46uM     // 1w9v.pdf (5-mer) IC50=1.1uM
1s5z  2.00  2005  Kd=0.62mM     // 1s5z.pdf (SON) Kd=0.62+/-0.05mM; Ki=1.3+/-0.2mM
2bt9  0.94  2005  Kd=0.64uM     // 2bt9.pdf (MFU)
1kjr  1.55  2005  Kd=0.88uM     // 1kjr.pdf (3-mer)
1ws4  1.90  2005  Kd=1.00mM     // 1ws4.pdf (GYP)
1xk5  2.40  2005  Kd=1.0uM      // 1xk5.pdf (TPG)
1ydk  1.95  2005  Kd=1.3uM      // 1ydk.pdf (GTX)
1y3p  2.00  2005  Kd=15uM       // 1y3p.pdf (4-mer)
1u1b  2.00  2005  Kd=16nM       // 1u1b.pdf (PAX)
1xh9  1.64  2005  Kd=17nM       // 1xh9.pdf (R69)
1y0l  2.50  2005  Kd=1nM        // 1y0l.pdf (HAN)
1t7j  2.20  2005  Kd=2.0nM      // 1t7j.pdf (478)
2byr  2.45  2005  Kd=2.8nM      // 2byr.pdf (MLK)
1y3n  1.60  2005  Kd=2.8uM      // 1y3n.pdf (2-mer) ligand is BEM-MAV
2arm  1.23  2005  Kd=21nM       // 2arm.pdf (OIN) Ki=7.4nM
2c3i  1.90  2005  Kd=25nM       // 2c3i.pdf (IYZ) ligand is compound imidazo[1,2-b]pyridazine 1
1yc4  1.81  2005  Kd=280nM      // 1yc4.pdf (43P)
1w96  1.80  2005  Kd=3.9nM      // 1w96.pdf (S1A)
1zhy  1.60  2005  Kd=300nM      // 1zhy.pdf (CLR)
2a4m  2.30  2005  Kd=30uM       // 2a4m.pdf (TRP)
1xh5  2.05  2005  Kd=3400nM     // 1xh5.pdf (R68) IC50=2400nM
1xh4  2.45  2005  Kd=34nM       // 1xh4.pdf (R69) IC50=30nM
2bak  2.20  2005  Kd=37nM       // 2bak.pdf (AQZ)
1tjp  1.50  2005  Kd=38uM       // 1tjp.pdf (HPF)
2baj  2.25  2005  Kd=4.0nM      // 2baj.pdf (1PP)
1xq0  1.76  2005  Kd=454nM      // 1xq0.pdf (4TR)
2bal  2.10  2005  Kd=490nM      // 2bal.pdf (PQA)
1rr6  2.50  2005  Kd=56pM       // 1rr6.pdf (IMH) Kd=860pM for PfPNP-IMH complex
1x8d  1.80  2005  Kd=6.16mM     // 1x8d.pdf (RNS) Kd=5.91mM measured with minor form of protein
1yc1  1.70  2005  Kd=680nM      // 1yc1.pdf (4BC)
1xr9  1.79  2005  Kd=70nM       // 1xr8.pdf (9-mer)
2f7i  1.60  2005  Kd=80nM       // 2f7i.pdf (26C)
1xpz  2.02  2005  Kd=84nM       // 1xpz.pdf (4TZ)
2b9a  1.54  2005  Kd=9nM        // 2b9a.pdf (FBC)
1wuq  2.00  2005  Ki=0.0054uM   // 1wuq.pdf (8GT)
1t4v  2.00  2005  Ki=0.021uM    // 1t4v.pdf (14A)
1x8j  2.35  2005  Ki=0.11uM     // 1x8j.pdf (AOI) ligand is Androsterone
1wur  1.82  2005  Ki=0.22uM     // 1wuq.pdf (8DG)
1ws1  2.00  2005  Ki=0.28nM     // 1ws1.pdf (BB2)
2bok  1.64  2005  Ki=0.28uM     // 2bok.pdf (784)
2a5s  1.70  2005  Ki=0.2uM      // 2a5s.pdf (GLU)
2b07  2.10  2005  Ki=0.37uM     // 2b07.pdf (598)
2ax9  1.65  2005  Ki=0.3nM      // 2ax9.pdf (BHM) ligand is compound R-3
1yvm  1.60  2005  Ki=0.4uM      // 1yvm.pdf (TMG)
2ayr  1.90  2005  Ki=0.51nM     // 2ayr.pdf (L4G)
1wcq  2.10  2005  Ki=0.55uM     // 1wcq.pdf (DAN)
1z71  1.80  2005  Ki=0.66nM     // 1z71.pdf (L17)
1x39  1.80  2005  Ki=0.6nM      // 1x39.pdf (IDE)
1y1z  1.50  2005  Ki=0.831mM    // 1y1z.pdf (192)
2brm  2.20  2005  Ki=1.3uM      // 2brm.pdf (DFZ)
1x38  1.70  2005  Ki=1.7nM      // 1x38.pdf (IDD)
1zp8  2.02  2005  Ki=1.7nM      // 1zp8.pdf (AB2) IC50=6nM
1zdp  1.70  2005  Ki=1.8uM      // 1zdp.pdf (TIO)
1zoh  1.81  2005  Ki=100nM      // 1zoh.pdf (K44) IC50=740nM
2brb  2.10  2005  Ki=13.7uM     // 2brb.pdf (PFQ)
1xk9  2.10  2005  Ki=140nM      // 1xk9.pdf (P34)
1xgi  1.96  2005  Ki=14uM       // 1xgi.pdf (NST)
1v1j  2.20  2005  Ki=15uM       // 1v1j.pdf (FA3)
1x8t  1.90  2005  Ki=16nM       // 1x8t.pdf (RC1)
2afw  1.56  2005  Ki=17uM       // 2afw.pdf (AHN)
1wvj  1.75  2005  Ki=185nM      // 1wvj.pdf (IBC)
1w4p  1.69  2005  Ki=18uM       // 1w4p.pdf (UM3)
2bvd  1.60  2005  Ki=1uM        // 2bvd.pdf (ISX)
2a14  1.70  2005  Ki=2.0uM      // 2a14.pdf (SAH) ligand is compound SAH
2erz  2.20  2005  Ki=2.2uM      // 2erz.pdf (HFS)
1t31  1.90  2005  Ki=2.3nM      // 1t31.pdf (OHH)
1z9g  1.70  2005  Ki=2.3uM      // 1z9g.pdf (RRT)
1wn6  1.80  2005  Ki=21uM       // 1wn6.pdf (BST)
1y3v  1.60  2005  Ki=2300nM     // 1y3v.pdf (UIR)
2azr  2.00  2005  Ki=230uM      // 2azr.pdf (982)
2bo4  1.95  2005  Ki=24.6uM     // 2bo4.pdf (FLC)
1yqy  2.30  2005  Ki=24nM       // 1yqy.pdf (915)
2f6t  1.70  2005  Ki=24uM       // 2f6t.pdf (1C2) IC50=42.5uM
1tx7  1.75  2005  Ki=25uM       // 1tx7.pdf (4CM)
1y6q  2.20  2005  Ki=2pM        // 1y6q.pdf (TDI)
1z4o  1.90  2005  Ki=30uM       // 1z4o.pdf (GL1)
1u71  2.20  2005  Ki=33nM       // 1u71.pdf (MXA) ligand is compound 4(PTX); Ki=0.025nM in J. Med. Chem., 1996, Vol.39, pp.892-903
1syi  2.10  2005  Ki=3590nM     // 1syi.pdf (CPW)
1vzq  1.54  2005  Ki=36nM       // 1vzq.pdf (SHY)
1t32  1.85  2005  Ki=38nM       // 1t32.pdf (OHH)
1syh  1.80  2005  Ki=393nM      // 1syh.pdf (CPW)
1zgi  2.20  2005  Ki=4.6uM      // 1zgi.pdf (382)
1y20  1.40  2005  Ki=4.8uM      // 1y20.pdf (1AC)
1zoe  1.77  2005  Ki=40nM       // 1zoe.pdf (K25)
1yfz  2.20  2005  Ki=45uM       // 1yfz.pdf (IMP)
1z6s  1.50  2005  Ki=46uM       // 1z6s.pdf (AMP)
1z1h  1.85  2005  Ki=4nM        // 1z1h.pdf (HBB)
1zpa  2.02  2005  Ki=4nM        // 1zpa.pdf (A83)
2al5  1.65  2005  Ki=4nM        // 2al5.pdf (FWD) ligand is compound (S)-2b
1w4q  1.68  2005  Ki=5.5uM      // 1w4q.pdf (UMF)
1t5f  2.20  2005  Ki=60uM       // 1t5f.pdf (DHH)
1xhy  1.85  2005  Ki=662nM      // 1xhy.pdf (KAI)
1w4o  1.60  2005  Ki=6uM        // 1w4o.pdf (UA3)
2afx  1.64  2005  Ki=7.1uM      // 2afx.pdf (1BN)
2br1  2.00  2005  Ki=7.2uM      // 2br1.pdf (PFP)
1yqj  2.00  2005  Ki=7.3nM      // 1yqj.pdf (6NP)
1zog  2.30  2005  Ki=70nM       // 1zog.pdf (K37) IC50=250nM
1y3x  1.70  2005  Ki=7315nM     // 1y3x.pdf (UIB)
1x8r  1.50  2005  Ki=750nM      // 1x8r.pdf (SC1)
1z95  1.80  2005  Ki=76nM       // 1z95.pdf (198)
1y6r  2.20  2005  Ki=77pM       // 1y6r.pdf (MTM)
2exm  1.80  2005  Ki=78uM       // 2exm.pdf (ZIP)
2c3l  2.35  2005  Ki=8.58uM     // 2c3l.pdf (IDZ)
1x1z  1.45  2005  Ki=8.8pM      // 1x1z.pdf (BMP)
1yq7  2.20  2005  Ki=82.2nM     // 1yq7.pdf (RIS) ligand is compound 8(risedronate); time-Dependent IC50 initial 452.9nM to final 5.7nM
2bqv  2.10  2005  Ki=9nM        // 2bqv.pdf (A1A)
2f34  1.74  2006  Kd=0.13uM     // 2f34.pdf (UBA)
2c94  1.90  2006  Kd=0.15uM     // 2c94.pdf (TSF)
2iwx  1.50  2006  Kd=0.21uM     // 2cgf.pdf (M1S) Kd measured by ITC, compound 15h
2ews  2.05  2006  Kd=0.24uM     // 2ews.pdf (ANP)
2euk  1.85  2006  Kd=0.25uM     // 2euk.pdf (3-mer)
2h21  2.45  2006  Kd=0.29uM     // 2h21.pdf (SAM)
2evl  2.20  2006  Kd=0.2uM      // 2evl.pdf (3-mer)
2cgf  2.20  2006  Kd=0.39uM     // 2cgf.pdf (P2N) Kd measured by ITC, compound 15a
2fgu  2.00  2006  Kd=0.66nM     // 2fgu.pdf (5-mer)
1zc9  2.00  2006  Kd=0.6mM      // 1zc9.pdf (PMP)
2c97  2.00  2006  Kd=0.72uM     // 2c97.pdf (JCL)
2ce9  2.12  2006  Kd=0.93uM     // 2ce8.pdf (5-mer)
2j79  1.94  2006  Kd=1.1uM      // 2j79.pdf (GTL)
2fw6  1.85  2006  Kd=1.2mM      // 2fw6.pdf (CIT)
2boj  1.80  2006  Kd=1.7uM      // 2boj.pdf (ARW)
2j7g  1.91  2006  Kd=100nM      // 2j7g.pdf (GI4)
2buv  1.80  2006  Kd=100uM      // 2bum.pdf (DHB)
2ewa  2.10  2006  Kd=11.5nM     // 2ewa.pdf (SB2)
2a5b  2.49  2006  Kd=117uM      // 2a5b.pdf (8HG)
2cbz  1.50  2006  Kd=118uM      // 2cbz.pdf (ATP)
2j77  2.10  2006  Kd=12.9uM     // 2j77.pdf (NOJ)
2haw  1.75  2006  Kd=12uM       // 2haw.pdf (2PN)
2hu6  1.32  2006  Kd=154uM      // 2hu6.pdf (37A)
2o4n  2.00  2006  Kd=15nM       // 2o4k.pdf (TPV)
2gl0  2.25  2006  Kd=15uM       // 2gl0.pdf (ADN)
2gzl  2.50  2006  Kd=15uM       // 2gzl.pdf (2AA) IC50=3mM
2ccc  1.70  2006  Kd=17.57nM    // 2ccc.pdf (LFN)
2b4l  2.00  2006  Kd=17uM       // 2b4l.pdf (BET)
2c92  1.60  2006  Kd=2.11uM     // 2c92.pdf (TP6)
2cbu  1.85  2006  Kd=2.1uM      // 2cbu.pdf (CTS) Ki=2uM
2bmk  2.30  2006  Kd=2.4uM      // 2bmk.pdf (PDD)
2a8g  1.99  2006  Kd=205uM      // 2a8g.pdf (GNG)
2hmv  2.20  2006  Kd=20nM       // 2hmu.pdf (ADP) Kd=20~70nM
2hmu  2.25  2006  Kd=20nM       // 2hmu.pdf (ATP) Kd=20~70nM
2cex  2.20  2006  Kd=20uM       // 2cex.pdf (DAN)
2fqw  1.71  2006  Kd=210nM      // 2fqw.pdf (NOS)
2j75  1.85  2006  Kd=225nM      // 2j75.pdf (NOY)
2ca8  2.49  2006  Kd=22uM       // 2ca8.pdf (GSH)
2ha2  2.05  2006  Kd=22uM       // 2h9y.pdf (SCK) Kd=22+/-1uM, Ki=21+/-2uM, Kd(decidium kinetics)=22+/-1uM
2j7b  1.87  2006  Kd=240nM      // 2j7b.pdf (NTZ)
2a5c  2.50  2006  Kd=24uM       // 2a5c.pdf (8DA)
2fqy  1.90  2006  Kd=270nM      // 2fqy.pdf (ADN)
2h3e  2.30  2006  Kd=2uM        // 2h3e.pdf (6PR)
2g5u  1.80  2006  Kd=3.2nM      // 2g5u.pdf (PCQ)
2cbv  1.95  2006  Kd=3.3uM      // 2cbv.pdf (CGB) Ki=4uM
2f35  1.87  2006  Kd=3.94uM     // 2f35.pdf (UBC)
2ccb  1.65  2006  Kd=35.76nM    // 2ccb.pdf (RBF)
2iko  1.90  2006  Kd=3571nM     // 2iko.pdf (7IG) IC50=6560nM
2o4k  1.60  2006  Kd=35pM       // 2o4k.pdf (DR7)
2amt  2.30  2006  Kd=36uM       // 2amt.pdf (1AA)
2j78  1.65  2006  Kd=384nM      // 2j78.pdf (GOX)
2h6b  2.20  2006  Kd=4.1uM      // 2h6b.pdf (3C4)
2fxv  2.05  2006  Kd=4.5uM      // 2fxv.pdf (5GP)
2c80  2.30  2006  Kd=4.7uM      // 2c80.pdf (GTX)
2ez7  2.00  2006  Kd=43.5uM     // 2ez7.pdf (DHI)
2j7f  2.28  2006  Kd=445nM      // 2j7f.pdf (GI3)
2j7e  2.19  2006  Kd=48nM       // 2j7e.pdf (GI2)
2ha6  2.25  2006  Kd=48uM       // 2h9y.pdf (SCK) Kd(ambenonium kinetics)=48+/-4uM
2c1p  2.00  2006  Kd=4uM        // 2c1p.pdf (FNZ) Kd=4~6uM
2ces  2.15  2006  Kd=56nM       // 2ces.pdf (GIM) Ki=138nM at pH=5.8
2gz2  2.10  2006  Kd=6.0uM      // 2gz2.pdf (A2P) Kd=6.0+/-1.0uM
2o4l  1.33  2006  Kd=608pM      // 2o4k.pdf (TPV)
2j7h  1.95  2006  Kd=65nM       // 2j7h.pdf (AZF)
2doo  2.43  2006  Kd=67nM       // 2doo.pdf (C4H) Kd=67+/-14nM; Ki=140+/-10nM; IC50=0.7+/-0.1uM
1zea  1.78  2006  Kd=6uM        // 1zea.pdf (9-mer)
2fqx  1.70  2006  Kd=71nM       // 2fqx.pdf (GMP)
2j7d  2.24  2006  Kd=74nM       // 2j7d.pdf (GI1)
2fgv  1.50  2006  Kd=760nM      // 2fgv.pdf (5-mer)
2fxu  1.35  2006  Kd=7nM        // 2fxu.pdf (BID)
2hnx  1.50  2006  Kd=83nM       // 2hnx.pdf (PLM) Kd=0.083uM for ALB2
2d0k  1.90  2006  Kd=9.51uM     // 2d0k.pdf (FOL)
2cet  1.97  2006  Kd=9.6nM      // 2cet.pdf (PGI) Ki=7.5nM at pH=5.8
2cc7  1.80  2006  Kd=9.88nM     // 2cc7.pdf (LUM)
2ha3  2.25  2006  Kd=930uM      // 2h9y.pdf (CHT) Kd=930+/-120uM, Kd(ambenonium kinetics)=930+/-120uM, Ki=1.4+/-0.2mM
2cer  2.29  2006  Ki<=0.6nM     // 2cer.pdf (PGI)
2cf8  1.30  2006  Ki=0.008uM    // 2cf8.pdf (ESH)
2cf9  1.79  2006  Ki=0.015uM    // 2cf9.pdf (348)
2aoe  1.54  2006  Ki=0.024uM    // 2aoe.pdf (0Q4)
2d1o  2.02  2006  Ki=0.02uM     // 2d1o.pdf (FA4)
2f7o  1.43  2006  Ki=0.036uM    // 2f7o.pdf (MSN)
2f81  1.25  2006  Ki=0.03nM     // 2f81.pdf (017)
2i3h  1.62  2006  Ki=0.04uM     // 2i3h.pdf (4-mer)
2i3i  2.30  2006  Ki=0.05uM     // 2i3i.pdf (618)
2bz6  1.60  2006  Ki=0.081uM    // 2bz6.pdf (346)
1zsf  1.98  2006  Ki=0.12nM     // 1zsf.pdf (0ZS)
2d3u  2.00  2006  Ki=0.12uM     // 2d3u.pdf (CCT)
2b1i  2.02  2006  Ki=0.15uM     // 2b1g.pdf (93A) compound 3, include AICAR transformylase and IMP cyclohydrolase
1z6e  1.80  2006  Ki=0.19nM     // 1z6e.pdf (IK8)
2b1g  2.10  2006  Ki=0.23uM     // 2b1g.pdf (13A) compound 2, include AICAR transformylase and IMP cyclohydrolase
2d3z  1.80  2006  Ki=0.23uM     // 2d3z.pdf (FIH)
2f7p  1.28  2006  Ki=0.249uM    // 2f7p.pdf (2SK)
2fqo  1.87  2006  Ki=0.37uM     // 2fqo.pdf (HYI)
2g94  1.86  2006  Ki=0.3nM      // 2g94.pdf (ZPQ)
2gvj  2.10  2006  Ki=0.3nM      // 2gvj.pdf (DGB)
2hoc  2.10  2006  Ki=0.3nM      // 2hoc.pdf (1CN) ligand is compound 16
2h4g  2.50  2006  Ki=0.3uM      // 2h4g.pdf (694)
2aqu  2.00  2006  Ki=0.48nM     // 2aqu.pdf (DR7)
2aog  1.10  2006  Ki=0.53uM     // 2aog.pdf (2NC)
1zvx  1.87  2006  Ki=0.6nM      // 1zvx.pdf (FIN)
2fqt  1.79  2006  Ki=0.72uM     // 2fqt.pdf (H1D)
2ewb  1.85  2006  Ki=0.8uM      // 2ewb.pdf (ZED)
2idw  1.10  2006  Ki=1.3nM      // 2idw.pdf (017)
2avo  1.10  2006  Ki=1.40nM     // 2avo.pdf (MK1)
1ypg  1.80  2006  Ki=10nM       // 1ypg.pdf (UIR)
2fpz  2.00  2006  Ki=110uM      // 2fpz.pdf (270)
2e1w  2.50  2006  Ki=11nM       // 2e1w.pdf (FR6)
2gvv  1.73  2006  Ki=125uM      // 2gvv.pdf (DI9)
2aoc  1.30  2006  Ki=13.0uM     // 2aoc.pdf (2NC)
2gv7  2.20  2006  Ki=14nM       // 2gv7.pdf (672)
2j34  2.01  2006  Ki=15nM       // 2j34.pdf (GS6)
2hb1  2.00  2006  Ki=160uM      // 2hb1.pdf (512)
2i19  2.28  2006  Ki=16nM       // 2i19.pdf (1BY)
2am4  1.70  2006  Ki=190uM      // 2am4.pdf (U2F)
2f94  1.94  2006  Ki=195nM      // 2f94.pdf (BFQ) ligand is compound 6(ibandronate); time-Dependent IC50 initial 1052 nM to final 25.4 nM
2fzc  2.10  2006  Ki=1990uM     // 2fzc.pdf (EOP) IC50=200uM; Ki=2160uM (for substrate CP); Ki=1990uM (for substrate Asp)
2j4i  1.80  2006  Ki=1nM        // 2j4i.pdf (GSJ)
2f8g  1.22  2006  Ki=2.0nM      // 2f8g.pdf (017)
2avm  1.10  2006  Ki=2.0uM      // 2avm.pdf (2NC)
2aod  1.40  2006  Ki=2.17uM     // 2aod.pdf (2NC)
2iuz  1.95  2006  Ki=2.8uM      // 2iuz.pdf (D1H)
2bvr  1.25  2006  Ki=200uM      // 2bvr.pdf (4CP)
2fx6  1.57  2006  Ki=200uM      // 2fx6.pdf (270)
2dw7  2.50  2006  Ki=20uM       // 2dw7.pdf (SRT)
2cn0  1.30  2006  Ki=22nM       // 2cn0.pdf (F25) Ki for racemic ligand
2fzk  2.50  2006  Ki=250uM      // 2fzk.pdf (EOZ) IC50=79uM; Ki=250uM (for substrate CP); Ki=310uM (for substrate Asp)
2gsu  2.00  2006  Ki=260uM      // 2gsu.pdf (AMP)
2fdp  2.50  2006  Ki=26nM       // 2fdp.pdf (FRP)
2avs  1.10  2006  Ki=27.0nM     // 2avs.pdf (MK1)
2f1g  1.90  2006  Ki=29nM       // 2f1g.pdf (GNF)
2b7d  2.24  2006  Ki=2nM        // 2b7d.pdf (C1B)
2f2h  1.95  2006  Ki=2uM        // 2f2h.pdf (XTG)
2ihq  2.00  2006  Ki=3.2nM      // 2ihq.pdf (LG7)
2h4k  2.30  2006  Ki=3.2uM      // 2h4k.pdf (509)
2hs1  0.84  2006  Ki=3.3nM      // 2hs1.pdf (017)
2j47  1.98  2006  Ki=3.9uM      // 2j47.pdf (GDV)
1zfq  1.55  2006  Ki=30nM       // 1zfq.pdf (ZEC) ligand is compound 21
2isw  1.75  2006  Ki=37nM       // 2isv.pdf (PGH) Ki=37+/-2nM
2boh  2.20  2006  Ki=3nM        // 2boh.pdf (IIA)
2fvd  1.85  2006  Ki=3nM        // 2fvd.pdf (LIA)
2hb3  1.35  2006  Ki=4.5pM      // 2hb3.pdf (GRL)
2hzy  1.35  2006  Ki=41nM       // 2hzy.pdf (DHJ) ligand is compound 1; Ki=41+/-0.4nM
2avq  1.30  2006  Ki=41uM       // 2avq.pdf (2NC)
2fzg  2.25  2006  Ki=420uM      // 2fzg.pdf (EOB) IC50=86uM; Ki=420uM (for substrate CP); Ki=420uM (for substrate Asp)
2gv6  2.10  2006  Ki=46nM       // 2gv6.pdf (730)
2j2u  1.90  2006  Ki=47nM       // 2j2u.pdf (GSQ)
2i0a  1.80  2006  Ki=4pM        // 2i0a.pdf (MUI)
2i80  2.19  2006  Ki=4uM        // 2i80.pdf (G1L)
2cbj  2.35  2006  Ki=5.4nM      // 2cbi.pdf (OAN) Ki(hOGA-OAN)=70nM for a homologue
1zge  1.65  2006  Ki=50nM       // 1zge.pdf (SDA) ligand is compound 9
2ceq  2.14  2006  Ki=53nM       // 2ceq.pdf (GIM)
2f80  1.45  2006  Ki=6.6nM      // 2f80.pdf (017)
2hnc  1.55  2006  Ki=60nM       // 2hnc.pdf (1SA) ligand is compound 13
2aj8  2.11  2006  Ki=638nM      // 2aj8.pdf (SC3)
1z9y  1.66  2006  Ki=65nM       // 1z9y.pdf (FUN) ligand is compound 7
2hxm  1.30  2006  Ki=6uM        // 2hxm.pdf (302)
1zs0  1.56  2006  Ki=700nM      // 1zs0.pdf (EIN)
1yp9  2.10  2006  Ki=7700nM     // 1yp9.pdf (UIZ)
2d1n  2.37  2006  Ki=7nM        // 2d1n.pdf (FA4)
2bvs  1.40  2006  Ki=80uM       // 2bvs.pdf (2CE)
2f9k  2.06  2006  Ki=85.9nM     // 2f9k.pdf (ZOL) ligand is compound 7(zoledronate); time-Dependent inhibition; Ki or IC50 increase 100 folds
2bq7  2.20  2006  Ki=89nM       // 2bq7.pdf (IID)
1ype  1.81  2006  Ki=8nM        // 1ype.pdf (UIP)
1w7g  1.65  2006  Ki=8uM        // 1w7g.pdf (MIU) Ki=8~18uM
1ypj  1.78  2006  Ki=95nM       // 1ypj.pdf (UIB)
2v7a  2.50  2007  Kd=0.005uM    // 2v7a.pdf (627) IC50=25nM
2uxi  2.50  2007  Kd=0.05uM     // 2uxh.pdf (G50) Kd=0.05+/-0.01uM; two independent binding sites
2v8w  2.30  2007  Kd=0.15uM     // 2v8w.pdf (MGO)
2jdu  1.50  2007  Kd=0.19uM     // 2jdu.pdf (MFU) G24N/Me-alpha-Fuc; Kd=0.19+/-0.03uM
2v00  1.55  2007  Kd=0.22mM     // 2v00.pdf (V15)
2jdp  1.30  2007  Kd=0.25uM     // 2jdp.pdf (MFU) S23A/Me-alpha-Fuc; Kd=0.25+/-0.01uM
2py4  1.49  2007  Kd=0.2uM      // 2py4.pdf (DUP) Kd=1.6uM for human dUTPase with DUP
2nn7  1.85  2007  Kd=0.3uM      // 2nmx.pdf (M29) Kd=0.3+/-0.01uM, Ki=0.1+/-0.02uM
2hkf  2.01  2007  Kd=0.42uM     // 2hkf.pdf (9-mer)
2qpq  1.92  2007  Kd=0.43uM     // 2qpq.pdf (CIT) Kd=0.43+/-0.07uM
2e27  1.70  2007  Kd=0.45nM     // 2e27.pdf (AB0) ligand is ciguatoxin 3C; Ka=2.22x10+9M-1
2e7f  2.20  2007  Kd=0.79uM     // 2e7f.pdf (C2F) wide type; equilibrium dialysis: Kd=10uM (pH=4.85-8.5); Tryptophan fluorescence quenching: Kd=0.6uM, Kd=2.1uM (pH=7.6); Isothermal calorimetry: Kd=0.79uM (pH=7.6), Kd=0.29uM (pH=5.1)
2fxs  2.00  2007  Kd=0.87uM     // 2fxs.pdf (RDA) HSP82 in complex with radamined; Kd=0.87+/-0.14uM
2nnd  1.60  2007  Kd=0.87uM     // 2nnd.pdf (PRZ) Kd=0.3uM for wt MUP with IBMP
2nn1  1.65  2007  Kd=1.5uM      // 2nmx.pdf (M28) Kd=1.5+/-0.1uM, Ki=2.3+/-0.1uM
2qta  1.85  2007  Kd=1.75uM     // 2qta.pdf (TDP) E401K mutant
2pgz  1.76  2007  Kd=1.8uM      // 2pgz.pdf (COC)
2v25  1.49  2007  Kd=1.9uM      // 2v25.pdf (ASP)
2r58  2.00  2007  Kd=10mM       // 2r58.pdf (MLY)
2oiq  2.07  2007  Kd=10uM       // 2oiq.pdf (STI)
2vhj  1.80  2007  Kd=125uM      // 2vhj.pdf (ADP) NTPase P4 PROTEIN S252A MUTANT, Kd=koff/kon=125uM
2pk6  1.45  2007  Kd=13pM       // 2pk5.pdf (O33)
2jg0  1.50  2007  Kd=15nM       // 2jf4.pdf (TTZ) compound 4; Kd=15nM, Ki=9nM
2nsj  2.31  2007  Kd=16.3uM     // 2nsh.pdf (C2R) H45Q mutant; Kd=16.3+/-2.6uM
2clk  1.50  2007  Kd=164uM      // 2cle.pdf (G3H)
2qm9  2.31  2007  Kd=17nM       // 2q9s.pdf (TDZ) Kd value derived from EC50
2i4z  2.25  2007  Kd=1978nM     // 2i4j.pdf (DRH) Kd=1978+/-523.5nM
2q8h  2.00  2007  Kd=1mM        // 2q8g.pdf (TF4)
2v3u  1.74  2007  Kd=1mM        // 2v3u.pdf (DSN)
2gh9  1.95  2007  Kd=1uM        // 2gh9.pdf (MLR)
2uyq  1.80  2007  Kd=2.1uM      // 2uyq.pdf (SAM)
2r5a  2.30  2007  Kd=2.5mM      // 2r58.pdf (MLZ)
2nmx  1.55  2007  Kd=2.7uM      // 2nmx.pdf (M25) Kd=2.7+/-0.1uM, Ki=2.0+/-0.1uM
2nsl  2.00  2007  Kd=20.9uM     // 2nsh.pdf (C2R) H45N mutant; Kd=20.9+/-1.9uM
2pk5  1.90  2007  Kd=20pM       // 2pk5.pdf (075)
2vba  1.36  2007  Kd=25uM       // 2vb8.pdf (P4T)
2vb8  1.52  2007  Kd=25uM       // 2vb8.pdf (TLM)
2hzl  1.40  2007  Kd=270nM      // 2hzl.pdf (PYR) Kd=270+/-20nM
2cle  1.50  2007  Kd=280uM      // 2cle.pdf (F6F)
3b50  1.40  2007  Kd=28nM       // 3b50.pdf (SLB) Kd=28+/-1nM
2uyn  1.60  2007  Kd=2mM        // 2uyn.pdf (2KT)
2r0z  2.10  2007  Kd=3.4uM      // 2ipu.pdf (6-mer)
2jdm  1.70  2007  Kd=3.96uM     // 2jdm.pdf (MFU) S22A/Me-alpha-Fuc; Kd=3.96+/-0.91uM
2ra6  1.50  2007  Kd=30uM       // 2ra6.pdf (ETY) Kd=14uM for 2-naphthol; Kd=30uM for 4-ethylphenol
2ogy  2.30  2007  Kd=33.2uM     // 2e7f.pdf (C2F) N199A mutant; equilibrium dialysis: Kd=26.5uM (pH=6.1); Tryptophan fluorescence quenching: Kd=21.3uM (pH=7.6); isothermal calorimetry: Kd=33.2uM (pH=5.1)
2uwd  1.90  2007  Kd=4.5nM      // 2uwd.pdf (2GG) Kd=4.5+/-2.2nM; IC50=21+/-4nM; GI50=78+/-15nM
2gj5  2.40  2007  Kd=4.74nM     // 2gj5.pdf (VD3) Kd=4.74+/-0.37nM (milk beta-lactoglobulin with VD3); Kd=45.67+/-3.12nM (heated beta-lactoglobulin with VD3 )
2hjb  1.85  2007  Kd=40.3uM     // 2hj4.pdf (PZM) Kd=40.3+/-1.7uM
2p09  1.65  2007  Kd=450nM      // 2p05.pdf (ATP)
2v95  1.93  2007  Kd=5.0nM      // 2v95.pdf (HCY)
2e2r  1.60  2007  Kd=5.5nM      // 2e2r.pdf (2OH)
2oi2  2.50  2007  Kd=500nM      // 2oi2.pdf (DP6)
2p15  1.94  2007  Kd=50pM       // 2p15.pdf (EZT)
2cli  1.70  2007  Kd=50uM       // 2cle.pdf (F9F)
2pql  2.20  2007  Kd=53nM       // 2pql.pdf (TSS)
2q7q  1.60  2007  Kd=5uM        // 2hj4.pdf (C2B)
2i4j  2.10  2007  Kd=684.8nM    // 2i4j.pdf (DRJ) Kd=684.8+/-106.8nM
2i6b  2.30  2007  Kd=68nM       // 2i6a.pdf (89I)
2pv1  1.30  2007  Kd=73nM       // 2pv1.pdf (7-mer)
2jf4  2.20  2007  Kd=7nM        // 2jf4.pdf (VDM) compound 2; Kd=7nM, Ki=10nM
2v88  2.00  2007  Kd=82.1uM     // 2v83.pdf (8-mer)
2clh  1.70  2007  Kd=87.6uM     // 2cle.pdf (F19)
2e94  2.18  2007  Ki=0.01uM     // 2e8t.pdf (364) IC50=0.03uM
2i2c  1.85  2007  Ki=0.02mM     // 2i2b.pdf (DTA)
2o4j  1.74  2007  Ki=0.08nM     // 2o4j.pdf (VD4)
2p16  2.30  2007  Ki=0.08nM     // 2p16.pdf (GG2)
2e92  2.31  2007  Ki=0.13uM     // 2e8t.pdf (M0N) IC50=0.34uM
2oxd  2.30  2007  Ki=0.15uM     // 2oxd.pdf (K32)
2ot1  2.05  2007  Ki=0.1mM      // 2ot1.pdf (N3P)
2oxx  2.30  2007  Ki=0.20uM     // 2oxd.pdf (K22)
2j4g  2.25  2007  Ki=0.25uM     // 2j4g.pdf (NB1)
2e91  2.14  2007  Ki=0.26uM     // 2e8t.pdf (ZOL) IC50=0.66uM
2pog  1.84  2007  Ki=0.29nM     // 2pog.pdf (WST)
2nt7  2.10  2007  Ki=0.30uM     // 2nt7.pdf (902) compound 49g
2oxy  1.81  2007  Ki=0.30uM     // 2oxd.pdf (K17)
2j27  1.15  2007  Ki=0.3mM      // 2j27.pdf (PGA) Ki=0.3+/-0.1mM
2p95  2.20  2007  Ki=0.43nM     // 2p93.pdf (ME5)
2o4r  1.98  2007  Ki=0.4nM      // 2o4j.pdf (VD5)
3bgz  2.40  2007  Ki=0.55uM     // 3bgp.pdf (VX3) ligand is compound 3
2yxj  2.20  2007  Ki=0.5nM      // 2yxj.pdf (N3C) Bcl-xl in complex with ABT-737
2p2a  2.26  2007  Ki=0.75uM     // 2p2a.pdf (MP9)
2flr  2.35  2007  Ki=0.8uM      // 2flr.pdf (7NH) Ki(fXa)=125uM, Ki(fIIa)=71.5uM, Ki(Trypsin)=46.5uM
2q54  1.85  2007  Ki=0.98nM     // 2q54.pdf (MU1)
2p4j  2.50  2007  Ki=1.1nM      // 2p4j.pdf (23I)
2pu1  1.80  2007  Ki=1.4uM      // 2pty.pdf (FSG) R28K mutant
2z94  1.78  2007  Ki=1.4uM      // 2z94.pdf (TLD)
3b7i  1.75  2007  Ki=1.5uM      // 3b3c.pdf (PLU) Ki=1.5+/-0.2uM
2uz9  2.30  2007  Ki=1.96uM     // 2uz9.pdf (XAN) ligand is Xanthinec
2i4x  1.55  2007  Ki=1.9pM      // 2i4d.pdf (KGQ) Ki=1.9+/-0.8pM, EC50(MT-2)=0.4+/-0.1nM
2qrl  1.60  2007  Ki=100uM      // 2qrk.pdf (OGA)
3b3c  1.46  2007  Ki=105uM      // 3b3c.pdf (PLU) Ki=105+/-11uM
2hah  1.70  2007  Ki=10nM       // 2hah.pdf (3TL) mutations(I37V, N55M, M56I, I57G, V59I, G62F, K63I, L97T, I98P, Q99V, P100N, L101I); Ki(wt FIV)=41nM
3b92  2.00  2007  Ki=10nM       // 3b92.pdf (440)
2oym  1.86  2007  Ki=10uM       // 2oyk.pdf (MNI)
2qe4  2.40  2007  Ki=11.0nM     // 2jj3.pdf (JJ3)
2v3d  1.96  2007  Ki=116uM      // 2v3d.pdf (NBV)
2p3a  1.75  2007  Ki=11nM       // 2p3a.pdf (3TL)
3bgq  2.00  2007  Ki=11nM       // 3bgp.pdf (VX2) ligand is compound 1
2ovv  2.00  2007  Ki=12nM       // 2o8h.pdf (PFH)
2fle  1.90  2007  Ki=14nM       // 2fle.pdf (AI) ligand is compound PC(9); Ki=14+/-3nM
2uwp  1.75  2007  Ki=154nM      // 2uwp.pdf (894)
2ptz  1.65  2007  Ki=15nM       // 2pty.pdf (PAH) R28K mutant
2pwg  2.20  2007  Ki=15uM       // 2pwd.pdf (CTS)
2nta  2.10  2007  Ki=16uM       // 2nt7.pdf (521) compound 26c
2on6  2.50  2007  Ki=172nM      // 2oc4.pdf (IMH)
2jh6  2.21  2007  Ki=17nM       // 2jh6.pdf (894)
1vso  1.85  2007  Ki=18.98uM    // 1vso.pdf (AT1) Ki=18.98+/-1.31uM for R/S racemic; ligand binding to iGluR5 core
2e2p  2.00  2007  Ki=18uM       // 2e2p.pdf (ADP)
2q55  1.90  2007  Ki=2.04nM     // 2q54.pdf (MU0)
2i4d  1.50  2007  Ki=2.1pM      // 2i4d.pdf (QFI) Ki=2.1+/-0.2pM
2oax  2.29  2007  Ki=2.232nM    // 2oax.pdf (SNL) ligand is spironolactone
2ojg  2.00  2007  Ki=2.3uM      // 2ojg.pdf (19A)
2cej  2.50  2007  Ki=2.4nM      // 2cej.pdf (1AH) EC50=1.1uM
2i4w  1.55  2007  Ki=2.6pM      // 2i4d.pdf (KGQ) Ki=2.6+/-1.5pM, EC50(PBMC)=2.8+/-0.5nM, EC50(MT-2)=3.5+/-1.5nM, EC50(PM-1)=2.2+/-1.4nM
2i4u  1.50  2007  Ki=2.7pM      // 2i4d.pdf (DJR) Ki=2.7+/-1.6pM, EC50(PBMC)=1.1+/-0.5nM, EC50(MT-2)=0.6+/-0.4nM, EC50(PM-1)=3.5+/-1.1nM
2jew  1.40  2007  Ki=206nM      // 2jew.pdf (720) compound 21
2fu8  1.80  2007  Ki=20uM       // 2fu7.pdf (MCO) Ki measured at neutral pH
2h15  1.90  2007  Ki=2135nM     // 2h15.pdf (B19) hCA II in complex with compound 8
2uy4  1.75  2007  Ki=21uM       // 2uy3.pdf (AZM) ligand is acetazolamide; Ki=21+/-2uM
2hl4  1.55  2007  Ki=23nM       // 2hl4.pdf (BO1) ligand is compound 1
2p3c  2.10  2007  Ki=24nM       // 2p3a.pdf (3TL)
2psu  1.93  2007  Ki=24nM       // 2psu.pdf (MUU)
2ihj  2.00  2007  Ki=25.7uM     // 2ihj.pdf (CSF)
3b3x  2.50  2007  Ki=250uM      // 3b3x.pdf (A33) ligand is compound 4
2o8h  1.80  2007  Ki=25nM       // 2o8h.pdf (227)
2jiw  1.95  2007  Ki=26uM       // 2jiw.pdf (BEU)
3b3s  1.18  2007  Ki=2800uM     // 3b3s.pdf (LEU)
2oi0  2.00  2007  Ki=28nM       // 2oi0.pdf (283)
2jh0  1.70  2007  Ki=2nM        // 2jh0.pdf (701)
2ojj  2.40  2007  Ki=2nM        // 2ojg.pdf (82A)
2uwo  1.75  2007  Ki=2nM        // 2uwo.pdf (701)
2o0u  2.10  2007  Ki=3.2uM      // 2o0u.pdf (C0M)
2uy5  1.60  2007  Ki=3.2uM      // 2uy3.pdf (H35) ligand is kinetin; Ki=3.2+/-0.3uM
2p3b  2.10  2007  Ki=3.3nM      // 2p3a.pdf (3TL)
2r5p  2.30  2007  Ki=3.3nM      // 2r5p.pdf (MK1) Ki=3.3+/-0.3nM
2oag  2.30  2007  Ki=3.4nM      // 2oae.pdf (DLI)
2hhn  1.55  2007  Ki=32nM       // 2hhn.pdf (GNQ) ligand is sulfone analog 37
2r2w  2.01  2007  Ki=34uM       // 2r2w.pdf (4PG)
2p53  2.10  2007  Ki=35nM       // 2p53.pdf (NNG)
2jh5  2.50  2007  Ki=367nM      // 2jh5.pdf (895)
2oxn  1.70  2007  Ki=36nM       // 2oxn.pdf (OAN)
2pou  1.60  2007  Ki=38nM       // 2pou.pdf (I7A)
2oc2  2.25  2007  Ki=3nM        // 2oc2.pdf (RX3)
2qu6  2.10  2007  Ki=3nM        // 2qu5.pdf (857)
2nmz  0.97  2007  Ki=4.3nM      // 2nmw.pdf (ROC) Ki=4.3+/-0.7nM, mutations(Q506K,L532I,L562I,C566A,V581A,C594A), P212121
2gkl  1.86  2007  Ki=4.5uM      // 2gkl.pdf (PD2) wild type protein; Ki=4.5+/-0.5uM for 4-PDCA(inhibitor 2)
2j62  2.26  2007  Ki=4.6pM      // 2j62.pdf (GSZ)
2pwd  1.80  2007  Ki=40uM       // 2pwd.pdf (NOJ)
2j95  2.01  2007  Ki=4nM        // 2j94.pdf (GSX) compound 1b
2ovy  1.80  2007  Ki=4nM        // 2o8h.pdf (PFJ)
2uwl  1.90  2007  Ki=4nM        // 2uwl.pdf (895) ligand is compound 1
2pbw  2.50  2007  Ki=5.56nM     // 1vso.pdf (DOQ) Ki=5.56+/-0.88nM; ligand binding to iGluR5 core
2jfz  1.86  2007  Ki=5.8uM      // 2jfn.pdf (003) Ki=5.8+/-0.03uM
2j94  2.10  2007  Ki=534nM      // 2j94.pdf (G15) compound 1x
2qzr  1.95  2007  Ki=55nM       // 2qzr.pdf (S79)
2qrk  1.75  2007  Ki=55uM       // 2qrk.pdf (AMP)
2o4z  2.10  2007  Ki=566nM      // 2o4z.pdf (HSW) ligand is compound 2
2psv  1.75  2007  Ki=58nM       // 2psu.pdf (MUV)
2q38  1.95  2007  Ki=5950nM     // 2q38.pdf (LSA) ligand is saccharin
2cen  1.70  2007  Ki=5nM        // 2cej.pdf (4AH) EC50=0.18uM
2q5k  1.95  2007  Ki=5pM        // 2q54.pdf (AB1)
2jds  2.00  2007  Ki=6.3nM      // 2jds.pdf (L20) Ki=160pM for PKB-alpha-L20 complex
2i4v  1.50  2007  Ki=6.3pM      // 2i4d.pdf (DJR) Ki=6.3+/-1.3pM, EC50(MT-2)=12.3+/-3.5nM
2qdt  2.00  2007  Ki=6.5uM      // 2qds.pdf (I38) Ki=6.5+/-2uM for compound 5a
2uy3  1.90  2007  Ki=600uM      // 2uy3.pdf (H33) ligand is 8-chlorotheophylline; Ki=600+/-64uM
2h6t  1.90  2007  Ki=60nM       // 2h6t.pdf (6-mer) Ki for pepA binding to SP3
2pow  1.75  2007  Ki=63nM       // 2pou.pdf (I7C)
3b3w  1.75  2007  Ki=65uM       // 3b3s.pdf (LEU)
2v2q  2.30  2007  Ki=71.2uM     // 2v2q.pdf (NVG) ligand is compound 3, Ki=71.2+/-6.2uM, IC50=1.67mM
2pov  1.60  2007  Ki=75nM       // 2pou.pdf (I7B)
2q1q  1.90  2007  Ki=7nM        // 2q1q.pdf (OSP)
2z1w  1.63  2007  Ki=83uM       // 2z1w.pdf (BDI) ligand is compound 6
2v2v  2.40  2007  Ki=85.8uM     // 2v2q.pdf (V12) ligand is compound 1, Ki=85.8+/-9.4uM, IC50=1.99mM
2glp  2.42  2007  Ki=9.7uM      // 2gll.pdf (BDE) ligand is compound 1; IC50=39.8+/-0.35uM
2q8m  2.05  2007  Ki=94uM       // 2q8m.pdf (AMP) Ki=94uM (with Mg2+); Ki=13uM (without Mg2+)
2q2a  1.79  2008  Kd=0.039uM    // 2pvu.pdf (ARG)
2vt3  2.00  2008  Kd=0.07mM     // 2vt3.pdf (ATP)
3exe  1.98  2008  Kd=0.11uM     // 3exe.pdf (TPP) cofactor ThDP binding to wt E1p in presence of Mn2+; Kd=0.11+/-0.01uM is for Mg2+
3cow  1.80  2008  Kd=0.125uM    // 3cow.pdf (52H) Kd=0.125+/-0.008uM; Ki=0.22+/-0.03uM
2vpn  1.55  2008  Kd=0.19uM     // 2vpn.pdf (4CS) Kd=0.19+/-0.02uM
2jgs  1.90  2008  Kd=0.24uM     // 2jgs.pdf (BTN) Kd=0.24+/-0.04uM
2vwc  2.40  2008  Kd=0.24uM     // 2vwc.pdf (BC2) Kd=0.24uM, IC50=2uM
2qpu  1.70  2008  Kd=0.25mM     // 2qpu.pdf (QPU) Kd=0.25+/-0.03mM
2p7z  2.50  2008  Kd=0.262uM    // 2p7a.pdf (OHT)
2p7g  2.10  2008  Kd=0.297uM    // 2p7a.pdf (2OH)
3d0b  1.74  2008  Kd=0.29uM     // 3d0b.pdf (SNX) ligand is compound 16, Kd=0.29uM, IC50=8.9uM
3bva  1.05  2008  Kd=0.30uM     // 3bva.pdf (2NC) Ka=(3.30+/-0.56)e+6M-1
3cj4  2.07  2008  Kd=0.31uM     // 3ciz.pdf (SX5) ligand is compound 8e, IC50=1.0uM
2p3i  1.75  2008  Kd=0.33mM     // 2p3i.pdf (MNA) ligand is Neu5Ac-alpha-2Me; Kd measured at 22C
3d2e  2.35  2008  Kd=0.38uM     // 3d2e.pdf (ATP) Kd=0.38+/-0.097uM(ATP and Sse1p-Hsp70); Kd=0.1uM(full-length proteins)
3c2o  2.30  2008  Kd=0.45mM     // 3c2f.pdf (NTM) Kd(stQAPRTase)=21uM; Kd=0.45+/-0.03mM
3cj5  1.92  2008  Kd=0.46uM     // 3ciz.pdf (SX6) ligand is compound 8i, IC50=0.25uM
2zb1  2.50  2008  Kd=0.48uM     // 2zaz.pdf (GK4) IC50=3uM
2pvu  1.79  2008  Kd=0.49uM     // 2pvu.pdf (LYS)
2q89  2.30  2008  Kd=0.5uM      // 2q88.pdf (6CS) Kd=0.5+/-0.1uM
2vrj  1.90  2008  Kd=0.5uM      // 2vrj.pdf (NCW) ligand is compound 9, Ki=0.28uM
3ebl  1.90  2008  Kd=0.5uM      // 3ebl.pdf (GA4)
2qbu  2.10  2008  Kd=0.645uM    // 2qbu.pdf (SAH) Kd=0.645+/-0.025uM
2p7a  2.30  2008  Kd=0.788uM    // 2p7a.pdf (43M)
3c2r  2.40  2008  Kd=0.78mM     // 3c2f.pdf (PHT) Kd=0.78+/-0.08mM
2vmd  1.90  2008  Kd=0.95mM     // 2vmc.pdf (MBG)
3coy  2.03  2008  Kd=0.96uM     // 3cow.pdf (53H) Kd=0.96+/-0.03uM; Ki=4+/-0.6uM
3ckb  2.30  2008  Kd=1.04mM     // 3ck7.pdf (MLR) Kd=1.04+/-0.017mM
2rcn  2.25  2008  Kd=1.0uM      // 2rcn.pdf (GDP) Kd=1.0+/-0.3uM
2vmc  1.90  2008  Kd=1.15mM     // 2vmc.pdf (NGA) Kd for GalNAc, N-acetyl-D-galactosamine
3eeb  2.10  2008  Kd=1.3uM      // 3eeb.pdf (IHP) Kd=1.3+/-0.2uM
3e5u  1.83  2008  Kd=1.4uM      // 3e5u.pdf (3C4)
2q88  1.90  2008  Kd=1.6uM      // 2q88.pdf (4CS) Kd=1.6+/-0.3uM
2vyt  1.90  2008  Kd=1.84mM     // 2vyt.pdf (MLZ) Kd=1.84+/-0.19mM
2pqc  1.60  2008  Kd=1.8uM      // 2pq9.pdf (RC1) Kd=1800+/-600nM
3c2f  2.35  2008  Kd=10.1mM     // 3c2f.pdf (PRP) Kd=10.1+/-3.3mM
3bxg  1.80  2008  Kd=10.98uM    // 2okg.pdf (BG6) protein from Bacillus subtilis; Kd=10.98+/-1.2uM
3bbb  1.30  2008  Kd=100nM      // 3bbb.pdf (2-mer) ligand is dinucleotide d(AG), Kd=100+/-20nM, Ki=280+/-30nM; binding data found in another reference
2rin  1.80  2008  Kd=100uM      // 2reg.pdf (ACH) Kd=100+/-12uM
3c39  1.85  2008  Kd=109uM      // 3c39.pdf (3PG) ligand is 3-phosphoglycerate
2vpe  1.70  2008  Kd=11.4uM     // 2vp7.pdf (9-mer) hPHD-HD1 and 9-MER H3K4ME2, Kd=11.4+/-1.1uM
2vo4  1.75  2008  Kd=11.6uM     // 2vo4.pdf (4NM) binding of p-nitrophenol to GmGSTU4-4 and Nb-GSH complex; Kd=11.6+/-0.1uM
3cd5  2.39  2008  Kd=12.7nM     // 3cct.pdf (7HI) IC50=5.1nM
2vuk  1.50  2008  Kd=125uM      // 2vuk.pdf (P83) Kd=125+/-10uM (ITC); Kd=167+/-12uM (NMR)
3exh  2.44  2008  Kd=13.1uM     // 3exe.pdf (TPP) cofactor ThDP binding to phospho-S1-E1p in presence of Mn2+; Kd=13.1+/-1.1uM is for Mg2+
3ccw  2.10  2008  Kd=13.5nM     // 3cct.pdf (4HI) IC50=7.9nM
3cd7  2.05  2008  Kd=14.3nM     // 3cct.pdf (882) IC50=1.8nM
2vmf  2.10  2008  Kd=1400nM     // 2vjx.pdf (MVL) ligand is compound 1a
3c84  1.94  2008  Kd=14nM       // 3c79.pdf (TH4) dissociation kinetics Kd=14nM
3cj2  1.75  2008  Kd=14uM       // 3ciz.pdf (SX3) ligand is compound 7e, IC50=17uM
2pym  1.90  2008  Kd=150nM      // 2pym.pdf (1UN) Kd=150+/-20nM; Ki=18+/-1nM.
2rcb  1.62  2008  Kd=163nM      // 2rc8.pdf (DSN) Kd=163+/-45nM
2r23  1.65  2008  Kd=190uM      // 2r1w.pdf (2-mer) ligand is KO1-KDA
2vfk  1.50  2008  Kd=194uM      // 2vfk.pdf (AMP) Kd=194+/-30uM
3f17  1.10  2008  Kd=2.36nM     // 3f15.pdf (HS4)
2reg  1.90  2008  Kd=2.3uM      // 2reg.pdf (CHT) Kd=2.3+/-1.0uM
3bex  1.51  2008  Kd=2.7uM      // 3bex.pdf (PAU) TmPanK-III dimer, Kd1=2.7+/-0.16uM; Kd2=6.4+/-0.24uM
3coz  2.00  2008  Kd=2.7uM      // 3cow.pdf (54H) Kd=2.7+/-0.1uM; Ki=18+/-3uM
3bxf  1.70  2008  Kd=2.87uM     // 2okg.pdf (FBP) protein from Bacillus subtilis; Kd=2.87+/-0.06uM
2rio  2.40  2008  Kd=20.4uM     // 2rio.pdf (ADP)
3bra  2.30  2008  Kd=2000uM     // 3bra.pdf (AEF)
3f3e  1.80  2008  Kd=20nM       // 3f3d.pdf (LEU)
3f8c  2.20  2008  Kd=21nM       // 3f8c.pdf (HT1) Kd=21+/-8nM
3fat  1.90  2008  Kd=22.8nM     // 3fat.pdf (AMQ) Kd=22.8+/-1.5nM
3ery  1.95  2008  Kd=2200nM     // 3ery.pdf (9-mer) Kd=2200+/-260nM(ITC); Kd=1600+/-200nM(SPR equilibrium analysis); Kd=3400+/-500nM (SPR kinetic analysis)
3buh  2.30  2008  Kd=220uM      // 3bra.pdf (AED)
3f8f  2.20  2008  Kd=236nM      // 3f8c.pdf (DM1) Kd=236+/-53nM
2pyy  2.10  2008  Kd=25uM       // 2pyy.pdf (GLU)
3d7k  2.49  2008  Kd=25uM       // 3d7k.pdf (D7K)
3cda  2.07  2008  Kd=26.3nM     // 3cct.pdf (8HI) IC50=3.0nM
3cd0  2.40  2008  Kd=26.9nM     // 3cct.pdf (6HI) IC50=2.9nM
3cct  2.12  2008  Kd=27.4nM     // 3cct.pdf (3HI)
2pyn  1.85  2008  Kd=27nM       // 2pym.pdf (1UN) Kd=27+/-5nM; Ki=7.0+/-0.4nM.
3b2q  2.10  2008  Kd=28uM       // 3b2q.pdf (ATP) Kd=28+/-2uM
3brn  2.00  2008  Kd=2nM        // 3brn.pdf (SRO) monotonin in complex with (5-HT)serotonin, Kd<=2nM
3c4h  2.10  2008  Kd=2uM        // 3c49.pdf (DRL) Kd=2+/-0.2uM
2q64  2.50  2008  Kd=3.0nM      // 2pym.pdf (1UN) Kd=3.0+/-0.5nM; Ki=1.4+/-0.2nM.
3bvb  1.30  2008  Kd=3.2uM      // 3bva.pdf (017) Ka=(3.17+/-0.29)e+5M-1
3bxe  1.80  2008  Kd=3.34uM     // 2okg.pdf (13P) protein from Bacillus subtilis; Kd=3.34+/-0.15uM
2zkj  2.00  2008  Kd=3.3uM      // 2zkj.pdf (ADP) Kd=3.3+/-0.7uM(without AZD7545); Kd=5.9+/-0.9uM(with AZD7545)
2vc9  2.36  2008  Kd=3.6nM      // 2vc9.pdf (NOK) Kd=3.6+/-0.3nM; Ki=21nM
2vpo  1.80  2008  Kd=3.8uM      // 2vpn.pdf (6CS) Kd=3.80+/-0.07uM
3bzf  2.50  2008  Kd=30uM       // 3bze.pdf (9-mer)
2r0h  1.90  2008  Kd=310uM      // 2r0h.pdf (CTO) Kd=310+/-4uM
2r1y  1.60  2008  Kd=31uM       // 2r1w.pdf (2-mer) ligand is KDO-KDR
2qtn  2.40  2008  Kd=382uM      // 2qtn.pdf (NCN) Kd=382+/-38uM for nicotinate mononucleotide (NaMN)
2zdm  1.93  2008  Kd=386nM      // 2zdk.pdf (46U) ligand is compound 2b(closed form); Kd=386+/-49nM; Ki=208+/-92nM
3f18  1.13  2008  Kd=39.5nM     // 3f15.pdf (HS5)
2vw5  1.90  2008  Kd=3nM        // 2vw5.pdf (BC6) ligand is compound 5
3b4p  1.70  2008  Kd=4.0uM      // 3b4p.pdf (3B4) Kd=4.0+/-0.6uM
3f6e  1.34  2008  Kd=4.14mM     // 3f6b.pdf (8PA)
2zdl  1.80  2008  Kd=402nM      // 2zdk.pdf (45U) ligand is compound 2a(closed form); Kd=402+/-78nM; Ki=285+/-74nM
2zdk  1.67  2008  Kd=428nM      // 2zdk.pdf (50U) ligand is compound 3b(closed form); Kd=428+/-38nM; Ki=226+/-119nM
3dp4  2.11  2008  Kd=43nM       // 3dp4.pdf (AMQ) Kd=43+/-5nM
3bbf  1.70  2008  Kd=5.2uM      // 3bbb.pdf (GDP) Kd=5.2+/-0.8uM
3f16  1.16  2008  Kd=5.91nM     // 3f15.pdf (HS3) Kd=5.91nM(D); Kd=41.5nM(L)
2vvn  1.85  2008  Kd=50nM       // 2vvn.pdf (NHT)
3ccz  1.70  2008  Kd=51.7nM     // 3cct.pdf (5HI) IC50=1.1nM
3f48  1.90  2008  Kd=512nM      // 3f3d.pdf (ALA)
2zdn  1.98  2008  Kd=562nM      // 2zdk.pdf (49U) ligand is compound 3a(closed form); Kd1=562+/-66nM; Kd2=584+/-107nM(Tricine); Kd3=506+/-34M(Hepes); Kd4=416+/-42nM(PPi); Ki=290+/-65nM
2qbw  1.80  2008  Kd=56nM       // 2qbw.pdf (8-mer) Kd=56+/-5nM; IC50=40nM
3f80  1.60  2008  Kd=60uM       // 3f80.pdf (6HN)
3f1a  1.25  2008  Kd=61.1nM     // 3f15.pdf (HS7)
2pqb  1.80  2008  Kd=63nM       // 2pq9.pdf (GG9) Kd=63+/-15nM
3c79  2.48  2008  Kd=63nM       // 3c79.pdf (IM4) dissociation kinetics Kd=63nM; association kinetics Kd=68+/-23nM
3f19  1.13  2008  Kd=65.1nM     // 3f15.pdf (HS6)
3bug  2.50  2008  Kd=660uM      // 3bra.pdf (AEH)
2q63  2.20  2008  Kd=66nM       // 2pym.pdf (1UN) Kd=66+/-8nM; Ki=9.9+/-0.7nM.
3f3d  2.30  2008  Kd=69nM       // 3f3d.pdf (MET)
3bu1  1.40  2008  Kd=7.1nM      // 3brn.pdf (HSM) Kd=7.1+/-1.0nM
3f15  1.70  2008  Kd=7.88nM     // 3f15.pdf (HS1)
2r75  1.40  2008  Kd=714nM      // 2r75.pdf (01G) Kd=714+/-51nM; IC50(Polymerization)=139uM; IC50(GTPase); =179+/-15uM.
3buf  2.30  2008  Kd=800uM      // 3bra.pdf (AEG)
3bxh  1.85  2008  Kd=94.34uM    // 2okg.pdf (F6P) protein from Bacillus subtilis; Kd=94.34+/-3.1uM
3cdb  2.30  2008  Kd=95.7nM     // 3cct.pdf (9HI) IC50=5.82nM
2qbp  2.50  2008  Ki=0.004uM    // 2qbp.pdf (527)
3c56  2.30  2008  Ki=0.013uM    // 3c52.pdf (PH4) ligand is compound 2
2qi5  1.85  2008  Ki=0.014nM    // 2qhy.pdf (MZ7) ligand is inhibitor 32c
2qi6  1.85  2008  Ki=0.027nM    // 2qhy.pdf (MZ8) ligand is inhibitor 28a
2qi4  1.80  2008  Ki=0.036nM    // 2qhy.pdf (MZ6) ligand is inhibitor 30a
2qbq  2.10  2008  Ki=0.036uM    // 2qbp.pdf (4B3)
2r38  1.81  2008  Ki=0.036uM    // 2r38.pdf (G4G) compound 9 in complex with HIV-1 protease I84V
3ekr  2.00  2008  Ki=0.03uM     // 3eko.pdf (PY9) ligand is compound 14; Ki=0.03uM, IC50=0.06uM, cell IC50=4uM
3c52  2.30  2008  Ki=0.05uM     // 3c52.pdf (PGH)
2qi7  1.85  2008  Ki=0.062nM    // 2qhy.pdf (MZ9) ligand is inhibitor 29b
2qi3  1.95  2008  Ki=0.063nM    // 2qhy.pdf (MZ5) ligand is inhibitor 30d
2qnn  1.48  2008  Ki=0.07uM     // 2pqz.pdf (QN1) ligand is inhibitor 6fg
2r3w  1.92  2008  Ki=0.128uM    // 2r38.pdf (G3G) compound 8 in complex with HIV-1 protease I84V
2vnp  2.19  2008  Ki=0.12nM     // 2vnp.pdf (DED)
2rfh  1.70  2008  Ki=0.15uM     // 2rfh.pdf (23N)
2zq0  1.60  2008  Ki=0.15uM     // 2zq0.pdf (ACR) Ki=0.15+/-0.03uM
2v2h  1.18  2008  Ki=0.17mM     // 2v2c.pdf (PGA) Ki=0.17+/-0.06mM
2qbs  2.10  2008  Ki=0.21uM     // 2qbp.pdf (024)
2za0  1.70  2008  Ki=0.23uM     // 2za0.pdf (MGI) Ki=0.23+/-0.1uM
2pwr  1.50  2008  Ki=0.26uM     // 2pqz.pdf (G4G) ligand is inhibitor 6fd
2pvh  2.20  2008  Ki=0.26uM     // 2pvh.pdf (P19)
2z4o  1.60  2008  Ki=0.27nM     // 2qci.pdf (065) Ki=0.27+/-0.06nM
2pwc  1.78  2008  Ki=0.27uM     // 2pqz.pdf (G3G) ligand is inhibitor 6gd
2vh6  1.95  2008  Ki=0.2nM      // 2vh6.pdf (GSV) ligand is compound 21
3eko  1.55  2008  Ki=0.2uM      // 3eko.pdf (PYU) ligand is compound 1; Ki=0.2uM, IC50=0.4uM, cell IC50 >20uM
2p4s  2.20  2008  Ki=0.31nM     // 2p4s.pdf (DIH)
2pvm  2.00  2008  Ki=0.36uM     // 2pvh.pdf (P29)
2v2c  1.89  2008  Ki=0.39mM     // 2v2c.pdf (PGA) Ki=0.39+/-0.14mM
2qnp  1.41  2008  Ki=0.39uM     // 2pqz.pdf (QN2) ligand is inhibitor 6af
2vw1  2.39  2008  Ki=0.3mM      // 2vw1.pdf (DAN)
3ckp  2.30  2008  Ki=0.449uM    // 3ckp.pdf (012)
2qbr  2.30  2008  Ki=0.47uM     // 2qbp.pdf (910)
2w26  2.08  2008  Ki=0.4nM      // 2w26.pdf (RIV) morpholinone derivative 5, Ki=0.4nM, IC50=0.7nM
3b65  1.80  2008  Ki=0.54nM     // 3b5r.pdf (3B6) ligand is compound s-24; Ki=0.54+/-0.03nM
2vw2  1.70  2008  Ki=0.5mM      // 2vw1.pdf (NHE)
3bkl  2.18  2008  Ki=0.679uM    // 3bkk.pdf (KAW)
2ri9  1.95  2008  Ki=0.6mM      // 2ri9.pdf (LDY)
2qnq  2.30  2008  Ki=0.77uM     // 2pqz.pdf (QN3) ligand is inhibitor 6cd
2qmg  1.89  2008  Ki=0.7nM      // 2qmg.pdf (SC6) ligand is inhibitor 11; cell line IC50=21nM
3d91  2.20  2008  Ki=0.7nM      // 3d91.pdf (REM) ligand is compound 12 (remikiren)
2qd7  1.11  2008  Ki=0.80nM     // 2qci.pdf (065) Ki=0.80+/-0.06nM
2rkf  1.80  2008  Ki=0.83nM     // 2rkf.pdf (AB1) Ki=0.83+/-0.11nM
3bkk  2.17  2008  Ki=0.83uM     // 3bkk.pdf (KAF)
2qd8  1.35  2008  Ki=0.85nM     // 2qci.pdf (065) Ki=0.85+/-0.15nM
3cke  2.40  2008  Ki=0.8uM      // 3bnx.pdf (FDF)
3bgb  1.90  2008  Ki=0.9uM      // 3bgb.pdf (LJG) ligand is compound 9b
2vqt  2.10  2008  Ki=1.0uM      // 2vjx.pdf (15A) ligand is compound 2a
3c2u  1.30  2008  Ki=1.25mM     // 3c2u.pdf (B3P) Ki=1.25+/-0.03mM(pH=8.0)
3b67  1.90  2008  Ki=1.4nM      // 3b5r.pdf (B67) ligand is compound c-23; Ki=1.4+/-0.3nM
3e93  2.00  2008  Ki=1.4nM      // 3e92.pdf (19B) ligand is compound 19, Ki=1.4nM
2r3t  1.80  2008  Ki=1.4uM      // 2r38.pdf (G4G) compound 9 in complex with HIV-1 protease I50V
2zcq  2.38  2008  Ki=1.5nM      // 2zcp.pdf (B65) IC50=100~300nM
3d1z  1.30  2008  Ki=1.6nM      // 3cyw.pdf (017) Ki=1.6+/-0.1nM
3b5r  1.80  2008  Ki=1.7nM      // 3b5r.pdf (B5R) ligand is compound c-31; Ki=1.7+/-0.2nM
3bqc  1.50  2008  Ki=1.85uM     // 3bqc.pdf (EMO) crystal structure in high pH
2vkm  2.05  2008  Ki=1.8nM      // 2vkm.pdf (BSD) inhibitor 24; IC50=1nM in Chinese hamster cells
2rkd  1.90  2008  Ki=1.9mM      // 2rk7.pdf (3PP) ligand is analogue 12, Ki=1.9+/-0.4mM
3ckz  1.90  2008  Ki=1.9nM      // 3ckz.pdf (ZMR) relative Ki=1.9*0.1nM
2qg0  1.85  2008  Ki=1.9uM      // 2qf6.pdf (A94) Ki=1.9+/-0.2uM
3cyx  1.20  2008  Ki=10nM       // 3cyw.pdf (ROC) Ki=10+/-1nM
3e92  2.00  2008  Ki=10nM       // 3e92.pdf (G6A) ligand is compound 6, Ki=10nM
2vjx  1.85  2008  Ki=11uM       // 2vjx.pdf (IFL) ligand is compound 6
3cf8  2.40  2008  Ki=12.7uM     // 3cf8.pdf (QUE) IC50=39.3+/-2.7uM, Ki=12.7+/-0.6uM
2uy0  1.76  2008  Ki=120nM      // 2uxz.pdf (HV1) ligand is compound 15
3bl0  1.90  2008  Ki=121nM      // 3bl0.pdf (BL0) ligand is compound 5
2qw1  1.70  2008  Ki=125uM      // 2qw1.pdf (3MG) Ki=125+/-15uM
3d7z  2.10  2008  Ki=12nM       // 3d7z.pdf (GK5) ligand is compound 3, IC50=75nM
2zcr  1.92  2008  Ki=135nM      // 2zcp.pdf (B69)
2zn7  2.10  2008  Ki=13nM       // 2zmm.pdf (410)
2vo5  2.30  2008  Ki=13uM       // 2vjx.pdf (VBZ) ligand is compound 4a
3d4z  1.39  2008  Ki=13uM       // 3d4y.pdf (GIM)
3ewj  1.80  2008  Ki=143nM      // 3ewj.pdf (642) ligand is compound 21
3dd8  1.90  2008  Ki=14nM       // 3dd8.pdf (2C7)
2r9x  1.90  2008  Ki=14uM       // 2pu2.pdf (WH6)
2ra0  2.30  2008  Ki=15.9nM     // 2ra0.pdf (JNJ) ligand is compound 51a
3c88  1.60  2008  Ki=157nM      // 3c88.pdf (5-mer)
3czv  2.00  2008  Ki=16nM       // 3czv.pdf (AZM) Ki=16+/-0.7nM
3fas  1.40  2008  Ki=171nM      // 3fas.pdf (GLU)
3cyw  1.40  2008  Ki=17nM       // 3cyw.pdf (017) Ki=17+/-2nM
3d50  1.79  2008  Ki=17uM       // 3d4y.pdf (OEV)
2zc9  1.58  2008  Ki=180nM      // 2zc9.pdf (22U) ligand is compound 2, Ki=180+/-140nM
2zgx  1.80  2008  Ki=180nM      // 2zc9.pdf (29U) ligand is compound 4, Ki=180+/-30nM
3b7u  1.90  2008  Ki=18nM       // 3b7u.pdf (KEL) ligand is KELatorphan
2rka  1.95  2008  Ki=1mM        // 2rk7.pdf (PGA) ligand is analogue 13, Ki=1.0+/-0.04mM
2p4y  2.25  2008  Ki=1nM        // 2p4y.pdf (C03)
2r43  1.58  2008  Ki=1uM        // 2r38.pdf (G3G) compound 8 in complex with HIV-1 protease I50V
3ddg  1.74  2008  Ki=1uM        // 3ddf.pdf (GB7) ligand is compound 12, measured at 20C
2pqz  1.55  2008  Ki=2.15uM     // 2pqz.pdf (G0G) ligand is inhibitor 6ad
2qd6  1.28  2008  Ki=2.1nM      // 2qci.pdf (065) Ki=2.1+/-0.4nM
2q8z  1.80  2008  Ki=2.1uM      // 2q8z.pdf (NUP) Ki=2.1uM (source pf); Ki=0.84+/-0.025uM (source mt)
3d1x  1.05  2008  Ki=2.2nM      // 3cyw.pdf (ROC) Ki=2.2+/-0.3nM
3bl1  2.10  2008  Ki=2.52uM     // 3bl1.pdf (BL1) ligand is compound 10
3b66  1.65  2008  Ki=2.5nM      // 3b5r.pdf (B66) ligand is compound s-21; Ki=2.5+/-0.2nM
3b7r  1.81  2008  Ki=20nM       // 2r59.pdf (BIR) Ki=20+/-4nM for inhibitor RB3040
2ves  1.90  2008  Ki=20nM       // 2ves.pdf (GVR)
1w0z  1.90  2008  Ki=21nM       // 1w0z.pdf (SI1)
3cs7  2.20  2008  Ki=21pM       // 3cs7.pdf (LG0) ligand is compound 2r
2yz3  2.30  2008  Ki=220nM      // 2yz3.pdf (M5P)
3ddf  1.20  2008  Ki=22uM       // 3ddf.pdf (GB6) ligand is compound 11, measured at 20C
2rk8  2.00  2008  Ki=230uM      // 2rk7.pdf (PPF) ligand is analogue 10, Ki=230+/-14uM
3dln  1.91  2008  Ki=249nM      // 3dln.pdf (GLU) ligand is glutamate
2pvl  1.90  2008  Ki=24nM       // 2pvh.pdf (P55)
3be9  2.00  2008  Ki=24nM       // 3be9.pdf (P04) ligand is compound 10; IC50=0.29uM (HCT116), IC50=0.88uM (PC3)
2zmm  2.10  2008  Ki=25nM       // 2zmm.pdf (35B) ligand is compound 8
2v54  2.40  2008  Ki=25uM       // 2v54.pdf (TYD) Ki=25+/-5uM
3djk  1.00  2008  Ki=26pM       // 3djk.pdf (G55) ligand is compound 3d, Ki=26pM, IC50=5nM
1w13  2.00  2008  Ki=2nM        // 1w0z.pdf (SM1)
2vj8  1.80  2008  Ki=2nM        // 2vj8.pdf (HA2) peptidase activity Ki=0.002uM, Epoxide hydrolase activity IC50=0.15uM
3eqr  2.00  2008  Ki=2nM        // 3eqp.pdf (T74) ligand is compound 2; Ki=0.002uM; IC50=0.01uM in cell lines
3d4y  1.52  2008  Ki=2uM        // 3d4y.pdf (MVL)
2vh0  1.70  2008  Ki=3.1nM      // 2vh0.pdf (GSI) ligand is compound 15
2uxz  1.75  2008  Ki=3.3nM      // 2uxz.pdf (HI1) ligand is compound 12d
2q6f  2.00  2008  Ki=3.6uM      // 2q6f.pdf (6-mer) Ki=3.6+/-0.4uM (IBV Mpro/N3); Ki=2.6+/-0.3uM(IBV Mpro/N27); Ki=2.8+/-0.2uM(IBV Mpro/H16)
2za5  2.30  2008  Ki=3.7nM      // 2za5.pdf (2FF) Ki=3.7+/-0.5nM; IC50=3.6+/-0.3nM
3bft  2.27  2008  Ki=323nM      // 3bft.pdf (S2P) Ki=323+/-84nM
2qhy  1.85  2008  Ki=33nM       // 2qhy.pdf (MZ1) ligand is inhibitor 12h
3cm2  2.50  2008  Ki=340nM      // 3clx.pdf (X23) Fluorescence IC50=970+/-120nM, Cheng-Prusoff, Kenakin, Huang get Ki=870, 420, 340nM
2pu2  1.86  2008  Ki=37uM       // 2pu2.pdf (DK2) IC50(R)=70uM, Ki(S)=158uM, Ki(R)=140uM
3bgs  2.10  2008  Ki=380pM      // 2q7o.pdf (DIH) ligand is compound 4
2qg2  1.80  2008  Ki=4.0uM      // 2qf6.pdf (A91) Ki=4.0+/-1.0uM
3d83  1.90  2008  Ki=4.4nM      // 3d83.pdf (GK6) ligand is compound 8
3bv9  1.80  2008  Ki=4.4uM      // 3bv9.pdf (6-mer) Ki=4.4+/-2.4uM; IC50=6.9+/-1.2uM
2qci  1.20  2008  Ki=4.6nM      // 2qci.pdf (065) Ki=4.6+/-0.7nM
2qi0  2.10  2008  Ki=42nM       // 2qhy.pdf (MZ3) ligand is inhibitor 11b
2vvs  2.24  2008  Ki=46nM       // 2vvs.pdf (OAN)
2r2m  2.10  2008  Ki=47.1nM     // 2r2m.pdf (I50) ligand is compound 1
2qtt  1.93  2008  Ki=48uM       // 2qtg.pdf (FMC) Ki=48+/-5uM; ligand in reference is referred to as Formycin A (FMA)
2vsl  2.10  2008  Ki=4nM        // 2vsl.pdf (4-mer) Ki=4+/-2nM; IC50=406+/-37nM
2zda  1.73  2008  Ki=4nM        // 2zc9.pdf (32U) ligand is compound 5, Ki=4+/-1.2nM
3b68  1.90  2008  Ki=4nM        // 3b5r.pdf (B68) ligand is compound s-4; Ki=4+/-0.7nM
3d0e  2.00  2008  Ki=4nM        // 3d0e.pdf (G93) IC50=13nM
3dyo  1.80  2008  Ki=5.0mM      // 3dyo.pdf (IPT) measured with 0.01mM Mg2+
3e5a  2.30  2008  Ki=5.9nM      // 3e5a.pdf (VX6)
2qi1  2.00  2008  Ki=50nM       // 2qhy.pdf (MZ4) ligand is inhibitor 11c
3d52  1.60  2008  Ki=520uM      // 3d4y.pdf (GHR)
3bfu  1.95  2008  Ki=531nM      // 3bft.pdf (R2P) Ki=531+/-98nM
2qhz  1.85  2008  Ki=53nM       // 2qhy.pdf (MZ2) ligand is inhibitor 12j
2ole  2.40  2008  Ki=56.2nM     // 2ole.pdf (KR2) compound 10f; Ki=56.2nM; IC50=70nM
2jkp  1.99  2008  Ki=59uM       // 2jke.pdf (CTS) ligand is castanospermine 2
2jke  1.70  2008  Ki=59uM       // 2jke.pdf (NOJ) ligand is deoxynojirimycin 1
2pvk  1.90  2008  Ki=5nM        // 2pvh.pdf (P45)
2rd6  2.30  2008  Ki=5nM        // 2rd6.pdf (78P) ligand is compound 4a
2vk6  1.50  2008  Ki=5uM        // 2vk6.pdf (DAN) Ki=5uM(pH=7); Ki=40uM(pH=5)
2r59  1.89  2008  Ki=6.5nM      // 2r59.pdf (PH0) Ki=6.5+/-1nM for inhibitor RB3041
2zfp  2.25  2008  Ki=6.8uM      // 2zc9.pdf (19U) ligand is compound 1, Ki=6.8+/-1.5uM
3b7j  2.40  2008  Ki=6.8uM      // 3b7j.pdf (JUG) Ki=6.8uM; IC50=30+/-4uM
2epn  1.61  2008  Ki=60nM       // 2epn.pdf (NGT) Ki=60+/-17nM
3c8a  1.52  2008  Ki=660nM      // 3c88.pdf (5-mer)
1w11  2.00  2008  Ki=6nM        // 1w0z.pdf (SK1)
2zcs  2.03  2008  Ki=6nM        // 2zcp.pdf (B70)
3d1y  1.05  2008  Ki=6nM        // 3cyw.pdf (ROC) Ki=6+/-1nM
3b4f  1.89  2008  Ki=7.2nM      // 3b4f.pdf (TUO) ligand is compound 5
2pq9  1.60  2008  Ki=7.8nM      // 2pq9.pdf (GG9) Ki=7.8+/-0.5nM
2e9u  2.00  2008  Ki=7.94nM     // 2e9u.pdf (A25) -logKi=8.1 in in supporting information
3d51  1.43  2008  Ki=70uM       // 3d4y.pdf (GOX)
2vot  1.95  2008  Ki=72nM       // 2vjx.pdf (NHV) ligand is compound 1c
3c8b  1.47  2008  Ki=786nM      // 3c88.pdf (5-mer)
2rkg  1.80  2008  Ki=8.2nM      // 2rkf.pdf (AB1) Ki=8.2+/-0.7nM
2qtg  1.84  2008  Ki=8.3uM      // 2qtg.pdf (MTH) Ki=8.3+/-1.2uM
2v77  1.60  2008  Ki=8.7uM      // 2v77.pdf (PAY)
2rke  1.80  2008  Ki=82.5uM     // 2rk7.pdf (SAT) ligand is analogue 23, Ki =82.5+/-5uM
3cl0  2.20  2008  Ki=84.8nM     // 3ckz.pdf (G39) relative Ki=265*0.32nM
3c89  1.58  2008  Ki=845nM      // 3c88.pdf (5-mer)
2pvj  1.70  2008  Ki=8nM        // 2pvh.pdf (P44)
2r9w  1.80  2008  Ki=8uM        // 2pu2.pdf (23C)
3bgc  1.80  2008  Ki=9.6uM      // 3bgb.pdf (LJH) ligand is compound 6d
2vnt  2.20  2008  Ki=9.9nM      // 2vnt.pdf (QGG) compound 33 or 34, preference for the R-isomer, QGG(R) Ki=9.9nM, (S)Ki=111nM
3f3c  2.10  2008  Ki=950nM      // 3f3a.pdf (PFF) Ki=950+/-100nM
2vl4  1.90  2008  Ki=975nM      // 2vjx.pdf (MNM) ligand is compound 5
2wjg  2.20  2009  Kd=0.08uM     // 2wjg.pdf (GDP)
2vk2  1.20  2009  Kd=0.13uM     // 2vk2.pdf (GZL) inferred affinity of YtfQ for galactofuranose is Kd=0.13uM
3fzy  1.95  2009  Kd=0.18uM     // 3fzy.pdf (IHP) Kd=0.18+/-0.02uM
3a1c  1.85  2009  Kd=0.1mM      // 3a1c.pdf (ACP)
3drf  1.30  2009  Kd=0.1uM      // 3drf.pdf (8-mer)
3drg  2.50  2009  Kd=0.1uM      // 3drf.pdf (9-mer)
3el1  1.70  2009  Kd=0.23nM     // 3ekp.pdf (DR7) ligand is atazanavir; Kd=0.23+/-0.12nM
3jvs  1.90  2009  Kd=0.29uM     // 3jvr.pdf (AGY) ligand is compound 3, Kd=0.29+/-0.07uM
3bwj  2.30  2009  Kd=0.319uM    // 3bwj.pdf (ARX) ligand is compound 1; Kd=0.319+/-0.057uM; IC50=2.6+/-0.3uM
3g3r  2.00  2009  Kd=0.33uM     // 3g3r.pdf (ANP) Vtc4p*-AppNHp-Mn2+, Kd=0.33+/-0.04uM
3ekx  1.97  2009  Kd=0.39nM     // 3ekp.pdf (1UN) ligand is NFV; Kd=0.39+/-0.07nM
3ekv  1.75  2009  Kd=0.39nM     // 3ekp.pdf (478) ligand is amprenavir; Kd=0.39+/-0.20nM
3fvh  1.58  2009  Kd=0.447uM    // 3c5l.pdf (7-mer) Kd=0.447+/-0.110uM
3ed0  2.30  2009  Kd=0.45uM     // 3ed0.pdf (EMO) Kd=0.45uM(ITC); Kd=4.59uM(SPR); Ki=1.9+/-0.3uM; IC50=9.7+/-1.0uM
3f33  1.70  2009  Kd=0.46mM     // 3f33.pdf (PFL) ligand is compound 1; binding data in suppl info
3f34  1.68  2009  Kd=0.69mM     // 3f33.pdf (DIE) ligand is compound 5(2); binding data in suppl info
2zym  1.80  2009  Kd=0.73uM     // 2zym.pdf (ACX) Kd=0.73+/-0.02uM
3gnw  2.39  2009  Kd=0.79nM     // 3gnv.pdf (XNC) NS5B in complex with (S)-4c; Kd=0.79nM, IC50=0.026uM
2v58  2.10  2009  Kd=0.82nM     // 2v58.pdf (LZJ) ligand is inhibitor 1, Kd=0.82+/-0.22nM(SPR); Kd<5.0nM(ITC).
3iw5  2.50  2009  Kd=0.839uM    // 3iw5.pdf (DF3) ligand is compound 14, Kd=0.839+/-0.145uM
3e12  1.70  2009  Kd=1.02uM     // 3e0i.pdf (KD0) Kd=1.02+/-0.01uM(pH=7.5); Kd=1.94+/-0.01uM(pH=5.0)
2w8j  1.50  2009  Kd=1.1mM      // 2w8j.pdf (PLS) Kd=1.1+/-0.1mM
3i9g  1.90  2009  Kd=1.1nM      // 3i9g.pdf (S1P) S1P:LT1009 Fab complex, Kd=1.1+/-0.1nM(50uM Ca2+), Kd=130+/-30nM (without Ca2+)
2weq  2.20  2009  Kd=1.27uM     // 2wep.pdf (GDM) Kd=1.27+/-0.09uM
3ekp  2.15  2009  Kd=1.3nM      // 3ekp.pdf (478) ligand is amprenavir; Kd=1.3+/-0.01nM
3h1x  1.40  2009  Kd=1.3uM      // 3h1x.pdf (IMN) ligand is indomethacin; Kd=1.3+/-0.2uM
3iue  1.73  2009  Kd=1.5uM      // 3imc.pdf (FG3) ligand is compound 4
3ivx  1.73  2009  Kd=1.8uM      // 3imc.pdf (FG6) ligand is compound 8
2w47  1.40  2009  Kd=10.5uM     // 2vzq.pdf (UNF) Ka=9.5x10+4M-1
3ekw  1.60  2009  Kd=10.9nM     // 3ekp.pdf (DR7) ligand is atazanavir; Kd=10.9+/-1.60nM
3ime  2.39  2009  Kd=1000uM     // 3imc.pdf (BZ2) ligand is compound 5
2wzf  2.10  2009  Kd=100nM      // 2wzf.pdf (UDP-BGC)
2whp  2.20  2009  Kd=100uM      // 2whp.pdf (HI6) Ki=31+/-2uM
3ijh  2.10  2009  Kd=100uM      // 3ijh.pdf (KO2) Fab fragment of S67-27 complex Ko, Kd=1000x10-7M
3hv8  1.45  2009  Kd=104.2nM    // 3hv8.pdf (C2E) ligand is c-di-GMP
3gkz  1.90  2009  Kd=10nM       // 3gkz.pdf (B40) scFv6H4 in complex with METH
3gvu  2.05  2009  Kd=10nM       // 3gvu.pdf (STI) ligand is imatinib
2vxn  0.82  2009  Kd=10uM       // 2vxn.pdf (PGH)
3cfn  1.87  2009  Kd=10uM       // 3cfn.pdf (2AN)
3imc  1.60  2009  Kd=1100uM     // 3imc.pdf (BZ3) ligand is compound 1
2weh  2.10  2009  Kd=1125nM     // 2weg.pdf (FB1) ligand is compound 5
2weo  1.40  2009  Kd=118nM      // 2weg.pdf (FBW) ligand is compound 3
3evd  1.50  2009  Kd=124nM      // 3eva.pdf (GTP) Kd=124+/-6nM; Ki=40+/-10nM
2wor  1.70  2009  Kd=125uM      // 2wor.pdf (2AN) S100A7 with 1,8 ANS, Kd=125+/-11uM
2wos  1.70  2009  Kd=125uM      // 2wor.pdf (6AN) S100A7 with 2,6 ANS, Kd=125+/-11uM
2w4x  2.42  2009  Kd=14uM       // 2w4x.pdf (STZ) Kd=14+/-0.4uM
3f70  2.10  2009  Kd=14uM       // 3f70.pdf (MLZ) L3MBTL2-H4K20me1 complex, Kd=14+/-0.2uM
3gcp  2.25  2009  Kd=15nM       // 3gcp.pdf (SB2) ligand is SB203580
2zwz  2.36  2009  Kd=16.3nM     // 2zwz.pdf (ZWZ) ligand is compound 1; Kd=16.3+/-2.5nM; Ki=16.3nM
3gcu  2.10  2009  Kd=165nM      // 3gcp.pdf (R48) ligand is compound 11d; Kd=165+/-58nM
3bpc  1.85  2009  Kd=16uM       // 3bpc.pdf (2-mer) ligand is KDA-KDB
3dsz  2.00  2009  Kd=17.1nM     // 3dsz.pdf (LIZ) Kd=17.1+/-2nM for Tb7.N9 structure, Kd=13.2+/-1.5nM for Tb7.N9.N34
3gm0  2.40  2009  Kd=17nM       // 3gkz.pdf (B41) scFv6H4 in complex with MDMA
3el5  1.60  2009  Kd=18.9nM     // 3ekp.pdf (1UN) ligand is NFV; Kd=18.9+/-0.25nM
3dgo  2.50  2009  Kd=180nM      // 3dgl.pdf (ATP) Kd=180+/-30nM
3fjg  2.20  2009  Kd=187uM      // 3fir.pdf (3PG)
2v59  2.40  2009  Kd=18nM       // 2v58.pdf (LZK) ligand is inhibitor 2, Kd=6.53+/-0.64nM(SPR); Kd=18+/-9nM(ITC).
3fuc  1.45  2009  Kd=190pM      // 3fuc.pdf (9D9&9DG) PNP in complex with DFPP-DG, Kd=190+/-90pM
3fj7  1.70  2009  Kd=195uM      // 3fir.pdf (PEQ) PEP and PEQ are the same ligands
2wf5  1.30  2009  Kd=1uM        // 2wf5.pdf (BG6)
3elc  2.50  2009  Kd=2.02mM     // 3elc.pdf (F01) Kd=2.02+/-0.42mM measured at 10C
3a1e  1.95  2009  Kd=2.2mM      // 3a1c.pdf (ACP)
3fwv  2.20  2009  Kd=2.3uM      // 3fwv.pdf (6-mer) TPR Protein, T-MOD(VMY) in complex with MEEVF peptide
3f37  1.54  2009  Kd=2.4mM      // 3f33.pdf (2MY) ligand is compound 8(2); binding data in suppl info
3e3c  2.50  2009  Kd=2.4uM      // 3e3c.pdf (HHG)
3e6y  2.50  2009  Kd=2.5uM      // 3e6y.pdf (CW1) ligand is cotylenin A
3jup  1.90  2009  Kd=2.63uM     // 3jum.pdf (AKD) ligand is compound S-1, Kd=2.63+/-1.1uM
3kjd  1.95  2009  Kd=2.9nM      // 3kcz.pdf (78P) ligand is inhibitor ABT-888
3dp9  2.30  2009  Kd=208pM      // 3dp9.pdf (BIG) Kd=208+/-46pM; IC50=6+/-1nM
3g0e  1.60  2009  Kd=20nM       // 3g0e.pdf (B49) KIT kinase domain in complex with sunitinib, Kd=20+/-13nM
3isj  2.20  2009  Kd=210uM      // 3imc.pdf (A8D) ligand is compound 2
3ioc  2.50  2009  Kd=210uM      // 3iob.pdf (A5D) ligand is compound PS-14a, Kd=210+/-20uM
3g19  1.85  2009  Kd=214nM      // 3g19.pdf (3-mer) ligand is LLL tripeptide
3d78  1.60  2009  Kd=23nM       // 3cyz.pdf (NBB) Kd=23+/-4nM
3ekt  1.97  2009  Kd=26pM       // 3ekp.pdf (017) ligand is DRV; Kd=26+/-10pM; same as 6dh0
2zq2  1.40  2009  Kd=276nM      // 2zdk.pdf (13U) ligand is compound 1d(open form); Kd=276+/-76nM; Ki=102+/-18nM
2zfs  1.51  2009  Kd=287nM      // 2zdk.pdf (12U) ligand is compound 1c(closed form); Kd=287+/-48nM; Ki=81+/-39nM
3iub  1.50  2009  Kd=29uM       // 3imc.pdf (FG2) ligand is compound 3
3fhb  2.30  2009  Kd=2uM        // 3c49.pdf (GAB)
2wn9  1.75  2009  Kd=3.0nM      // 2wn9.pdf (ZY5) Kd=3.0+/-0.096nM
3da9  1.80  2009  Kd=3.1uM      // 3da9.pdf (44U) IC50=18uM
3iw6  2.10  2009  Kd=3.29uM     // 3iw5.pdf (PP0) ligand is compound 10, Kd=3.29+/-0.64uM
3ga5  1.87  2009  Kd=3.2uM      // 3ga5.pdf (RGG) Salmonella GBP in complex with GGal; binding data found in another reference
2zft  1.76  2009  Kd=300nM      // 2zdk.pdf (10U) ligand is compound 1a(closed form); Kd1=300+/-34nM(Tris); Kd2=316+/-60nM(Tricine); Kd3=301+/-43M(Hepes); Kd4=245+/-38nM(PPi); Ki=117+/-25nM
2weg  1.10  2009  Kd=314nM      // 2weg.pdf (FBV) ligand is compound 2
2wnj  1.80  2009  Kd=330nM      // 2wn9.pdf (ZY7) Kd=330+/-58nM
3gx0  2.30  2009  Kd=330uM      // 3gx0.pdf (GDS) GST-like protein yfcG in complex with GSH, Kd=330+/-10uM
3dri  1.80  2009  Kd=37.7uM     // 3drf.pdf (6-mer)
2we3  2.00  2009  Kd=37uM       // 2we0.pdf (DUT)
2w08  1.70  2009  Kd=380uM      // 2w08.pdf (TPO)
3iob  1.80  2009  Kd=380uM      // 3iob.pdf (A4D) ligand is compound PS-6, Kd=380+/-30uM
3el9  1.60  2009  Kd=4.00nM     // 3ekp.pdf (DR7) ligand is atazanavir; Kd=4.00+/-0.21nM
3jzh  2.05  2009  Kd=400uM      // 3jpx.pdf (5-mer)
2w9h  1.48  2009  Kd=430nM      // 2w9h.pdf (TOP) Kd=430nM(without NADPH); Kd=0.97nM(with 200uM NADPH)
3kv2  1.55  2009  Kd=47.51nM    // 3kv2.pdf (NNH) nor-NOHA (Nx-hydroxy-nor-Larginine), Kd=517nM(SPR), Kd=47.51nM(ITC)
2wnc  2.20  2009  Kd=479nM      // 2wn9.pdf (TKT) Kd=479+/-57nM
2wc4  1.70  2009  Kd=5.1uM      // 2wbg.pdf (AMF) ligand is compound 9
3ivg  1.95  2009  Kd=50uM       // 3imc.pdf (FG5) ligand is compound 7
2wuf  1.90  2009  Kd=51uM       // 2wue.pdf (KEM) ligand is compound DSHA; Kd=51+/-2uM
2vzr  1.95  2009  Kd=52.6uM     // 2vzq.pdf (GCU) Ka=1.9x10+4M-1
3a6t  1.96  2009  Kd=52nM       // 3a6s.pdf (8OG) MutT in complex with 8-OXO-DGMP
3jrs  2.05  2009  Kd=52uM       // 3jrq.pdf (A8S) (+)-ABA-bound PYL1, Kd=52uM(ITC), Kd=340uM(SPR)
3ioe  1.95  2009  Kd=540uM      // 3iob.pdf (A7D) ligand is compound PS-14b, Kd=540+/-20uM
3cz1  1.50  2009  Kd=55.0nM     // 3cyz.pdf (NBB) Kd=55.0+/-8.0nM
3gcs  2.10  2009  Kd=56nM       // 3gcp.pdf (BAX) ligand is sorafenib; Kd=56+/-5nM
3h78  1.70  2009  Kd=57uM       // 3h77.pdf (BE2) PqsD C112A mutant in complex with 2-AMINOBENZOIC ACID
3cyz  1.80  2009  Kd=60.0nM     // 3cyz.pdf (9OD) Kd=60.0+/-15.0nM
3dzt  1.80  2009  Kd=60.2nM     // 3dye.pdf (EAH) Kd=60.2+/-10.5nM
3cft  1.87  2009  Kd=64uM       // 3cfn.pdf (5NS) Kd=64+/-18uM
3el4  2.00  2009  Kd=67.4nM     // 3ekp.pdf (ROC) ligand is SQV; Kd=67.4+/-0.3nM
2w8w  2.14  2009  Kd=7.5mM      // 2w8j.pdf (PLS) Kd=7.5+/-0.5mM
3fql  1.80  2009  Kd=71nM       // 3fqk.pdf (79Z) ligand is compound HCV-796; Kd=71+/-28nM; IC50=81+/-19nM
3hww  1.95  2009  Kd=75nM       // 3hww.pdf (AKG) EcMenD oxoglutarate complex, Kd=7.5x10-8M (pH=7.5)
3a1d  1.85  2009  Kd=75uM       // 3a1c.pdf (ADP)
3ivc  2.13  2009  Kd=75uM       // 3imc.pdf (FG4) ligand is compound 6
2v57  1.90  2009  Kd=79nM       // 2v57.pdf (PRL) one proflavine to homodimer Kd1=79nM, two proflavine to monomer Kd2=4.3uM
3ifl  1.50  2009  Kd=8.4nM      // 3ifl.pdf (7-mer)
3juo  2.20  2009  Kd=8.55uM     // 3jum.pdf (AJD) ligand is compound R-1, Kd=8.55+/-2.6uM
3f78  1.60  2009  Kd=800uM      // 3f78.pdf (ICF)
3gk1  2.10  2009  Kd=80uM       // 3gk1.pdf (32A) ligand is compound SBi132+Ca2+ S100B, Kd=0.08+/-0.02mM
3iod  1.75  2009  Kd=80uM       // 3iob.pdf (A6D) ligand is compound PS-14b, Kd=80+/-10uM
2wej  1.45  2009  Kd=839nM      // 2weg.pdf (FB2) ligand is compound 1
3kr8  2.10  2009  Kd=8nM        // 3kr8.pdf (XAV) ligand is inhibitor XAV939, Kd=8+/-3nM
2wer  1.60  2009  Kd=90nM       // 2wep.pdf (RDC) Kd=90+/-0.007nM
3fzn  1.62  2009  Kd=97uM       // 3fzn.pdf (D7K) BFDC in complex with MBP, Kd=97+/-9uM
2wgj  2.00  2009  Ki=0.002uM    // 2wgj.pdf (VGH)
3g35  1.41  2009  Ki=0.021mM    // 3g2y.pdf (F13) ligand is compound 12(F13); Ki=0.021mM
3h89  2.50  2009  Ki=0.023uM    // 3h89.pdf (NSX) ligand is inhibitor 4
3f5k  1.80  2009  Ki=0.024mM    // 3aht.pdf (CE5) ligand is compound cellopentaose; Ki=0.024+/-0.02mM
2zjw  2.40  2009  Ki=0.02uM     // 2zjw.pdf (REF) IC50=0.04uM
2zy1  1.78  2009  Ki=0.04uM     // 2zy1.pdf (830) IC50=8nM
3f5j  1.95  2009  Ki=0.052mM    // 3aht.pdf (CTT) ligand is compound cellotetraose; Ki=0.052+/-0.06mM
3ikg  1.86  2009  Ki=0.057uM    // 3ikd.pdf (J8Z) ligand is compound 22b and Pin1 K77 82Q construct
3h5b  1.29  2009  Ki=0.099nM    // 3h5b.pdf (031) ligand is compound 19b; Ki=0.099nM; IC50=0.026nM
3jya  2.10  2009  Ki=0.1301uM   // 3jya.pdf (LWG) ligand is compound 3b
3fx6  1.85  2009  Ki=0.16uM     // 3fx6.pdf (BPX) CPA-R-5 complex; compound R-5 is incorrect in reference
3ikd  2.00  2009  Ki=0.179uM    // 3ikd.pdf (J9Z) ligand is compound 18b and Pin1 K77 82Q construct
3dk1  1.07  2009  Ki=0.18nM     // 3dk1.pdf (G05) ligand is compound 3; IC50=170nM
3f5l  1.37  2009  Ki=0.191mM    // 3aht.pdf (LB2) ligand is compound laminaribiose; Ki=0.191+/-0.02mM
3g32  1.31  2009  Ki=0.194mM    // 3g2y.pdf (3G3) ligand is compound 6(3G3); Ki=0.194mM
3gs6  2.30  2009  Ki=0.26uM     // 2wca.pdf (NP6)
3gsm  2.40  2009  Ki=0.33uM     // 2wca.pdf (VPU)
3fv3  1.85  2009  Ki=0.3nM      // 3fv3.pdf (6-mer) Sapp1p in complex with pepstatin A
3g0w  1.95  2009  Ki=0.3nM      // 3g0w.pdf (LGB) ligand is compound 6c, Ki=0.3+/-0.1nM
3g5k  1.70  2009  Ki=0.3nM      // 3g5k.pdf (BB2) ligand is compound 1(actinonin)
3ctt  2.10  2009  Ki=0.45uM     // 2jjb.pdf (3CU)
2wk6  2.50  2009  Ki=0.48mM     // 2wk6.pdf (IUR)
3h8b  1.80  2009  Ki=0.511uM    // 3h89.pdf (NSY) ligand is inhibitor 9
3hk1  1.70  2009  Ki=0.67uM     // 3hk1.pdf (B64) AFABP/aP2 complexed with 1, Ki=0.67+/-0.18uM
2wb5  2.31  2009  Ki=0.74nM     // 2wb5.pdf (VGB) ligand is GlcNAcstatins D; Ki=0.74+/-0.09nM
3ibu  1.41  2009  Ki=0.7nM      // 3ibi.pdf (O48) adducts of sulfamates 2 with hCA II
2w8y  1.80  2009  Ki=0.82nM     // 2w8y.pdf (486) Ki=0.82+/-0.01nM; binding data measured with rabbit protein; LBD of rabbit and human proteins are identical
2wc3  2.00  2009  Ki=0.83uM     // 2wbg.pdf (AM3) ligand is compound 8
3gba  1.35  2009  Ki=0.848nM    // 3gba.pdf (DYH) ligand is compound DH; Ki=0.848+/-0.150nM.
3ffg  1.54  2009  Ki=0.84nM     // 3ffg.pdf (FFG) ligand is compound 5d
3hb4  2.21  2009  Ki=0.9nM      // 3hb4.pdf (E2B) Ki=0.9+/-0.15nM; IC50=42nM
3iss  2.50  2009  Ki=0.9uM      // 3iss.pdf (EPU) MurA3 UDP-MurNAc3 phosphite structure
3g34  1.31  2009  Ki=1.1mM      // 3g2y.pdf (1CE) ligand is compound 11(1CE); Ki=1.1mM
3dcc  1.60  2009  Ki=1.1nM      // 3d8w.pdf (D9Z) ligand is inhibitor CHL, Ki=1.1+/-0.2nM
3ebp  2.00  2009  Ki=1.24uM     // 3ebo.pdf (CPB) ligand is Flavopiridol
3egt  2.00  2009  Ki=1.26nM     // 3dyf.pdf (722)
3g31  1.70  2009  Ki=1.3mM      // 3g2y.pdf (GF1) ligand is compound 4(GF1); Ki=1.3mM
3ehy  1.90  2009  Ki=1.4uM      // 3ehx.pdf (TBL) ligand is compound 2; Ki=1.4+/-0.2uM
2zxg  1.55  2009  Ki=1.5nM      // 2zxg.pdf (S23) crystal structure(E. coli APN); Ki=1.5+/-0.2nM(E. coli APN); Ki=2.2+/-0.5nM(Hog kidney APN)
3fcq  1.75  2009  Ki=1.7mM      // 3f28.pdf (M3S) ligand is compound 9
2wkz  1.70  2009  Ki=1.7nM      // 2wkz.pdf (5AH)
3jvr  1.76  2009  Ki=1.89uM     // 3jvr.pdf (AGX) ligand is compound 2, Ki=1.89+/-0.32uM
3djq  1.53  2009  Ki=1046.4uM   // 3djo.pdf (UDP) Ki=1046.4+/-50.2uM
3g2y  1.31  2009  Ki=10mM       // 3g2y.pdf (GF4)
2vwn  1.61  2009  Ki=10nM       // 2vvc.pdf (H25) ligand is compound 14
3fur  2.30  2009  Ki=10nM       // 3fur.pdf (Z12) PPARg with INT131, displace [3H]-rosiglitazone with a Ki of 10 nM
3hs4  1.10  2009  Ki=10nM       // 3hs4.pdf (AZM)
3gbe  1.70  2009  Ki=10uM       // 3gbd.pdf (NOJ) SmuA in complex with the inhibitor deoxynojirimycin
3daz  1.60  2009  Ki=11.8nM     // 3d8w.pdf (MZM) ligand is inhibitor MZM, Ki=11.8+/-1.8nM
3iww  2.30  2009  Ki=11nM       // 3iww.pdf (YZE) GCPII in complex with compound 32d
2w67  2.25  2009  Ki=11uM       // 2w66.pdf (F34) ligand is compound 5, Ki=11+/-1uM
3gbb  2.10  2009  Ki=126nM      // 3gba.pdf (MS8) ligand is compound MSV-19; Ki=126+/-45nM.
2jjb  1.90  2009  Ki=12nM       // 2jjb.pdf (3CU+GLC) compound 2; casuarine 6-O-a-glucopyranoside
3eft  1.85  2009  Ki=12nM       // 3eft.pdf (3BS)
3eax  1.90  2009  Ki=12uM       // 3eax.pdf (LZP) ligand is compound LZP6, Ki=12+/-0.6uM; IC50=16+/-2uM
3hig  2.09  2009  Ki=13nM       // 3hig.pdf (BRN) human diamine oxidase in complex with Berenil, Ki=13+/-1nM
3ibl  1.55  2009  Ki=14.6nM     // 3ibi.pdf (O59) adducts of sulfamates 3 with hCA II
2wzs  2.25  2009  Ki=140uM      // 2wvz.pdf (MVL) ligand is mannoimidazole
3i7e  1.70  2009  Ki=14pM       // 3i6o.pdf (DJR) ligand is compound 2, Ki=14pM, IC50=1.2nM
3dx2  1.40  2009  Ki=150nM      // 3dx0.pdf (MZB) ligand is compound 2
3djx  1.69  2009  Ki=1557.9uM   // 3djo.pdf (C5P) Ki=1557.9+/-84.3uM
3eb1  2.40  2009  Ki=16.3uM     // 3eax.pdf (LZQ) ligand is compound LZP25, Ki=16.3+/-1.1uM; IC50=20+/-5uM
2wl0  1.90  2009  Ki=16nM       // 2wkz.pdf (5AH)
3dnd  2.26  2009  Ki=16uM       // 3dnd.pdf (LL2) ligand B
3ggu  1.80  2009  Ki=170pM      // 3ggt.pdf (017) PRDRV5 in complex with darunavir, Ki=170+/-20pM
3d6p  1.60  2009  Ki=179uM      // 3d6o.pdf (U2S) Ki=179+/-3uM
3ebo  1.90  2009  Ki=19.01uM    // 3ebo.pdf (57D) ligand is Chrysin
3f6g  2.00  2009  Ki=19uM       // 3f6g.pdf (ILE)
3dd0  1.48  2009  Ki=1nM        // 3d8w.pdf (EZL)
3d9z  1.65  2009  Ki=2.0nM      // 3d8w.pdf (D9Z) ligand is inhibitor CHL, Ki=2.0+/-0.4nM
2wky  2.20  2009  Ki=2.57nM     // 2wky.pdf (IBC)
2wca  2.30  2009  Ki=2.5uM      // 2wca.pdf (NP6)
3kgp  2.35  2009  Ki=2.68mM     // 3kgp.pdf (4AZ) ligand is inhibitor AMBA
3gvb  1.80  2009  Ki=2.6mM      // 3gqz.pdf (3GV) ligand is compound 8
3ibi  1.93  2009  Ki=2.6nM      // 3ibi.pdf (BOW) adducts of sulfamates 1 with hCA II
3ejq  1.45  2009  Ki=2.7nM      // 3ejp.pdf (HN3) ligand is compound 3; IC50=29nM
3ejr  1.27  2009  Ki=2.7nM      // 3ejp.pdf (HN4) ligand is compound 4; IC50=29nM
3ejp  1.32  2009  Ki=2.8nM      // 3ejp.pdf (HN2) ligand is compound 2; IC50=30nM
3ewc  2.11  2009  Ki=20nM       // 3ewc.pdf (MCF) Ki=20+/-5nM
3fee  1.56  2009  Ki=230nM      // 3fec.pdf (QUS) Ki=230+/-24nM
2zx8  2.33  2009  Ki=231.4pM    // 2zwz.pdf (ZX8)
3hl7  1.88  2009  Ki=23nM       // 3hl7.pdf (I47) ligand is SD-0006, Ki=0.023uM
3ibn  2.20  2009  Ki=24.5nM     // 3ibi.pdf (O60) adducts of sulfamates 4 with hCA II
3iph  2.10  2009  Ki=25.1nM     // 3iph.pdf (G11) p38 in complex with inhibitor 11, Ki=25.1nM
2zx6  2.42  2009  Ki=25.1pM     // 2zwz.pdf (ZX6)
3g0i  2.10  2009  Ki=250uM      // 3g0i.pdf (VPR) Aspergillus niger epoxide hydrolase in complex with valpromide
3ehx  1.90  2009  Ki=25nM       // 3ehx.pdf (BDL) ligand is compound 1; Ki=25+/-2nM
3gc4  1.80  2009  Ki=25nM       // 3eos.pdf (AAQ) ligand is compound 11; Ki=25+/-2nM
3dx1  1.21  2009  Ki=265uM      // 3dx0.pdf (YHO) ligand is compound 3
3djv  1.60  2009  Ki=27.9uM     // 3djo.pdf (C3P) Ki=27.9+/-1.3uM
3ff3  1.37  2009  Ki=270uM      // 3ff3.pdf (GLU)
3h30  1.56  2009  Ki=29.2uM     // 2rkp.pdf (RFZ) Ki=29.2uM(competitive); Ki=39.7uM(noncompetitive)
2zz1  1.57  2009  Ki=29uM       // 2zz1.pdf (6CN) wild type enzyme in complex with 6-CN-UMP
2zz2  1.53  2009  Ki=29uM       // 2zz2.pdf (6CN) ligand is compound 34
3ge7  1.50  2009  Ki=2nM        // 3eos.pdf (AFQ) ligand is compound 13; Ki=2+/-1nM
3hvj  1.79  2009  Ki=2nM        // 3hvj.pdf (705) compound 5 is a bisubstrate inhibitor, Ki=2nM, IC50=9nM
3g30  1.80  2009  Ki=3.1mM      // 3g2y.pdf (G30) ligand is compound 3(G30); Ki=3.1mM
2wr8  1.77  2009  Ki=3.6uM      // 2wr8.pdf (SAH)
3dx3  1.42  2009  Ki=300nM      // 3dx0.pdf (YTB) ligand is compound 4a
2vwo  1.60  2009  Ki=31nM       // 2vvc.pdf (LZG) ligand is compound 22
2zx7  2.48  2009  Ki=32.2pM     // 2zwz.pdf (ZX7)
3g1d  1.50  2009  Ki=330uM      // 3g1d.pdf (U) ligand is compound 1
3fed  1.29  2009  Ki=34.6nM     // 3fec.pdf (BIX) Ki=34.6+/-5.7nM
3hl5  1.80  2009  Ki=34uM       // 3hl5.pdf (9JZ)
2wbg  1.85  2009  Ki=35.2uM     // 2wbg.pdf (LGS) ligand is compound 7
3gr2  1.80  2009  Ki=3mM        // 3gqz.pdf (GF4) ligand is compound 3
2vvc  1.95  2009  Ki=3nM        // 2vvc.pdf (LZF) ligand is compound 15
3hkt  2.36  2009  Ki=4.1uM      // 3hkt.pdf (2SD)
3g2z  1.50  2009  Ki=4.4mM      // 3g2y.pdf (GZ2) ligand is compound 2(GZ2); Ki=4.4mM
3hkn  1.80  2009  Ki=4.51uM     // 3hkn.pdf (MFS) ligand is compound 4
3hkq  1.70  2009  Ki=4.55uM     // 3hkq.pdf (1SD) ligand is 1-S-D-Galactopyranosylsulfonamide
3gtc  1.90  2009  Ki=4.5mM      // 3gqz.pdf (GTC) ligand is compound 20
3dc3  1.70  2009  Ki=4.9nM      // 3d8w.pdf (AZM) ligand is inhibitor AZM, Ki=4.9+/-1nM
3djo  1.60  2009  Ki=40.8uM     // 3djo.pdf (U2P) Ki=40.8+/-3.4uM
3kmc  1.80  2009  Ki=400nM      // 3kmc.pdf (403) catalytic domain of TACE in complex with inhibitor 2
3d8z  1.98  2009  Ki=423uM      // 3d6o.pdf (TXS) Ki=423+/-6uM
3f7g  2.30  2009  Ki=43nM       // 3f7g.pdf (389) ligand is compound 1
3i6o  1.17  2009  Ki=45pM       // 3i6o.pdf (GR6) ligand is compound 14c, Ki=45pM, IC50=2nM
3f7i  1.90  2009  Ki=46nM       // 3f7g.pdf (G13) ligand is compound 14b
3ebh  1.65  2009  Ki=478.2nM    // 3ebh.pdf (BES) IC50=8~14uM
3ip8  1.50  2009  Ki=5.2mM      // 3ip8.pdf (B85) AMDase in complex with benzylphosphonate, competitive inhibitor Ki=5.2mM
3hek  1.95  2009  Ki=5.4nM      // 3hek.pdf (BD0) HSP90 N-terminal domain in complex with compound 15, Ki=5.4nM, IC50=112nM
3hll  1.95  2009  Ki=5.8nM      // 3hl7.pdf (I45) ligand is PH-797804, Ki=5.8+/-0.3nM
3fl5  2.30  2009  Ki=52nM       // 3fl5.pdf (TXQ) IC50=0.11uM
3gc5  1.40  2009  Ki=55nM       // 3eos.pdf (2MQ) ligand is compound 8; Ki=55+/-3nM
3f8e  2.00  2009  Ki=59nM       // 3f8e.pdf (TE1) ligand is compound 4z
3fqe  2.50  2009  Ki=5nM        // 3fqe.pdf (P5C) ligand is compound 3, Ki=5-20nM
3hku  1.80  2009  Ki=5nM        // 3hku.pdf (TOR) ligand is topiramate, Ki=0.005uM
3hvi  1.20  2009  Ki=5nM        // 3hvi.pdf (619) compound 4 is a bisubstrate inhibitor, Ki=5nM, IC50=21nM
3jy0  2.40  2009  Ki=5nM        // 3jy0.pdf (LYG) ligand is compound 6e
2zxd  2.15  2009  Ki=6.0uM      // 2zwz.pdf (ZXD) ligand is compound 9
3hit  2.29  2009  Ki=6.4nM      // 3hio.pdf (DYN) Saporin-L1 complex s3(9-DA)Gs 2-OMe, Ki=6.4+/-1.7nM, in ref.15
3gqz  1.80  2009  Ki=6.7mM      // 3gqz.pdf (GF7) ligand is compound 5
3djp  1.60  2009  Ki=63.2uM     // 3djo.pdf (UA3) Ki=63.2+/-4.5uM
3k2f  1.98  2009  Ki=63nM       // 3k2f.pdf (NKX) ligand is compound 8
3g1v  1.30  2009  Ki=645uM      // 3g1v.pdf (5FU) ligand is compound 39
3gdt  1.60  2009  Ki=64nM       // 3gdt.pdf (UP6)
2vvv  1.73  2009  Ki=6nM        // 2vvc.pdf (H21) ligand is compound 10, Ki=0.006uM
3dne  2.00  2009  Ki=6uM        // 3dnd.pdf (LL1) ligand A
3d8w  1.70  2009  Ki=7.0nM      // 3d8w.pdf (D8W) ligand is inhibitor BZM, Ki=7.0+/-0.9nM
3gv9  1.80  2009  Ki=7.5mM      // 3gqz.pdf (GV9) ligand is compound 21
3a9i  1.80  2009  Ki=70.7uM     // 2ztj.pdf (LYS)
3ffp  1.81  2009  Ki=72.5nM     // 3ffp.pdf (LC1) ligand is compound 2
3dx4  1.38  2009  Ki=76nM       // 3dx0.pdf (GOO) ligand is compound 5
3d6o  1.58  2009  Ki=77uM       // 3d6o.pdf (U1S) Ki=77+/-1uM
3ebi  2.00  2009  Ki=79nM       // 3ebh.pdf (BEY) IC50=24~62uM
3f68  1.75  2009  Ki=8.7uM      // 2zc9.pdf (91U) ligand is compound 8, Ki=8.7+/-1.0uM
3dbu  1.70  2009  Ki=8.8nM      // 3d8w.pdf (D8W) ligand is inhibitor BZM, Ki=8.8+/-1.2nM
3f7h  1.80  2009  Ki=82nM       // 3f7g.pdf (419) ligand is compound 14a
2w5g  1.70  2009  Ki=860nM      // 2w5g.pdf (ATP) ligand is 5-ATP(pppA)
2w66  2.27  2009  Ki=89uM       // 2w66.pdf (HQ6)
2vvu  2.30  2009  Ki=8nM        // 2vvc.pdf (H22) ligand is compound 12
2vwm  1.96  2009  Ki=93nM       // 2vvc.pdf (LZI) ligand is compound 26
2vwl  1.80  2009  Ki=95nM       // 2vvc.pdf (LZH) ligand is compound 23
2wvz  2.40  2009  Ki=96uM       // 2wvz.pdf (KIF) ligand is kifunensine
2jkh  1.25  2009  Ki=9nM        // 2jkh.pdf (BI7) ligand is compound 3
3lzs  1.95  2010  Kd=0.0109nM   // 3lzs.pdf (017) ligand is Darunavir, Kd=0.0109+/-0.0003nM
3myg  2.40  2010  Kd=0.02nM     // 3myg.pdf (EML)
3m5e  1.70  2010  Kd=0.043uM    // 3m5e.pdf (JDR) ligand is compound 7b, affinity at 37C
3mhl  1.90  2010  Kd=0.056uM    // 3mhl.pdf (J71) ligand is compound 10b, affinity at 37C
3lzu  1.76  2010  Kd=0.087nM    // 3lzs.pdf (017) ligand is Darunavir, Kd=0.087+/-0.062nM
3hu3  2.20  2010  Kd=0.13uM     // 3hu1.pdf (AGS) Kd=0.13+/-0.01uM
3kdb  1.66  2010  Kd=0.14nM     // 3kdb.pdf (006) ligand is KNI-10006; Kd=0.14+/-0.04nM
3m3x  1.68  2010  Kd=0.15uM     // 3m3x.pdf (JS7) ligand is compound 10c, affinity at 37C
3lxk  2.00  2010  Kd=0.16nM     // 3lxk.pdf (MI1) ligand is compound CP-690550
3m40  1.60  2010  Kd=0.17uM     // 3m40.pdf (J45) ligand is compound 5a, affinity at 37C
3m67  1.80  2010  Kd=0.18uM     // 3m67.pdf (E36) Kd=0.02uM(thermal shift assay), Kd=0.18uM (ITC)
3kdm  1.50  2010  Kd=0.1uM      // 3kdm.pdf (TES) IC50=900nM
3mhm  1.50  2010  Kd=0.1uM      // 3mhm.pdf (J75) ligand is compound 8b, affinity at 37C
3ip6  1.40  2010  Kd=0.25uM     // 3ip5.pdf (PRO)
3hzk  2.15  2010  Kd=0.2uM      // 3hzk.pdf (KDA&KDO) Kdo(2.4)Kdo, Kd=0.2+/-0.02uM(immobilized glycoconjugates); Kd=0.3+/-0.01uM(solution affinity to free oligosaccharides)
3mhi  1.70  2010  Kd=0.2uM      // 3mhi.pdf (J90) ligand is compound 11b, affinity at 37C
2xjj  1.90  2010  Kd=0.31uM     // 2xab.pdf (L81) ligand is compound 4; IC50=25uM
3mho  1.15  2010  Kd=0.32uM     // 3mho.pdf (J43) ligand is compound 7a, affinity at 37C
3nw3  2.50  2010  Kd=0.32uM     // 3ng4.pdf (MU2) ligand is MDP
2xdx  2.42  2010  Kd=0.35uM     // 2xdk.pdf (WOE) ligand is compound 6
3hzv  1.90  2010  Kd=0.3uM      // 3hzk.pdf (KDA&KDO) Kdo(2.8)Kdo(2.4)Kdo, Kd=0.3+/-0.03uM(immobilized glycoconjugates); Kd=0.2+/-0.003uM( solution affinity to free oligosaccharides)
3k1j  2.00  2010  Kd=0.4uM      // 3k1j.pdf (ADP)
3kdc  2.20  2010  Kd=0.52nM     // 3kdb.pdf (JZP) ligand is KNI-10074; Kd=0.52+/-0.24nM
2xab  1.90  2010  Kd=0.54nM     // 2xab.pdf (VHD) ligand is compound 1; Ic50=31nM
3hcm  2.00  2010  Kd=0.5mM      // 3hcm.pdf (S45) ligand is compound SEN205A; Kd=0.5-1.0mM
3k5v  1.74  2010  Kd=0.5uM      // 3k5v.pdf (STJ) GNF-2 binding to the imatinib/Abl complex, Kd=0.5+/-0.1uM; IC50=0.26uM
3acl  2.35  2010  Kd=0.6uM      // 3acl.pdf (3F1) ligand is compound A
3ip5  1.35  2010  Kd=0.6uM      // 3ip5.pdf (ALA)
3p2e  1.68  2010  Kd=0.6uM      // 3p2e.pdf (SAH) ligand is compound AdoHcy
2xjx  1.66  2010  Kd=0.71nM     // 2xab.pdf (XJX) ligand is compound 35; IC50=48nM
3nex  1.70  2010  Kd=1.0uM      // 3nee.pdf (G24) ligand is compound GC-24; Kd=1.0+/-0.2uM
2xht  2.27  2010  Kd=1.1uM      // 2xdk.pdf (C0Y) ligand is compound 21; IC50=22uM in cell lines
3kgu  1.85  2010  Kd=1.2uM      // 3kgt.pdf (GEN) ligand is genistein, Kd=1.2+/-0.4uM
3neo  2.00  2010  Kd=1.2uM      // 3nee.pdf (G24) ligand is compound GC-24; Kd=1.2+/-0.1uM
3lka  1.80  2010  Kd=1.5mM      // 3lka.pdf (M4S) ligand is compound PMS
3k00  1.55  2010  Kd=1.7uM      // 3jyr.pdf (MTT) ligand is maltotetraose; Kd=1.7+/-0.2uM
3gy2  1.57  2010  Kd=1.80uM     // 3gy2.pdf (BRN) ligand is diminazene; Kd=1.80+/-0.05uM
3k02  1.55  2010  Kd=10.0uM     // 3jyr.pdf (TXT) ligand is compound 5c; Kd=10.0+/-0.6uM
3huc  1.80  2010  Kd=1030nM     // 3hub.pdf (G97) ligand is compound 6; Kd=1030+/-180nM
3a5y  1.90  2010  Kd=11nM       // 3a5y.pdf (KAA) ligand is compound LysAMS
3juk  2.30  2010  Kd=12.9uM     // 3juk.pdf (UPG)
3m8u  1.85  2010  Kd=12.9uM     // 3m8u.pdf (GDS) glutathione disulfide(GSSG), Kd=12.9+/-0.3uM measured at T=37C
3ies  2.00  2010  Kd=120pM      // 3ies.pdf (M24) ligand is PTC124-AMP; Kd=120+/-30pM
3lp4  1.90  2010  Kd=13.1uM     // 3lp4.pdf (LYS)
3lzz  2.50  2010  Kd=146uM      // 3lzz.pdf (GDP) Kd=159+/-51uM (physiological concentration of GDP); Kd=146+/-11uM(radient concentration of GDP)
2xjg  2.25  2010  Kd=15nM       // 2xab.pdf (XJG) ligand is compound 2; IC50=2.5uM
3kmx  1.70  2010  Kd=15uM       // 3kmx.pdf (G00) Kd=15+/-7uM
3nq3  1.90  2010  Kd=167uM      // 3nq3.pdf (DKA) ligand is capric acid; Ka=6.0+/-0.5*10^3M-1
3iqu  1.05  2010  Kd=17.0uM     // 3iqj.pdf (6-mer) Kd=17.0+/-1.6uM
3nim  2.00  2010  Kd=17.7uM     // 3nih.pdf (4-mer) Zn-containing; Kd=17.7+/-0.325uM (ITC, pH=8)
2wq5  1.65  2010  Kd=180uM      // 2wq5.pdf (MIY)
3lk8  1.80  2010  Kd=19.7nM     // 3lk8.pdf (Z79) ligand is compound 3
3jrx  2.50  2010  Kd=1nM        // 3jrx.pdf (S1A) ligand is compound soraphen A
3gy3  1.70  2010  Kd=2.36uM     // 3gy2.pdf (PNT) ligand is pentamidine; Kd=2.36+/-0.19uM
3lpl  2.10  2010  Kd=2.39uM     // 3lpl.pdf (TDP)
3hkw  1.55  2010  Kd=2.3nM      // 3hkw.pdf (IX6) ligand is compound 4; 1b_J4 polymerase; Kd=2.3+/1.7nM, PDB is 1a, but reference indicates 1b
3ip9  1.80  2010  Kd=2.4uM      // 3ip5.pdf (ABU)
3nes  1.75  2010  Kd=2.4uM      // 3nee.pdf (B72) ligand is compound GC-1; Kd=2.4+/-1.2uM
2x4z  2.10  2010  Kd=2.7nM      // 2x4z.pdf (X4Z) ligand is compound PF-3758309; Kd=2.7+/-0.3nM; Ki=18.7+/-6.6nM;
3jyr  1.75  2010  Kd=2.9uM      // 3jyr.pdf (ACR) ligand is acarbose; Kd=2.9+/-0.3uM
3l59  2.00  2010  Kd=200uM      // 3l58.pdf (BDJ) ligand is compound 10
3nkk  1.12  2010  Kd=20uM       // 3nk8.pdf (JLZ)
3miy  1.67  2010  Kd=21nM       // 3miy.pdf (B49) ligand is sunitinib
3oy8  2.19  2010  Kd=220uM      // 3oy8.pdf (2-mer) GAL-GCO(LBA); Kd=220+/-75uM; IC50=14.18mM
3mss  1.95  2010  Kd=22uM       // 3ms9.pdf (MS7) ligand is imatinib; compound 2
3ljo  1.50  2010  Kd=239nM      // 2zdk.pdf (11U) ligand is compound 1b(open form); Kd=239+/-26nM; Ki=49+/-15nM
3lgs  2.20  2010  Kd=24.8uM     // 3lgs.pdf (SAH) Kd=24.8+/-2.6 uM
3jzj  1.40  2010  Kd=248uM      // 3jyr.pdf (ACR) ligand is acarbose; Kd=248+/-9uM
3o4k  2.11  2010  Kd=24nM       // 3o4k.pdf (LTC) ligand is LTA
2xdk  1.97  2010  Kd=250uM      // 2xdk.pdf (XDK) ligand is compound 1
3fh7  2.05  2010  Kd=25nM       // 3fh5.pdf (25P) ligand is compound 20; IC50=47nM(enzyme); IC50=37nM(HWB)
3p8p  2.50  2010  Kd=28uM       // 3p8e.pdf (LN6) ligand is compound 4; Kd=28+/-2uM
3kgt  1.95  2010  Kd=3.1uM      // 3kgt.pdf (GEN) ligand is genistein, Kd=3.1+/-0.5uM
3i73  2.40  2010  Kd=3.23uM     // 3i4l.pdf (ADP)
3hmp  2.30  2010  Kd=3.24uM     // 3hmn.pdf (CX4) ligand is compound 4; Kd=3.24+/-0.28uM; IC50=38.41+/-4.6uM
2xde  1.40  2010  Kd=3.42uM     // 2xde.pdf (1B0) ligand is compound PF-3450074
3kdd  1.80  2010  Kd=3.45nM     // 3kdb.pdf (JZQ) ligand is KNI-10265; Kd=3.45+/-0.69nM
3lp7  2.04  2010  Kd=3.6uM      // 3kv2.pdf (HAR) NOHA (Nx-hydroxy-L-arginine)
2xbv  1.66  2010  Kd=3.7nM      // 2xbv.pdf (XBV) ligand is compound 27; Ki=7nM
3nhi  1.43  2010  Kd=3.7nM      // 3nhi.pdf (EAH) ligand is compound LTC4; Kd=3.7+/-0.6nM
3ng4  1.73  2010  Kd=3.7uM      // 3ng4.pdf (2-mer) ligand is GlcNAc-maltose; Affinity for GlcNAc and Beta-maltose separately are in the range of 10^-4M and 10^-5M, while for mixture (MAL-NAG) is 3.7uM
3hmo  2.40  2010  Kd=30.5nM     // 3hmn.pdf (STU) IC50=0.102+/-0.015uM, Kd=0.0305+/-0.001uM; ligand is inhibitor staurosporine
3gy7  1.55  2010  Kd=30uM       // 3gy2.pdf (BEN) bovine beta-trypsin in complexed with bis-benzamidine
3kmy  1.90  2010  Kd=32uM       // 3kmx.pdf (D8Y)
3o8p  2.10  2010  Kd=350nM      // 3o8p.pdf (BMU) ligand is compound M1, wild type protein binding data from ref. 31
3nik  1.85  2010  Kd=358.8uM    // 3nih.pdf (4-mer) Zn-containing; Kd=358.8+/-20.2uM (ITC, pH=8)
3kqr  1.50  2010  Kd=36.8uM     // 3kqr.pdf (OPE)
2wyf  2.40  2010  Kd=37uM       // 2wyf.pdf (GLA-MBG)
3hzm  1.80  2010  Kd=3uM        // 3hzk.pdf (KDO) Kd=3+/-0.06uM (solution affinity to free oligosaccharides)
3mf5  2.00  2010  Kd=4.32uM     // 3mf5.pdf (HJZ) Kd=4.32+/-0.555 uM; IC50=0.042uM
3npc  2.35  2010  Kd=4.6nM      // 3npc.pdf (B96) ligand is BIRB796
3nee  1.55  2010  Kd=4.6uM      // 3nee.pdf (B72) ligand is compound GC-1; Kd=4.6+/-2.1uM
2x00  2.40  2010  Kd=4.7pM      // 2wzy.pdf (GYN) ligand is gymnodimine A, Kd=0.0047nM
3k8q  2.50  2010  Kd=5.2pM      // 3k8q.pdf (22A) ligand is SerMe-Imm-H; Ki=5pM
3n9s  1.85  2010  Kd=5.5uM      // 3n9r.pdf (TD4) ligand is compound 1; IC50=131nM; Zn-containing
3lq2  1.96  2010  Kd=5.97uM     // 3lpl.pdf (TDP) measured with 0.5mM TDP
2xib  2.20  2010  Kd=55.1nM     // 2xib.pdf (DFU) ligand is compound 3; Kd1=55.1+/-10.1nM(pH=7.0); Kd4=372+/-11.0nM(pH=8.5)
3p5o  1.60  2010  Kd=55.2nM     // 3p5o.pdf (EAM) ligand is compound I-BET; Kd=50.5~61.3nM; IC50=32.5-42.5nM
3o84  2.10  2010  Kd=58nM       // 3o82.pdf (HTJ) ligand is compound 8; structure and Kd=58+/-11nM for strain AB900; Kd=78+/-7nM(FP), 99+/-13nM(ITC) and Ki=58+/-11nM for strain ATCC
3kyq  2.44  2010  Kd=60uM       // 3kyq.pdf (DPV)
2xii  1.80  2010  Kd=63.3nM     // 2xib.pdf (TA9) ligand is compound 4; Kd1=63.3+/-12.6nM(pH=7.0); Kd4=157+/-14.3nM(pH=8.5)
3ms9  1.80  2010  Kd=6uM        // 3ms9.pdf (MS9) IC50>100uM, with imatinib; compound 1
3n1c  2.00  2010  Kd=6uM        // 3n1c.pdf (F6P)
3nx7  1.80  2010  Kd=7.88nM     // 3lk8.pdf (NHK) ligand is compound 6
2wvt  1.80  2010  Kd=755nM      // 2wvs.pdf (FHN) ligand is compound 5; Kd=755+/-55nM(pH=6.0) for BtFuc2970; Kd=230+/-7uM for fucose
3oyw  2.50  2010  Kd=78uM       // 3oy8.pdf (TDG) Kd=78+/-20uM; IC50=1.156mM
2xdl  1.98  2010  Kd=790uM      // 2xdk.pdf (2DL) ligand is compound 3
3hub  2.25  2010  Kd=8.2nM      // 3hub.pdf (469) ligand is compound 7; Kd=8.2+/-2.9nM; IC50=9nM
3k8o  2.40  2010  Kd=8.6pM      // 3k8o.pdf (229) ligand is DATMe-Imm-H; Ki=9pM
3hky  1.90  2010  Kd=80nM       // 3hkw.pdf (IX6) ligand is compound 4; 1a_18 polymerase; Kd=80+/-15nM, PDB is 1b, but reference indicates 1a
3m3c  2.00  2010  Kd=86.21uM    // 3afk.pdf (3-mer)
3gy4  1.55  2010  Kd=8uM        // 3gy2.pdf (PBZ) ligand is p-aminobenzamidine
2xbp  1.20  2010  Kd=9.6uM      // 2xbp.pdf (ATP) Kd=9.6+/-1.3uM
3ouj  2.30  2010  Kd=900nM      // 3ouj.pdf (AKG) ligand is compound 2-Oxoglutarate(2OG)
3n8k  2.25  2010  Kd=90uM       // 3n59.pdf (D1X)
3nq9  1.90  2010  Kd=92.6uM     // 3nq3.pdf (OCA) ligand is caprylic acid; Ka=10.8+/-1.7*10^3M-1
3nht  1.45  2010  Kd=98nM       // 3nhi.pdf (U46) ligand is compound U46619; Kd=98+/-6.8nM
2xeg  1.59  2010  Ki=0.020nM    // 2xef.pdf (CI9) ligand is compound ARM-P4(4); Ki=0.020+/-0.008nM; IC50=0.46+/-0.18nM
2xei  1.69  2010  Ki=0.024nM    // 2xef.pdf (ARK) ligand is compound ARM-P2(3); Ki=0.024+/-0.008nM; IC50=0.54+/-0.18nM
3liw  2.22  2010  Ki=0.025uM    // 3liw.pdf (RUP)
3i51  1.80  2010  Ki=0.02uM     // 3hgi.pdf (45C) ligand is 4, 5-Dichlorocatechol
3hfb  1.92  2010  Ki=0.03uM     // 3hfb.pdf (ML4) ligand is LP-534193; Ki=0.03+/-0.001uM (Trp as the varied substrate); Ki=0.17+/-0.01uM(Trp as the fixed substrate)
3l4u  1.90  2010  Ki=0.03uM     // 3l4t.pdf (DSK) Ki=0.03+/-0.01uM, compound de-O-sulfonated kotalanol
3mxe  1.85  2010  Ki=0.097nM    // 3mxd.pdf (K54) ligand is compound 18d
3i4y  1.85  2010  Ki=0.09uM     // 3hgi.pdf (35C) ligand is 3, 5-Dichlorocatechol
3l4y  1.80  2010  Ki=0.10uM     // 3l4t.pdf (NR4) Ki=0.10+/-0.02uM, compound NR4-8II
3gt9  1.70  2010  Ki=0.11mM     // 3gt9.pdf (516) ligand is compound 11c
2xmy  1.90  2010  Ki=0.11nM     // 2xmy.pdf (CDK) ligand is compound 11; Ki=0.11+/-0.05nM; IC50=221+/-75nM(A2780); IC50=98+/-10nM(MES-SA)
3iae  2.30  2010  Ki=0.13mM     // 3iae.pdf (D7K) ligand is compound MBP, ligand structure is not consist with the one in reference
3l4x  1.90  2010  Ki=0.13uM     // 3l4t.pdf (NR3) Ki=0.13+/-0.02uM, compound NR4-8
2xef  1.59  2010  Ki=0.145nM    // 2xef.pdf (AR8) ligand is compound ARM-P8(6); Ki=0.145+/-0.050nM; IC50=3.29+/-1.14nM
3m36  2.15  2010  Ki=0.15nM     // 3m35.pdf (M35) ligand is DPC423
3nu3  1.02  2010  Ki=0.15nM     // 3nu3.pdf (478) Ki=0.15+/-0.04nM
3nuo  1.35  2010  Ki=0.16nM     // 3nu3.pdf (478) Ki=0.16+/-0.01nM
2xhm  1.96  2010  Ki=0.16uM     // 2xhm.pdf (K26)
3l4v  2.10  2010  Ki=0.19uM     // 3l4t.pdf (KTL) Ki=0.19+/-0.03uM, compound kotalanol
3l4z  2.00  2010  Ki=0.19uM     // 3l4t.pdf (SSD) Ki=0.19+/-0.02uM, compound Salacinol
2wly  2.40  2010  Ki=0.25uM     // 2wk2.pdf (2-mer) ligand is chitotriose thiazoline 4
3hf8  1.85  2010  Ki=0.31uM     // 3hf8.pdf (ML0) ligand is LP-533401; Ki=0.31+/-0.01uM (Trp as the varied substrate); Ki=0.81+/-0.03uM(Trp as the fixed substrate)
2xd9  1.95  2010  Ki=0.35uM     // 2xd9.pdf (XD9)
3nuj  1.50  2010  Ki=0.41nM     // 3nu3.pdf (478) Ki=0.41+/-0.05nM
3aaq  2.00  2010  Ki=0.5mM      // 3aaq.pdf (ARU) ligand is compound ARL 67156, poor Ki=0.5mM, data not shown
3fv1  1.50  2010  Ki=0.5nM      // 2zns.pdf (DYH)
3nu6  1.16  2010  Ki=0.5nM      // 3nu3.pdf (478) Ki=0.50+/-0.06nM
3lpp  2.15  2010  Ki=0.60uM     // 3lpp.pdf (KTL)
2xb7  2.50  2010  Ki=0.65nM     // 2xb7.pdf (GUI) ligand is compound NVP-TAE684; Ki=0.65+/-0.07nM; IC50=17nM
2xda  1.85  2010  Ki=0.6uM      // 2xd9.pdf (JPS)
3p8z  1.70  2010  Ki=0.82uM     // 3p8z.pdf (36A)
3a2o  0.88  2010  Ki=0.83nM     // 3a2o.pdf (KNJ) ligand is compound 13k
3fvl  1.85  2010  Ki=0.86uM     // 3fvl.pdf (BHK) ligand is compound L-1
3owj  1.85  2010  Ki=0.86uM     // 3owj.pdf (1EL)
3lea  2.00  2010  Ki=0.8nM      // 3le9.pdf (Z93) ligand is compound 27
3lpk  1.93  2010  Ki=0.8nM      // 3lnk.pdf (Z76) IC50=7.0nM in cell lines
3mdz  2.32  2010  Ki=0.8nM      // 3mdz.pdf (EZL) ligand is compound 3
3m37  1.90  2010  Ki=0.91nM     // 3m35.pdf (M37) ligand is DPC602, compound 40c
3nu9  1.85  2010  Ki=0.9nM      // 3nu3.pdf (478) Ki=0.9+/-0.2nM
3l4w  2.00  2010  Ki=1.0uM      // 3l4t.pdf (MIG) Ki=1.0+/-0.1uM, compound miglitol
3lmk  2.44  2010  Ki=1.16uM     // 3lmk.pdf (GLU)
3k8c  2.10  2010  Ki=1.2mM      // 3k7s.pdf (RES)
3k37  2.00  2010  Ki=1.2nM      // 3k37.pdf (BCZ) ligand is Peramivir; Ki=1.2nM(no preincubation); Ki=0.6nM(preincubation); IC501=27.8nM(no preincubation); IC502=2.8nM(preincubation)
2xej  1.78  2010  Ki=1.34nM     // 2xef.pdf (OKD) ligand is compound MeO-P4 (10); Ki=1.34+/-0.64nM; IC50=30.2+/-14.4nM
3mxd  1.95  2010  Ki=1.47nM     // 3mxd.pdf (K53) ligand is compound 17c
3fvk  1.50  2010  Ki=1.5nM      // 2zns.pdf (8DX)
3nu4  1.20  2010  Ki=1.5nM      // 3nu3.pdf (478) Ki=1.5+/-0.2nM
2wtv  2.40  2010  Ki=1.8nM      // 2wtv.pdf (ZZL) ligand is compound MLN8054; Ki=1.8+/-0.2nM
2xbw  1.72  2010  Ki=10nM       // 2xbv.pdf (455) ligand is compound 10
3k97  1.95  2010  Ki=10nM       // 3k97.pdf (4CD) ligand is compound 2a; IC50=1uM
2x95  1.96  2010  Ki=11.3uM     // 2x8y.pdf (X95) ligand is lisW-S; Ki=7uM(for C-domain of sACE)
3lir  1.90  2010  Ki=119nM      // 3lik.pdf (EEC)
2x8z  1.98  2010  Ki=11nM       // 2x8y.pdf (X8Z) ligand is L-captopril; Ki1=14nM for C-domains of sACE; Ki2=8.9nM for N-domains of sACE
3mhc  1.70  2010  Ki=11nM       // 3mhc.pdf (ARZ)
3n2u  1.81  2010  Ki=14.3nM     // 3n2u.pdf (D3X) ligand is compound 4; Ki=14.3+/-7.0nM; Zn-containing
2xnb  1.85  2010  Ki=149nM      // 2xnb.pdf (Y8L) ligand is ompound 14; Ki=149+/-40nM; IC50=131+/-9nM(A2780); IC50=150+/-16nM(MES-SA)
2xbx  1.85  2010  Ki=15nM       // 2xbv.pdf (RR8) ligand is compound 2
3fvn  1.50  2010  Ki=169nM      // 2zns.pdf (9DX)
3agl  2.10  2010  Ki=16nM       // 3agl.pdf (A03) ligand is compound ARC-1039; IC50=97nM
3gi4  1.85  2010  Ki=16pM       // 3gi4.pdf (K60) ligand is SAR-KB60, Ki=0.016nM
3acw  1.63  2010  Ki=17.5uM     // 3acw.pdf (651) ligand is compound BPH-651
2x09  2.40  2010  Ki=175uM      // 2x09.pdf (X09) ligand is compound 4; Ki=175+/-8uM
3mi2  1.20  2010  Ki=17nM       // 3mi2.pdf (PFU) ligand is compound 8, Ki=1.7x10-5mM
3ljg  1.31  2010  Ki=18.6nM     // 3lik.pdf (EEF)
2x91  1.98  2010  Ki=180nM      // 2x8y.pdf (LPR) ligand is lisinopril; Ki1=2.4nM for C-domains of sACE; Ki2=44nM for N-domains of sACE
2xc0  2.05  2010  Ki=192nM      // 2xbv.pdf (8NC) ligand is compound 35
2wyj  2.38  2010  Ki=1nM        // 2wyg.pdf (898) ligand is compound 22
3lvw  2.50  2010  Ki=2.12mM     // 3lvv.pdf (GSH)
3nox  2.34  2010  Ki=2.2nM      // 3nox.pdf (6A5) ligand is compound 24c
2x97  1.85  2010  Ki=2200nM     // 2x8y.pdf (RX4) ligand is RXP407; Ki=12nM for N-domain of sACE
2xj7  2.00  2010  Ki=220nM      // 2xj7.pdf (GC2) ligand is compound 6-Ac-Cas
2x7t  1.89  2010  Ki=232nM      // 2x7s.pdf (WZB) ligand is compound 4; Ki=232+/-57nM; IC50=290nM(end point); IC50=169+/-31nM(initial rate)
3l0v  1.75  2010  Ki=23nM       // 3l0t.pdf (724) ligand is compound 3
3lxe  1.90  2010  Ki=250nM      // 3lxe.pdf (TOR) ligand is topiramate
3kr4  2.00  2010  Ki=25nM       // 3kr4.pdf (BES)
2wlz  1.82  2010  Ki=25uM       // 2wk2.pdf (2-mer) ligang is chitotriose thiazoline 3
2x0y  2.25  2010  Ki=25uM       // 2x0y.pdf (X0T) Ki=25+/-2uM; IC50=60+/-10uM
2xb8  2.40  2010  Ki=26nM       // 2xb8.pdf (XNW) ligand is compound 4a
3hp9  1.60  2010  Ki=26uM       // 3hl8.pdf (CF1) ligand is compound CFAM; Ki=26+/-4uM; IC50=8+/-1nM
3ipq  2.00  2010  Ki=27nM       // 3ipq.pdf (965) ligand is compound GW3965; Ki=27+/-4nM
3fuz  1.65  2010  Ki=290nM      // 2zns.pdf (GLU)
2wyg  1.88  2010  Ki=2nM        // 2wyg.pdf (461) ligand is compound 21
3i60  2.50  2010  Ki=2nM        // 3i4b.pdf (E86)
3i5z  2.20  2010  Ki=2nM        // 3i4b.pdf (Z48)
3acx  1.31  2010  Ki=2uM        // 3acx.pdf (673) ligand is compound BPH-673
3kku  1.28  2010  Ki=2uM        // 3kku.pdf (B95) ligand is compound 27
3i25  2.10  2010  Ki=3.1nM      // 3i25.pdf (MV7) ligand is compound 2c
3mi3  2.38  2010  Ki=3.56uM     // 3mi3.pdf (LYS)
3mjl  1.90  2010  Ki=3.6mM      // 3mjl.pdf (2AI) 2-Aminoimidazole is a weak noncompetitive inhibitor
3mfv  1.90  2010  Ki=3000uM     // 3mfv.pdf (Z70) ligand is compound AHH, Ki=3000+/-10uM
3mfw  1.47  2010  Ki=300uM      // 3mfv.pdf (B3U) ligand is compound 2AH, Ki=300+/-9uM
2wm0  1.90  2010  Ki=30uM       // 2wk2.pdf (3-mer) ligand is chitobiose thiazoline thioamide 9
3n2v  1.55  2010  Ki=31nM       // 3n2u.pdf (JT5) ligand is compound 30; Ki=31+/-4.8nM; Zn-containing
3aas  1.75  2010  Ki=31uM       // 3aas.pdf (GUS) ligand is compound 1; Cu-containing complex
3nyx  2.50  2010  Ki=32nM       // 3nyx.pdf (TZ1) ligand is compound 1
3hl8  1.55  2010  Ki=32uM       // 3hl8.pdf (BBP) ligand is compound BCBP; Ki=32+/-4uM; IC50=23+/-3nM
3l3l  2.50  2010  Ki=33nM       // 3l3l.pdf (L3L) ligand is compound 4e
3pd8  2.48  2010  Ki=348nM      // 3pd8.pdf (HA7) ligand is compound 5(S); Ki for GluA2(R); structure for GluA2-S1S2
3own  2.00  2010  Ki=34nM       // 3own.pdf (3OX)
3k5x  1.40  2010  Ki=390nM      // 3itc.pdf (P8D) ligand is compound 1; Ki=390+/-21nM
3lpi  2.05  2010  Ki=3nM        // 3lnk.pdf (Z74) IC50=5nM
3iog  1.41  2010  Ki=3uM        // 2wrs.pdf (SDF) ligand is compound 18
3m1k  1.35  2010  Ki=4.1uM      // 3m1k.pdf (BEW) ligand is compound 4
3kek  1.97  2010  Ki=4.4nM      // 3kec.pdf (3EK) ligand is compound 29b; structure(catalytic domain); Ki=4.4+/-0.15nM(MMP-13/FL)
3nu5  1.29  2010  Ki=4.5nM      // 3nu3.pdf (478) Ki=4.5+/-0.6nM
3k4q  2.20  2010  Ki=4.6uM      // 3k4q.pdf (IHS)
3ipu  2.40  2010  Ki=48nM       // 3ipq.pdf (O40) ligand is compound benzisoxazole urea; Ki=48+/-4nM
3mhw  1.45  2010  Ki=5.03mM     // 3mhw.pdf (ABV)
3o5x  2.00  2010  Ki=5.2uM      // 3o5x.pdf (JZG) ligand is compound 9; Ki=5.2+/-0.3uM; IC50=5.5+/-0.4uM
3i3b  2.20  2010  Ki=5.9mM      // 3i3b.pdf (149)
3ok9  1.27  2010  Ki=5.9pM      // 3ok9.pdf (G52) ligand is compound 4; Ki=5.9pM; IC50=1.8nM
2x7u  2.12  2010  Ki=5340nM     // 2x7s.pdf (WZA) ligand is compound 3; Ki=5340+/-833nM; IC50=376nM(end point); IC50=2113+/-256nM(initial rate)
3gta  1.70  2010  Ki=53uM       // 3gt9.pdf (851) ligand is compound 26d
3n3g  1.60  2010  Ki=58nM       // 3n3g.pdf (93N) ligand is compound 18
3kgq  1.70  2010  Ki=5mM        // 3kgq.pdf (CIT)
3gjw  2.30  2010  Ki=5nM        // 3gjw.pdf (GJW) ligand is compound 9c
2wzm  1.64  2010  Ki=6.0uM      // 2wzm.pdf (NA7) Ki=6.0+/-1.2uM, INH-NADPH adducts inhibit activity of AKR5H1
3l3n  2.30  2010  Ki=6.6nM      // 3l3n.pdf (LSW)
3pd9  2.10  2010  Ki=600nM      // 3pd8.pdf (HA5) ligand is compound 4(R); Ki for GluA2(R); structure for GluA2-S1S2
3k99  2.10  2010  Ki=60nM       // 3k97.pdf (PFT) ligand is compound 2b; IC50=7uM
3m35  2.20  2010  Ki=60nM       // 3m35.pdf (M35) ligand is DPC423
3mz6  2.00  2010  Ki=63nM       // 3mz3.pdf (B3N) ligand is compound M344; with Fe2+; Ki=63+/-2nM(HDAC8); structure(D101L HDAC8); Kd(metal)=1.1+/-0.3uM(Fe2+ with HDAC8)
3nsn  2.10  2010  Ki=65nM       // 3nsn.pdf (TMX-CTO)
3l3m  2.50  2010  Ki=6nM        // 3l3m.pdf (A92) ligand is compound 25b
3le9  1.85  2010  Ki=6nM        // 3le9.pdf (727) ligand is compound 1
3gi6  1.84  2010  Ki=6pM        // 3gi4.pdf (D78) ligand is SAR-AD78, Ki=0.006nM
3gi5  1.80  2010  Ki=6pM        // 3gi4.pdf (K62) ligand is SAR-KB62, Ki=0.006nM
3iof  1.44  2010  Ki=6uM        // 2wrs.pdf (IFS) ligand is compound 10a
3fv2  1.50  2010  Ki=7.7nM      // 2zns.pdf (NDZ)
3n9r  1.80  2010  Ki=70nM       // 3n9r.pdf (TD3) ligand is compound 2; Zn-containing
2xg9  1.80  2010  Ki=70uM       // 2xg9.pdf (GLC-NOJ) ligand is G1M
3n7o  1.80  2010  Ki=72nM       // 3n7o.pdf (N7O) ligand is compound JNJ-18054478
3k4d  2.39  2010  Ki=7750nM     // 3k4d.pdf (EVA) ligand is Glucaro-d-lactam; Ki=7750+/-475nM; IC50=26400+/-483nM
3i4b  2.30  2010  Ki=7nM        // 3i4b.pdf (Z48) ligand is compound 2
3nxq  1.99  2010  Ki=7nM        // 3nxq.pdf (RX4) ligand is analogue 21 (RXP407)
3kwa  2.00  2010  Ki=84uM       // 3kwa.pdf (SPM) Ki=84+/-2uM
3mof  1.75  2010  Ki=860uM      // 3moe.pdf (OXL) measured with Mn2+, GDP; Ki=860+/-33uM(A467G); Ki=106+/-6uM(WT)
3aho  1.88  2010  Ki=88.9nM     // 3ahn.pdf (3A2) Zn-containing
3aau  1.80  2010  Ki=9.0uM      // 3aas.pdf (GZC) ligand is compound 2; Cu-containing complex
3ahn  1.80  2010  Ki=90.1nM     // 3ahn.pdf (3A1) Zn-containing
3igp  1.65  2010  Ki=94.5nM     // 3igp.pdf (DT7) ligand is compound 2
2x96  1.85  2010  Ki=94uM       // 2x8y.pdf (RX3) ligand is RXPA380; Ki=3nM for C-domain of sACE
2xc4  1.67  2010  Ki=9nM        // 2xbv.pdf (IVK) ligand is compound 11
3ag9  2.00  2010  Ki=9nM        // 3ag9.pdf (A02) ligand is compound ARC-1012; IC50=54nM
3b24  1.70  2011  Kd=0.042mM    // 3b24.pdf (B2J)
3arp  1.55  2011  Kd=0.07uM     // 3arp.pdf (DEQ) ligand is Dequalinlium, DEQ; IC50=0.4+/-0.1uM(pNP assay)
3qx9  2.00  2011  Kd=0.09mM     // 3qx8.pdf (ATP)
3ap4  2.33  2011  Kd=0.12mM     // 3ap4.pdf (LBT) ligand is LACTOSE
3r1v  2.19  2011  Kd=0.12uM     // 3r1o.pdf (AZB)
3uex  2.10  2011  Kd=0.12uM     // 3ueu.pdf (STE) complex between LGB and STE; Kd=0.12uM(fluorescence); Kd=0.63uM(ESI-MS); Kd=2.59uM(EPA)
3rdo  1.40  2011  Kd=0.14nM     // 3rdo.pdf (BTN)
3s8o  1.85  2011  Kd=0.14uM     // 3ov1.pdf (5-mer)
3ao2  1.80  2011  Kd=0.17mM     // 3ao1.pdf (AVX)
3aqt  2.50  2011  Kd=0.19uM     // 3aqt.pdf (RCO)
3zyu  1.50  2011  Kd=0.1uM      // 3zyu.pdf (1GH)
3b26  2.10  2011  Kd=0.23uM     // 3b24.pdf (B2L)
3ove  1.82  2011  Kd=0.27uM     // 3ov1.pdf (5-mer)
3s0e  1.60  2011  Kd=0.28uM     // 3s0b.pdf (EOL)
3pgu  1.70  2011  Kd=0.2uM      // 3pgu.pdf (OLA)
3s0b  1.22  2011  Kd=0.32uM     // 3s0b.pdf (FNA)
2yki  1.67  2011  Kd=0.35nM     // 2yjw.pdf (YKI)
3o9p  2.07  2011  Kd=0.3uM      // 3o9p.pdf (MHI)
3tf6  2.35  2011  Kd=0.40uM     // 3tf6.pdf (DBH) ligand is 2,3-DHBA; Kd=0.40+/-0.01uM
3qlm  2.50  2011  Kd=0.431uM    // 3qlm.pdf (PLM)
3rdq  1.60  2011  Kd=0.49nM     // 3rdo.pdf (DTB)
3uew  2.00  2011  Kd=0.49uM     // 3ueu.pdf (PLM) complex between LGB and PLM; Kd=0.49uM(ITC); Kd=0.10uM(fluorescence); Kd=2.63uM(ESI-MS); Kd=2.56uM(EPA)
3arq  1.50  2011  Kd=0.4uM      // 3arp.pdf (DM5) ligand is Idarubicin, IDA; Kd=0.4+/-0.02uM
3rux  1.70  2011  Kd=0.53nM     // 3rux.pdf (BS5)
3s8n  1.71  2011  Kd=0.62uM     // 3ov1.pdf (5-mer)
3u5l  1.39  2011  Kd=0.64uM     // 3u5l.pdf (08K)
3arw  1.50  2011  Kd=0.7uM      // 3arp.pdf (CTI) ligand is Chelerythrine, CHE; Kd=0.7+/-0.03uM(Fluorescence)
3b25  1.75  2011  Kd=0.86uM     // 3b24.pdf (B2K)
3pwm  1.46  2011  Kd=0.8nM      // 3pwm.pdf (017)
2yay  1.86  2011  Kd=0.8uM      // 2yay.pdf (DUP) ligand is DUPNPP; Ca-containing
3t1m  1.55  2011  Kd=0.91mM     // 3t1l.pdf (DQT)
3alt  2.50  2011  Kd=1.19mM     // 3alt.pdf (MLB) ligand is Melibiose; Ca-containing
3rz7  1.80  2011  Kd=1.1nM      // 3ryj.pdf (RZ7)
3uev  1.90  2011  Kd=1.29uM     // 3ueu.pdf (MYR) complex between LGB and MYR; Kd=1.29uM(ITC); Kd=0.33uM(fluorescence); Kd=5.26uM(ESI-MS)
3tcg  2.00  2011  Kd=1.36uM     // 3tcf.pdf (3-mer)
3ppr  2.10  2011  Kd=1.5mM      // 3ppo.pdf (4CS)
3qqa  2.20  2011  Kd=1.5uM      // 3qps.pdf (TCH)
3rm4  1.90  2011  Kd=1.69uM     // 3rm4.pdf (3RM)
2xp7  2.00  2011  Kd=1.7uM      // 2xp3.pdf (4F8)
3rz1  1.51  2011  Kd=1.8nM      // 3ryj.pdf (RZ1)
3p9m  2.00  2011  Kd=10uM       // 3p9l.pdf (8-mer)
2xn3  2.09  2011  Kd=1198nM     // 2xn3.pdf (ID8)
3rlb  2.00  2011  Kd=120pM      // 3rlb.pdf (VIB)
3pju  2.50  2011  Kd=13.1uM     // 3pjt.pdf (C2E)
3pyy  1.85  2011  Kd=137nM      // 3pyy.pdf (3YY)
2ylc  1.30  2011  Kd=13nM       // 2ylc.pdf (U)
3rz5  1.65  2011  Kd=13nM       // 3ryj.pdf (RZ5)
3zyf  1.94  2011  Kd=14.1uM     // 3zyb.pdf (147) ligand is NPG; Kd=14.1+/-0.2uM
3ru1  2.30  2011  Kd=14.2uM     // 3rsv.pdf (3RU)
2yb0  2.28  2011  Kd=140uM      // 2yay.pdf (DUR)
3s75  1.50  2011  Kd=150nM      // 3s71.pdf (EVG)
3ryj  1.39  2011  Kd=16nM       // 3ryj.pdf (RYJ)
3rm9  2.10  2011  Kd=17uM       // 3rm4.pdf (613)
3p7i  1.71  2011  Kd=19.9nM     // 3p7i.pdf (P7I)
3q6z  2.23  2011  Kd=192uM      // 3q6z.pdf (APR) Kd=192+/-7uM
3td4  1.79  2011  Kd=2.2uM      // 3td4.pdf (API)
3s71  1.25  2011  Kd=2.3nM      // 3s71.pdf (EVD)
3s8l  1.71  2011  Kd=2.3uM      // 3ov1.pdf (5-mer)
3ldp  2.20  2011  Kd=2.41uM     // 3ldl.pdf (3P1)
3u5j  1.60  2011  Kd=2.46uM     // 3u5j.pdf (08H)
3ryz  1.37  2011  Kd=2.4nM      // 3ryj.pdf (RYZ)
3qps  2.35  2011  Kd=2.5uM      // 3qps.pdf (CHD)
3ovn  1.95  2011  Kd=2.8mM      // 3ao1.pdf (MPV)
2y7i  1.90  2011  Kd=2.9uM      // 2y7i.pdf (ARG)
3ujd  1.50  2011  Kd=20.2uM     // 3uj6.pdf (PC) complex between PfPMT-Y19F and pCho; Kd=20.2+/-6.8uM
2xn5  1.70  2011  Kd=205nM      // 2xn3.pdf (FUN)
3o75  2.30  2011  Kd=209nM      // 3o75.pdf (F1X) Kd=209+/-20nM
2x6x  1.48  2011  Kd=210uM      // 2x6w.pdf (6-mer) ligand is hexasaccharide; Kd=210+/-7uM
3q7q  2.30  2011  Kd=2256nM     // 3q72.pdf (GNP)
3uj9  1.24  2011  Kd=23.4uM     // 3uj6.pdf (PC) complex between PfPMT and pCho; Kd=23.4+/-1.6uM
3sk2  1.01  2011  Kd=244uM      // 3sk2.pdf (GRI)
3p3s  1.60  2011  Kd=26nM       // 3p3r.pdf (3M2) ligand is compound 14
3ujc  1.19  2011  Kd=26uM       // 3uj6.pdf (PC) ligand is H132A-pCho; Kd=26.0+/-11.3uM
3ocp  2.49  2011  Kd=27nM       // 3ocp.pdf (CMP)
3q6w  1.75  2011  Kd=27nM       // 3q6w.pdf (Q6W) lignad is compound 1; Kd=27+/-7nM
2xj1  2.13  2011  Kd=28nM       // 2xix.pdf (XJ1)
3rz0  1.80  2011  Kd=28nM       // 3ryj.pdf (RZ0)
3ppq  1.91  2011  Kd=28uM       // 3ppo.pdf (CHT)
3s73  1.75  2011  Kd=2nM        // 3s71.pdf (EVF)
2yix  2.30  2011  Kd=3.3nM      // 2yis.pdf (YIX)
3u10  2.30  2011  Kd=3.6uM      // 3u0z.pdf (CMP) complex between cAMP and MBP-HCN2; Kd by ITC
3r6u  1.61  2011  Kd=30.5uM     // 3r6u.pdf (CHT)
3myq  1.35  2011  Kd=30nM       // 3m96.pdf (E27)
3m6r  2.40  2011  Kd=32nM       // 3m6r.pdf (BB2)
3ta0  2.30  2011  Kd=338uM      // 3ta0.pdf (ATP) Kd measured with Mg2+
3s78  1.98  2011  Kd=340nM      // 3s71.pdf (EVJ)
3axz  2.25  2011  Kd=372uM      // 3axz.pdf (ADN)
3rsx  2.48  2011  Kd=38.8uM     // 3rsv.pdf (RSV)
3ryy  1.16  2011  Kd=38nM       // 3ryj.pdf (RYY)
3qkd  2.02  2011  Kd=4.2nM      // 3qkd.pdf (HI0)
3arx  1.16  2011  Kd=4.7uM      // 3arp.pdf (POY) ligand is propentofylline(PRO); Kd=4.7+/-0.5uM(Fluorescence)
3s72  1.60  2011  Kd=400nM      // 3s71.pdf (EVE)
3n35  2.00  2011  Kd=431uM      // 3n35.pdf (A2G)
2ydw  1.90  2011  Kd=46.0nM     // 2ydw.pdf (WSH)
3qxv  2.50  2011  Kd=4nM        // 3qxt.pdf (MTX)
3r24  2.00  2011  Kd=5.59uM     // 3r24.pdf (SAM)
3ueu  2.10  2011  Kd=5.81uM     // 3ueu.pdf (DAO) complex between LGB and DAO; Kd=5.81uM(ITC); Kd=0.71uM(fluorescence); Kd=24.4uM(ESI-MS); Kd=24.4uM(EPA)
3ao5  1.80  2011  Kd=5.9mM      // 3ao1.pdf (BBY)
2yel  1.65  2011  Kd=52.5nM     // 2yel.pdf (WSH) Kd for BRD4-BD1,2
3p3r  1.25  2011  Kd=56.05nM    // 3p3r.pdf (3M1) ligand is Ro41-0960; Kd=56.05+/-4.14nM; IC50=0.755uM(in supp info)
3ta1  1.90  2011  Kd=568uM      // 3ta1.pdf (ADP) Kd measured with Mg2+
3p3t  1.45  2011  Kd=57.91nM    // 3p3r.pdf (3M3) ligand is compound 7; Kd=57.91+/-13.2nM; IC50=0.296uM(in supp info)
3zqe  2.19  2011  Kd=59.0uM     // 3zqe.pdf (DXC)
3p9l  2.00  2011  Kd=5uM        // 3p9l.pdf (8-mer)
3q71  2.20  2011  Kd=6.0uM      // 3q6z.pdf (AR6) Kd=6.0+/-0.1uM
3ov1  1.60  2011  Kd=6.25uM     // 3ov1.pdf (5-mer)
3rz8  1.70  2011  Kd=6.7nM      // 3ryj.pdf (RZ8)
3b27  1.50  2011  Kd=6.9uM      // 3b24.pdf (B2T)
3m96  1.40  2011  Kd=60nM       // 3m96.pdf (E38)
2yek  1.98  2011  Kd=61.3nM     // 2yek.pdf (EAM) ligand is compound I-BET
3s77  1.86  2011  Kd=61nM       // 3s71.pdf (EVI)
2xj2  2.20  2011  Kd=66nM       // 2xix.pdf (985)
3qfd  1.68  2011  Kd=68uM       // 3qfd.pdf (9-mer) ligand is Mart-1 peptide(27-35); Kd=68+/-4uM
3ppp  2.40  2011  Kd=6uM        // 3ppo.pdf (BET)
3qxt  1.70  2011  Kd=6uM        // 3qxt.pdf (MTX)
3tao  1.45  2011  Kd=7.28uM     // 3tao.pdf (PGH)
3ryx  1.60  2011  Kd=7.3nM      // 3ryj.pdf (RYX)
2yaz  2.40  2011  Kd=7.3uM      // 2yay.pdf (UMP) ligand is DUMP; Mg-containing
2yk1  1.85  2011  Kd=7.4nM      // 2yk1.pdf (NCT)
3ozj  2.10  2011  Kd=7.7uM      // 3ozj.pdf (BGV)
3mam  1.80  2011  Kd=76uM       // 3mam.pdf (BET)
3o56  2.42  2011  Kd=794pM      // 3o56.pdf (ZG1)
2ygf  2.00  2011  Kd=8.06uM     // 2yga.pdf (GDM)
3ao4  1.95  2011  Kd=8.5mM      // 3ao1.pdf (833)
2xm1  2.00  2011  Kd=8.5uM      // 2xm1.pdf (LTM)
2yge  1.96  2011  Kd=8.62uM     // 2yga.pdf (GDM)
3rlp  1.70  2011  Kd=84nM       // 3rlp.pdf (3RP)
3ryv  1.20  2011  Kd=86nM       // 3ryj.pdf (RYV)
2xxt  1.90  2011  Kd=9.0nM      // 2xxt.pdf (KAI)
3s76  1.60  2011  Kd=9000nM     // 3s71.pdf (EVH)
3s0d  1.24  2011  Kd=90nM       // 3s0b.pdf (CTV)
3po1  1.65  2011  Kd=95uM       // 3po1.pdf (MKY) ligand is compound 2; Kd=95+/-4uM (by spectrophotometric assay)
3zxz  1.80  2011  Ki=0.004uM    // 3zxz.pdf (KRW) ligand is compound 2
2xpk  2.40  2011  Ki=0.005nM    // 2xpk.pdf (Z0M)
3u8n  2.35  2011  Ki=0.067nM    // 3u8j.pdf (09S) lignad is compound 5; Ki=0.067+/-0.026nM
3pbb  1.95  2011  Ki=0.095uM    // 3pb7.pdf (PBD) ligand is PBD150; Ki=0.095+/-0.003uM; Zn-containing
3r4n  2.00  2011  Ki=0.13uM     // 3r4m.pdf (FU5)
3mv0  2.20  2011  Ki=0.14mM     // 3mv0.pdf (149)
3n76  1.90  2011  Ki=0.14uM     // 3n59.pdf (CA2)
3pe2  1.90  2011  Ki=0.175nM    // 3pe1.pdf (E1B)
3pe1  1.60  2011  Ki=0.223nM    // 3pe1.pdf (3NG)
3pwd  2.20  2011  Ki=0.22uM     // 3pwd.pdf (CZ0)
3ozp  2.00  2011  Ki=0.24uM     // 3ozp.pdf (OAN)
3pb9  1.12  2011  Ki=0.262uM    // 3pb7.pdf (1BN) ligand is 1-benzylimidazole; Ki=0.262+/-0.062uM; Zn-containing
3qox  2.30  2011  Ki=0.27uM     // 3qow.pdf (SAH)
3ppm  1.78  2011  Ki=0.29nM     // 3ppm.pdf (JG1)
3sr4  2.50  2011  Ki=0.29uM     // 3sr4.pdf (TT8)
3sm2  1.75  2011  Ki=0.2nM      // 3slz.pdf (478)
3muz  1.90  2011  Ki=0.35mM     // 3muz.pdf (IPT)
2xog  1.72  2011  Ki=0.37mM     // 2xog.pdf (SFB)
3p8n  1.90  2011  Ki=0.53nM     // 3p8n.pdf (L4T) ligand is BI201335; Ki=0.53+/-0.05nM
3nzk  1.80  2011  Ki=0.54nM     // 3nzk.pdf (C90)
3rf4  1.80  2011  Ki=0.56uM     // 3rf4.pdf (FUN)
3ozg  1.99  2011  Ki=0.65nM     // 3ozf.pdf (SSI) ligand is compound 3; Ki=0.65+/-0.04nM by spectrophotometric assay
3rwp  1.92  2011  Ki=0.6nM      // 3rwp.pdf (ABQ)
2ya7  1.89  2011  Ki=0.72mM     // 2ya5.pdf (ZMR)
3qfy  2.30  2011  Ki=0.75uM     // 3qfy.pdf (IFM-SO4)
3zq9  1.86  2011  Ki=0.95uM     // 2yjq.pdf (NOY-BGC) ligand is Glc-noeuromycin
3r4m  1.70  2011  Ki=1.2uM      // 3r4m.pdf (WOE)
2y7x  1.90  2011  Ki=1.3nM      // 2y7x.pdf (MZA)
3zze  1.87  2011  Ki=1.3nM      // 3zxz.pdf (6XP) ligand is compound 10
3qgw  2.10  2011  Ki=1.3uM      // 3qgw.pdf (L7A)
3o9i  1.45  2011  Ki=1.5pM      // 3o99.pdf (A61) ligand is compound 11e; Ki=1.5+/-1pM
3oaf  1.70  2011  Ki=1.6nM      // 3oaf.pdf (OAG) ligand is OAAG324; Ki=1.6+/-0.06nM
2ya8  1.75  2011  Ki=1.77uM     // 2ya5.pdf (G39)
3pb7  1.40  2011  Ki=1.817uM    // 3pb7.pdf (PBD) ligand is PBD150; Ki=1.817+/-0.154uM; Zn-containing
3m3z  2.10  2011  Ki=1.85uM     // 3ldl.pdf (3F5)
3p8o  2.30  2011  Ki=1.89nM     // 3p8n.pdf (L5T) ligand is analog 1; Ki=1.89+/-0.06nM
3oy0  1.60  2011  Ki=10.1nM     // 3oy0.pdf (OY0)
3oyq  1.47  2011  Ki=10.3nM     // 3oy0.pdf (OYQ)
3t82  2.00  2011  Ki=101nM      // 3t82.pdf (SG4)
3slz  1.40  2011  Ki=102nM      // 3slz.pdf (3TL)
3t83  1.80  2011  Ki=105nM      // 3t82.pdf (MG5&SG5)
3t84  2.00  2011  Ki=106nM      // 3t82.pdf (SG6)
3sio  2.32  2011  Ki=10nM       // 3sio.pdf (MLK)
3t85  2.40  2011  Ki=11.3nM     // 3t82.pdf (SG7)
3pn1  2.00  2011  Ki=110nM      // 3pn1.pdf (IVH)
3r4p  1.70  2011  Ki=11nM       // 3r4m.pdf (FU7)
3old  2.00  2011  Ki=1254.9nM   // 3old.pdf (6-mer)
3oe5  1.52  2011  Ki=132nM      // 3nw9.pdf (611)
3pn4  1.90  2011  Ki=140nM      // 3pn3.pdf (BB2) AtPDF1B in complex with actinonin
2y5g  1.29  2011  Ki=146nM      // 2y5f.pdf (FJD)
3ohi  2.30  2011  Ki=14uM       // 3ohi.pdf (HDX)
2xyd  2.15  2011  Ki=150nM      // 2xy9.pdf (3ES)
3ai8  2.11  2011  Ki=154.4uM    // 3ai8.pdf (HNQ)
3s2v  2.50  2011  Ki=157nM      // 3s2v.pdf (3HU)
3prs  1.38  2011  Ki=15nM       // 3ms3.pdf (RIT)
3n2p  1.65  2011  Ki=15nM       // 3mzc.pdf (AYX)
3o99  1.95  2011  Ki=15pM       // 3o99.pdf (K13) ligand is compound 10a; Ki=15+/-8pM
2y5h  1.33  2011  Ki=1620nM     // 2y5f.pdf (Y5H)
3qgy  2.10  2011  Ki=16nM       // 3qgw.pdf (L7O)
3o5n  1.83  2011  Ki=17.2uM     // 3o5n.pdf (BR0)
3oim  1.45  2011  Ki=180nM      // 3oim.pdf (VZ5) ligand is compound 16; Ki=180+/-10nM by membrane-inlet mass spectrometry; Zn-containing
3p3g  1.65  2011  Ki=180pM      // 3p3c.pdf (3P3)
3nb5  1.80  2011  Ki=18nM       // 3nb5.pdf (R21)
3o9d  1.85  2011  Ki=19pM       // 3o99.pdf (K19) ligand is compound 10e; Ki=19+/-23pM
3ui7  2.28  2011  Ki=1nM        // 3ui7.pdf (C1L)
3ucj  1.85  2011  Ki=1uM        // 3ucj.pdf (AZM) ligand is Co-CA-AZM
3u8k  2.47  2011  Ki=2.2nM      // 3u8j.pdf (09P) lignad is compound 2; Ki=2.2+/-0.1nM
3rf5  2.10  2011  Ki=2.37uM     // 3rf4.pdf (FUZ)
3n86  1.90  2011  Ki=2.3uM      // 3n59.pdf (RJP)
3qaa  1.40  2011  Ki=2.9pM      // 3qaa.pdf (G04)
3n7a  2.00  2011  Ki=200uM      // 3n59.pdf (FA1)
3th9  1.34  2011  Ki=20nM       // 3th9.pdf (9Y9)
3o9a  1.90  2011  Ki=20pM       // 3o99.pdf (K14) ligand is compound 10b; Ki=20+/-15pM
3oil  1.50  2011  Ki=2100nM     // 3oil.pdf (VZ5) ligand is compound 16; Ki=2100+/-220nM by membrane-inlet mass spectrometry; Zn-containing
3mzc  1.50  2011  Ki=226nM      // 3mzc.pdf (S6I)
3sjf  1.65  2011  Ki=23nM       // 3sje.pdf (JRG)
2xm2  1.95  2011  Ki=24uM       // 2xm1.pdf (LOG)
3p58  1.49  2011  Ki=25.4nM     // 3p58.pdf (P58)
3t8v  1.80  2011  Ki=260nM      // 3t8v.pdf (BTJ)
2xxr  1.60  2011  Ki=280nM      // 2xxr.pdf (GLU) GluR6 wt LBD dimer in complex with glutamate
3ni5  2.10  2011  Ki=28nM       // 3ni5.pdf (C1H)
2y5f  1.29  2011  Ki=2nM        // 2y5f.pdf (XWG)
2y81  1.70  2011  Ki=2nM        // 2y7z.pdf (931)
2y7z  1.84  2011  Ki=2nM        // 2y7z.pdf (C0Z)
2ya6  2.00  2011  Ki=2uM        // 2ya5.pdf (DAN)
3ml5  2.05  2011  Ki=3.0nM      // 3ml5.pdf (AZM) ligand is acetazolamide
2ydt  1.60  2011  Ki=3.0uM      // 2ydp.pdf (EDG-AHR)
3tza  1.90  2011  Ki=3.15uM     // 3tza.pdf (TZG)
3u8j  2.35  2011  Ki=3.1nM      // 3u8j.pdf (09O) lignad is compound 1; Ki=3.1+/-0.9nM
3b1m  1.60  2011  Ki=3.3nM      // 3b1m.pdf (KRC)
3n3j  1.50  2011  Ki=3.3nM      // 3mzc.pdf (WWV)
2xyf  1.80  2011  Ki=3.6nM      // 2xyf.pdf (G40) ligand is compound 9d
3str  1.75  2011  Ki=3.96nM     // 3str.pdf (3LI)
3rlr  1.70  2011  Ki=30nM       // 3rlp.pdf (3RR)
3sw8  1.70  2011  Ki=31.72uM    // 3str.pdf (5LI)
3p17  1.43  2011  Ki=33.4uM     // 3p17.pdf (99P) ligand is compound 2; Ki=33.4+/-19.0uM
3nyd  1.23  2011  Ki=330uM      // 3nyd.pdf (3NY) ligand is TSA 5-NBT
3t01  1.60  2011  Ki=33uM       // 3t01.pdf (PPF)
3oe4  1.49  2011  Ki=34nM       // 3nw9.pdf (610)
3ocz  1.35  2011  Ki=35nM       // 3ocz.pdf (SRA)
3pfp  2.35  2011  Ki=360nM      // 3pfp.pdf (035-036) ligands are compound (R)-4 and (S)-4; Ki1=360+/-50nM((R)-4); Ki2=620+/-110nM((S)-4); Mn-containing
3mmf  1.50  2011  Ki=37nM       // 3mmf.pdf (D9H)
2xys  1.91  2011  Ki=38nM       // 2xys.pdf (SY9)
2xxx  2.10  2011  Ki=390nM      // 2xxx.pdf (GLU) GluR6 D776K LBD dimer in complex with glutamate (P21 21 21)
3r17  1.70  2011  Ki=390nM      // 3r16.pdf (5UM)
3ldq  1.90  2011  Ki=4.32uM     // 3ldl.pdf (3P1)
3t1a  2.40  2011  Ki=4.3nM      // 3t19.pdf (5MA)
3qt6  2.05  2011  Ki=4.3uM      // 3qt6.pdf (2P0) ligand is DOGP; Ki=4.3+/-1.0uM; X-ray(S-DPGP), Ki(RS-DPGP)
2xye  2.00  2011  Ki=4.6nM      // 2xye.pdf (CXG) ligand is compound 9a
3q1x  1.59  2011  Ki=4.7uM      // 3p47.pdf (SER)
3p5l  1.50  2011  Ki=40.8nM     // 3p58.pdf (IT5)
3rlq  1.90  2011  Ki=40nM       // 3rlp.pdf (3RQ)
3u9q  1.52  2011  Ki=41.7uM     // 3u9q.pdf (DKA) complex between PPAR gamma and decanoic acid and PGC-1a peptide
3mna  1.50  2011  Ki=41nM       // 3mna.pdf (DWH) ligand is compound 7
3oku  1.45  2011  Ki=440nM      // 3oku.pdf (VZ4) ligand is compound 15; Ki=440+/-50nM by membrane-inlet mass spectrometry; Zn-containing
3rt8  2.43  2011  Ki=451nM      // 3rt8.pdf (CWD) ligand is compound (S)-2c
3rtf  1.70  2011  Ki=45nM       // 3rtf.pdf (CWD) ligand is compound (S)-2c
3ozs  1.44  2011  Ki=4645nM     // 3nw9.pdf (OZS)
3pww  1.22  2011  Ki=48nM       // 3ms3.pdf (ROC)
3q44  1.80  2011  Ki=490nM      // 3q43.pdf (D50)
2y82  2.20  2011  Ki=4nM        // 2y7z.pdf (930)
3sww  2.00  2011  Ki=4nM        // 3sww.pdf (KXB)
3pb8  1.13  2011  Ki=5.748uM    // 3pb7.pdf (AHN) ligand is N-w-Acetylhistamine; Ki=5.748+/-0.366uM; Zn-containing
2xyt  2.05  2011  Ki=509.2nM    // 2xys.pdf (TC9)
3n0n  1.50  2011  Ki=50nM       // 3mzc.pdf (P9B)
3r16  1.60  2011  Ki=50nM       // 3r16.pdf (5UN)
3tfu  1.94  2011  Ki=520uM      // 3tfu.pdf (PL8)
3o7u  1.71  2011  Ki=52nM       // 3o7u.pdf (O7U)
3qfz  2.39  2011  Ki=570uM      // 3qfz.pdf (NOJ-SO4)
3rv4  1.98  2011  Ki=5mM        // 3rup.pdf (ADP) Ca2+ and Mg2+ containing; Ki=5~20mM
3o9e  1.50  2011  Ki=5pM        // 3o99.pdf (A60) ligand is compound 11a; Ki=5+/-6pM
3st5  1.45  2011  Ki=5pM        // 3st5.pdf (G89)
3pgl  2.35  2011  Ki=5uM        // 3pgl.pdf (RZX)
3roc  1.70  2011  Ki=6.4nM      // 3roc.pdf (29A)
3q2j  2.15  2011  Ki=66.1uM     // 3q2j.pdf (CKI)
3ps1  1.85  2011  Ki=67pM       // 3ps1.pdf (ZH2)
3ljz  2.00  2011  Ki=7.3nM      // 3ljt.pdf (LA3)
3s9e  1.60  2011  Ki=7.43uM     // 3s9e.pdf (GLU)
3ozr  1.73  2011  Ki=7022nM     // 3nw9.pdf (OZR)
3ozt  1.48  2011  Ki=74.9uM     // 3nw9.pdf (OZZ)
2x2r  2.20  2011  Ki=76.2nM     // 2x2r.pdf (X2O)
3tu7  2.49  2011  Ki=8.17nM     // 3tu7.pdf (0BM)
2yfx  1.70  2011  Ki=8.2nM      // 2yfx.pdf (VGH) ligand is crizotinid
3u8l  2.32  2011  Ki=8.9nM      // 3u8j.pdf (09Q) lignad is compound 3; Ki=8.9+/-0.9nM
3po6  1.47  2011  Ki=87.3nM     // 3po6.pdf (DT9)
3p4v  2.00  2011  Ki=8uM        // 3nb5.pdf (PMX)
3n4b  1.60  2011  Ki=96nM       // 3mzc.pdf (WWZ)
2y80  1.90  2011  Ki=9nM        // 2y7z.pdf (439)
3ml2  1.80  2011  Ki=9nM        // 3ml2.pdf (SU0)
4b74  2.18  2012  Kd=0.022uM    // 4b6e.pdf (1LH)
4asj  2.25  2012  Kd=0.028uM    // 4arw.pdf (N6A) ligand is compound 8a; Kd=0.028+/-0.003uM; IC50=0.073+/-0.01uM
3uug  1.75  2012  Kd=0.031mM    // 3uug.pdf (BDP)
4dy6  2.20  2012  Kd=0.04mM     // 2i2b.pdf (A22)
4b73  2.50  2012  Kd=0.062uM    // 4b6e.pdf (4VA)
4arw  2.20  2012  Kd=0.074uM    // 4arw.pdf (HNR) ligand is compound 1; Kd=0.074+/-0.006uM; IC50=0.21+/-0.03uM
4daf  2.50  2012  Kd=0.076uM    // 4d8a.pdf (0J4) X-ray((R)-compound 19), Kd((RS)-compound 19)
4fcq  2.15  2012  Kd=0.101uM    // 4fcp.pdf (2N6)
4dew  1.90  2012  Kd=0.10uM     // 4der.pdf (LU2) Kd=0.10+/-0.01uM (Model:Independent)
3v3q  2.22  2012  Kd=0.25uM     // 3v3q.pdf (TMY)
4dkq  1.89  2012  Kd=0.25uM     // 4dko.pdf (0LK)
4h75  2.10  2012  Kd=0.25uM     // 4h75.pdf (8-mer) Kd=0.25+/-0.03uM; ligand is peptide H3K4(me3)
4db7  2.50  2012  Kd=0.273uM    // 4d8a.pdf (Z25)
4a4v  2.00  2012  Kd=0.287uM    // 4a4v.pdf (YFD) ligand is amorfrutin 2
4aqh  2.40  2012  Kd=0.29uM     // 4aqh.pdf (TB7) ligand is AZ3976; Kd1=0.29+/-0.05uM(latent PAI-1,ITC),Kd2=0.38+/-0.05uM(Active PAI-1,ITC),Kd3=0.24+/-0.03uM(Active PAI-1,SPR),Kd4=0.19+/-0.01uM(latent PAI-1,SPR);IC501=26uM(enzymatic chromogenic assay),IC502=16uM(plasma clot lysis assay)
4ewn  1.90  2012  Kd=0.2uM      // 4ewn.pdf (0VR)
4dkr  1.80  2012  Kd=0.30uM     // 4dko.pdf (0LJ)
4b5s  1.68  2012  Kd=0.32mM     // 4b5s.pdf (PYR) ligand is pyruvate; Kd=0.32+/-0.02mM
4dko  1.98  2012  Kd=0.3uM      // 4dko.pdf (0LM)
3tay  1.85  2012  Kd=0.42mM     // 3tay.pdf (MN0) Kd=0.42+/-0.095mM
3t6b  2.40  2012  Kd=0.44uM     // 3t6b.pdf (5-mer) ligand is peptide tynorphin; Kd=0.44+/-0.02uM (at 25C); Kd=0.22+/-0.03uM (at 35C)
4b0b  1.90  2012  Kd=0.47mM     // 4b0b.pdf (54F) fragment 2; Ka=2140+/-31.8M(ITC)
4b5t  1.92  2012  Kd=0.47mM     // 4b5s.pdf (2KT) ligand is ketobutyrate; Kd=0.47+/-0.02mM
4b5w  1.79  2012  Kd=0.47mM     // 4b5s.pdf (PYR) ligand is pyruvate; Kd=0.47+/-0.001mM (with 0.5mM Co2+)
4der  1.90  2012  Kd=0.49uM     // 4der.pdf (AGI) Kd=0.49+/-0.13uM (Model:Independent)
4erf  2.00  2012  Kd=0.4nM      // 4ere.pdf (0R3) IC50=1.1+/-0.5nM(0% human serum), IC50=4.2+/-1.8nM(15% human serum)
4eu0  1.70  2012  Kd=0.4uM      // 4etz.pdf (C2E) one molecule (c-di-GMP) in the asymmetric unit
4d8z  2.20  2012  Kd=0.51uM     // 4d8a.pdf (0J2) X-ray((R)-compound 24), Kd((RS)-compound 24)
3vhd  1.52  2012  Kd=0.52nM     // 3vha.pdf (VHE) ligand is compound 16
4etz  2.05  2012  Kd=0.5uM      // 4etz.pdf (C2E) two molecules (c-di-GMP) in the asymmetric unit
4aq4  1.80  2012  Kd=0.68uM     // 4aq4.pdf (G3P) complex between UgpB and G3P; Kd=0.68+/-0.02uM
3sfg  2.21  2012  Kd=0.865uM    // 3sfg.pdf (2TU) Kd=0.865+/-0.4uM
4gah  2.30  2012  Kd=0.8uM      // 4gah.pdf (0ET) Kd=0.8+/-0.1uM
4g0p  1.80  2012  Kd=0.98mM     // 4g0p.pdf (U5P) Kd=0.98+/-0.01mM
4ara  2.50  2012  Kd=0.9uM      // 4ara.pdf (C56) complex between Mus musculus AChE and R-6
4fm8  1.90  2012  Kd=1.06uM     // 4fm7.pdf (0UQ) ligand is compound 12a; binding free energy = -8.15 kcal/mol (ITC); IC50=2.4uM
3uil  2.20  2012  Kd=1.0uM      // 3t2v.pdf (DAO) ligand is lauric acid; Kd=1.0+/-0.63uM
4dst  2.30  2012  Kd=1.1mM      // 4dsn.pdf (9LI) Kd=1.1+/-0.5mM; Mg-containing
4ai5  2.22  2012  Kd=1.2mM      // 4ai5.pdf (ADK) complex between Y16F-mutant and 3-MeA
3vhc  1.41  2012  Kd=1.3nM      // 3vha.pdf (VHC) ligand is compound 11
4arb  2.25  2012  Kd=1.3uM      // 4ara.pdf (C57) complex between Mus musculus AChE and S-6
4des  1.75  2012  Kd=1.40uM     // 4der.pdf (57D) Kd=1.40+/-0.06uM (Model:Independent); IC50=12.16+/-1.08uM
3udh  1.70  2012  Kd=1.4mM      // 3udh.pdf (091) ligand is compound 1
4dsu  1.70  2012  Kd=1.5mM      // 4dsn.pdf (BZI) Kd=1.5+/-0.3mM; Mg-containing
4fxq  1.96  2012  Kd=1.7uM      // 4fk7.pdf (G9L) Kd=1.7+/-0.2uM, Ki=1.8+/-0.4uM, IC50=6.1+/-1.2uM;
4dkp  1.80  2012  Kd=1.9uM      // 4dko.pdf (0LL)
3qbc  1.65  2012  Kd=10.8uM     // 3qbc.pdf (B55) Kd=10.8+/-0.4uM(SPR)
3zsq  1.70  2012  Kd=10.9uM     // 3zcm.pdf (O4N) ligand is compound 10; Kd=10.9+/-2.7uM(Core3H); Kd=74+/-16uM(Core4H)
4agm  1.52  2012  Kd=105uM      // 4agl.pdf (P86) ligand is compound 4; Kd=105uM(ITC); Kd=104+/-23uM(NMR)
4agn  1.60  2012  Kd=107uM      // 4agl.pdf (NXG) ligand is compound 9; Kd=107uM(ITC); Kd=114+/-8uM(NMR)
3t0x  1.96  2012  Kd=10nM       // 3t0v.pdf (DIW)
4dmw  2.50  2012  Kd=11.4uM     // 4dmw.pdf (UDP) Kd=11.4+/-0.9uM; Mn-containing; Kd by nonradioactive glycotransferase assay, Kd(UDP-glucose-Mn-Tcd); X-ray(UDP-Mn-TcdA)
4hbm  1.90  2012  Kd=12.0nM     // 2lzg.pdf (0Y7) Kd=12.0+/-0.1nM
4g8m  2.05  2012  Kd=12.8nM     // 4g8m.pdf (G8M)
3uyr  1.70  2012  Kd=127nM      // 3uo1.pdf (8-mer) ligand is pC35-55Ld; Kd=127+/-1.4nM
4aj4  1.90  2012  Kd=130uM      // 4aj1.pdf (VAB) ligand is compound 18
3zt3  1.95  2012  Kd=1375uM     // 3zcm.pdf (ZT4) ligand is compound 2; Kd=1375+/-149uM(Core3H); Kd=763+/-372uM(Core4H)
3zt2  1.70  2012  Kd=1435uM     // 3zcm.pdf (ZT2) ligand is compound 3; Kd=1435+/-304uM(Core3H); Kd=724+/-347uM(Core4H)
4ago  1.45  2012  Kd=15.5uM     // 4agl.pdf (P74) ligand is compound 11; Kd by ITC
4aba  1.25  2012  Kd=153uM      // 4ab8.pdf (SW1) ligand is CC 11513
4fys  2.01  2012  Kd=15uM       // 4fyr.pdf (6-mer) Kd=15+/-4.0 uM
4ajl  1.77  2012  Kd=160uM      // 4aj1.pdf (88W) ligand is compound 24
3vjc  1.89  2012  Kd=18.9nM     // 3vjc.pdf (ZGA) ligand is ZA-A; Kd=18.9+/-0.4nM
4flp  2.23  2012  Kd=190.1nM    // 4flp.pdf (JQ1) Kd=190.1+/-7.6nM; K-containing
4a4w  2.00  2012  Kd=19nM       // 4a4v.pdf (YFB) ligand is amorfrutin B
4egk  1.69  2012  Kd=19nM       // 4egh.pdf (RDC) Kd value from ref.28
4det  2.05  2012  Kd=2.10uM     // 4der.pdf (KMP) Kd=2.10+/-0.63uM (Model:Independent); IC50=8.26+/-1.06uM
4deu  1.60  2012  Kd=2.29uM     // 4der.pdf (NAR) Kd=2.29+/-0.18uM (Model:Independent); IC50=12.39+/-1.16uM
2yhw  1.64  2012  Kd=2.5uM      // 2yhw.pdf (BM3) ligand is N-acetylmannosamine
3r5t  1.45  2012  Kd=2.65nM     // 3r5t.pdf (VBN) Fe-containing; Kd=2.65+/-0.63nM
3ubd  1.53  2012  Kd=2.9uM      // 3ubd.pdf (SL0) ligand is compound SL0101
3v78  2.30  2012  Kd=2.9uM      // 3v78.pdf (ET) complex between Rv3066 and ethidium; Kd=2.9+/-0.2uM
4agp  1.50  2012  Kd=20.6uM     // 4agl.pdf (P51) ligand is compound 12; Kd by ITC
4aje  2.35  2012  Kd=210uM      // 4aj1.pdf (2B4) ligand is compound 20
4aia  1.80  2012  Kd=220uM      // 4ai5.pdf (ADK) Kd=220uM(pH=7.8,ITC); Kd=470uM(pH=5.8,ITC); Kd=78uM(pH=7.8,fluorescence); Kd=165uM(pH=5.8,fluorescence)
4fl2  2.19  2012  Kd=220uM      // 4fl1.pdf (ANP) Kd=220+/-30uM; Mg-containing
4agl  1.70  2012  Kd=225uM      // 4agl.pdf (P84) ligand is compound 3; Kd=225uM(ITC); Kd=184+/-23uM(NMR)
2yme  2.40  2012  Kd=22nM       // 2ymd.pdf (CWB)
4gq4  1.27  2012  Kd=22nM       // 4gq3.pdf (0RT)
4avi  2.40  2012  Kd=23.6nM     // 4auy.pdf (XNS) ligand is compound 2; Kd=23.6+/-3.6nM
3umq  2.20  2012  Kd=24.1uM     // 3t2v.pdf (BUA) ligand is butyric acid; Kd=24.1+/-2.0uM
4dbm  2.30  2012  Kd=24nM       // 4dbm.pdf (0J0) Kd=24+/-6.8nM
3tk2  1.35  2012  Kd=24uM       // 3tcy.pdf (PHE) cPAH co-crystallized with Phe; Kd=24+/-1.1uM
3u90  1.90  2012  Kd=24uM       // 3u90.pdf (SDS) complex between apoferritin and SDS; Kd=24+/-9uM(at 293K)
4abf  1.30  2012  Kd=24uM       // 4ab8.pdf (513) ligand is CC 33513
4ad3  2.00  2012  Kd=24uM       // 4acz.pdf (GLC-DMJ)
4fnn  2.24  2012  Kd=27.2nM     // 3t2v.pdf (STE) ligand is stearic acid; Kd=27.2+/-7.4nM
4abg  1.52  2012  Kd=271uM      // 4ab8.pdf (91B) ligand is CC 35913
4aji  1.93  2012  Kd=280uM      // 4aj1.pdf (88R) ligand is compound 21
3uo4  2.45  2012  Kd=299nM      // 3unj.pdf (0C0) ligand is compound 3; Kd=299+/-27nM; IC50=149+/-23nM
4b76  2.14  2012  Kd=29uM       // 4b6e.pdf (PW1)
4eo6  1.79  2012  Kd=2nM        // 4eo6.pdf (0S2) Kd(HCV NS5B GT-1b delta21); IC50(RNA dependent HCV GT-1b NS5B polymerase)
4g0q  1.80  2012  Kd=3.00mM     // 4g0p.pdf (C5P) Kd=3.00+/-0.48mM
3ttm  2.00  2012  Kd=3.0nM      // 3ttm.pdf (PUT)
4f5y  2.40  2012  Kd=3.70uM     // 4f5y.pdf (C2E) a dimeric receptor-ligand complex with 2:1 stoichiometry, Ca-containing
4gzw  2.45  2012  Kd=30.0uM     // 4gzp.pdf (3-mer) ligand is SIA-NAG-GAL; Kd=30.0+/-5.5uM
4abb  1.25  2012  Kd=31uM       // 4ab8.pdf (K9S) ligand is CC 12313
4emr  1.75  2012  Kd=32.1nM     // 4emf.pdf (MGP)
4e67  2.10  2012  Kd=330nM      // 4e67.pdf (8-mer) ligand is PLHSpTA peptide
4epy  1.80  2012  Kd=340uM      // 4epr.pdf (0QY)
3t2w  1.50  2012  Kd=35nM       // 3szj.pdf (BTN)
4avj  2.10  2012  Kd=36.5nM     // 4auy.pdf (J73) ligand is compound 5; Kd=36.5+/-6.4nM
4ffs  1.90  2012  Kd=36pM       // 4ffs.pdf (BIG)
4axd  2.05  2012  Kd=37uM       // 4axd.pdf (ANP) ligand is AMPPNP, Kd=37+/-9 uM
4f7v  1.73  2012  Kd=4.16uM     // 4f7v.pdf (J1D) Kd=4.16+/-0.25uM
3tif  1.80  2012  Kd=4.2uM      // 3tif.pdf (ADP) Kd=4.2+/-0.6uM
3r7o  2.30  2012  Kd=4.4nM      // 3q6w.pdf (M61) lignad is compound 1 (MK-2461)
2yi7  1.40  2012  Kd=4.8nM      // 2yi0.pdf (BZ8) ligand is ICPD 47
4g0y  1.65  2012  Kd=4.99mM     // 4g0p.pdf (AMP) Kd=4.99+/-0.67mM
4abe  1.30  2012  Kd=400uM      // 4ab8.pdf (913) ligand is CC 32913
3re4  2.00  2012  Kd=40nM       // 3re4.pdf (TO1)
3up2  2.30  2012  Kd=40nM       // 3unj.pdf (0C8) ligand is compound 5; Kd=40+/-5.6nM; IC50=28+/-4.8nM
3vha  1.39  2012  Kd=40nM       // 3vha.pdf (VHA) ligand is compound 8
4abd  1.25  2012  Kd=40uM       // 4ab8.pdf (SW2) ligand is CC 21913
4ab9  1.20  2012  Kd=466uM      // 4ab8.pdf (VXQ) ligand is CC 00813
3uod  2.50  2012  Kd=49nM       // 3unj.pdf (0C3) ligand is compound 4; Kd=49+/-5.2nM; IC50=35+/-4.1nM
4ahu  1.90  2012  Kd=5.4mM      // 3vq4.pdf (ICO) ligand is compound 67
3tkw  1.55  2012  Kd=5.4uM      // 3tkg.pdf (017) ligand is DRV; Kd=5.4+/-1.4uM
3ug2  2.50  2012  Kd=5.6nM      // 3ug2.pdf (IRE) Kd=5.6nM(G719S/T790M); Kd=31.9nM(G719S); Kd=14.2nM(WT)
4b1j  2.08  2012  Kd=50.0nM     // 4a0d.pdf (A1R) complex between hPARG26 and ADP-HPD; Kd=50.0+/-6.4nM; IC50=1.10+/-0.22uM
3upk  2.00  2012  Kd=50uM       // 3su9.pdf (UD1) ligand is UNAG
4i3z  2.05  2012  Kd=51.3uM     // 4i3z.pdf (ADP) Kd=51.3+/-1.1uM([Mg2+]=10mM,[ADP]=5mM), Mg-containing
3zsx  1.95  2012  Kd=519uM      // 3zcm.pdf (N44) ligand is compound 9; Kd=519+/-49uM(Core3H); Kd=880+/-99uM(Core4H)
4fl1  1.79  2012  Kd=520uM      // 4fl1.pdf (ANP) Kd=520+/-60uM; Mg-containing
4fm7  1.56  2012  Kd=57nM       // 4fm7.pdf (0UP) ligand is compound 14g; binding free energy = -9.88 kcal/mol (ITC); IC50=0.10uM
4avh  2.10  2012  Kd=59.5nM     // 4auy.pdf (FK9) ligand is compound 1; Kd=59.5+/-4.7nM
3zsy  2.20  2012  Kd=595uM      // 3zcm.pdf (OM3) ligand is compound 7; Kd=595+/-16uM(Core3H); Kd=1180+/-198uM(Core4H)
3upv  1.60  2012  Kd=5uM        // 3upv.pdf (7-mer) ligand is PTVEEVD; Kd=5+/-0.4uM
4g0z  1.75  2012  Kd=6.13mM     // 4g0p.pdf (5GP) Kd=6.13+/-1.03mM
4a6s  2.15  2012  Kd=6.3uM      // 4a6s.pdf (GS9) ligand is compound 11; Kd=6.3+/-0.4uM
4ahs  1.75  2012  Kd=6.4mM      // 3vq4.pdf (AKH) ligand is compound 66
4ahr  1.90  2012  Kd=6.5mM      // 3vq4.pdf (I2E) ligand is compound 63
4duh  1.50  2012  Kd=6.6uM      // 4duh.pdf (RLI) Kd=6.6+/-2.0uM
4av5  1.40  2012  Kd=61.0nM     // 4auy.pdf (FYZ) ligand is compound 8; Kd=61.0+/-9.6nM
4ad2  2.10  2012  Kd=625nM      // 4acz.pdf (GLC-IFM)
4g8n  2.30  2012  Kd=63nM       // 4g8m.pdf (G8M)
4gzx  2.45  2012  Kd=645uM      // 4gzp.pdf (2-mer) ligand is SIA-GAL; Kd=645+/-55uM
3tsk  2.00  2012  Kd=67nM       // 3ts4.pdf (QEG) ligand is compound 8
2ymd  1.96  2012  Kd=693uM      // 2ymd.pdf (SRO) Kd=693+/-29uM
4aci  1.65  2012  Kd=6mM        // 4aci.pdf (CIT) Mg-containing; Crystal Form II
2yi0  1.60  2012  Kd=7.5nM      // 2yi0.pdf (YI0) ligand is ICPD 26
3zso  1.75  2012  Kd=7.6uM      // 3zcm.pdf (O2N) ligand is compound 11; Kd=7.6+/-1.2uM(Core3H); Kd=76+/-11uM(Core4H)
4f1l  1.90  2012  Kd=7.6uM      // 4f0e.pdf (0RY)
4abh  1.25  2012  Kd=71uM       // 4ab8.pdf (7Z3) ligand is CC 38513
3ttp  2.23  2012  Kd=750pM      // 3ttp.pdf (017) ligand is darunavir
3v4t  2.50  2012  Kd=77uM       // 3su9.pdf (UD1) ligand is UNAG
3udd  1.95  2012  Kd=79nM       // 3udd.pdf (34M) ligand is compound 24
4eo8  1.80  2012  Kd=7nM        // 4eo6.pdf (0S3) Kd(HCV NS5B GT-1b delta21); IC50(RNA dependent HCV GT-1b NS5B polymerase)
4dcs  2.25  2012  Kd=8.0uM      // 4dcs.pdf (GDP) Kd=8.0+/-1.0uM (no salt)
3tb6  2.21  2012  Kd=8.4uM      // 3tb6.pdf (ARB) Kd=8.4+/-0.4uM
2yfa  1.80  2012  Kd=8.5uM      // 2yfa.pdf (LMR)
4fxp  1.95  2012  Kd=80.4uM     // 4fxp.pdf (ADX) Kd1=80.4+/-5.2uM(first site); Kd2=460+/-99uM(second site)
4emf  1.77  2012  Kd=83.9nM     // 4emf.pdf (M7G)
3tz0  2.50  2012  Kd=9.2uM      // 3tz0.pdf (03H) ligand is compound 2; Kd=9.2+/-1.4uM
3usx  2.28  2012  Kd=9.53uM     // 3t2v.pdf (MYR) ligand is Myristic Acid; Kd=9.53+/-0.10uM
3vje  2.12  2012  Kd=9.7nM      // 3vjc.pdf (ZGA) ligand is ZA-A; Kd=9.7+/-0.4nM
4agq  1.42  2012  Kd=9.7uM      // 4agl.pdf (P96) ligand is compound 13; Kd by ITC
4av4  1.90  2012  Kd=94.3nM     // 4auy.pdf (FVQ) ligand is compound 7; Kd=94.3+/-18.1nM
4b8y  1.90  2012  Kd=9nM        // 4b8y.pdf (6-mer) Fe-containing; Kd=9+/-0.5nM; ligand is peptide from VIRULENCE FACTOR
4euo  1.28  2012  Kd=9uM        // 4euo.pdf (ABU) Kd=9+/-2uM
4a7i  2.40  2012  Ki=0.002uM    // 4a7i.pdf (A7I) ligand is compound 1a
4djr  1.55  2012  Ki=0.003nM    // 4djo.pdf (0KJ)
4aoi  1.90  2012  Ki=0.004uM    // 3zxz.pdf (4K0) ligand is compound 24
4ap7  1.80  2012  Ki=0.011uM    // 3zxz.pdf (F47) ligand is compound 12
3utu  1.55  2012  Ki=0.012nM    // 3utu.pdf (1TS) ligand is compound 65
3uw5  1.71  2012  Ki=0.014uM    // 3uw4.pdf (4-mer)
3vd4  2.00  2012  Ki=0.015mM    // 3vd4.pdf (IPT) complex between N460D and IPTG; Ki=0.015+/-0.001mM
4gid  2.00  2012  Ki=0.017nM    // 4gid.pdf (0GH)
3uw4  1.79  2012  Ki=0.017uM    // 3uw4.pdf (4-mer)
4ase  1.83  2012  Ki=0.01nM     // 4ag8.pdf (AV9) complex between tivozanib and plus-JM
4agc  2.00  2012  Ki=0.020nM    // 4ag8.pdf (AXI) complex between axitinib and plus-JM
3t5u  1.75  2012  Ki=0.026uM    // 3t5u.pdf (A09) ligand is compound 53
4djp  1.40  2012  Ki=0.028nM    // 4djo.pdf (M73)
4e7r  2.25  2012  Ki=0.02uM     // 4e7r.pdf (0NW)
4dq2  2.50  2012  Ki=0.03uM     // 3v7c.pdf (BTX) ligand is compound 2; Ki=0.03+/-0.01uM
4djq  1.40  2012  Ki=0.048nM    // 4djo.pdf (M86)
3t0b  2.40  2012  Ki=0.05mM     // 3t08.pdf (IPT) ligand is IPTG; Na-containing
4app  2.20  2012  Ki=0.064uM    // 4app.pdf (N53) ligand is compound 3; Ki(SDS-PAGE and autoradiography, ref 13)
3uz5  1.90  2012  Ki=0.06uM     // 3uxd.pdf (0CU) complex between R13-3/11H and 5,7-Cl; Ki=0.06+/-0.02uM
3vd9  2.05  2012  Ki=0.10mM     // 3vd4.pdf (IPT) complex between N460S and IPTG; Ki=0.10+/-0.01mM
3t09  1.75  2012  Ki=0.16mM     // 3t08.pdf (149) ligand is D-galactonolactone; Na-containing
4djv  1.73  2012  Ki=0.19uM     // 4dju.pdf (0KM) ligand is R-4b in crystal structure
3t2q  2.40  2012  Ki=0.22mM     // 3t08.pdf (149) ligand is D-galactonolactone; Na-containing
2yfe  2.00  2012  Ki=0.236uM    // 2yfe.pdf (YFE) ligand is Amorfrutin 1
3s54  1.42  2012  Ki=0.23nM     // 3s43.pdf (017) ligand is DRV; in space group P21212
4b7r  1.90  2012  Ki=0.23nM     // 4b7j.pdf (G39) Ki=0.23+/-0.12nM
4ax9  1.90  2012  Ki=0.27nM     // 4ax9.pdf (N5N) ligand is compound 19f
3tfn  2.07  2012  Ki=0.27uM     // 3tfn.pdf (2CJ) ligand is compound 6
4fk6  2.20  2012  Ki=0.2nM      // 4fk6.pdf (0UJ)
3t64  1.65  2012  Ki=0.2uM      // 3t60.pdf (DU3) ligand is compound 15a
3t60  2.40  2012  Ki=0.2uM      // 3t60.pdf (DUA) lignad is compound 24
3tfp  2.00  2012  Ki=0.34uM     // 3tfn.pdf (03L) ligand is compound 8 (the Cl atom is missing in the reference)
4ea2  2.05  2012  Ki=0.36uM     // 4e9u.pdf (RWZ) ligand is compound Z-3
3pwk  1.50  2012  Ki=0.45mM     // 3pwk.pdf (L14)
3vf5  1.25  2012  Ki=0.46nM     // 3vf5.pdf (031) Ki=0.46+/-0.04nM
4a4q  1.80  2012  Ki=0.4nM      // 4a4q.pdf (UX9) ligand is compound 13i
2y8c  2.10  2012  Ki=0.4uM      // 2y8c.pdf (DUQ) ligand is compound 4c
4asd  2.03  2012  Ki=0.52nM     // 4ag8.pdf (BAX) complex between sorafenib and plus-JM
4djw  1.90  2012  Ki=0.53uM     // 4dju.pdf (0KP) ligand is R-4j in crystal structure
4dv8  1.63  2012  Ki=0.58nM     // 4dv8.pdf (0LX) Zn-containing
3vh9  1.29  2012  Ki=0.58uM     // 3vh9.pdf (HQY) ligand is compound 9
3t70  1.80  2012  Ki=0.5uM      // 3t60.pdf (DU4) ligand is compound 15g
3vfa  1.43  2012  Ki=0.65nM     // 3vfa.pdf (031) Ki=0.65+/-0.05nM
4b9k  2.00  2012  Ki=0.67uM     // 4b95.pdf (TG0)
3su3  1.30  2012  Ki=0.74nM     // 3su0.pdf (SU3) ligand is Vaniprevir; Ki=0.74+/-0.07nM
3vf7  1.30  2012  Ki=0.80nM     // 3vf7.pdf (031) Ki=0.80+/-0.08nM
3sue  2.20  2012  Ki=0.84nM     // 3su0.pdf (SUE) ligand is MK-5172; Ki=0.84+/-0.05nM
3t08  2.00  2012  Ki=0.91mM     // 3t08.pdf (IPT) ligand is IPTG; Na-containing
3vfb  1.55  2012  Ki=0.92nM     // 3vfb.pdf (031) Ki=0.92+/-0.10nM
4e4n  1.90  2012  Ki=0.9nM      // 4e4l.pdf (0NL)
3u6h  2.00  2012  Ki=1.0nM      // 3u6h.pdf (03X) Ki=1.0+/-0.3nM; IC50=20+/-7.5nM(PC3), compound 26
3v5p  2.10  2012  Ki=1.1nM      // 3sx9.pdf (C88) ligand is compound 12; Ki by nonradioactive luciferase assay
4ag8  1.95  2012  Ki=1.1nM      // 4ag8.pdf (AXI) complex between axitinib and minus-JM
4de1  1.26  2012  Ki=1.1uM      // 4dds.pdf (0J6)
4e6d  2.22  2012  Ki=1.2nM      // 4e4l.pdf (0NU)
3zv7  2.26  2012  Ki=1.2uM      // 3zv7.pdf (NHG) ligand is compound 2a; Ki=1.2+/-0.24uM
4gqq  1.35  2012  Ki=1.3mM      // 4gqq.pdf (0XR) Ki=1.3+/-0.1mM (uncompetitive)
4de0  1.12  2012  Ki=1.3uM      // 4dds.pdf (0JB)
4do5  1.51  2012  Ki=1.48uM     // 4do4.pdf (DGJ) Ki=1.48+/-0.15uM
3qqs  1.97  2012  Ki=1.5uM      // 3qqs.pdf (17C) ligand is ACS172; Ki=1.5+/-0.1uM
4dld  2.00  2012  Ki=1.5uM      // 4dld.pdf (TZG) Ki=1.5+/-0.2uM
4e9u  2.10  2012  Ki=1.5uM      // 4e9u.pdf (RWY) Mg-containing
4g8v  1.70  2012  Ki=1.6uM      // 4g8v.pdf (0EY) Ki=1.6+/-0.2uM
4a95  1.55  2012  Ki=1.73uM     // 4a95.pdf (9MT) ligand is compound 1; Ki=1.73+/-0.16uM(PvNMT); Ki=1.69+/-0.22uM(HsNMT1); Ki=11.39+/-2.11(HsNMT2)
3qdd  1.79  2012  Ki=1.7nM      // 3qdd.pdf (94M) ligand is compound 14
4e4l  2.00  2012  Ki=1.7nM      // 4e4l.pdf (0NH)
4ei4  2.22  2012  Ki=1.8nM      // 4ehz.pdf (0Q2)
4dfg  1.23  2012  Ki=1.8pM      // 4dfg.pdf (0JV)
3ts4  1.59  2012  Ki=1.9nM      // 3ts4.pdf (EEG) ligand is compound 3
3shc  1.90  2012  Ki=1.9uM      // 3p17.pdf (B01) ligand is compound 8; Ki=1.9+/-0.8uM
4e3g  1.55  2012  Ki=10.6uM     // 4e3d.pdf (PHB) Ki measured in CO2 hydration assay
4b6o  2.00  2012  Ki=100nM      // 4b6o.pdf (3DQ)
4fai  1.65  2012  Ki=101.3nM    // 4f9u.pdf (PBD) Ki=101.3+/-0.2nM(pH=7); Zn-containing
4a6l  2.05  2012  Ki=10nM       // 4a6l.pdf (P43) ligand is compound 2
4ehz  2.17  2012  Ki=10nM       // 4ehz.pdf (JAK)
4b7j  2.42  2012  Ki=11.1nM     // 4b7j.pdf (G39) Ki=11.1+/-1.10nM
3uxk  2.20  2012  Ki=11.7uM     // 3uxk.pdf (BHO) ligand is compound BzH; Ki=11.7+/-1.2uM
4hge  2.30  2012  Ki=11.9nM     // 4hge.pdf (15V)
4gqr  1.20  2012  Ki=110uM      // 4gqq.pdf (MYC) Ki=110+/-15uM (competitive binding)
3twp  1.83  2012  Ki=119uM      // 3qqs.pdf (SAL) ligand is ACS10; Ki=119+/-20uM
3uuo  2.11  2012  Ki=11nM       // 3uuo.pdf (0CV) ligand is compound 1
3veh  2.00  2012  Ki=11uM       // 3rv6.pdf (0GA) ligand is methyl-AMT; Ki=11+/-1uM; Ki(Z/E=9:1) while X-ray(Z-form)
4b5d  2.20  2012  Ki=12.8nM     // 4b5d.pdf (SW4) Ki=12.8+/-0.4nM
4a6c  1.50  2012  Ki=12nM       // 4a6b.pdf (QG9) ligand is compound 19b
3rv8  2.29  2012  Ki=12uM       // 3rv6.pdf (RVC/VCE) ligand is (Z/E)-cyclopropyl-AMT; Ki=12+/-1uM;
3si4  1.27  2012  Ki=132.2uM    // 3p17.pdf (B04) ligand is compound 5; Ki=132.2+/-35.3uM
3spf  1.70  2012  Ki=138uM      // 3spf.pdf (B50) ligand is compound 4; Ki=138+/-7.6uM
4gzp  2.30  2012  Ki=14.3nM     // 4gzp.pdf (G39) Ki=14.3+/-2.3nM; Ca-containing
4b6r  2.00  2012  Ki=1420nM     // 4b6o.pdf (3DQ)
3sut  1.90  2012  Ki=14nM       // 3sur.pdf (OAN) ligand is PUGNAc; Ki=14+/-2nM
3r88  1.73  2012  Ki=15uM       // 3qqs.pdf (14F) ligand is ACS145; Ki=15+/-4uM
3su0  1.16  2012  Ki=162nM      // 3su0.pdf (TSV) ligand is Danoprevir; Ki=162+/-16nM
4gzt  2.19  2012  Ki=17.0nM     // 4gzp.pdf (G39) Ki=17.0+/-1.5nM; Ca-containing
3tzm  1.70  2012  Ki=17nM       // 3tzm.pdf (085) ligand is compound SB-431542
3tvc  2.43  2012  Ki=18nM       // 3ts4.pdf (E3P) ligand is compound 18
4f39  1.83  2012  Ki=1980nM     // 4f39.pdf (KAI)
3u6i  2.10  2012  Ki=1nM        // 3u6i.pdf (044) ligand is compound (R)-58a
3uri  2.10  2012  Ki=1nM        // 3uri.pdf (8-mer) complex between endothiapepsin and DB5 peptide
4h3f  1.70  2012  Ki=1nM        // 4h1e.pdf (10O)
4hf4  2.00  2012  Ki=2.4nM      // 4heu.pdf (15H)
3s43  1.26  2012  Ki=2.53nM     // 3s43.pdf (478) ligand is amprenavir
3sxf  2.04  2012  Ki=2.5nM      // 3sx9.pdf (BK5) ligand is compound 3a; Ki by nonradioactive luciferase assay
3t3u  2.10  2012  Ki=2.5nM      // 3sx9.pdf (BK6) ligand is compound 2b; Ki by nonradioactive luciferase assay
4efs  1.63  2012  Ki=2.5nM      // 3ts4.pdf (E37) ligand is compound 16
3sha  1.52  2012  Ki=2.6uM      // 3p17.pdf (P97) ligand is compound 10; Ki=2.6+/-1.1uM
3v7x  1.03  2012  Ki=2.7nM      // 3v7x.pdf (D7A) complex between compound I and hCAII; Ki=2.7+/-0.1nM
3uxl  2.20  2012  Ki=2.7uM      // 3uxk.pdf (CFI) ligand is compound CfN
3uzj  1.69  2012  Ki=2.82uM     // 3uxd.pdf (0CT) complex between R13-3/11H and benzotriazole; Ki=2.82+/-0.19uM
3v51  1.95  2012  Ki=2.8nM      // 3sx9.pdf (I76) ligand is compound 11; Ki by nonradioactive luciferase assay
4f09  2.40  2012  Ki=200nM      // 4ehz.pdf (JAK)
3su1  1.40  2012  Ki=208nM      // 3su0.pdf (TSV) ligand is Danoprevir; Ki=208+/-66nM
4acc  2.21  2012  Ki=20nM       // 4acc.pdf (7YG) ligand is compound 23
4fsl  2.50  2012  Ki=20nM       // 4fsl.pdf (0VB) I-containig
3suw  1.90  2012  Ki=20uM       // 3sur.pdf (GC2) ligand is NHAc-CAS; Ki=20+/-3uM
4gkh  1.86  2012  Ki=21.5uM     // 4ej7.pdf (0J9) Ki=21.5+/-1.7uM
3qtv  1.63  2012  Ki=22.5uM     // 3p17.pdf (06P) ligand is compound 7; Ki=22.5+/-13.2uM
4e5w  1.86  2012  Ki=22nM       // 4e4l.pdf (0NT)
4g8y  1.80  2012  Ki=25.8uM     // 4g8v.pdf (0FT) Ki=25.8+/-2.4uM
3vhk  2.49  2012  Ki=25uM       // 3vhk.pdf (BPK) ligand is compound E
4bc5  1.98  2012  Ki=25uM       // 4bc2.pdf (5FX) Ki=25+/-2uM
3su5  1.55  2012  Ki=2635nM     // 3su0.pdf (SU3) ligand is Vaniprevir; Ki=2635+/-702nM
3suf  2.19  2012  Ki=27.8nM     // 3su0.pdf (SUE) ligand is MK-5172; Ki=27.8+/-12.1nM
4fs4  1.74  2012  Ki=270nM      // 4fs4.pdf (H24) ligand is compound 4, ligand structure is diffrent: -NH2 and =NH
3rr4  1.68  2012  Ki=28.05uM    // 3gev.pdf (HRD) ligand is compound 11a; Ki=28.05+/-11.97uM
3suv  1.60  2012  Ki=28uM       // 3sur.pdf (NOK) ligand is NHAc-DNJ; Ki=28+/-4uM
3vdb  2.05  2012  Ki=3.03mM     // 3vd4.pdf (149) complex between N460T and galactonolactone; Ki=3.03+/-0.20mM
3s45  1.51  2012  Ki=3.24nM     // 3s43.pdf (478) ligand is amprenavir
4dju  1.80  2012  Ki=3.6uM      // 4dju.pdf (0KK)
4fev  1.89  2012  Ki=3.8uM      // 4ej7.pdf (PP1) Ki=3.8+/-0.4uM
4g90  1.90  2012  Ki=30.8uM     // 4g8v.pdf (0G0) Ki=30.8+/-4.4uM
3u92  1.90  2012  Ki=32.8nM     // 3u92.pdf (KAI) ligand is kainate
4dhl  2.30  2012  Ki=33uM       // 4dhl.pdf (0K7) Ki=33+/-10uM; Zn-containing
4gki  1.88  2012  Ki=34.4uM     // 4ej7.pdf (0JN) Ki=34.4+/-1.9uM
3qw5  1.60  2012  Ki=358nM      // 3qw5.pdf (5-mer) ligand is peptide RRGF; Zn-containing
4dff  2.11  2012  Ki=35nM       // 4dff.pdf (0JP) Zn-containing; Mg-containing
4i8n  2.50  2012  Ki=35uM       // 4i8n.pdf (1CG)
3u81  1.13  2012  Ki=36uM       // 3r6t.pdf (SAH)
3rbu  1.60  2012  Ki=370pM      // 3rbu.pdf (G88) Ki=370+/-80pM(HPLC assay); Zn-containing
4dsy  2.30  2012  Ki=37uM       // 4dhl.pdf (0LO) Ki=37+/-16uM; Zn-containing; Fe-containing
4ek9  2.50  2012  Ki=38000nM    // 4ek9.pdf (EP4)
4exs  2.40  2012  Ki=39.0uM     // 4exs.pdf (X8Z) Zn-containing
3s5y  2.10  2012  Ki=39.1nM     // 3s5y.pdf (DGJ) Ki=39.1+/-1.9 nM
3uxd  1.80  2012  Ki=39.3uM     // 3uxd.pdf (0CU) complex between R1-7/10H and 5,7-Cl; Ki=39.3+/-0.2uM
3suu  1.60  2012  Ki=3nM        // 3sur.pdf (OGN) ligand is Gal-PUGNAc; Ki=3+/-2nM
4djo  1.78  2012  Ki=3pM        // 4djo.pdf (MK5)
4en4  2.15  2012  Ki=3uM        // 4en4.pdf (GT0)
4a6b  1.80  2012  Ki=4.2nM      // 4a6b.pdf (QG8) ligand is compound 19d
3t0d  1.93  2012  Ki=4.3mM      // 3t08.pdf (149) ligand is D-galactonolactone; Na-containing
4e6q  1.95  2012  Ki=4.4nM      // 4e4l.pdf (0NV)
3su2  1.50  2012  Ki=44.8nM     // 3su0.pdf (TSV) ligand is Danoprevir; Ki=44.8+/-3.6nM
3s6t  2.30  2012  Ki=45nM       // 3s6t.pdf (OAN)
3u93  1.88  2012  Ki=494nM      // 3u93.pdf (GLU) ligand is glutamate
3tt4  1.88  2012  Ki=5.3nM      // 3ts4.pdf (E1S) ligand is compound 17
4djy  1.86  2012  Ki=5.4nM      // 4dju.pdf (0KR) ligand is R-24 in crystal structure
4eoh  2.10  2012  Ki=50uM       // 4en4.pdf (TEP)
4do4  1.40  2012  Ki=51nM       // 4do4.pdf (DJN) Ki=51+/-6nM
4alx  2.30  2012  Ki=52nM       // 4alx.pdf (IZN) complex between DHbetaE and Ls-AChBP; Ki=52+/-5nM
3qwc  1.75  2012  Ki=55.4uM     // 3p17.pdf (98P) ligand is compound 11; Ki=55.4+/-21.4uM
3su4  2.25  2012  Ki=554nM      // 3su0.pdf (SU3) ligand is Vaniprevir; Ki=554+/-64nM
4ha5  1.83  2012  Ki=58nM       // 4h1e.pdf (13W)
4djx  1.50  2012  Ki=59nM       // 4dju.pdf (0KQ) liagnd is R-17h in crystal structure
3t3c  2.10  2012  Ki=59pM       // 3t3c.pdf (017) ligand is DRV; Ki=59+/-7pM
4afg  2.00  2012  Ki=5nM        // 4afg.pdf (QMR) complex between Ct-AChBP and varenicline; Ki=5+/-1nM
4few  1.98  2012  Ki=6.2uM      // 4ej7.pdf (PP2) Ki=6.2+/-0.5uM
4gg7  2.27  2012  Ki=6.3nM      // 4gg5.pdf (0J8)
3uu1  1.82  2012  Ki=6.3uM      // 3qqs.pdf (14B) ligand is ACS142; Ki=6.3+/-0.8uM
3sug  1.80  2012  Ki=620nM      // 3su0.pdf (SUE) ligand is MK-5172; Ki=620+/-71nM
3qx5  1.35  2012  Ki=63.5uM     // 3p17.pdf (02P) ligand is compound 9; Ki=63.5+/-13.6uM
3sv2  1.30  2012  Ki=64.0uM     // 3p17.pdf (P05) ligand is compound 6; Ki=64.0+/-20.0uM
3si3  1.55  2012  Ki=69.3uM     // 3p17.pdf (B03) ligand is compound 4; Ki=69.3+/-0.1uM
3v5t  2.13  2012  Ki=6nM        // 3sx9.pdf (UW9) ligand is compound 13; Ki by nonradioactive luciferase assay
4h3g  1.85  2012  Ki=6nM        // 4h1e.pdf (10Q)
3sur  1.90  2012  Ki=70uM       // 3sur.pdf (NGT) ligand is NAG-thiazoline; Ki=70+/-4uM
3sus  1.80  2012  Ki=71uM       // 3sur.pdf (GNL) ligand is Gal-NAG-thiazoline; Ki=71+/-5uM
3qto  1.52  2012  Ki=74.8uM     // 3p17.pdf (10P) ligand is compound 3; Ki=74.8+/-20.5uM
4b6p  2.30  2012  Ki=74nM       // 4b6o.pdf (2HN)
4de2  1.40  2012  Ki=76.0uM     // 4dds.pdf (DN3)
4e0x  2.00  2012  Ki=76nM       // 4e0w.pdf (KAI)
3vbd  1.05  2012  Ki=8.6nM      // 3v7x.pdf (0FZ) ligand is compound 2a; Ki=8.6+/-0.6nM
4b9z  2.00  2012  Ki=81.4uM     // 4b9z.pdf (ACR) ligand is Acarbose
4h3j  1.60  2012  Ki=90nM       // 4h1e.pdf (10W)
4f9u  1.80  2012  Ki=944nM      // 4f9u.pdf (PBD) Ki=944+/-93nM(pH=7); Zn-containing
3su6  1.10  2012  Ki=958nM      // 3su0.pdf (SU3) ligand is Vaniprevir; Ki=958+/-162nM
4b6s  1.90  2012  Ki=970nM      // 4b6o.pdf (2HN)
4f6w  2.39  2013  Kd=0.03uM     // 4f6s.pdf (0SS) compound 1
3zi0  1.90  2013  Kd=0.04uM     // 3zhx.pdf (FM8) Mn-containing; ligand is compound 14i
4ly1  1.57  2013  Kd=0.0552uM   // 4lxz.pdf (20Y) ligand is compound 1
4ggz  1.75  2013  Kd=0.066nM    // 4ggz.pdf (BTN) Kd=0.066+/-0.015nM
4i9h  2.17  2013  Kd=0.068uM    // 4i8x.pdf (1E4) IC50=0.440uM
4ko8  1.98  2013  Kd=0.07uM     // 4kln.pdf (AGS) Kd=0.07+/-0.01 uM
4k9y  2.00  2013  Kd=0.111uM    // 4k8a.pdf (K9Y) ligand is compound 13
4i54  2.50  2013  Kd=0.11uM     // 4i53.pdf (1C1) Kd=0.11+/-0.03uM
4jyb  2.10  2013  Kd=0.11uM     // 4jyb.pdf (GNP) ligand is GMPPNP; Kd=0.11+/-0.01 uM
4loh  2.25  2013  Kd=0.11uM     // 4loh.pdf (1SY) ligand is c[G(2',5')pA(3',5')p]
4g4p  1.50  2013  Kd=0.13uM     // 4g4p.pdf (GLN) Kd=0.13+/-0.01uM
4loi  1.89  2013  Kd=0.17uM     // 4loh.pdf (1YC) ligand is c[G(2',5')pA(2',5')p]
4lxz  1.85  2013  Kd=0.182uM    // 4lxz.pdf (SHH) ligand is SAHA
4lhv  1.95  2013  Kd=0.1nM      // 4lhv.pdf (GDP)
4jyc  2.20  2013  Kd=0.20uM     // 4jyb.pdf (GDP) Kd=0.20+/-0.01 uM
3zhx  2.00  2013  Kd=0.21uM     // 3zhx.pdf (FM6) Mn-containing; ligand is compound 14a
4iuo  1.80  2013  Kd=0.23mM     // 4gui.pdf (QIC) Kd=0.23+/-0.04mM
4btk  2.00  2013  Kd=0.24uM     // 4btj.pdf (DTQ) Kd=0.46 uM(Phosphorylated TTBK1), Kd=0.24 uM(Nonphosphorylated TTBK1)
4gqp  2.00  2013  Kd=0.25nM     // 4gqp.pdf (B40) Kd=0.25+/-0.014nM
4iue  2.38  2013  Kd=0.28uM     // 3w51.pdf (AJ4) ligand is compound 11
4io2  1.37  2013  Kd=0.2uM      // 4io2.pdf (GLU) Kd=0.2+/-0.02uM
4b7p  1.70  2013  Kd=0.346nM    // 4b7p.pdf (9UN) ligand is NMS-E973
4n07  1.87  2013  Kd=0.35uM     // 4n07.pdf (2J9) ligand is compound 3; Kd=0.35+/-0.02 uM
4jfk  1.15  2013  Kd=0.36uM     // 4jfi.pdf (JFK) Kd=0.36+/-0.1uM
3zll  2.00  2013  Kd=0.395uM    // 4arw.pdf (4WF) ligand is compound 2; Kd=0.395+/-0.02uM; IC50=1.14+/-0.19uM
3w07  1.03  2013  Kd=0.42mM     // 3w07.pdf (U5P) Kd=0.42+/-0.02mM
4b33  1.50  2013  Kd=0.43mM     // 4b2i.pdf (1NP) ligand is compound 9
3v2p  1.87  2013  Kd=0.44uM     // 3v2n.pdf (STE) Kd=0.44+/-0.06uM
4b32  1.50  2013  Kd=0.46mM     // 4b2i.pdf (03V) ligand is compound 10
3zk6  2.48  2013  Kd=0.46uM     // 3zk6.pdf (H1I) ligand is compound 2; Kd=230+/-20nM
3w9k  1.80  2013  Kd=0.48uM     // 3w9k.pdf (MYR) Kd=0.48+/-0.05uM
3v2q  2.20  2013  Kd=0.51uM     // 3v2n.pdf (PLM) Kd=0.51+/-0.07uM
4f0c  1.90  2013  Kd=0.54uM     // 4f0c.pdf (GDS) ligand is GSSG
3zlr  2.03  2013  Kd=0.55nM     // 3zk6.pdf (X0B) ligand is WEHI-539
4b2l  1.50  2013  Kd=0.57mM     // 4b2i.pdf (TR7) ligand is compound 8
4ddh  2.07  2013  Kd=0.5mM      // 4ddh.pdf (MS0) Kd=0.5+/-0.01 mM
4e1k  2.00  2013  Kd=0.5uM      // 4e1k.pdf (0N5)
4bqg  1.90  2013  Kd=0.60uM     // 4bqg.pdf (50Q)
4k6i  2.10  2013  Kd=0.629uM    // 4k4j.pdf (9RA) ligand is Targretin; Ka=1.59+/-0.04 uM^(-1)(25 C)
4fht  2.15  2013  Kd=0.67uM     // 4fht.pdf (DHB) Kd=0.67+/-0.01uM
4f6u  2.10  2013  Kd=0.70uM     // 4f6s.pdf (0SR) compound 5
4b34  1.55  2013  Kd=0.73mM     // 4b2i.pdf (ABV) ligand is compound 6
4k4j  2.00  2013  Kd=0.752uM    // 4k4j.pdf (1O8) ligand is 9cUAB30; Ka=1.33+/-0.04 uM^(-1)(25 C)
4hp0  1.19  2013  Kd=0.76uM     // 4hp0.pdf (4-mer)
4kao  2.39  2013  Kd=0.77uM     // 4k8a.pdf (KAO) ligand is compound 27
4de5  2.25  2013  Kd=0.7mM      // 4ddh.pdf (0JD) Kd=0.7+/-0.02 mM
4fzj  1.63  2013  Kd=0.7mM      // 4ddh.pdf (0W1) Kd=0.7+/-0.02 mM
4io3  1.66  2013  Kd=0.87uM     // 4io2.pdf (ASP) Kd=0.87+/-0.08uM
4l50  2.10  2013  Kd=0.88uM     // 4l4z.pdf (D8X) ligand is D8P; Kd=0.88+/-0.14uM
3v2n  1.80  2013  Kd=0.8uM      // 3v2n.pdf (MYR) Kd=0.8+/-0.1uM
4km0  1.30  2013  Kd=0.91uM     // 4klx.pdf (CP6) ligand is PYR
4g5f  2.33  2013  Kd=0.9mM      // 4ddh.pdf (0JD) Kd=0.9+/-0.04 mM
4kqp  0.95  2013  Kd=0.9uM      // 4g4p.pdf (GLN) Kd=0.9+/-0.2uM
4az5  1.73  2013  Kd=1.02uM     // 4az5.pdf (NGW) ligand is NGT; Kd=1.02+/-0.14uM
4nkt  1.90  2013  Kd=1.08uM     // 4nkt.pdf (2KH) Kd=1.08+/-0.02 uM
4b2i  1.30  2013  Kd=1.0mM      // 4b2i.pdf (LZ1) ligand is compound 5
4lkk  2.49  2013  Kd=1.20uM     // 4kol.pdf (2-mer)
4ef6  1.94  2013  Kd=1.2mM      // 4ddh.pdf (I2E) Kd=1.2+/-0.01 mM
4azc  2.09  2013  Kd=1.38uM     // 4az5.pdf (NGW) ligand is NGT; Kd=1.38+/-0.04uM
4jne  1.96  2013  Kd=1.38uM     // 4jn4.pdf (ATP) Kd=1.38+/-0.06uM; Mg-containing
4b35  1.40  2013  Kd=1.3mM      // 4b2i.pdf (4ME) ligand is compound 4
4km2  1.40  2013  Kd=1.43uM     // 4klx.pdf (TOP) ligand is TMP
4l4v  1.90  2013  Kd=1.65uM     // 4l4t.pdf (1VY) ligand is rRL-6-CH2OH; Kd =1.65+/-0.16 uM
4ezx  1.70  2013  Kd=1.6uM      // 4ezo.pdf (7-mer) Kd=1.6+/-0.5 uM
4lps  2.00  2013  Kd=1.8uM      // 4lps.pdf (GDP) Ni2+ containing; Kd=1.8+/-0.6 uM
4br3  2.20  2013  Kd=1.9uM      // 4br3.pdf (U85)
4knm  1.90  2013  Kd=10.0nM     // 4kni.pdf (E1E) ligand is compound 2f
4bcs  1.80  2013  Kd=103nM      // 4bcs.pdf (BTN) Kd at PH=7 by ITC
4i7l  1.52  2013  Kd=103uM      // 4i7j.pdf (IPH)
4att  1.25  2013  Kd=104.6nM    // 4att.pdf (HNV) ligand is 1OMe; Kd=53+/-2.3nM(SPR); Kd=104.6+/-21.9nM(ITC)
4ceb  1.75  2013  Kd=1080uM     // 4ce9.pdf (ZSV) Kd=1080+/-123 uM
4ht0  1.60  2013  Kd=10nM       // 4ht0.pdf (V50) Zn-containing
4knj  2.00  2013  Kd=11.1nM     // 4kni.pdf (E1F) ligand is compound 2j
4bup  2.17  2013  Kd=11.2uM     // 4au7.pdf (SAM) Kd=11.2+/-1uM
4ido  2.09  2013  Kd=11.63uM    // 4idn.pdf (GDP) Kd=11.63+/-1.18uM; Mg-containing
4bi6  1.45  2013  Kd=113.3uM    // 4bi6.pdf (PGA) Ki=560+/-59uM, Kd=113.3+/-41.7uM
4mr3  1.68  2013  Kd=1142nM     // 4mr3.pdf (1K0) ligand is RVX-208; Kd=1142+/-46 nM
4igt  1.24  2013  Kd=12.8nM     // 4igr.pdf (3ZA)
4ipj  2.15  2013  Kd=13.5uM     // 4ipi.pdf (LMR) Kd=13.5+/-0.4uM, Mn-containing
3w5n  1.80  2013  Kd=135uM      // 3w5n.pdf (RAM)
4i9u  2.50  2013  Kd=137uM      // 4i8x.pdf (1E7) IC50=770uM
4hpi  1.19  2013  Kd=14.2uM     // 4hp0.pdf (3-mer)
3vvy  1.63  2013  Kd=14.6uM     // 3vvy.pdf (ET) ligand is Ethidium bromide; Kd=14.6+/-0.10uM
4k3h  2.45  2013  Kd=140nM      // 4k3h.pdf (1OM)
4kn1  2.30  2013  Kd=144nM      // 4kmz.pdf (04J) ligand is Aminopterin; Kd=144+/-5 nM(pH 7.4),crystal(pH 8.0)
4ieh  2.10  2013  Kd=14nM       // 4ieh.pdf (1E9) Bcl-2/BAK complex, IC50=17nM
4j7e  1.63  2013  Kd=14uM       // 4j7e.pdf (I29)
4io6  1.60  2013  Kd=15.1uM     // 4io2.pdf (MET) Kd=15.1+/-2.5uM
4aq6  1.98  2013  Kd=15.8uM     // 3zds.pdf (OMD) Fe-containing; Kd=15.8+/-1.4uM
4bks  2.20  2013  Kd=150uM      // 4bks.pdf (X6C) Kd=150+/-9uM
3vx3  2.10  2013  Kd=15nM       // 3vx3.pdf (ADP) Kd=15+/-1.8nM
4kni  1.80  2013  Kd=16.7nM     // 4kni.pdf (E1E) ligand is compound 2f
4knn  1.40  2013  Kd=16.7nM     // 4kni.pdf (E1F) ligand is compound 2j
4ad6  1.85  2013  Kd=16.7uM     // 4ad6.pdf (GSY) ligand is compound 21a; Kd=16.7+/-3.5uM
4j3l  2.09  2013  Kd=16nM       // 3w51.pdf (AJ5) ligand is compound 17
3vw2  2.34  2013  Kd=17.9uM     // 3vvy.pdf (BER) ligand is berberine; Kd=17.9+/-0.03uM
4kax  1.85  2013  Kd=17uM       // 4kax.pdf (GTP)
4auj  1.53  2013  Kd=18.3nM     // 4auj.pdf (HNW) ligand is 2OH; Kd=18.3+/-5.9nM(ITC); Kd=36.9+/-3.0nM(SPR)
4ayu  1.50  2013  Kd=18.6uM     // 4avt.pdf (N8P) ligand is N-Acetyl-D-Proline
4fz3  2.10  2013  Kd=184.3uM    // 4fz3.pdf (6-mer) Kd=184.3+/-9.8 uM
4f9y  1.85  2013  Kd=184nM      // 4f9w.pdf (LM3)
4j22  2.12  2013  Kd=18nM       // 3w51.pdf (AJ7) ligand is compound 16
4ih6  2.20  2013  Kd=18uM       // 4ih5.pdf (1EP)
4ljh  1.45  2013  Kd=19.4uM     // 4ljh.pdf (GAL-MHD) ligand is compound 15; Kd=19.4+/-1.5 uM
4k0o  2.15  2013  Kd=1mM        // 4k0o.pdf (NAG-MBG)
4bb9  1.47  2013  Kd=1uM        // 4bb9.pdf (F1P)
4b3c  1.90  2013  Kd=2.1mM      // 4b2i.pdf (5H1) ligand is compound 1
4b3d  1.59  2013  Kd=2.1mM      // 4b2i.pdf (5MI) ligand is compound 2
4jn2  1.71  2013  Kd=2.1pM      // 4jn1.pdf (4CC) ligand is dabigatran
4l4z  2.30  2013  Kd=2.1uM      // 4l4z.pdf (D5X) ligand is D5P; Kd=2.1+/-0.3 uM
3zi8  1.50  2013  Kd=2.2uM      // 3zi8.pdf (FU4) ligand is alpha-MeFuc-fucose
4i8x  2.23  2013  Kd=2.3mM      // 4i8x.pdf (6P3) IC50>2mM
4jx9  1.40  2013  Kd=2.4nM      // 4jwk.pdf (URI) ligand is Uridine; Kd=3.11*10^(-9) M(fluorescence), 2.4*10^(-9) M(SPR)
4dzy  2.10  2013  Kd=2.4uM      // 4dzy.pdf (WJ1) Kd=2.4+/-0.4uM; IC50=6.3 uM; Mg-containing; K-containing
4bqh  1.75  2013  Kd=2.58uM     // 4bqh.pdf (9VU) Kd=2.58+/-0.07uM
4kmz  2.30  2013  Kd=2.7nM      // 4kmz.pdf (FOL) ligand is Folic acid; Kd=2.7+/-1.5 nM(pH 7.4), 23+/-5 nM(pH 6.5),crystal(pH 8.0)
4hj2  2.10  2013  Kd=2.95mM     // 4hj2.pdf (LZ6) Kd=2.95+/-0.5mM, Kd=6.05+/-0.8mM (for fast and slow reactions, respectively)
4nxu  2.30  2013  Kd=2.9uM      // 4nxu.pdf (ADP) Kd=2.9+/-0.8uM
4lar  2.38  2013  Kd=20.7uM     // 4lar.pdf (1WE)
4j7d  1.25  2013  Kd=20uM       // 4j7d.pdf (I31)
4j93  1.74  2013  Kd=20uM       // 4j93.pdf (1JR)
4luz  1.90  2013  Kd=20uM       // 4luo.pdf (1XT) ligand is compound 7
4del  1.58  2013  Kd=21.1nM     // 4del.pdf (PGH) Zn-containing; Kd=21.1+/-0.2 nM
3vw1  2.21  2013  Kd=21.2uM     // 3vvy.pdf (CVI) ligand is violet; Kd=21.2+/-0.52uM
4nku  1.94  2013  Kd=21.3uM     // 4nkt.pdf (2-mer) Kd=21.3+/-3.2 uM; ligand is A-U
4io7  1.92  2013  Kd=211uM      // 4io2.pdf (PHE) Kd=211+/-45uM
2ypo  2.00  2013  Kd=21uM       // 2ypo.pdf (PHE) Kd=21+/-1uM
4io4  1.94  2013  Kd=24.5uM     // 4io2.pdf (SER) Kd=24.5+/-1.9uM
4bkt  2.35  2013  Kd=240uM      // 4bks.pdf (QD0) Kd=240+/-17uM
4c6u  2.40  2013  Kd=25.6uM     // 4c6u.pdf (TLG) Kd=25.6+/-0.5uM
4b3b  1.19  2013  Kd=250uM      // 4b2i.pdf (6-mer) ligand is FHTA peptide; Kd=250+/-50uM
4mr6  1.67  2013  Kd=251nM      // 4mr3.pdf (1K0) ligand is RVX-208; Kd=251+/-17 nM
4jal  2.00  2013  Kd=25uM       // 4jal.pdf (SAH)
4bi7  1.60  2013  Kd=26.4uM     // 4bi6.pdf (PGA) Kd=26.4+/-2.6uM, Ki=87+/-15uM
4ht2  1.45  2013  Kd=290nM      // 4ht0.pdf (V50) Zn-containing
4hu1  1.95  2013  Kd=29nM       // 4ht0.pdf (V13) Zn-containing
4k55  1.91  2013  Kd=3.06uM     // 4jkw.pdf (H6P)
4efk  1.70  2013  Kd=3.2mM      // 4ddh.pdf (0OC) Kd=3.2+/-0.2 mM
3zdv  1.41  2013  Kd=3.3uM      // 3zdv.pdf (F1A-MMA) ligand is compound 5e
4jfm  1.02  2013  Kd=3.3uM      // 4jfi.pdf (1KZ) Kd=3.3+/-0.5uM
3zln  2.29  2013  Kd=3.4nM      // 3zk6.pdf (H0Y) ligand is compound 3
4n7m  2.12  2013  Kd=3.4uM      // 4n5d.pdf (2GQ) ligand is compound 5
4ddm  1.83  2013  Kd=3.5mM      // 4ddh.pdf (0HO) Kd=3.5+/-0.04 mM
4ksy  1.88  2013  Kd=3.79nM     // 4ksy.pdf (1SY)
4nxv  2.30  2013  Kd=3.8uM      // 4nxu.pdf (GDP) Kd=3.8+/-0.9uM
4i7p  1.60  2013  Kd=317uM      // 4i7j.pdf (ES3)
4mme  2.50  2013  Kd=318nM      // 4mm4.pdf (29Q) ligand is mazindol; Kd=318+/-10nM
4avs  1.40  2013  Kd=322uM      // 4avs.pdf (N7P) ligand is N-acetyl-L-proline
4l6t  1.86  2013  Kd=32nM       // 4l6t.pdf (5-mer) ligand is GM1;Kd=32+/-2 nM
4kp8  1.80  2013  Kd=3330nM     // 4kni.pdf (E1G) ligand is compound 3j
4azi  1.98  2013  Kd=35.56nM    // 4az5.pdf (OAN) ligand is PUGNAc; Kd=35.56+/-2.27nM
4ge1  2.15  2013  Kd=370nM      // 4ge1.pdf (TSS)
4jpy  2.13  2013  Kd=37uM       // 3tcy.pdf (PHE) Fe3+ and Phe-bound cPAH; Kd=37+/-0.3uM
4kcx  2.00  2013  Kd=37uM       // 4kcx.pdf (1QK)
3zm9  1.90  2013  Kd=38nM       // 3zm9.pdf (QMQ) ligand is compound 1; Kd1=38nM for the first monomer; Kd2=190nM for the second monomer
4j21  1.93  2013  Kd=39nM       // 3w51.pdf (AJ6) ligand is compound 14
4ej8  2.35  2013  Kd=4.1uM      // 4ej8.pdf (1F1) Kd=4.1+/-1.4uM
4jwk  1.87  2013  Kd=4.79nM     // 4jwk.pdf (CTN) ligand is Cytidine; Kd= 4.79*10^(-9) M(fluorescence), 5.3*10^(-9) M(SPR)
4ipi  1.75  2013  Kd=4.8uM      // 4ipi.pdf (LMR) Kd=4.8+/-0.1uM, Mn-containing
4ipn  2.41  2013  Kd=408.7uM    // 4ipn.pdf (1FT) Kd=408.7+/-9.3uM
4kn0  2.10  2013  Kd=40nM       // 4kmz.pdf (MTX) ligand is Methotrexate; Kd=40+/-7 nM(pH 7.4), 332+/-64 nM(pH 6.5),crystal(pH 8.0)
4hfp  2.40  2013  Kd=42nM       // 4hfp.pdf (15U) Kd=42+/-2nM
4gu9  2.40  2013  Kd=43uM       // 4gu6.pdf (4GU)
4gu6  1.95  2013  Kd=44nM       // 4gu6.pdf (10N)
4nbn  1.75  2013  Kd=44uM       // 4n5d.pdf (2J7) ligand is compound 14
4ayq  1.10  2013  Kd=47nM       // 4ayp.pdf (MVL) ligand is compound 2
4i7j  1.67  2013  Kd=480uM      // 4i7j.pdf (BNZ)
4kow  1.45  2013  Kd=49.3uM     // 4klv.pdf (CFX) ligand is Cefoxitin; Kd=49.3+/-2.9 uM
4bj8  2.40  2013  Kd=5.13nM     // 4bj8.pdf (BTN) Kd=5.13+/-2.36nM
4ddk  1.75  2013  Kd=5.1mM      // 4ddh.pdf (0HN) Kd=5.1+/-0.2 mM
4e70  1.61  2013  Kd=5.26uM     // 4e70.pdf (N7I)
4idn  2.25  2013  Kd=5.77uM     // 4idn.pdf (GNP) Kd=5.77+/-0.479uM; Mg-containing
4kfq  2.20  2013  Kd=5.86nM     // 4kfq.pdf (KFQ) ligand is TK40
4gue  1.80  2013  Kd=5.8uM      // 4gue.pdf (QCT)
4ih7  2.30  2013  Kd=5.8uM      // 4ih5.pdf (1ER)
4azb  2.10  2013  Kd=57.69nM    // 4az5.pdf (OAN) ligand is PUGNAc; Kd=57.69+/-10.84nM
4ezr  1.90  2013  Kd=6.3uM      // 4ezo.pdf (8-mer) Kd=6.3+/-0.3 uM
4ezz  2.05  2013  Kd=6.4uM      // 4ezo.pdf (7-mer) Kd=6.4+/-0.6 uM
4n5d  2.06  2013  Kd=607uM      // 4n5d.pdf (2FQ) ligand is compound 1
4gny  1.64  2013  Kd=60uM       // 4gny.pdf (SDS) Kd=52uM(ITC, 15C, pH=7.0), Kd=60uM(ITC, 25C, pH=7.0)
4nra  1.85  2013  Kd=65uM       // 4nr9.pdf (2LW) ligand is compound 6
4jkw  2.01  2013  Kd=69.9uM     // 4jkw.pdf (IPE)
4jpx  1.55  2013  Kd=7.0uM      // 3tcy.pdf (PHE) Kd=7.0+/-0.3uM
4h85  2.10  2013  Kd=7.0uM      // 4h85.pdf (HRI) Kd=7.0+/-1.5uM; K-containing, Mg-containing
4ejl  2.44  2013  Kd=7.2uM      // 4ej8.pdf (IOP) Kd=7.2+/-1.7uM
4h81  2.05  2013  Kd=7.5uM      // 4h81.pdf (WJ2) Kd=7.5 +/-2.2uM; K-containing, Mg-containing
4c1t  2.39  2013  Kd=70.8nM     // 4c1t.pdf (4-mer)
4i7m  1.48  2013  Kd=72uM       // 4i7j.pdf (2LP)
4cgi  2.07  2013  Kd=752uM      // 4ce9.pdf (NZL) Kd=752+/-158 uM
4ayp  0.85  2013  Kd=755nM      // 4ayp.pdf (SMD) ligand is compound 1
4kzq  2.25  2013  Kd=788nM      // 4bs4.pdf (DFL) Zn-containing
4ih5  1.90  2013  Kd=78uM       // 4ih5.pdf (12R)
4azg  2.40  2013  Kd=79.05nM    // 4az5.pdf (OAN) ligand is PUGNAc; Kd=79.05+/-0.44nM
4loo  1.95  2013  Kd=7nM        // 4loo.pdf (SB4) in monoclinic crystal form
4ly9  2.35  2013  Kd=7nM        // 4ly9.pdf (1YY)
4h7q  2.10  2013  Kd=8.8uM      // 4h7q.pdf (COI) Kd=8.8+/-0.5uM; K-containing, Mg-containing
4c1u  2.00  2013  Kd=81nM       // 4c1t.pdf (3-mer)
4ghi  1.50  2013  Kd=81nM       // 4ghi.pdf (0X3)
4kp5  1.45  2013  Kd=833nM      // 4kni.pdf (E1F) ligand is compound 2j
4jym  1.35  2013  Kd=9.05uM     // 4jym.pdf (KKN) Kd=9.05+/-2.03 uM
4lk7  1.76  2013  Kd=9.1uM      // 4ljh.pdf (2-mer) ligand is 04G-GAL (compound 16); Kd=9.1+/-0.6 uM
4io5  1.72  2013  Kd=9.27uM     // 4io2.pdf (ALA) Kd=9.27+/-1.24uM
4np9  1.92  2013  Kd=9.4uM      // 4np9.pdf (I3P) Kd=9.4+/-1.4 uM
4i7k  1.72  2013  Kd=905uM      // 4i7j.pdf (MBN)
4l51  1.90  2013  Kd=995uM      // 4l4z.pdf (HSX) ligand is R5P; Kd=995+/-50 uM
4gbd  1.98  2013  Ki=0.0048nM   // 4gbd.pdf (MCF) Zn-containing; Ki=0.0048+/-0.0005nM
4gih  2.00  2013  Ki=0.0048uM   // 4gfm.pdf (0X5)
4kb9  1.29  2013  Ki=0.01nM     // 4kb9.pdf (G79) ligand is compound 16a
4fp1  1.68  2013  Ki=0.027mM    // 4fp1.pdf (BFM) Ki=0.027+/-0.004mM
4gfm  2.30  2013  Ki=0.06uM     // 4gfm.pdf (0X2)
4bny  1.80  2013  Ki=0.08uM     // 4bnt.pdf (36I) IC50= 0.08 uM (AcAcCoA as substrate), IC50=2.7uM (3-OH decanoyl-NAC as substrate)
4bcm  2.45  2013  Ki=0.123uM    // 4bcf.pdf (T7Z) ligand is compound 4
4bco  2.05  2013  Ki=0.131uM    // 4bcf.pdf (T6Q) ligand is compound 12t
4ew3  1.70  2013  Ki=0.18uM     // 4ew2.pdf (DXZ)
4ivc  2.35  2013  Ki=0.1nM      // 4iva.pdf (1J6)
4isu  2.30  2013  Ki=0.21mM     // 4isu.pdf (IKM) Ki=0.21+/-0.02mM by radioactive binding assay
4ew2  1.60  2013  Ki=0.21uM     // 4ew2.pdf (DXY)
4gfo  2.30  2013  Ki=0.24uM     // 4gfm.pdf (0X2)
4gql  1.15  2013  Ki=0.26nM     // 4gql.pdf (R47) Zn-containing
4gr0  1.50  2013  Ki=0.28nM     // 4gql.pdf (R4B) Zn-containing
4hw3  2.40  2013  Ki=0.32uM     // 4hw2.pdf (19G) Ki=0.32+/-0.01uM
4da5  2.40  2013  Ki=0.36uM     // 4da5.pdf (0H7) Ki=0.36+/-0.01 uM, IC50=0.47+/-0.08 uM (coupled spectrophotometric assay)
4ivd  1.93  2013  Ki=0.3nM      // 4iva.pdf (15T)
4ca5  1.85  2013  Ki=0.41nM     // 4ca5.pdf (3EF) Ki=0.41+/-0.03nM; Zn-containing
4bt4  1.60  2013  Ki=0.46mM     // 4bt3.pdf (QFH) Ki=0.46+/-0.18 mM; Zn-containing
4mss  1.80  2013  Ki=0.4uM      // 4mss.pdf (2CZ)
4jia  1.85  2013  Ki=0.6nM      // 4ji9.pdf (1K3)
4m0e  2.00  2013  Ki=0.6uM      // 4m0e.pdf (1YL) Ki=0.6+/-0.8uM
4mdn  1.91  2013  Ki=0.6uM      // 4mdn.pdf (Y30)
4bt3  1.10  2013  Ki=0.76mM     // 4bt3.pdf (WTZ) Ki=0.76+/-0.40 mM; Zn-containing
4az6  1.36  2013  Ki=0.8nM      // 4az5.pdf (OAN) ligand is PUGNAc; Ki=0.8+/-0.1nM
4hws  1.70  2013  Ki=0.8nM      // 4hwo.pdf (1B3) Zn-containing; Ki by a coupled spectrophotometric assay
4jh0  2.35  2013  Ki=0.94nM     // 4jh0.pdf (1MD) Ki=0.94+/-0.18nM
4baq  1.89  2013  Ki=0.98nM     // 4bah.pdf (M4Z) ligand is compound 4; Ki=0.98+/-0.02nM
4i72  2.05  2013  Ki=0.9nM      // 4i71.pdf (UA2) Ca-containing
4bps  1.08  2013  Ki=1.02mM     // 4bps.pdf (3EB) Ki=1.02+/-0.22 mM(by spectrophotometric assay )
4bam  1.88  2013  Ki=1.14nM     // 4bah.pdf (MM9) ligand is compound 3; Ki=1.14+/-0.02nM
4k18  2.05  2013  Ki=1.1nM      // 4k0y.pdf (1OB) ligand is compound 2
4heg  1.46  2013  Ki=1.20nM     // 4hdb.pdf (G52) Ki=1.20+/-0.08nM
4bak  1.94  2013  Ki=1.22nM     // 4bah.pdf (M67) ligand is compound 5; Ki=1.22+/-0.08nM
4kyh  2.50  2013  Ki=1.2uM      // 4kyh.pdf (ZST) ligand is zopolrestat
4gj3  2.50  2013  Ki=1.4nM      // 4gii.pdf (0XP)
4i5c  2.10  2013  Ki=1.5nM      // 4i5c.pdf (C5I)
4ks1  2.20  2013  Ki=1.5nM      // 4ks1.pdf (2H8) ligand is compound 4
4f3c  1.93  2013  Ki=1.5pM      // 4f1w.pdf (BIG) Ki=1.5+/-0.4 pM
4bt5  1.10  2013  Ki=1.72mM     // 4bt3.pdf (23B) Ki=1.72+/-0.98 mM; Zn-containing
4m0f  2.30  2013  Ki=1.7nM      // 4m0f.pdf (1YK)
4j45  1.48  2013  Ki=1.7uM      // 4j44.pdf (4-mer)
4j44  1.30  2013  Ki=1.87uM     // 4j44.pdf (4-mer)
4gii  2.31  2013  Ki=1.8nM      // 4gii.pdf (0X6)
4ish  1.82  2013  Ki=1.9nM      // 4ish.pdf (1GE)
4ivb  1.90  2013  Ki=1.9nM      // 4iva.pdf (1J5)
3zcl  1.40  2013  Ki=10.1nM     // 3zbx.pdf (5TF) ligand is compound 28f
4mo8  1.85  2013  Ki=10.1nM     // 4mo8.pdf (2VQ) ligand is compound 7
4in9  1.55  2013  Ki=10.7uM     // 4in9.pdf (4-mer)
4f9w  2.00  2013  Ki=114nM      // 4f9w.pdf (LM4)
4k3n  2.00  2013  Ki=11nM       // 4k3n.pdf (1OT) ligand is compound 6
4jsa  1.50  2013  Ki=11uM       // 4js6.pdf (FB2) Ki=11+/-2uM; Hg-containing
4j47  1.35  2013  Ki=12.02uM    // 4j44.pdf (4-mer)
4i8w  1.96  2013  Ki=12.7pM     // 4hla.pdf (G07)
4bcn  2.10  2013  Ki=12nM       // 4bcf.pdf (T9N) ligand is compound 3
4mjp  1.85  2013  Ki=131uM      // 4mjp.pdf (27O) ligand is (R)-Vedaprofen
3wjw  1.59  2013  Ki=134uM      // 3wjw.pdf (U6M) ligand is 6-methyl-UMP; Ki=134+/-5uM
4gr8  1.30  2013  Ki=14.7nM     // 4gql.pdf (R4C) Zn-containing
4iic  1.90  2013  Ki=14uM       // 4iic.pdf (IFM) Ki=14+/-2uM
4gr3  1.49  2013  Ki=15.5nM     // 4gql.pdf (R45) Zn-containing
4eb8  2.30  2013  Ki=151pM      // 4ear.pdf (IM5) Ki=151+/-16 pM
4k0y  1.95  2013  Ki=15nM       // 4k0y.pdf (1OA) ligand is compound 1
4n6z  2.20  2013  Ki=16nM       // 4n6z.pdf (2HW) ligand is compound 3f
4hla  1.95  2013  Ki=16pM       // 4hla.pdf (017)
4hwp  1.81  2013  Ki=17.2nM     // 4hwo.pdf (X16) Zn-containing; Ki by a coupled spectrophotometric assay
4ca6  1.91  2013  Ki=180nM      // 4ca5.pdf (3EF) Ki=180+/-25nM; Zn-containing
4i71  1.28  2013  Ki=18nM       // 4i71.pdf (AGV) Ca-containing
4kyk  2.00  2013  Ki=18uM       // 4kyh.pdf (IMN) ligand is indomethacin
4i74  1.68  2013  Ki=190nM      // 4i71.pdf (MBY) Ca-containing
4bah  1.94  2013  Ki=2.01nM     // 4bah.pdf (MEL) ligand is Melagatran; Ki=2.01+/-0.09nM
4j28  1.73  2013  Ki=2.0uM      // 4j28.pdf (EAT) Ki=2.0+/-0.1uM
4j48  2.10  2013  Ki=2.41uM     // 4j44.pdf (4-mer)
4ban  1.87  2013  Ki=2.43nM     // 4bah.pdf (M6S) ligand is compound 2; Ki=2.43+/-0.07nM
4iid  2.30  2013  Ki=2.4uM      // 4iic.pdf (NOJ) Ki=2.4+/-0.3uM
4gj2  2.40  2013  Ki=2.5nM      // 4gii.pdf (0XH)
3vtr  2.50  2013  Ki=2.714uM    // 3vtr.pdf (TCG)
4hwo  1.91  2013  Ki=2.9nM      // 4hwo.pdf (409) Zn-containing; Ki by a coupled spectrophotometric assay
4ca8  1.99  2013  Ki=210nM      // 4ca5.pdf (3ES) Zn-containing; Ki=210nM, 95% confidence interval 180-246 nM
4hzm  1.45  2013  Ki=23.2uM     // 4hzm.pdf (1BW)
4k77  2.40  2013  Ki=235nM      // 4k6z.pdf (1Q4) ligand is compound 6
4lch  1.60  2013  Ki=24pM       // 4lcf.pdf (1WN) ligand is compound 24c; Ki=0.024+/-0.004 nM (EcLpxC)
4hy1  1.90  2013  Ki=2nM        // 4gee.pdf (19X) Ki by coupled spectrophotometric Enzchek assay
4bs0  1.09  2013  Ki=2uM        // 4bs0.pdf (6NT)
4hdf  1.29  2013  Ki=3.2nM      // 4hdb.pdf (G52) Ki=3.2+/-0.2nM
4m2r  1.99  2013  Ki=3.2nM      // 4m2r.pdf (BZ1) ligand is BRZ
4hdp  1.22  2013  Ki=30.9nM     // 4hdb.pdf (G52) Na-containing; Ki=30.9+/-0.6nM
4kzu  2.10  2013  Ki=313nM      // 4bs4.pdf (A73) Zn-containing
4h42  2.01  2013  Ki=341uM      // 4h42.pdf (11E)
4k5p  1.85  2013  Ki=345uM      // 4k3n.pdf (1OS) ligand is compound 7
3znr  2.40  2013  Ki=36nM       // 3znr.pdf (NU9) ligand is TMP269,1
4m2v  1.72  2013  Ki=36nM       // 4m2r.pdf (BZ1) ligand is BRZ
3zns  2.45  2013  Ki=39nM       // 3znr.pdf (NU7) ligand is TMP942,3
4bao  1.87  2013  Ki=4.29nM     // 4bah.pdf (MVF) ligand is compound 1; Ki=4.29+/-0.10nM
3zpu  1.80  2013  Ki=4.2nM      // 3zps.pdf (M8B) ligand is (R)-19b
4iie  2.00  2013  Ki=4.6mM      // 4iic.pdf (CGB) Ki=4.6+/-1.0mM
4ca7  1.82  2013  Ki=44nM       // 4ca5.pdf (3EF) Zn-containing
4lvt  2.05  2013  Ki=44pM       // 4lvt.pdf (1XJ) ligand is Navitoclax(1); Ki=0.044nM(TR-FRET)
3zdh  2.20  2013  Ki=45nM       // 3zdg.pdf (XRS) ligand is compound 7
4bck  2.05  2013  Ki=4nM        // 4bcf.pdf (T3E) ligand is compound 12c
4ij1  1.79  2013  Ki=4uM        // 4giu.pdf (17C) ligand is compound ACS172, Competitive Ki value
3zps  1.55  2013  Ki=5.0nM      // 3zps.pdf (EQM) ligand is (R)-17b, ring of ligand is opening in the crystal.
4f2w  2.00  2013  Ki=5.0pM      // 4f1w.pdf (TDI) Ki=5.0+/-0.4 pM
4j46  1.42  2013  Ki=5.24uM     // 4j44.pdf (4-mer)
4jfs  2.00  2013  Ki=5.4uM      // 4jfs.pdf (16Z)
4jsz  1.90  2013  Ki=5000uM     // 4js6.pdf (FB2) Ki=5000+/-1100uM; Zn-containing
4eor  2.20  2013  Ki=500nM      // 4eoi.pdf (4SP) Ki=500+/-30nM
4jss  1.50  2013  Ki=500uM      // 4js6.pdf (BEW) Ki=500+/-60uM; Zn-containing
4iwz  1.60  2013  Ki=51nM       // 4iwz.pdf (1GO) Ki=51+/-3.1nM by stopped-flow CO2 hydrase assay; Zn-containing
4m2w  1.66  2013  Ki=52nM       // 4m2r.pdf (ETS) ligand is DRZ
4bcp  2.26  2013  Ki=568nM      // 4bcg.pdf (T3C) ligand is compound 12u
4lxd  1.90  2013  Ki=59nM       // 4lvt.pdf (1XV) ligand is compound 2
4lko  2.43  2013  Ki=6.0nM      // 4jh0.pdf (1WH)
3w37  1.70  2013  Ki=6.68uM     // 3w37.pdf (ACR)
4iif  2.45  2013  Ki=6.6uM      // 4iic.pdf (CTS) Ki=6.6+/-0.6uM
4gkm  1.67  2013  Ki=6.8uM      // 4giu.pdf (683) ligand is compound 14
4elg  2.10  2013  Ki=6.9nM      // 4elb.pdf (52I/52J) Ki=6.9+/-0.5 nM; Ca-containing
4bqs  2.15  2013  Ki=62uM       // 4bqs.pdf (K2Q) Ki=62+/-1uM
4n9a  1.90  2013  Ki=64uM       // 4n94.pdf (2J2) ligand is compound 8
4iva  1.50  2013  Ki=68.4nM     // 4iva.pdf (1J5) Ki=1.9nM(when protein is JAK1); Ki(JAK2)/Ki(JAK1)=36
4f3k  1.85  2013  Ki=69.0pM     // 4f1w.pdf (HCE) Ki=69.0+/-12.1 pM
3zbx  2.20  2013  Ki=6nM        // 3zbx.pdf (6XE) ligand is compound 7
4hym  1.90  2013  Ki=6nM        // 4gee.pdf (CJC) Ki by coupled spectrophotometric Enzchek assay
4lrr  2.41  2013  Ki=6uM        // 4lrr.pdf (CF9) ligand is compound 3; Ki=6+/-0.2 uM
4isi  1.94  2013  Ki=7.3nM      // 4isi.pdf (1GG)
4ks4  2.50  2013  Ki=72nM       // 4ks1.pdf (1SN) ligand is compound 7
3zc5  2.20  2013  Ki=74nM       // 3zbx.pdf (W9Z) ligand is compound 8
4kx8  2.40  2013  Ki=74nM       // 4kx8.pdf (4-mer) ligand is peptide from amastatin (L20-VAL-VAL-SAP)
4kxb  2.40  2013  Ki=75uM       // 4kx8.pdf (BES) ligand is bestatin
3zdg  2.48  2013  Ki=79nM       // 3zdg.pdf (XRX) ligand is compound 4
4elh  2.10  2013  Ki=8.2nM      // 4elb.pdf (53I/53J) Ki=8.2+/-0.5 nM; Ca-containing
4hdb  1.49  2013  Ki=8.9nM      // 4hdb.pdf (G52) Na-containing; Kd=8.9+/-0.4nM
4i8z  1.75  2013  Ki=8.9pM      // 4hla.pdf (G08)
4m2u  2.00  2013  Ki=9.1nM      // 4m2r.pdf (ETS) ligand is DRZ
4elf  2.30  2013  Ki=9.4nM      // 4elb.pdf (35I) Ca-containing; Ki=9.4+/-0.5 nM
4qyy  1.65  2014  Kd=0.05uM     // 4qyy.pdf (3G7) compound 4; unphosphorylated ERK2 (apo ERK2); TdF
4mo4  1.67  2014  Kd=0.06mM     // 4mo4.pdf (ACP)
4w97  1.60  2014  Kd=0.08uM     // 4w97.pdf (UCA) ligand is HIP-CoA; Kd=0.08+/-0.01uM
4cg8  1.75  2014  Kd=0.11uM     // 4cg8.pdf (G8S) compound14
4w9h  2.10  2014  Kd=0.185uM    // 4w9c.pdf (3JF) ligand is 7; Kd=0.185+/-0.006uM
4o0a  1.20  2014  Kd=0.19uM     // 4o0a.pdf (2P9) ligand is compound 8
4qnb  2.00  2014  Kd=0.26uM     // 4qnb.pdf (1B0) ligand is PF74; Kd=0.26+/-0.09uM
4w9k  2.10  2014  Kd=0.291uM    // 4w9c.pdf (3JO) ligand is 14; Kd=0.291+/-0.02uM
4m13  1.85  2014  Kd=0.2uM      // 4m0y.pdf (1E0) ligand is compound 8, Kd1: allosteric pocket, Kd2: ATP pocket
4m14  1.55  2014  Kd=0.2uM      // 4m0y.pdf (QWS) ligand is compound 9, Kd1: allosteric pocket, Kd2: ATP pocket
4q3t  2.14  2014  Kd=0.33uM     // 4q3q.pdf (HAR) SmARG-NOAH; Kd=0.33+/-0.09uM; PH=8.5;the first binding site
4m0y  1.70  2014  Kd=0.35uM     // 4m0y.pdf (M0Y) ligand is compound 1, Kd1: allosteric pocket, Kd2: ATP pocket
4q3u  2.50  2014  Kd=0.36uM     // 4q3q.pdf (NNH) SmARG-nor NOAH; Kd=0.36+/-0.08uM; PH=8.5
4d3h  2.00  2014  Kd=0.37uM     // 4d3h.pdf (2BA) ligand is compound c-di-AMP
4nbl  1.76  2014  Kd=0.47uM     // 4n6g.pdf (2J6) ligand is compound 12
3wha  1.30  2014  Kd=0.48nM     // 3wha.pdf (WHA) ligand is compound 16l
4qac  2.10  2014  Kd=0.4nM      // 4qaa.pdf (KK3) ligand is compound 33; Kd=0.0004+/-0.0002uM
4cga  1.74  2014  Kd=0.4uM      // 4cg8.pdf (QLW) ligand is compound 5
4lj5  2.40  2014  Kd=0.51uM     // 4lj5.pdf (ADP)
4n7u  1.46  2014  Kd=0.51uM     // 4n7u.pdf (2JA) ligand is compound cHDMAPP
4r4i  1.40  2014  Kd=0.54uM     // 4r4i.pdf (3HV) ligand is compound 7j; Kd= 0.54+/- 0.2uM
4r4t  1.28  2014  Kd=0.55uM     // 4r4t.pdf (3J0) ligand is compound 7f; Kd= 0.55+/- 0.1uM
4w9j  2.20  2014  Kd=0.588uM    // 4w9c.pdf (3JH) ligand is 13; Kd=0.588+/-0.04uM
4np3  1.61  2014  Kd=0.5mM      // 4mrd.pdf (2L2) ligand is compound 5a
4oag  2.00  2014  Kd=0.5uM      // 4oag.pdf (ADP) Kd=0.5+/-0.008uM
4pow  1.55  2014  Kd=0.5uM      // 4pow.pdf (OP1) ligand is pyronopaline; Kd=0.5+/-0.07uM
4cg9  1.83  2014  Kd=0.62uM     // 4cg8.pdf (GQG) ligand is compound 12
4q6e  1.12  2014  Kd=0.667uM    // 4q6d.pdf (KR5) ligand is compound 18
3w9r  1.90  2014  Kd=0.66uM     // 3w9r.pdf (A8S) ligand is (+)-ABA
4pfu  2.05  2014  Kd=0.67uM     // 4pft.pdf (MAB) ligand is Mannobiose
4m7j  1.95  2014  Kd=0.781uM    // 4m7j.pdf (3-mer) ligand is  Kdo(2.8)Kdo(2.4)Kdo trisaccharide
4kxn  1.90  2014  Kd=0.8uM      // 4kxl.pdf (6K6) ligand is compound 5
4m12  2.15  2014  Kd=0.9uM      // 4m0y.pdf (1YZ) ligand is compound 7, Kd1: allosteric pocket, Kd2: ATP pocket
4p3h  1.45  2014  Kd=1.0uM      // 4p2t.pdf (25G) ligand is compound 2; IC50=1.0+/-0.1uM
4w9i  2.40  2014  Kd=1.10uM     // 4w9c.pdf (3JS) ligand is 10; Kd=1.10+/-0.07uM
4mrg  1.69  2014  Kd=1.1mM      // 4mrd.pdf (24W) ligand is compound 3
4csd  1.35  2014  Kd=1.23uM     // 4csd.pdf (MFU) ligand is alpha-MeFuc
4rdn  2.10  2014  Kd=1.2uM      // 4rdn.pdf (6MD) Kd=1.2+/-0.1uM
4u0f  2.22  2014  Kd=1.2uM      // 4u0a.pdf (3A8) BI-2; -DTT
4cfl  1.32  2014  Kd=1.33uM     // 4cfk.pdf (8DQ) ligand is compound LY303511
4wk1  1.98  2014  Kd=1.3uM      // 4wk1.pdf (2BA) ligand is c-di-AMP; Kd=1.3+/-0.07uM
4qdk  1.70  2014  Kd=1.4uM      // 4qdk.pdf (SAH) ligand is SAH;Kd=1.4+/-0.1uM(wild-type); Kd=8.1+/-0.2uM(H139N mutant);Kd=31.0+/-1.7uM(H139Q mutant)
4rww  1.60  2014  Kd=1.4uM      // 4rww.pdf (2BA) ligand is Cyclic-di-AMP (c-di-AMP)
4lj8  2.10  2014  Kd=1.5uM      // 4lj5.pdf (ADP)
4r4o  1.33  2014  Kd=1.5uM      // 4r4o.pdf (3HW) ligand is compound 7e; Kd= 1.5+/- 0.3uM
4rqk  1.55  2014  Kd=1.5uM      // 4rqk.pdf (R1S) ligand is RS1
4mn3  1.54  2014  Kd=1.77uM     // 4mn3.pdf (7-mer) ligand is compound 11
4q9o  2.20  2014  Kd=1.7uM      // 4q9m.pdf (2ZW) ligand is UK-106051; Kd=1.7+/-0.3 uM
4ndu  1.30  2014  Kd=1.8mM      // 4ndu.pdf (AMG) ligand is alpha-methylgalactoside, data from Goldstein et al. 2007
4w9d  2.20  2014  Kd=10.2uM     // 4w9c.pdf (3JK) ligand is 3; Kd=10.2+/-0.50uM
4ibc  1.75  2014  Kd=1049uM     // 4ibb.pdf (12G) ligand is compound GA246, estimate Kd value
4ibg  1.41  2014  Kd=108.0uM    // 4ibb.pdf (1D6) ligand is compound VPL48
4nj9  1.95  2014  Kd=108nM      // 4nj9.pdf (2M9) ligand is MPTS
4qsu  1.90  2014  Kd=10mM       // 4qsu.pdf (TDR) ligand is Thymine
4qsv  1.90  2014  Kd=10mM       // 4qsv.pdf (THM) ligand is Thymidine
4o2c  1.80  2014  Kd=10nM       // 4o2c.pdf (10-mer) ligand is NAc-SL9
4poh  2.30  2014  Kd=10nM       // 4poh.pdf (2VR) ligand is compound 4; Kd=10+/-1nM
4rpn  2.27  2014  Kd=110nM      // 4rpn.pdf (PCI) ligand is PCP; Kd1=110nM
4q4s  1.25  2014  Kd=111.6nM    // 4q4o.pdf (S98) ligand is compound 4a; Kd=111.6+/-11.8nM
4phu  2.33  2014  Kd=12.04nM    // 4phu.pdf (2YB) TAK-875; hGPR40 mutant L42A,F88A,G103A,Y202F with GS linker Kd=12.04+/-0.9nM
4n9c  1.75  2014  Kd=126uM      // 4n9b.pdf (2ZM) ligand is compound 24
4q0k  1.34  2014  Kd=13.4uM     // 4psb.pdf (GA3) Kd=13.4+/-0.5uM (pH=5.5)
4nl1  2.30  2014  Kd=130uM      // 4nhv.pdf (Z13) ligand is compound 11; Kd= 130+/-1uM
4rvr  1.98  2014  Kd=136nM      // 4ir3.pdf (3WQ) compound 19, GSK2801, ITC data is available
4nbk  1.94  2014  Kd=136uM      // 4n6g.pdf (2J5) ligand is compound 6
4m8e  2.40  2014  Kd=13nM       // 4m8e.pdf (29V) ligand is (S)-1
4l9i  2.32  2014  Kd=13uM       // 4l9i.pdf (8PR) ligand is paroxetine, biolayer interferometry
4pnu  1.90  2014  Kd=13uM       // 4ovf.pdf (2VD) compound 5l; ITC data is available
4kif  2.50  2014  Kd=14.6uM     // 4kib.pdf (PPY) ligand is phenylpyruvic acid
4uof  2.10  2014  Kd=14.6uM     // 4uof.pdf (DAT) ligand is dADP
4ovh  2.25  2014  Kd=14uM       // 4ovf.pdf (2VE) compound 5b; ITC data is available
4k7i  2.25  2014  Kd=1500uM     // 4k7i.pdf (CAQ) ligand is compound 1, CATECHOL, 15N-HSQC experiments
4mmm  1.47  2014  Kd=150uM      // 4k7i.pdf (BP7) ligand is compound 4
4pp3  2.00  2014  Kd=15nM       // 4poh.pdf (2VZ) ligand is compound 2 ; Kd=15+/-2nM
4q4q  1.41  2014  Kd=1638.9nM   // 4q4o.pdf (SAQ) ligand is compound 4b; Kd=1638.9+/-204.7nM
4ogj  1.65  2014  Kd=164nM      // 4ogi.pdf (2TA) ligand is TG-101348; Kd=164+/-10nM
4qem  1.20  2014  Kd=16nM       // 4qem.pdf (HC4) ligand is (i) p-Coumaric acid
4lzs  2.20  2014  Kd=16uM       // 4lys.pdf (L46) ligand is compound XD46
4pb2  2.30  2014  Kd=16uM       // 4pb1.pdf (5UD) ligand is 5-fluorouridine; Kd=16+/-1uM
4lov  1.50  2014  Kd=17.1nM     // 4lov.pdf (KGM) ligand is Heptylmannoside
4muv  1.25  2014  Kd=1731nM     // 4muv.pdf (PCG) ligand is cyclic-GMP
4tu4  1.73  2014  Kd=175uM      // 4tt2.pdf (37N) ligand is compound 2; Kd=175+/-3uM
4uoh  2.01  2014  Kd=17uM       // 4uog.pdf (ADP) ligand is ADP
4pum  1.93  2014  Kd=188.1nM    // 4puj.pdf (2WU) ligand is compound 2; Kd=188.1+/-59.1nM; TGT mutant Asp156Asn
4pp5  2.00  2014  Kd=18nM       // 4poh.pdf (2W0) ligand is compound 1 ; Kd=18+/-3nM
4mmp  1.57  2014  Kd=19.7nM     // 4mmp.pdf (SLB) ligand is compound Neu5Ac
4pzv  1.70  2014  Kd=2.0uM      // 4pzv.pdf (J1D) HP-26; Kd=2.0+/-0.3uM
4ncn  1.87  2014  Kd=2.12uM     // 4n3g.pdf (GTP)
4c52  2.05  2014  Kd=2.1uM      // 4c52.pdf (X0D) ligand is compound 39b
4pft  1.75  2014  Kd=2.3nM      // 4pft.pdf (MAB) ligand is Mannobiose
4up5  1.65  2014  Kd=2.5mM      // 4up0.pdf (94W) ligand is CF4
4qf7  1.48  2014  Kd=2.5nM      // 4qem.pdf (C0R) ligand is (iv) Corticosterone
4o3f  2.11  2014  Kd=2.78uM     // 4o33.pdf (TZN) Kd=2.78+/-0.90uM
4ll3  1.95  2014  Kd=2.7pM      // 3ttp.pdf (017) ligand is darunavir
4qij  2.20  2014  Kd=2.9uM      // 4qii.pdf (1HA) 1-hydroxy-2-naphthoyl-CoA(HNA-CoA); Kd=2.9+/-0.3uM
4r4c  1.40  2014  Kd=2.9uM      // 4r4c.pdf (3HS) ligand is compound 7i; Kd=2.9+/- 0.8uM
4mgd  1.90  2014  Kd=20.19uM    // 4mg5.pdf (27N) ligand is compound HPTE
4tpw  1.50  2014  Kd=20.5uM     // 4tpw.pdf (33R) ligand is 4EGI1-1E; m7GTP-eIF4E; Kd=20.5+/-2.2uM
4tte  1.80  2014  Kd=202uM      // 4tt2.pdf (36Z) ligand is compound 1; Kd=202+/-5uM
4lzr  1.85  2014  Kd=20uM       // 4lys.pdf (LOC) ligand is compound XD25
4ibd  1.84  2014  Kd=214.6uM    // 4ibb.pdf (1DL) ligand is compound VPL27
4cig  1.70  2014  Kd=214uM      // 4cie.pdf (X0P) ligand is compound 101121
4v27  1.90  2014  Kd=217nM      // 4v27.pdf (2-mer) ManIFG(24); mannose-alpha-1,3-isofagomine; wild type protein
4w9c  2.20  2014  Kd=22.2uM     // 4w9c.pdf (3JG) ligand is 2; 2-pVHL-Elo B-EloC; Kd=22.2+/-1.46uM
4rpo  1.95  2014  Kd=22.8nM     // 4rpn.pdf (T6C) ligand is TCP;  2,4,6-trichlorophenol
4oeu  2.20  2014  Kd=22nM       // 4oes.pdf (HIS) YpYntA binds to Ni(L-His)2; Kd=22+/-6nM
4qev  1.80  2014  Kd=22nM       // 4qev.pdf (31O) ligand is ME
4tt2  2.50  2014  Kd=22uM       // 4tt2.pdf (6-mer) ligand is H4(1-20)K5Ac peptide
4lyw  1.95  2014  Kd=237nM      // 4lys.pdf (21Q) ligand is compound XD14
4mpn  1.75  2014  Kd=239nM      // 4mp2.pdf (PV0) ligand is PS10
4psb  1.42  2014  Kd=23uM       // 4psb.pdf (GA3) Kd=23+/-1uM (pH=7.4)
4ocq  1.88  2014  Kd=24.7uM     // 4ock.pdf (A2G) ligand is GalNAc; Kd=24.7+/-1.5uM
4c1y  2.23  2014  Kd=251uM      // 4ah4.pdf (MFB) ligand is b-methylfucoside, Beta MeFuc
4cjq  1.70  2014  Kd=256uM      // 4cie.pdf (VXO) ligand is compound 40812
4m8h  2.20  2014  Kd=25nM       // 4m8e.pdf (R4M) ligand is (R)-1
4uyf  1.60  2014  Kd=25nM       // 4uyf.pdf (73B) ligand is compound 47; Kd=25+/-8nM
4ck3  1.79  2014  Kd=268uM      // 4cie.pdf (K1T) ligand is compound 17650
4cu7  2.20  2014  Kd=26nM       // 4cu7.pdf (GIF) ligand is compound GIF
4ibb  1.75  2014  Kd=270.7uM    // 4ibb.pdf (1DK) ligand is compound GA-017
4lbu  1.17  2014  Kd=276nM      // 4kwo.pdf (1WJ) ligand is compound 6b
4nvp  2.50  2014  Kd=27nM       // 4nvp.pdf (7CH) ligand is 7-CH-cAMP; Kd=27+/-7nM
4pmm  2.00  2014  Kd=27nM       // 4pmm.pdf (31V) ligand is compound 2
4og3  2.01  2014  Kd=285nM      // 4og3.pdf (2S6) ligand is compound 11 (MIV-3)R isome
4leq  1.41  2014  Kd=288nM      // 4kwo.pdf (1WK) ligand is compound 6a
4uac  1.60  2014  Kd=288nM      // 4ua8.pdf (ACR) ligand is acarbose; Kd=288+/-5.9nM
4myd  1.37  2014  Kd=28uM       // 4myd.pdf (164) ligand is compound SHCHC
4qer  1.20  2014  Kd=29nM       // 4qem.pdf (STL) ligand is (ii) Resveratrol
4qxo  1.88  2014  Kd=3.12uM     // 4qxo.pdf (1YE) ligand is DMXAA; hSTING(group2)
4w9f  2.10  2014  Kd=3.27uM     // 4w9c.pdf (3JU) ligand is 5; Kd=3.27+/-0.22uM
4pf5  2.04  2014  Kd=3.3uM      // 4pf5.pdf (M3N) Ps.Man9(5); a synthetic derivative of high-mannose chain
4n6g  2.14  2014  Kd=3.4uM      // 4n6g.pdf (2GQ) ligand is compound 5
4pox  2.29  2014  Kd=3.7uM      // 4pow.pdf (2W2) ligand is nopaline;Kd=3.7+/-0.6uM
4tun  1.93  2014  Kd=3.87uM     // 4tun.pdf (MVH)
4trc  2.40  2014  Kd=30uM       // 4trc.pdf (ADE) ligand is adenine
4qf8  1.65  2014  Kd=31nM       // 4qem.pdf (SPD) ligand is (iii) Spermidine
4k7n  2.30  2014  Kd=330uM      // 4k7i.pdf (MCT) ligand is compound 2, 4-METHYLCATECHOL, 15N-HSQC experiments
4oks  2.25  2014  Kd=33uM       // 4ojq.pdf (2T9) ligand is compound 19; IC50=3uM
4q4o  1.35  2014  Kd=34.3nM     // 4q4o.pdf (2YM) ligand is compound 3a; Kd=34.3+/-6.5nM
4mq6  1.70  2014  Kd=340nM      // 4mq6.pdf (29W) compound 10
4tz2  1.70  2014  Kd=350uM      // 4tyl.pdf (39R) ligand is compound 5
4ibf  2.29  2014  Kd=36.8uM     // 4ibb.pdf (1D5) ligand is compound VPL42
4q4r  1.45  2014  Kd=369.2nM    // 4q4o.pdf (SQO) ligand is compound 2b; Kd=369.2+/-25.3nM
4qgd  1.80  2014  Kd=37nM       // 4qem.pdf (PZZ) ligand is (v) Gramine derivative
4wt2  1.42  2014  Kd=38pM       // 4wt2.pdf (3UD) ligand is compound 25(AM-7209)
4cc5  1.88  2014  Kd=38uM       // 4cc5.pdf (L5V) ligand is compound 3
4p5z  2.00  2014  Kd=39.3nM     // 4p4c.pdf (Q7M) ligand is compound 7m
3wgg  2.10  2014  Kd=39.9uM     // 3wgg.pdf (8NA) ligand is compound alpha-NAD+
4pp0  1.57  2014  Kd=39.9uM     // 4pow.pdf (OP1) ligand is pyronopaline; Kd=39.9+/-7uM
4je7  2.10  2014  Kd=395nM      // 4je7.pdf (BB2) ligand is actinonin
4qpl  1.90  2014  Kd=39nM       // 4qpl.pdf (V3L) iso-ADPr; Kd=39+/-7nM
4o6w  1.45  2014  Kd=3nM        // 4o6w.pdf (7-mer) ligand is compound 3m
4c5d  2.30  2014  Kd=4.0uM      // 4c52.pdf (X0R) ligand is compound 41
4us3  2.10  2014  Kd=4.8uM      // 4us3.pdf (TRP) ligand is HiLiDe; L-Trp Kd=4.8+/-0.6uM
4q4p  1.54  2014  Kd=407.4nM    // 4q4o.pdf (2YO) ligand is compound 3b; Kd=407.4+/-46.0nM
4q6d  1.12  2014  Kd=43.5nM     // 4q6d.pdf (WW3) ligand is compound 31
4cj4  1.80  2014  Kd=432uM      // 4cie.pdf (S3G) ligand is compound GL5243104
4mnp  2.50  2014  Kd=45.5nM     // 4mmp.pdf (SLB) ligand is compound Neu5Ac
4muf  2.50  2014  Kd=460nM      // 4mq6.pdf (2DJ) compound 12
4ibj  1.54  2014  Kd=47.0uM     // 4ibb.pdf (1D9) ligand is compound VPL58
4cjp  2.00  2014  Kd=481uM      // 4cie.pdf (4D2) ligand is compound 40811
4d1j  1.80  2014  Kd=485nM      // 4d1j.pdf (DGJ) Kd=485+/-42 nM
4c9x  1.20  2014  Kd=48nM       // 4c9w.pdf (VHS) ligand is S-crizotinib
4u43  2.18  2014  Kd=48uM       // 4u43.pdf (3D8) ligand is compound 6
4nyf  1.90  2014  Kd=49nM       // 4nyf.pdf (4BI) ligand is compound 16
4m3p  1.90  2014  Kd=4uM        // 4m3p.pdf (HCS) ligand is Homocysteine, Kd in presence of potassium ion
4ozj  1.45  2014  Kd=4uM        // 4ozj.pdf (ADP)
4pin  1.90  2014  Kd=4uM        // 4pin.pdf (AVI) ligand is N-alpha-dimethylhistidine; Kd=4+/-2uM
4np2  1.75  2014  Kd=5.5mM      // 4mrd.pdf (2L1) ligand is compound 5
4non  2.50  2014  Kd=5.71uM     // 4non.pdf (GDP) Kd=5.71+/-0.59uM
4ibk  1.85  2014  Kd=50.4uM     // 4ibb.pdf (1DE) ligand is compound VPL60
4k7o  1.98  2014  Kd=50uM       // 4k7i.pdf (EKZ) ligand is compound 3, 4-tert-butylbenzene-1,2-diol, 15N-HSQC experiments
4o61  1.90  2014  Kd=50uM       // 4o61.pdf (CIT) ligand is citrate
4ua8  1.54  2014  Kd=550nM      // 4ua8.pdf (MLR) ligand is maltotriose; Kd=550+/-14nM
4wiv  1.56  2014  Kd=550nM      // 4wiv.pdf (3P2) ligand is compound 32
4nnr  1.98  2014  Kd=55nM       // 4nnr.pdf (FK5)
4mre  1.58  2014  Kd=6.4mM      // 4mrd.pdf (2C9) ligand is compound 1
4nja  2.20  2014  Kd=600nM      // 4nj9.pdf (2M9) ligand is MPTS
4je8  2.40  2014  Kd=6100nM     // 4je7.pdf (3-mer) ligand is Met-Ala-Ser
4mul  1.75  2014  Kd=610nM      // 4mq6.pdf (2DW) compound 13
4o9w  1.69  2014  Kd=69.91nM    // 4o9w.pdf (6-mer) Kd=69.91+/-15.95nM
4buq  2.20  2014  Kd=7.3nM      // 4buq.pdf (KGM) ligand is compound HM
4pop  2.20  2014  Kd=7.44nM     // 4pop.pdf (2VY) compound 9;
4v01  2.33  2014  Kd=7.7nM      // 4v01.pdf (0LI) ligand is ponatinib; Kd=7.7+/-0.03nM
4ibe  1.95  2014  Kd=70.6uM     // 4ibb.pdf (11Y) ligand is compound VPL-029
4ibi  1.47  2014  Kd=73.0uM     // 4ibb.pdf (1D8) ligand is compound VPL57
4whs  1.35  2014  Kd=75uM       // 4who.pdf (3N8) ligand is 4CF, PH=8.5; ITC PH=7,5
4cjr  1.80  2014  Kd=793uM      // 4cie.pdf (FYM) ligand is compound 101119
4qew  1.70  2014  Kd=86nM       // 4qev.pdf (31P) ligand is ET
4cs9  2.01  2014  Kd=8mM        // 4cs8.pdf (AMP) fluorescence-based thermal shift assays (TSA)
4poj  2.00  2014  Kd=8nM        // 4poh.pdf (2VP) ligand is compound 3 ; Kd=8+/-2nM
4w9l  2.20  2014  Kd=9.52uM     // 4w9c.pdf (3JJ) ligand is 15; Kd=9.52+/-1.02uM
4uye  1.65  2014  Kd=9.54nM     // 4uyd.pdf (9F9) ligand is compound 3; IC50=79.43nM; for cellular protein interaction assay, IC50=0.98uM
4ql1  1.50  2014  Kd=93nM       // 4ql1.pdf (35Q) ligand is compound OICR-9429
4og4  1.45  2014  Kd=952nM      // 4og3.pdf (2VK) ligand is compound 11 (MIV-3)S isomer
4oct  2.28  2014  Kd=9uM        // 4o61.pdf (AKG) ligand is 2OG; ALKBH5 wild-type
4rqv  1.50  2014  Kd=9uM        // 4rqk.pdf (R2S)
4l2l  1.65  2014  Ki=0.002mM    // 4l2l.pdf (1V6) ligand is compound 4 (ARM1)
4cwr  2.00  2014  Ki=0.005uM    // 4cwf.pdf (HAJ) ligand is compound 7o
4cws  2.30  2014  Ki=0.012uM    // 4cwf.pdf (G3R) ligand is compound 12b
4ngm  1.84  2014  Ki=0.0449nM   // 4ngm.pdf (JB7) ligand is compound 22a
4jyt  2.00  2014  Ki=0.04uM     // 4jyt.pdf (N4A) ligand is compound 10, Ki=0.04uM
4jzi  2.00  2014  Ki=0.04uM     // 4jzi.pdf (N4C) ligand is compound 24
4m8x  2.05  2014  Ki=0.063nM    // 4m8x.pdf (KGQ) ligand is GS-8374, with PR2
4kz4  1.42  2014  Ki=0.07mM     // 4kz3.pdf (4A1) ligand is fragment compound 60
4cwq  2.00  2014  Ki=0.088uM    // 4cwf.pdf (W2D) ligand is compound 7n
4m8y  2.22  2014  Ki=0.11nM     // 4m8x.pdf (KGQ) ligand is GS-8374, with PR1
4mhz  1.95  2014  Ki=0.134uM    // 4mhz.pdf (PBD) Apo-ls-QC-PBD150, without Zn2+
4nue  1.30  2014  Ki=0.15uM     // 4nuc.pdf (NUE) ligand is compound 28(MS267)
4qy3  1.50  2014  Ki=0.15uM     // 4qy3.pdf (3G1) ligand is compound 3
4cwp  1.95  2014  Ki=0.170uM    // 4cwf.pdf (TV2) ligand is compound 7l
4cwt  1.90  2014  Ki=0.179uM    // 4cwf.pdf (IK9) ligand is compound 18a
3zj6  2.40  2014  Ki=0.22uM     // 3zj6.pdf (VM2) ligand is compound 1
4mc6  1.31  2014  Ki=0.26nM     // 4mc6.pdf (23K) ligand is compound 48
4cd0  2.23  2014  Ki=0.2nM      // 4ccb.pdf (AWJ)
4jz1  1.90  2014  Ki=0.2uM      // 4jz1.pdf (F4D) ligand is compound 8
3wmc  2.10  2014  Ki=0.31uM     // 3wmb.pdf (NF6) ligand is naphthalimide derivative Q2
4mhy  1.38  2014  Ki=0.342uM    // 4mhy.pdf (PBD) Zn-ls-QC-PBD150, with Zn2+
4mc9  1.19  2014  Ki=0.36nM     // 4mc9.pdf (23L) ligand is compound 47
4ty7  2.09  2014  Ki=0.3nM      // 4ty6.pdf (39F) ligand is compound 16b
4lhm  1.52  2014  Ki=0.41mM     // 4lhm.pdf (AZZ) Ki measured at 0.8mM AZT concentration
4qge  2.00  2014  Ki=0.5nM      // 4qge.pdf (35O) ligand is compound 3r
4o04  1.82  2014  Ki=0.69uM     // 4o04.pdf (2Q8) ligand is compound 8; Ki=0.58+/-0.13uM
4clj  1.66  2014  Ki=0.70nM     // 4cli.pdf (5P8) ligand is compound 8k
4p6w  1.95  2014  Ki=0.7nM      // 4p6w.pdf (MOF) ligand is MOF
4cmo  1.83  2014  Ki=0.85nM     // 4cli.pdf (YPW) ligand is compound 6h
4kz6  1.68  2014  Ki=0.8mM      // 4kz3.pdf (ZB6) ligand is fragment compound 13
4l19  1.66  2014  Ki=0.8uM      // 4l19.pdf (1UA) ligand is compound 2 (Q1)
4r5t  1.98  2014  Ki=0.8uM      // 4r5t.pdf (R5T) ligand is compound 7
4nuc  1.40  2014  Ki=0.91uM     // 4nuc.pdf (435) ligand is compound 4(MS435)
4r3w  1.91  2014  Ki=1.0mM      // 4r3w.pdf (A2P) 2,5-ADP; Ki=1.0+/-0.08mM
4kwg  2.10  2014  Ki=1.0uM      // 4kwf.pdf (2AK) ligand is compound 1, competitive Inhibition Data versus Varied Aldehyde
4msc  2.47  2014  Ki=1.1uM      // 4lkq.pdf (2ZT) ligand is compound ZT1595
4p5d  2.11  2014  Ki=1.5uM      // 4p5d.pdf (N6P) ligand is compound 1a; Ki=1.5+/-0.1uM
4nwc  2.01  2014  Ki=1.74uM     // 4nwc.pdf (2QE) ligand is compound 1; Ki=1.74+/-0.29uM
4kz3  1.67  2014  Ki=1.7mM      // 4kz3.pdf (1U1) ligand is fragment compound 44
4m6u  1.80  2014  Ki=1.8mM      // 4m6u.pdf (TTN) tartronate was a competitive inhibitor of MR
4o2b  2.30  2014  Ki=1.8uM      // 4o2a.pdf (LOC) ligand is colchicine;Ki=1.8+/-0.15uM
4ngp  1.63  2014  Ki=10.97nM    // 4ngp.pdf (J31) ligand is compound 20(H)b;Kd=10.97+/-0.57nM
4owm  1.99  2014  Ki=1090uM     // 4n5v.pdf (3F0) substrate is compound 3FA
4o9v  1.90  2014  Ki=10nM       // 4o97.pdf (NT4) ligand is compound 15
4r59  1.65  2014  Ki=11nM       // 4r59.pdf (3J3) ligand is compound 5d
4lm3  1.49  2014  Ki=1200uM     // 4lkq.pdf (9ZE) ligand is compound ZT0464 (4)
4qgi  1.90  2014  Ki=125uM      // 4qgi.pdf (ROC) Saquinavir(SQV); Ki=125+/-15uM
4llx  1.75  2014  Ki=1300uM     // 4lkq.pdf (5ZE) ligand is compound ZT0434 (18)
4kiu  2.40  2014  Ki=140uM      // 4ki7.pdf (KIU) ligand is compound 49d
4mc1  1.39  2014  Ki=14nM       // 4mc1.pdf (526) ligand is compound 52
4pcs  1.77  2014  Ki=14nM       // 4pcs.pdf (2M7) ligand is compound 5
4r76  2.50  2014  Ki=14nM       // 4r5t.pdf (R5X) ligand is compound 13l
4rak  2.04  2014  Ki=14nM       // 4rak.pdf (652) ligand is compound 18
4ciw  2.20  2014  Ki=15.0uM     // 4civ.pdf (XH2) ligand is compound 6
4ih3  2.49  2014  Ki=15.2uM     // 4ih3.pdf (PDC)
4keq  2.28  2014  Ki=150uM      // 4keq.pdf (5PN)
4kwf  2.31  2014  Ki=15uM       // 4kwf.pdf (3AK) ligand is compound 3, competitive Inhibition Data versus Varied Aldehyde
4omc  2.30  2014  Ki=16.7pM     // 4omc.pdf (5-mer) ligand is inhibitor I1: meta-guanidinomethyl- Phac-RVR-Amba; Ki=16.7+/-0.6pM
4w9p  1.50  2014  Ki=16nM       // 4w9o.pdf (3JR) ligand is (S)-19
4llp  1.75  2014  Ki=16uM       // 4lkq.pdf (4ZE) ligand is compound ZT0401(NA)
4rj8  2.50  2014  Ki=17nM       // 4rj3.pdf (3QS) ligand is compound 8
4w9o  1.27  2014  Ki=17nM       // 4w9o.pdf (3JQ) ligand is (R)-19
4r5b  1.50  2014  Ki=185nM      // 4r59.pdf (3J4) ligand is compound 5e
4jxs  1.90  2014  Ki=18uM       // 4jxs.pdf (18U) ligand is compound 4
4cd5  1.10  2014  Ki=194nM      // 4cd4.pdf (2-mer) ligand is compound 4
4c2v  1.49  2014  Ki=1nM        // 4c2v.pdf (YJA)
4bf1  1.35  2014  Ki=2.4nM      // 4bf1.pdf (9FK) ligand is compound 10
4o3c  1.50  2014  Ki=2.57mM     // 4o3a.pdf (ASP) 50 mM L-Asp; Ki= 2.57+/-0.13mM
4cwn  1.80  2014  Ki=2.6uM      // 4cwf.pdf (6LV) ligand is compound 7h
4pqa  1.78  2014  Ki=2.8uM      // 4pqa.pdf (X8Z) ZnZn(NmDapE)
4cpz  2.20  2014  Ki=20.85nM    // 4cpm.pdf (ZMR) ligand is Zanamivir
4ovg  1.90  2014  Ki=204uM      // 4ovf.pdf (2VF) compound 2a
4cpt  1.70  2014  Ki=20nM       // 4coe.pdf (1T8) ligand is compound 10b
4o09  1.96  2014  Ki=20nM       // 4o04.pdf (2R6) ligand is compound 30; Ki=0.020+/-0.004uM
4q93  2.10  2014  Ki=22.3uM     // 4q93.pdf (STL) Resveratrol(RSV)
4g95  1.35  2014  Ki=24.4nM     // 4g95.pdf (OAG) ligand is OAAG324
4oc1  1.75  2014  Ki=254nM      // 4oc0.pdf (2QS) ligand is compound 5
4p58  2.06  2014  Ki=25uM       // 4p58.pdf (2F6) ligand is compound 6
4cd4  1.20  2014  Ki=263nM      // 4cd4.pdf (2-mer) ligand is compound 3
4ngn  1.64  2014  Ki=28.1nM     // 4ngn.pdf (J96) ligand in paper is compound 20a(Br), ligand in RCSB PDB is compound 9b (for code 4NGR in paper)
4r5a  1.64  2014  Ki=2nM        // 4r59.pdf (3J4) ligand is compound 5e
4kz7  1.43  2014  Ki=3.2mM      // 4kz3.pdf (1U5) ligand is fragment compound 16
4uma  1.76  2014  Ki=3.9uM      // 4uma.pdf (GZ3) ligand is vinyl phosphonate 6; Ki=3.9+/-0.4uM
4mrz  1.58  2014  Ki=300uM      // 4lkq.pdf (2ZV) ligand is compound ZT0429 (10)
4ty6  1.85  2014  Ki=30nM       // 4ty6.pdf (39D) ligand is compound 11h
4cpw  1.70  2014  Ki=31.5nM     // 4coe.pdf (V78) ligand is compound 11d
4oc0  1.85  2014  Ki=318nM      // 4oc0.pdf (2R7) ligand is compound 3
4cwf  2.00  2014  Ki=32.4uM     // 4cwf.pdf (H05) ligand is compound 3
4cu8  2.50  2014  Ki=33.9uM     // 4cu7.pdf (DGJ) ligand is compound DGJ
4kwo  1.32  2014  Ki=353nM      // 4kwo.pdf (1UD) ligand is compound beta 6c
4cpr  1.80  2014  Ki=35nM       // 4coe.pdf (378) ligand is compound 9e
4umc  2.34  2014  Ki=360uM      // 4uma.pdf (PEQ) ligand is (S)-phospholactate 8; Ki=360+/-30uM
4o05  1.79  2014  Ki=37nM       // 4o04.pdf (2Q9) ligand is compound 23; Ki=0.037+/-0.017uM
4ou3  1.95  2014  Ki=38.7uM     // 4ou3.pdf (6-mer) CNGRCG tumor-homing peptide
4llj  1.56  2014  Ki=380uM      // 4lkq.pdf (1XN) ligand is compound ZT0214 (11)
4n8q  2.08  2014  Ki=380uM      // 4n5v.pdf (FA0) substrate is compound 4FA
4nh8  1.65  2014  Ki=3nM        // 4nh7.pdf (2LC) ligand is SNX0723
4o97  2.20  2014  Ki=3nM        // 4o97.pdf (NTX) ligand is compound 43
4v24  1.80  2014  Ki=4.3nM      // 4v24.pdf (GYR) ligand is PF-543 (compound 1)
4bf6  1.82  2014  Ki=4.5nM      // 4bf1.pdf (X0Q) ligand is compound 13
4pee  1.95  2014  Ki=4.8nM      // 4pcs.pdf (2OX) ligand is compound 4
4na9  2.24  2014  Ki=41nM       // 4na7.pdf (1T7) ligand is compound 29, Ki for Factor VIIa is 41nM
4o07  1.86  2014  Ki=42nM       // 4o04.pdf (FGH) ligand is compound 28; Ki=0.042+/-0.012uM
4lkq  1.62  2014  Ki=450uM      // 4lkq.pdf (1XM) ligand is compound ZT0017 (1)
4owv  1.90  2014  Ki=45uM       // 4n5v.pdf (BE2) ligand is anthranilate
4cpy  1.80  2014  Ki=491.35nM   // 4cpm.pdf (G39) ligand is Oseltamivir
4nh7  2.00  2014  Ki=4nM        // 4nh7.pdf (E0G) ligand is SNX2112
4ual  1.71  2014  Ki=4nM        // 4uak.pdf (3FV) ligand is BDP5290
4oc3  1.79  2014  Ki=5.3nM      // 4oc0.pdf (2QP) ligand is compound 1
4oc2  1.65  2014  Ki=5.3nM      // 4oc0.pdf (2QQ) ligand is compound 6
4cps  1.55  2014  Ki=5.4nM      // 4coe.pdf (1T8) ligand is compound 10a
4u8w  1.30  2014  Ki=5.8pM      // 4u8w.pdf (G10) ligand is inhibitor 4
4msa  1.62  2014  Ki=500uM      // 4lkq.pdf (2ZM) ligand is compound ZT0449 (6)
4mrw  1.96  2014  Ki=500uM      // 4lkq.pdf (MRW) ligand is compound ZT0120 (b) (3)
4itp  1.70  2014  Ki=54nM       // 4itp.pdf (1GD)
4lm0  1.66  2014  Ki=560uM      // 4lkq.pdf (5NI) ligand is compound ZT0448 (c)(8)
4oak  2.00  2014  Ki=59.7uM     // 4muq.pdf (2-mer) ligand is D-Alanine-D-Alanine
4lm1  1.60  2014  Ki=590uM      // 4lkq.pdf (7ZE) ligand is compound ZT0450 (19)
4o0b  1.93  2014  Ki=5nM        // 4o04.pdf (2QA) ligand is compound 31; Ki=0.005+/-0.002uM
4cwo  2.31  2014  Ki=6.1uM      // 4cwf.pdf (T62) ligand is compound 8b
4m0r  1.96  2014  Ki=6.2uM      // 4giu.pdf (644) ligand is compound 38
4mc2  1.56  2014  Ki=6.4nM      // 4mc2.pdf (525) ligand is compound 50
4o0y  2.20  2014  Ki=60nM       // 4o0r.pdf (2OO) ligand is compound 13; PAK4 Ser residue modified
4o0x  2.48  2014  Ki=68nM       // 4o0r.pdf (2OQ) ligand is compound 8; PAK4 Ser residue modified
4oma  1.60  2014  Ki=68uM       // 4oma.pdf (LCS) ligand is L-cycloserine; Ki=0.068+/-0.07mM
4cp7  1.80  2014  Ki=7.8nM      // 4coe.pdf (9MW) ligand is compound 9a
4ovf  2.05  2014  Ki=74uM       // 4ovf.pdf (2VG) compound 1e
4loy  1.77  2014  Ki=8.1nM      // 4loy.pdf (6XS) ligand is Compound 15 (SAR107375)
4q19  2.09  2014  Ki=8.9nM      // 4q18.pdf (2XL) ligand is compound 5; Ki=8.9+/-0.9nM
4oc5  1.70  2014  Ki=85nM       // 4oc0.pdf (2QM) ligand is compound 2
4lm4  1.48  2014  Ki=910uM      // 4lkq.pdf (JPZ) ligand is compound ZT0902 (25)
4p6x  2.50  2014  Ki=91nM       // 4p6w.pdf (HCY) ligand is cortisol
4lm2  1.55  2014  Ki=940uM      // 4lkq.pdf (8ZE) ligand is compound ZT0462 (14)
4msn  2.30  2014  Ki=94uM       // 4lkq.pdf (2ZQ) ligand is compound ZT0451 (7)
4llk  1.55  2014  Ki=990uM      // 4lkq.pdf (MEW) ligand is compound ZT0217 (60)
4umb  2.17  2014  Ki=99uM       // 4uma.pdf (0V5) ligand is (R)-phospholactate 7; Ki=99+/-16uM
5bs4  1.29  2015  Kd=0.0099nM   // 5bry.pdf (4UX) ligand is entry7(compound 25g)
4xtx  2.30  2015  Kd=0.027nM    // 4xtv.pdf (590) compound 57;
4zzz  1.90  2015  Kd=0.087uM    // 4zzx.pdf (FSU) compound 10b
3wtn  2.09  2015  Kd=0.091uM    // 3wth.pdf (N2Y) ligand is DN-IMI
3wtl  2.30  2015  Kd=0.092uM    // 3wth.pdf (N1Y) ligand is CH-IMI
5epl  1.81  2015  Kd=0.094uM    // 5epk.pdf (6-mer) peptide inhibitor UNC3866
3wtm  2.48  2015  Kd=0.100uM    // 3wth.pdf (N1Y) ligand is CH-IMI
3wzn  1.30  2015  Kd=0.10uM     // 3wzn.pdf (BTN) ligand is BTN
3wto  2.25  2015  Kd=0.119uM    // 3wth.pdf (N2Y) ligand is DN-IMI
4zzx  1.65  2015  Kd=0.125uM    // 4zzx.pdf (FSU) compound 10b
4xtz  1.90  2015  Kd=0.153nM    // 4xtv.pdf (594) compound 69
4rd0  1.71  2015  Kd=0.24uM     // 4rcy.pdf (GDP) ligand is GDP
4zzd  2.35  2015  Kd=0.25uM     // 4zzd.pdf (RBF) [Nonstandard assay: pH=8, 20 mM Tris-HCl, 150 mM NaCl, 1 mMEDTA] RIBOFLAVIN;
3wtj  2.24  2015  Kd=0.297uM    // 3wth.pdf (TH4) ligand is Thiacloprid
4xu3  2.24  2015  Kd=0.315nM    // 4xtv.pdf (44R) compound 90;
5cp9  1.90  2015  Kd=0.31mM     // 5cp9.pdf (6O5) ligand is compound MB605; Kd=0.31+/-0.04mM
4xu1  1.70  2015  Kd=0.324nM    // 4xtv.pdf (44O) compound 82;
4rd3  1.69  2015  Kd=0.34uM     // 4rcy.pdf (GDP) ligand is GDP
4ymh  1.88  2015  Kd=0.35uM     // 4ymg.pdf (SAH) higher affinity in presence of Mg2+;
4zeb  1.89  2015  Kd=0.3uM      // 4ra1.pdf (AGR) ligand is agrocinopine A; another lower resolution structure is 4ze9
4zvi  2.20  2015  Kd=0.47uM     // 4zvi.pdf (4S4) compound 18a;
4rd6  1.94  2015  Kd=0.52uM     // 4rcy.pdf (GDP) ligand is GDP
4zb6  1.80  2015  Kd=0.53uM     // 4f0c.pdf (GDS) ligand is GSSG
4xtv  1.45  2015  Kd=0.54nM     // 4xtv.pdf (44K) compound 36;
4xu2  1.85  2015  Kd=0.592nM    // 4xtv.pdf (44Q) compound 87;
4xty  1.80  2015  Kd=0.614nM    // 4xtv.pdf (44L) compound 63;
4xu0  1.60  2015  Kd=0.769nM    // 4xtv.pdf (44N) compound 73;
4tqn  1.70  2015  Kd=0.77uM     // 4tqn.pdf (UL4) compound 10, UL04
3x00  1.30  2015  Kd=0.83nM     // 3x00.pdf (ZOF) ligand is bis iminobiotin long tail (Bis-IMNtail)
4xk9  2.20  2015  Kd=0.86nM     // 4xhe.pdf (41J) A-AChBP in complex with pinnatoxin G
4tkj   .87  2015  Kd=0.913uM    // 3wvm.pdf (PLM) [Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is palmitic acid
4xtw  2.30  2015  Kd=0.933nM    // 4xtv.pdf (44M) compound 46;
4zb8  2.00  2015  Kd=0.94uM     // 4f0c.pdf (GDS) ligand is GSSG
4tjz   .87  2015  Kd=1.07uM     // 3wvm.pdf (DKA) [Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is capric acid, DKA
4rr6  1.88  2015  Kd=1.0uM      // 4rr6.pdf (A3S) ligand is L-Ser3AA
4ra1  1.75  2015  Kd=1.16uM     // 4ra1.pdf (ALX-BNX) ligand is D-Glucose-2-phosphate; mixture of alpha ALX and beta BNX
4und  2.20  2015  Kd=1.1nM      // 4r5w.pdf (2YQ) complex is PARP1/Talazoparib
4d4d  1.40  2015  Kd=1.1uM      // 4d4b.pdf (MAN-IFM) ligand is compound 3; 1,6-ManIFG, two combined units
5ct2  2.00  2015  Kd=1.2mM      // 5ct2.pdf (CXS) ligand is compound CAPS
4y5d  1.20  2015  Kd=1.2uM      // 4y59.pdf (MT6) ligand is ALiS-2
4zei  2.30  2015  Kd=1.33uM     // 4ra1.pdf (LAO) ligand is L-arabinose-2-phosphate
4cst  1.10  2015  Kd=1.3nM      // 4css.pdf (CWK) compound 10j
4zec  2.15  2015  Kd=1.5uM      // 4ra1.pdf (C84) ligand is agrocin 84
4ymq  2.00  2015  Kd=1.6uM      // 4ymq.pdf (ZBD) compound 14
4ysl  1.46  2015  Kd=1.6uM      // 4ysl.pdf (GSH) ligand is glutathione;
5cbr  2.00  2015  Kd=1.80uM     // 5cbr.pdf (4ZK) ligand is compound (S)-37, functional Kb value
4tkh   .93  2015  Kd=1.84uM     // 3wvm.pdf (MYR) [Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is myristic acid
3wvm   .88  2015  Kd=1.95uM     // 3wvm.pdf (STE) [Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is stearic acid, STE
4czs  1.73  2015  Kd=10.0uM     // 4czs.pdf (5-mer) ligand is 5-mer Man-WYD
4rlt  2.05  2015  Kd=10.9uM     // 4rlj.pdf (FSE) ligand is Fisetin, this pdf is protected
5boj  1.75  2015  Kd=100nM      // 5boj.pdf (4TX) ligand is compound GEM, Gemfibrozil
5aba  1.62  2015  Kd=1040uM     // 5ab9.pdf (UL7) compound 5;
4xxh  2.40  2015  Kd=10uM       // 1byk.pdf (T6P)
5cst  1.78  2015  Kd=110nM      // 5cst.pdf (CDP) ligand is cytidine diphosphate (CDP)
4y2q  2.40  2015  Kd=1200uM     // 4y2j.pdf (49N) fragment 3
4qtl  1.80  2015  Kd=120nM      // 4qiy.pdf (WWO) compound 10d
5e1s  2.26  2015  Kd=12nM       // 5e1s.pdf (5JA) Inhibitor BI 885578
4rlw  2.20  2015  Kd=13.4uM     // 4rlj.pdf (BUN) ligand is Butein
4rra  1.70  2015  Kd=13.4uM     // 4rr6.pdf (A3T) ligand is L-Thr3AA
4zl4  2.37  2015  Kd=13.8nM     // 4zl4.pdf (4PK) WEHI-842
4xya  2.05  2015  Kd=1370nM     // 4xy8.pdf (43S) [Nonstandard assay: NaCl=150mM, HEPES=50mM, pH=7.5(Temp 25)] compound 11;
5efc  1.90  2015  Kd=14.1uM     // 5efa.pdf (GTP) ligand is GTP
5d1r  2.00  2015  Kd=14.4uM     // 5d1r.pdf (56S) ligand is compound Isopropyl laurate
5efa  1.90  2015  Kd=14.7uM     // 5efa.pdf (MGT) ligand is m7GTP
4x5r  1.65  2015  Kd=14nM       // 4x50.pdf (3XO) compound 6; Direct ITC assay
4rlu  2.20  2015  Kd=15.2uM     // 4rlj.pdf (HCC) ligand is HCC, 2',4,4'-TRIHYDROXYCHALCONE
4rrg  1.93  2015  Kd=1538.5uM   // 4rr6.pdf (A3T) [Multiple sites: site 1: Kd=1538.5uM; site 2: Kd=3875.9uM] ligand is L-Thr3AA
4qpd  2.10  2015  Kd=15nM       // 4qpd.pdf (THG) ligand is tetrahydrofolate
4q46  1.80  2015  Kd=169uM      // 4q46.pdf (GDP)
4pg9  2.40  2015  Kd=16nM       // 4pg9.pdf (9-mer) ligand is peptide FAPGNYPAL
4qjw  1.55  2015  Kd=16nM       // 4qiy.pdf (WWO) compound 10d
4wop  2.39  2015  Kd=17.2uM     // 4wop.pdf (CTP) ligand is CTP
4x50  2.00  2015  Kd=17.7nM     // 4x50.pdf (3X8) compound 2; Direct ITC assay
4pvx  2.18  2015  Kd=172nM      // 4pvx.pdf (YS1) ligand is YS05035
4w52  1.50  2015  Kd=175uM      // 4w52.pdf (BNZ) ligand is benzene
5am6  1.96  2015  Kd=185nM      // 5am6.pdf (38O) ligand is TKI258, e.g. dovitinib
5alb  2.16  2015  Kd=19.6pM     // 5alb.pdf (TIQ) ligand is compound ticagrelor
4crl  2.40  2015  Kd=195pM      // 4crl.pdf (C1I) ligand is cortistatin A
4pvy  2.05  2015  Kd=197nM      // 4pvx.pdf (JD1) ligand is JDS05119
4u0w  2.00  2015  Kd=1mM        // 4u0v.pdf (16G) GlcNAc-6-P (NagR), data from ref 7
4x5q  1.12  2015  Kd=1nM        // 4x50.pdf (3XN) compound 5; Competitive ITC assay
4zek  2.09  2015  Kd=2.2uM      // 4ra1.pdf (LAH) ligand is L-arabinose-2-isopropylphosphate
4zyf  1.80  2015  Kd=2.3nM      // 4zyf.pdf (4T4) compound 1;
5e8f  2.10  2015  Kd=2.3nM      // 5e8f.pdf (5-mer) ligand is 5-mer fully modified geranylgeranylated PDE6C Peptide
4tkb   .86  2015  Kd=2.56uM     // 3wvm.pdf (DAO) [Nonstandard assay: 20 mM Tris-HCl, pH 8.0, and 100 mM NaCl, or 20 mM potassium phosphate, pH 7.0, and 100 mM NaCl] ligand is lauric acid
4zzy  2.20  2015  Kd=2.5uM      // 4zzx.pdf (D7N) compound 20by
5afv  2.25  2015  Kd=2.6uM      // 5afv.pdf (JH5) [Nonstandard assay: NaCl=150mM; Tris/HCl=25mM] ligand is hit 10;
5a81  2.03  2015  Kd=2.9uM      // 5a81.pdf (78J) compound 13
4ymg  1.90  2015  Kd=21uM       // 4ymg.pdf (SAM) higher affinity in presence of Mg2+;
5a5q  1.97  2015  Kd=21uM       // 5a5n.pdf (6XC) compound 25
5aoj  1.47  2015  Kd=21uM       // 5ab9.pdf (Y0V) compound 9
4x5z  1.86  2015  Kd=23.6nM     // 4x5y.pdf (3XY) ligand is MI-136
5dqe  2.18  2015  Kd=234uM      // 5dqe.pdf (5E4) ligand is bromo-fenamic acid, ITC Kd for TEAD2 or TEAD4 is not clear
4rrf  1.70  2015  Kd=239.2uM    // 4rr6.pdf (A3S) [Multiple sites: site 1: Kd=239.2uM; site 2: Kd=555.6uM] ligand is L-Ser3AA
4r73  1.60  2015  Kd=23nM       // 4r73.pdf (G6P) ligand is endogenous G6P/M6P mixture in crystal
5e73  1.71  2015  Kd=23uM       // 5e73.pdf (UO1) ligand is compound 47
4uin  2.50  2015  Kd=24nM       // 4uik.pdf (QI9) ligand is quinine
4ynl  2.10  2015  Kd=24uM       // 4ynl.pdf (6-mer) ligand is Heterocyst inhibition-signaling peptide, PatS6
4x8o  2.10  2015  Kd=250nM      // 4x8l.pdf (AP5) inhibitor Ap5a
5dqf  2.15  2015  Kd=253uM      // 5dqf.pdf (CZE) ligand is Cetirizine, RS mixture in crystal (CZE/LCR)
4or4  2.21  2015  Kd=26.8uM     // 4or4.pdf (M7G) [Nonstandard assay: Temp 20] ligand is m7GDP,
4x3k  1.45  2015  Kd=27.7uM     // 4x3k.pdf (7-mer) ligand is H3K27me3 peptide
5a7b  1.40  2015  Kd=271uM      // 5a7b.pdf (KMN) compound 3
4yrd  2.44  2015  Kd=27uM       // 4yrd.pdf (3IT) 3-isopropenyl-tropolone;
5btx  2.10  2015  Kd=280uM      // 5btx.pdf (CMP) ligand is CYCLIC AMP, CAMP
5cqu  2.35  2015  Kd=290nM      // 5cqu.pdf (JRJ) compound 14, final deposition
4rwj  2.49  2015  Kd=2nM        // 4rwj.pdf (66T) ligand is AZD4547
4zba  1.50  2015  Kd=3.09uM     // 4f0c.pdf (GDS) ligand is GSSG
4urz  2.24  2015  Kd=3.0mM      // 4uru.pdf (VJP) compound 6
4u5n  2.31  2015  Kd=3.3mM      // 4u54.pdf (3D4) [Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 12;
4uc5  2.19  2015  Kd=3.3uM      // 4uc5.pdf (PHE) [Multiple sites: site 1: Kd=3.3 uM; site 2: Kd=11 uM] ligand is allosteric inhibitor phe, two binding site
4qb3   .94  2015  Kd=3.4uM      // 4qb3.pdf (30M) compound 4b,  Olinone
4css  1.07  2015  Kd=3.5nM      // 4css.pdf (CWX) compound 10e
4u5o  2.00  2015  Kd=3.8mM      // 4u54.pdf (3D5) [Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 15
5cbs  1.80  2015  Kd=3.90uM     // 5cbr.pdf (E42) ligand is compound (R)-38, functional Kb value
4u5s  2.12  2015  Kd=3.9mM      // 4u54.pdf (3D0) [Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 13
5c3p  2.10  2015  Kd=34.4uM     // 5c3p.pdf (AKG) ligand is compound alpha-KG
4zji  1.99  2015  Kd=340nM      // 4zji.pdf (4OQ) compound 11
5azf  1.60  2015  Kd=36.1uM     // 5azf.pdf (4-mer) ligand is 4-mer WEEL peptide
4xy8  1.70  2015  Kd=397nM      // 4xy8.pdf (43U) [Nonstandard assay: NaCl=150mM, HEPES=50mM, pH=7.5(Temp 25)] compound 7d;
4wn5  1.15  2015  Kd=39nM       // 4wn5.pdf (MVC) ligand is 18:1-1-monoacylglycerol;
5e74  1.78  2015  Kd=39uM       // 5e73.pdf (5KH) ligand is compound 50
4cl6  2.41  2015  Kd=4.05uM     // 4cl6.pdf (7SB) [Nonstandard assay: Temp 20, pH=7.5, 100 mM sodium phosphate, 7.5% DMSO] ligand is N42FTA
5d21  1.90  2015  Kd=4.2nM      // 5d21.pdf (56N) ligand is compound GalAxPSG3
4or6  2.29  2015  Kd=4.9uM      // 4or6.pdf (GDP) [Nonstandard assay: Temp 20] ligand is GDP,
4omk  1.75  2015  Kd=40.10uM    // 4omj.pdf (SQL) ligand is squalene
4zt8  1.98  2015  Kd=41uM       // 4zt8.pdf (CYT) ligand is CYS; SPR Kd=41uM, fluorescence Kd=0.23mM
4z93  1.27  2015  Kd=44.6nM     // 4z93.pdf (4LD) compound 18
4xmb  2.43  2015  Kd=44nM       // 4xmb.pdf (41P) compound 12e
4cp5  2.32  2015  Kd=452uM      // 4cp5.pdf (EOI) ligand is compound 6, S-PMPApp
5aol  1.50  2015  Kd=4800uM     // 5ab9.pdf (UFV) compound 11;
4qj0  1.55  2015  Kd=48nM       // 4qiy.pdf (WWX) compound 10p
4ucc  2.05  2015  Kd=48uM       // 4uc8.pdf (ZKW) compound M76
4omj  1.60  2015  Kd=5.44uM     // 4omj.pdf (2TX) ligand is 2,3-oxidosqualene
4y59  1.22  2015  Kd=5.8uM      // 4y59.pdf (T21) ligand is ALiS-1
4q08  1.07  2015  Kd=500nM      // 4pyx.pdf (V90) compound 1
4zme  1.98  2015  Kd=50uM       // 4zme.pdf (ADN) Adenosine;
4qjx  1.95  2015  Kd=52nM       // 4qiy.pdf (WWO) compound 10d
4qfo  2.30  2015  Kd=53.4uM     // 4qfo.pdf (2-mer) ligand is Met-Leu
4r0a  1.90  2015  Kd=55uM       // 4r07.pdf (URI) ligand is uridine
4r75  1.28  2015  Kd=57nM       // 4r73.pdf (S7P) ligand is S7P
4qfp  1.90  2015  Kd=58.6uM     // 4qfp.pdf (2-mer) ligand is Val-Thr
4unp  2.30  2015  Kd=590uM      // 4unn.pdf (TXW) compound 28, Kd data available
4ury  2.47  2015  Kd=6.0mM      // 4uru.pdf (RV1) compound 5
4x5p  1.00  2015  Kd=6.2nM      // 4x50.pdf (3XJ) compound 7; Direct ITC assay
5acy  2.01  2015  Kd=6.4nM      // 5acy.pdf (9S3) I-BET858
4q09  1.20  2015  Kd=6.7nM      // 4pyx.pdf (V14) compound 3
5aut  1.70  2015  Kd=6.7uM      // 5aut.pdf (2AN) ligand is compound ANS
5ahw  2.15  2015  Kd=6.82uM     // 5ahw.pdf (CMP)
5am7  1.96  2015  Kd=64.5nM     // 5am6.pdf (38O) ligand is TKI258, e.g. dovitinib
5bv3  2.25  2015  Kd=68nM       // 5bv3.pdf (M7G) ligand is m7GDP, Kd=68nM for close site
5cs3  2.50  2015  Kd=7.0mM      // 5cs3.pdf (EP1) ligand is compound (H)EPPS
4qfl  1.75  2015  Kd=7.7uM      // 4qfl.pdf (2-mer) ligand is peptide Ala-Phe
4xt2  1.70  2015  Kd=70nM       // 4xt2.pdf (43L) (S,R)-24
5dq8  2.31  2015  Kd=73uM       // 5dq8.pdf (FLF) ligand is FA, flufenamic acid
5c5t  1.60  2015  Kd=746uM      // 5c5t.pdf (AKG) Kd under 520 nm absorbance measurements
4zow  2.45  2015  Kd=75uM       // 4zow.pdf (CLM) ligand is chloramphenicol
4qfn  2.30  2015  Kd=76uM       // 4qfn.pdf (2-mer) ligand is Gly-Glu
4ymx  1.48  2015  Kd=79nM       // 4yms.pdf (ARG) [Nonstandard assay: 20 mM Hepes, 200 mM NaCl] ligand is ARGININE
4oiv  1.70  2015  Kd=8.29uM     // 4oiv.pdf (XX9) ligand is NDB
4u54  2.41  2015  Kd=8.7mM      // 4u54.pdf (3C5) [Nonstandard assay: Temp=25,PH=6.0;100 mM citrate, 200 mM NaCl, 10% DMSO] compound 1
5a2i  1.88  2015  Kd=8.8uM      // 5a2i.pdf (6-mer) [Nonstandard assay: 10 mM sodium phosphate buffer containing 150 mM NaCl] ligand is glycopeptide m2*
5cc2  2.50  2015  Kd=80uM       // 5cc2.pdf (CKA) ligand is compound 7-CKA
4xmr  1.30  2015  Kd=86uM       // 4xmr.pdf (ILE) isoleucine;
4r74  1.93  2015  Kd=8nM        // 4r73.pdf (F6P) ligand is F6P
4x5y  1.59  2015  Kd=9.3nM      // 4x5y.pdf (3XW) ligand is MI-503
5cso  1.78  2015  Kd=940nM      // 5cso.pdf (CTN) ligand is cytidine
4qp2  2.23  2015  Kd=940uM      // 4qp1.pdf (36R) compound 2
5aoi  1.78  2015  Kd=940uM      // 5ab9.pdf (RZH) compound 6;
5bry  1.34  2015  Ki=0.0015nM   // 5bry.pdf (4UY) ligand is entry 6(compoud 25f)
4crc  1.60  2015  Ki=0.0019uM   // 4cr5.pdf (OTM) compound 10
4yth  2.04  2015  Ki=0.002uM    // 4ytc.pdf (467) compound 44
5dgu  1.22  2015  Ki=0.0045nM   // 5dgu.pdf (5B7) ligand is compound 30b
5dgw  1.62  2015  Ki=0.009nM    // 5dgu.pdf (5B5) ligand is compound 30j
4ytc  2.16  2015  Ki=0.013uM    // 4ytc.pdf (4HW) compound 1
4crb  1.85  2015  Ki=0.027uM    // 4cr5.pdf (7P0) compound 9
4yo8  2.10  2015  Ki=0.030nM    // 4wkn.pdf (4EZ) compound 54
5ceq  1.91  2015  Ki=0.042uM    // 5ceo.pdf (50F) ligand is compound 11
4ynb  2.00  2015  Ki=0.043nM    // 4wkn.pdf (4EH) compound 32
5bwc  2.45  2015  Ki=0.061uM    // 5bwb.pdf (HBP) ligand is compound ORTHO-7
4cra  1.80  2015  Ki=0.06uM     // 4cr5.pdf (XJ8) compound 8
4zbf  2.20  2015  Ki=0.074uM    // 4zbf.pdf (4M7) compound 24
5cep  1.99  2015  Ki=0.145uM    // 5ceo.pdf (50E) ligand is compound 3
4zo5  2.50  2015  Ki=0.15nM     // 4zo5.pdf (4Q0) compound 8j
4wkn  2.00  2015  Ki=0.19nM     // 4wkn.pdf (TDI) compound 2
4o2p  2.10  2015  Ki=0.20uM     // 4o2p.pdf (11V) ligand is compound 3-R
4zip  1.11  2015  Ki=0.21nM     // 4zip.pdf (G64) compound 5o
5cjf  1.83  2015  Ki=0.26nM     // 5cjf.pdf (520) ligand is compound 20
4wkp  1.58  2015  Ki=0.28nM     // 4wkn.pdf (3QA) compound 36
4pv5  2.30  2015  Ki=0.29uM     // 4pv5.pdf (CBW) ligand is 18-beta-glycyrrhetinic acid (GA)
4zbi  2.50  2015  Ki=0.31uM     // 4zbf.pdf (4M6) compound 20
4wko  1.90  2015  Ki=0.34nM     // 4wkn.pdf (HCE) compound 22
4qll  1.85  2015  Ki=0.42mM     // 4qlj.pdf (CTT) ligand is cellotetraose
4z0k  1.41  2015  Ki=0.462uM    // 4yzu.pdf (4LN) compound 14a
4q99  1.50  2015  Ki=0.52uM     // 4q7p.pdf (HT4) ligand is 4-CH3-2mp
4qlk  1.83  2015  Ki=0.57mM     // 4qlj.pdf (CTT) ligand is cellotetraose
4crf  2.30  2015  Ki=0.5nM      // 4cr5.pdf (R9B) compound 13
4ymb  1.93  2015  Ki=0.62uM     // 4yma.pdf (4E7) compound 2f;
4wrb  1.81  2015  Ki=0.65uM     // 4wr8.pdf (3TW) [Nonstandard assay: PH=6, 500 mM boric acid] compound 3b
4s1g  2.10  2015  Ki=0.6nM      // 4s1g.pdf (43T) compound 12
5aml  1.36  2015  Ki=0.7nM      // 5amd.pdf (51J) ligand is compound 3e
5dit  2.25  2015  Ki=0.7uM      // 5dit.pdf (5B8) ligand is compound 41
4zls  1.53  2015  Ki=0.82nM     // 4zls.pdf (G61) compound 17a
3wz6  1.40  2015  Ki=1.1uM      // 3wz6.pdf (IXZ) compound 5
5cas  2.10  2015  Ki=1.4nM      // 5c8k.pdf (4ZQ) ligand is compound 41a
4x6n  2.10  2015  Ki=1.5nM      // 4x6m.pdf (3Y5) compound 26
3wz8  1.45  2015  Ki=1.5uM      // 3wz6.pdf (IXV) compound 8
5cau  2.25  2015  Ki=1.6nM      // 5c8k.pdf (4ZR) ligand is compound 41b
5e2p  2.11  2015  Ki=1.6nM      // 5e2o.pdf (7P0) ligand is compound 27
4rhx  2.03  2015  Ki=1.6uM      // 4rht.pdf (3QF) compound 9
4ykk  1.38  2015  Ki=1.7mM      // 4ykj.pdf (DSN) D-serine;
3wz7  1.90  2015  Ki=1.8uM      // 3wz6.pdf (IXY) compound 6
4x6o  2.10  2015  Ki=1.9nM      // 4x6m.pdf (3Y4) compound 30
4re2  2.00  2015  Ki=10.4uM     // 4re2.pdf (MVL) [Nonstandard assay: Temp 30, PH=5.0 ] ligand is mannoimidazole;
4riv  1.63  2015  Ki=100nM      // 4riu.pdf (LSA) ligand is SAC
4twp  2.40  2015  Ki=100pM      // 4twp.pdf (AXI) ligand is axitinib
4p6c  1.86  2015  Ki=100uM      // 4p6c.pdf (RES) ligand is 4PEH
5fl4  1.82  2015  Ki=101nM      // 5fl4.pdf (9FK) ligand is compound 2
4xar  2.26  2015  Ki=107nM      // 4xaq.pdf (40F) [Nonstandard assay: pH=7.6, K3PO4=10mM, KBr=100mM] compound 1;
4zx0  1.60  2015  Ki=10nM       // 4zwx.pdf (5L2) compound 623
5a6k  2.10  2015  Ki=1130nM     // 5a6k.pdf (NSG) ligand is Gal-NGT
4rn4  1.53  2015  Ki=114nM      // 4rn4.pdf (3T7) compound 3
4xir  1.70  2015  Ki=115nM      // 4xip.pdf (40X) [Nonstandard assay: 50 mMKCl, 5 mMMgCl2, 20 mMHEPES, 0.1% CHAPS (Sigma C5070), 0.1% bovine gamma-globulin (Sigma G7516), and 2 mM dithiothreitol (Sigma 646563)] compound 13;
4y79  2.10  2015  Ki=11nM       // 4y76.pdf (4O6) [Nonstandard assay: NaCl=150mM, CaCl2=5mM, HEPESa=50mM] compound 1c;
4ruy  1.14  2015  Ki=12.8nM     // 4rux.pdf (3W6) compound 2b
4rux  1.14  2015  Ki=12nM       // 4rux.pdf (3W3) compound 2d
4x8v  2.50  2015  Ki=130nM      // 4x8s.pdf (3Z9) compound 18
4ufk  2.40  2015  Ki=130uM      // 4ufh.pdf (LDU) ligand is DIL
4re4  2.29  2015  Ki=135nM      // 4re4.pdf (IFM) [Nonstandard assay:  Temp 30, PH=5.0 ] ligand is isofagomine
4q87  1.55  2015  Ki=14uM       // 4q7p.pdf (4FH) ligand is 4-CF3-1,2-HOPTO
4z84  1.55  2015  Ki=1500nM     // 4z83.pdf (NVX) ligand is (+)-1c
4x24  1.50  2015  Ki=166pM      // 4wkb.pdf (TDI) ligand is MTDIA
5c1m  2.10  2015  Ki=16pM       // 5c1m.pdf (4VO) ligand is BU72, Ki in presence of nanobody 39
4z2b  1.80  2015  Ki=17.5nM     // 4z2b.pdf (4LC) compound 3;
4x48  1.89  2015  Ki=170nM      // 4x48.pdf (XPF) compound 3
5cbm  2.30  2015  Ki=17nM       // 4zqt.pdf (4ZN) compound 12; S isomer
4ufm  2.40  2015  Ki=190uM      // 4ufh.pdf (DGJ) ligand is DGJ
5e2o  2.08  2015  Ki=2.0nM      // 5e2o.pdf (5JM) ligand is compound 6
4q9y  1.55  2015  Ki=2.1uM      // 4q7p.pdf (M3T) ligand is 3-CH3-TP
5c28  1.56  2015  Ki=2.2uM      // 5c1w.pdf (4XV) ligand is compound 6
4ufl  2.40  2015  Ki=2.3mM      // 4ufh.pdf (DZX) ligand is DGN
4qd6  2.45  2015  Ki=2.3nM      // 4qd6.pdf (30T) compound 4b
5egm  1.84  2015  Ki=2.4nM      // 5egm.pdf (5NY) ligand is compound 82
5caq  2.50  2015  Ki=2.7nM      // 5c8k.pdf (4ZJ) ligand is compound 33
4wkb  1.37  2015  Ki=2.7pM      // 4wkb.pdf (TDI) ligand is MTDIA
5amd  1.50  2015  Ki=2.8nM      // 5amd.pdf (45I) ligand is compound 3i
4ygf  2.00  2015  Ki=21nM       // 4ygf.pdf (AZM) ligand is acetazolamide (AAZ)
4yha  2.20  2015  Ki=225nM      // 4ygf.pdf (MZM) methazolamide (MZA)
4ruz  1.63  2015  Ki=23.1nM     // 4rux.pdf (3W8) compound 2a
4q7w  1.45  2015  Ki=2300uM     // 4q7p.pdf (6MH) ligand is 6-CH3-1,2-HOPTO
4q8y  1.45  2015  Ki=2300uM     // 4q7p.pdf (HQT) ligand is 2,1-HIQTO
4xip  1.70  2015  Ki=235nM      // 4xip.pdf (40W) compound 5
4xas  2.35  2015  Ki=260nM      // 4xaq.pdf (40H) [Nonstandard assay: pH=7.6, K3PO4=10mM, KBr=100mM] compound 5;
4q7v  1.60  2015  Ki=260uM      // 4q7p.pdf (5MH) ligand is 5-CH3-1,2-HOPTO
4q8x  1.55  2015  Ki=270uM      // 4q7p.pdf (7FH) ligand is 5-CF3-1,2-HOPTO
5c8n  2.40  2015  Ki=28nM       // 5c8k.pdf (4YX) ligand is compound 23
4zwz  1.62  2015  Ki=2nM        // 4zwx.pdf (510) compound 626
4zwx  1.70  2015  Ki=2nM        // 4zwx.pdf (5KZ) compound 623
4q1w  1.85  2015  Ki=2pM        // 4q1w.pdf (017)
4x8u  2.10  2015  Ki=3.5mM      // 4x8s.pdf (3ZB) compound 15
4zae  1.86  2015  Ki=3.6nM      // 4zae.pdf (4M1) compound 13
4y8x  1.90  2015  Ki=3.7nM      // 4y8x.pdf (4GR) compound 3
4u6z  1.80  2015  Ki=3.9uM      // 4u1b.pdf (Q07) compound 19
5byi  1.15  2015  Ki=30.7nM     // 5byi.pdf (4WA) ligand is compound 1d
4qf9  2.28  2015  Ki=37.1uM     // 4qf9.pdf (35K) compound 1b
4ykj  1.40  2015  Ki=37uM       // 4ykj.pdf (ALA) ligand is alanine
4wa9  2.20  2015  Ki=3800pM     // 4twp.pdf (AXI) ligand is axitinib
4ufh  2.16  2015  Ki=380nM      // 4ufh.pdf (GIF) ligand is IGF
4q7s  1.80  2015  Ki=38uM       // 4q7p.pdf (2YU) ligand is 4-CH3-1,2-HOPTO
4yml  1.75  2015  Ki=4.5nM      // 4yml.pdf (4F0) compound 2
4z1k  1.35  2015  Ki=4.7nM      // 4z0q.pdf (4KB) compound 4b
5c2a  2.00  2015  Ki=4.8nM      // 5c1w.pdf (4Y2) ligand is compound 9s
4u1b  1.89  2015  Ki=4.9uM      // 4u1b.pdf (Q08) compound 20
4z83  1.80  2015  Ki=40nM       // 4z83.pdf (4L7) ligand is (+)-1p
5fl6  1.95  2015  Ki=43.6nM     // 5fl4.pdf (Y0R) ligand is compound 3
4q1y  1.50  2015  Ki=45pM       // 4q1w.pdf (017)
4q7p  1.65  2015  Ki=48uM       // 4q7p.pdf (3MH) ligand is 3-CH3-1,2-HOPTO
4y0a  1.91  2015  Ki=4950uM     // 4y0a.pdf (SKM) ligand is shikimate
4ryd  2.15  2015  Ki=5.5pM      // 4ryd.pdf (5-mer) compound 19; para-guanidinomethyl-Phac-R-Tle-R-Amba
4rfc  1.65  2015  Ki=5.7nM      // 4rfc.pdf (3O1) compound 4c
4z1e  2.01  2015  Ki=5.7nM      // 4z0q.pdf (DF5) comopound 5c
4x6m  2.40  2015  Ki=5.8nM      // 4x6m.pdf (3Y3) compound 25
4riu  1.65  2015  Ki=50nM       // 4riu.pdf (3QR) compound 1
5cap  2.40  2015  Ki=52nM       // 5c8k.pdf (4ZH) ligand is compound 30
4ufj  2.20  2015  Ki=52uM       // 4ufh.pdf (IF7) ligand is IGL
4u69  1.60  2015  Ki=54.8uM     // 4u1b.pdf (Q07) compound 19
4xit  1.86  2015  Ki=54nM       // 4xip.pdf (40Z) compound 26
5e13  1.34  2015  Ki=57.8uM     // 5e13.pdf (5J9) ligand is compound 11c
5amg  1.55  2015  Ki=6.0nM      // 5amd.pdf (IW7) ligand is compound 3d
4u71  1.80  2015  Ki=6.0uM      // 4u1b.pdf (Q03) compound 15
5fl5  2.05  2015  Ki=6.4nM      // 5fl4.pdf (82E) ligand is compound 1
4u73  1.80  2015  Ki=6.6uM      // 4u1b.pdf (Q02) compound 2
4z0q  1.45  2015  Ki=6.8nM      // 4z0q.pdf (4K9) compound 5e
4u6w  1.83  2015  Ki=61.3uM     // 4u1b.pdf (Q08) compound 20
4ufi  2.40  2015  Ki=630nM      // 4ufh.pdf (AGK) ligand is AGF
4q83  1.55  2015  Ki=64uM       // 4q7p.pdf (3FH) ligand is 3-CF3-1,2-HOPTO
5dwr  2.00  2015  Ki=6pM        // 5dwr.pdf (5H7) ligand is compound 8
4q90  1.54  2015  Ki=7.0mM      // 4q7p.pdf (4H2) ligand is 4-CH3-2MPyr
4qrh  1.65  2015  Ki=7.0uM      // 4qrh.pdf (0O2) ligand is (p)ppGpp
4z1j  1.27  2015  Ki=7.7nM      // 4z0q.pdf (4KC) compound 4e
4cr5  2.00  2015  Ki=70uM       // 4cr5.pdf (0TU) compound 5
4xaq  2.21  2015  Ki=71.7nM     // 4xaq.pdf (40F) [Nonstandard assay: pH=7.6, K3PO4=10mM, KBr=100mM] compound 1;
4zx1  1.50  2015  Ki=725nM      // 4zwx.pdf (5L3) compound 625
4wov  1.80  2015  Ki=72nM       // 4wov.pdf (3SM) ligand is BMS066
4yc0  1.50  2015  Ki=74uM       // 4yc0.pdf (5OF) ligand is M6;
4q1x  1.90  2015  Ki=7pM        // 4q1w.pdf (017)
5c2h  2.09  2015  Ki=8.2pM      // 5c1w.pdf (4XU) ligand is compound 15h
5c1w  1.70  2015  Ki=8.7uM      // 5c1w.pdf (4XS) ligand is compound 5
4rfd  1.63  2015  Ki=8.9nM      // 4rfc.pdf (3O5) compound 5c
4cr9  1.70  2015  Ki=80uM       // 4cr5.pdf (OTW) compound 6
5e2r  1.60  2015  Ki=86.2nM     // 5cjf.pdf (520) ligand is compound 20
4xiq  1.84  2015  Ki=86nM       // 4xip.pdf (40Y) compound 6;
4u70  1.60  2015  Ki=9.5uM      // 4u1b.pdf (Q04) compound 16
4yes  1.50  2015  Ki=9.6nM      // 4yes.pdf (45S) compound 10
4u6c  1.91  2015  Ki=9.9uM      // 4u1b.pdf (Q06) compound 18
4rfm  2.10  2015  Ki=90pM       // 4rfm.pdf (3P6) compound 28
4q81  1.55  2015  Ki=950uM      // 4q7p.pdf (7MH) ligand is 4,6-CH3-1,2-HOPTO
4yzu  1.41  2015  Ki=9uM        // 4yzu.pdf (4K6) compound 1
5anu  1.80  2016  Kd=0.0004uM   // 5ans.pdf (58T) compound 15
5anv  1.16  2016  Kd=0.0005uM   // 5ans.pdf (RGJ) compound 19
5fnu  1.78  2016  Kd=0.0013uM   // 5fnq.pdf (L6I) compound 7
5ih9  1.79  2016  Kd=0.002uM    // 5ih8.pdf (6BF) ligand is compound 8a; has SPR derived KD data
5izj  1.85  2016  Kd=0.003nM    // 5izf.pdf (4-mer) ligand is compound  ARC-1411 (6J9-AZ1-DAR-DAR)
5fck  1.86  2016  Kd=0.006uM    // 5fah.pdf (5WC) compound 6; SPR data available
5e89  1.50  2016  Kd=0.014uM    // 5e88.pdf (TD2) compound 4
5ive  1.78  2016  Kd=0.027uM    // 5isl.pdf (6E8) ligand is compound  N8
5i8g  1.41  2016  Kd=0.03uM     // 5i83.pdf (69E) Compound 28 (CPI-637); has Kd for this compound
5tbm  1.85  2016  Kd=0.049uM    // 5tbm.pdf (79A) ligand is PT2385
5hvt  1.75  2016  Kd=0.055uM    // 5hvs.pdf (NVS) ligand is compound NVS-2
5hvs  1.75  2016  Kd=0.071uM    // 5hvs.pdf (65V) compound 3i
5hva  2.10  2016  Kd=0.086uM    // 5hva.pdf (DUP) ligand is dUMPNPP
5cqt  1.60  2016  Kd=0.124uM    // 5coi.pdf (EB3) compound 28
5dx4  2.30  2016  Kd=0.137uM    // 5coi.pdf (E0C) compound 85
5js3  1.16  2016  Kd=0.185uM    // 5js3.pdf (6MG) ligand is compound 3
5izf  2.10  2016  Kd=0.18nM     // 5izf.pdf (6-mer) ligand is compound  ARC-1408 (6J9-AZ1-DAR-ACA-DAR-NH2)
5cy9  1.55  2016  Kd=0.218uM    // 5coi.pdf (E0A) compound 58
5jt9  1.26  2016  Kd=0.233uM    // 5js3.pdf (7AF) ligand is compound 2
5i2e  1.60  2016  Kd=0.23uM     // 5i2e.pdf (67D) ligand is compound 7
5l4i  1.45  2016  Kd=0.26uM     // 5jid.pdf (6J3) ligand is Clonixin
4rfr  1.50  2016  Kd=0.29uM     // 4rfr.pdf (RHN) ligand is rhein
5jvi  1.12  2016  Kd=0.31uM     // 5js3.pdf (6QC) ligand is compound 5
5cu4  1.56  2016  Kd=0.320uM    // 5cu4.pdf (54S) ligand is compound CAM4066 (7)
5i2f  1.25  2016  Kd=0.32uM     // 5i2e.pdf (BS5) ligand is Bio-AMS
5jss  1.19  2016  Kd=0.354uM    // 5js3.pdf (6NG) ligand is compound 6
5dbm  1.86  2016  Kd=0.35uM     // 4yk0.pdf (58N) ligand is CPI703
5ivy  1.45  2016  Kd=0.36uM     // 5isl.pdf (6EO) ligand is compound N16
5jxn  1.38  2016  Kd=0.388uM    // 5js3.pdf (6NN) ligand is compound 4
5d0r  2.24  2016  Kd=0.43uM     // 5d0r.pdf (B1T)
5ant  2.00  2016  Kd=0.440uM    // 5ans.pdf (RJE) compound 27
5ivv  1.85  2016  Kd=0.45uM     // 5isl.pdf (6EN) ligand is compound N12
5lz5  2.05  2016  Kd=0.45uM     // 5lyy.pdf (7K4) ligand is compound (s)-15; ITC data available
5kbe  2.50  2016  Kd=0.46uM     // 5kbe.pdf (IPH) ligand is phenol
5ekm  1.33  2016  Kd=0.48uM     // 5ekh.pdf (TG5) compound 4
5gmh  2.20  2016  Kd=0.49uM     // 5gmf.pdf (RX8) [Nonstandard assay: pH 5.5, 150 mM NaCl] ligand is R848
5i3y  2.15  2016  Kd=0.4nM      // 5i3v.pdf (68K) ligand is compound 9
5d25  1.70  2016  Kd=0.50uM     // 5d24.pdf (56M) compound 2
5lz7  2.10  2016  Kd=0.53uM     // 5lyy.pdf (7BK) ligand is compound (R)-15; ITC data available
5lwd  1.23  2016  Kd=0.57uM     // 5lif.pdf (79E) ligand is compound 6
5htl  1.37  2016  Kd=0.5uM      // 5htl.pdf (C2E) ligand is c-di-GMP
5fnt  1.79  2016  Kd=0.67uM     // 5fnq.pdf (0PL) compound  6
5i3w  2.15  2016  Kd=0.6nM      // 5i3v.pdf (68L) ligand is compound 2
5kax  2.00  2016  Kd=0.78uM     // 5kat.pdf (RHQ) ligand is RHODAMINE 6G (RH6G)
5ftg  1.45  2016  Kd=0.7uM      // 5ftg.pdf (NBR) compound 10a
5d26  1.82  2016  Kd=0.81uM     // 5d24.pdf (L28) compound 3
5e7n  1.21  2016  Kd=0.81uM     // 5e7n.pdf (5KR) compound 20c
5h9r  1.58  2016  Kd=0.84uM     // 4y24.pdf (TGZ) ligand is TAZTDG
5d3l  1.50  2016  Kd=0.88uM     // 5d24.pdf (57F) compound 13
5kcb  2.10  2016  Kd=0.99uM     // 5kat.pdf (ET) ligand is ethidium bromide (ET)
5g2g  1.60  2016  Kd=0.9uM      // 5g2g.pdf (EQU) ligand is equilenin
4xo8  1.70  2016  Kd=1.1nM      // 4xo8.pdf (KGM)
5cp5  1.79  2016  Kd=1.234uM    // 5coi.pdf (EB0) compound 17
5lvl  1.40  2016  Kd=1.25uM     // 5lvl.pdf (537) ligand is PS653
5ivc  1.57  2016  Kd=1.2uM      // 5isl.pdf (6E7) ligand is compound N3
5lwm  1.55  2016  Kd=1.34nM     // 5lwm.pdf (79T) ligand is compound 4 (FM381); commercial displacement assay
5lif  1.31  2016  Kd=1.34uM     // 5lif.pdf (6XO) ligand is compound 5
5eh5  1.21  2016  Kd=1.35uM     // 5eh5.pdf (XCZ) compound 1
5ipj  2.10  2016  Kd=1.3nM      // 5ipj.pdf (6CD) ligand is compound 17; DiscoveRx assay
5fsy  1.70  2016  Kd=1.3uM      // 5fsx.pdf (AR6) ligand is ADP-ribose
5dw2  1.12  2016  Kd=1.44uM     // 5dw1.pdf (5GD) ligand is compound RVX-297
5egu  2.21  2016  Kd=1.4uM      // 5egu.pdf (5NQ) compound 1
5eng  1.30  2016  Kd=1.4uM      // 5eic.pdf (5QN) ligand is compound 12
5lso  2.22  2016  Kd=1.4uM      // 5lso.pdf (6-mer) ligand is cyclic peptide inhibitor compound 3
5tb6  1.79  2016  Kd=1.53uM     // 5luu.pdf (77X) Kd=1.53+/-0.01uM; CREBBP(1)/CPD-A
5fsn  1.69  2016  Kd=1.7uM      // 5fsi.pdf (6Q3) ligand is compound 6
5eis  1.60  2016  Kd=1.8uM      // 5egu.pdf (5OU) compound 5
5fsx  2.00  2016  Kd=1.9mM      // 5fsx.pdf (ADP) ligand is ADP
5ikb  2.05  2016  Kd=1.9nM      // 5ikb.pdf (KAI) ligand is kainate
4z07  2.50  2016  Kd=10.3nM     // 4z07.pdf (PCG) PKG1beta; Kd = 10.3 +/- 0.5 nM
5ehw  1.39  2016  Kd=1005uM     // 5eh5.pdf (5OO) compound 10
5g4n  1.35  2016  Kd=101uM      // 5g4m.pdf (O83) compound 3
4yx4  1.01  2016  Kd=1073.4nM   // 4yx4.pdf (FB2) compound 1
5flq  1.70  2016  Kd=1080uM     // 5eh5.pdf (IO2) compound 4
5eqy  2.50  2016  Kd=10nM       // 5eqe.pdf (5RA) compound 65
5fng  2.05  2016  Kd=1105uM     // 5eh5.pdf (YIE) compound 40
5fou  1.50  2016  Kd=113uM      // 5fot.pdf (6-mer) [Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHPA TETRAPEPTIDE
4zv2  1.43  2016  Kd=1170uM     // 4zv1.pdf (GLN) L-glutamine
5hbn  1.60  2016  Kd=12.9uM     // 5hbn.pdf (RPI) ligand is phospho-arginine (pArgAA)
5ii2  2.10  2016  Kd=12.9uM     // 5hrv.pdf (LU2) compound 15, according to structure in RCSB PDB
5flt  1.67  2016  Kd=1280uM     // 5eh5.pdf (VJJ) compound 3
5i1q  1.50  2016  Kd=12nM       // 5i1q.pdf (67C) compound 5; BROMOscan bromodomain selectivity data
5d3t  1.93  2016  Kd=12uM       // 5d24.pdf (56Y) compound 16
5eqe  2.40  2016  Kd=132uM      // 5eqe.pdf (5R8) compound 11
5j0d  1.05  2016  Kd=134nM      // 5j0d.pdf (6F9) ligand is compound 102
5fh7  1.47  2016  Kd=137nM      // 5fh6.pdf (5XL) ligand is compound 18
5g4m  1.38  2016  Kd=138uM      // 5g4m.pdf (O82) compound 2
5l3a  1.98  2016  Kd=13uM       // 5l3a.pdf (6DP) ligand is compound 1
5f1h  1.82  2016  Kd=14.1nM     // 5eu1.pdf (5U6) compound 2 (BI-9564)
5ie1  2.30  2016  Kd=140nM      // 5i3v.pdf (6BS) ligand is compound 5
5btv  1.70  2016  Kd=140uM      // 5btv.pdf (4-mer) ligand is a 4-mer Tau-pS324 peptide; MST assays
5ewk  1.60  2016  Kd=14uM       // 5ewk.pdf (P34) inhibitor PJ34
5eu1  1.60  2016  Kd=15.4nM     // 5eu1.pdf (5SW) compound 1 (BI-7273)
5exw  1.90  2016  Kd=150nM      // 5evz.pdf (7DT) ligand is 7-deazaATP
5fov  1.74  2016  Kd=1590uM     // 5fot.pdf (6-mer) [Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHTG TETRAPEPTIDE
4ybk  2.50  2016  Kd=15nM       // 4ybj.pdf (4B7) ligand is DAS-CHO-I; assay by KINOMEscan service
5i29  1.21  2016  Kd=15nM       // 5i1q.pdf (67B) compound 2; BROMOscan bromodomain selectivity data
5fbi  1.47  2016  Kd=1600uM     // 5fah.pdf (5WD) compound 4; NMR Kd available
5i3v  1.62  2016  Kd=16nM       // 5i3v.pdf (68M) ligand is compound 1
5lne  2.20  2016  Kd=17.43uM    // 5lne.pdf (2-mer) ligand is Thomsen-Friedenreich (TF) antigen; also named Gal-beta1-3GalNAc (A2G-GAL)
5fh8  1.55  2016  Kd=170nM      // 5fh6.pdf (5XK) ligand is compound 28
4yhm  2.16  2016  Kd=173pM      // 4yhi.pdf (4CC) aDabi-Fab2b: Dabigatran complex
5er4  1.81  2016  Kd=1752uM     // 5er4.pdf (5RL) ligand is compound SC0025
5hbs   .89  2016  Kd=18.5nM     // 5h8t.pdf (RTL) ligand is all-trans-retinol
4yk0  1.65  2016  Kd=181uM      // 4yk0.pdf (98) ligand is CPI098
5ia0  1.95  2016  Kd=187nM      // 5i9v.pdf (A5B) ligand is alisertib (MLN8237)
4yho  1.82  2016  Kd=18pM       // 4yhi.pdf (4CC) ligand is Dabigatran
5k03  1.81  2016  Kd=18uM       // 5k03.pdf (6P4) ligand is compound 2
4yb5  2.24  2016  Kd=19.3uM     // 4yb5.pdf (HIS) [Multiple sites: Kd = 19.3 +/- 0.2 uM, 14.5 +/- 0.2 uM, 36 +/-1 uM, 50 +/- 1 uM, 47 +/- 1 uM. sequential binding model (five events)] ligand is His
5his  1.77  2016  Kd=19.6uM     // 5hio.pdf (60P) compound 3
5l9g  1.75  2016  Kd=19.8nM     // 5l9g.pdf (MO0) ligand is mannopine
5ia2  1.62  2016  Kd=19nM       // 5i9v.pdf (L66) ligand is compound 66
5hjq  2.30  2016  Kd=19uM       // 5hjq.pdf (I3P) ligand is inositol(1,4,5)triphosphate; IP3
5f0f  1.76  2016  Kd=1uM        // 5eyr.pdf (5TD) compound 15
5f1r  2.25  2016  Kd=1uM        // 5f1r.pdf (42O) compound 1
5ey0  1.60  2016  Kd=2.26mM     // 5ey0.pdf (GTP)
5epn  2.30  2016  Kd=2.2nM      // 5epn.pdf (5R2) ligand is compound 5172-mcP1P3
5d0c  1.49  2016  Kd=2.340uM    // 5coi.pdf (E0B) compound 42
5g46  1.76  2016  Kd=2.5mM      // 5g42.pdf (6VD) ligand is CT49
5i9y  1.23  2016  Kd=2.8nM      // 5i9v.pdf (1N1) ligand is Dasatinib
5dus  1.43  2016  Kd=2.95uM     // 5dus.pdf (APR) ligand is ADP-ribose
5sxm  2.00  2016  Kd=2.9nM      // 5sxm.pdf (8-mer)
5fe9  2.35  2016  Kd=20.98uM    // 5fdz.pdf (5WS) [Nonstandard assay: ITC at Temp 15C] compound SL1122 (compound 13)
5dkn  1.53  2016  Kd=202.6uM    // 5dkn.pdf (B7I) compound 5a (SBi4225); Kd calculated from fluorescent polarization competition assay (FPCA) IC50 data
5a6x  1.55  2016  Kd=202nM      // 5a6x.pdf (MFU) ligand is alpha-methyl-fucoside, compound 2
5fs5  1.42  2016  Kd=206.4nM    // 5fs5.pdf (KGM) ligand is HM
5fog  2.30  2016  Kd=213uM      // 5fog.pdf (VRT) ligand is Nva2AA
5fol  1.77  2016  Kd=215uM      // 5fog.pdf (SO8) ligand is Ile2AA
4d7b  1.15  2016  Kd=21nM       // 4d7b.pdf (TCW) [Multiple sites: site 1: Kd=21 nM; site 2: Kd=58 nM] ligand is tolcapone; two ligand-binding sites
5eq1  1.55  2016  Kd=21uM       // 5c7n.pdf (BEA) compound 1
5ji8  1.42  2016  Kd=23.4uM     // 5ji8.pdf (6KT) ligand is compound 1, pKd=4.63
5ko1  2.16  2016  Kd=230nM      // 5knj.pdf (6UY) ligand is compound 4
5hu9  1.53  2016  Kd=24.2nM     // 5hu9.pdf (66K) ligand is CHMFL-074; MST assay
5i88  1.40  2016  Kd=250nM      // 5i1q.pdf (69G) compound 4; BROMOscan bromodomain selectivity data
5lvr  2.05  2016  Kd=250uM      // 5luu.pdf (78Y) Kd=250+/-10uM; PCAF/CPD-E
5ia5  1.78  2016  Kd=25nM       // 5i9v.pdf (GV0) ligand is golvatinib (E7050)
5evz  1.85  2016  Kd=270nM      // 5evz.pdf (ADP) ligand is ADP
5c2o  2.35  2016  Kd=28.2uM     // 5c2o.pdf (TTP) dTTP
5fpk  1.34  2016  Kd=280uM      // 5fot.pdf (6-mer) [Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FATA TETRAPEPTIDE
5etb  1.33  2016  Kd=29uM       // 5c7n.pdf (5RO) compound 15
5dlx  1.90  2016  Kd=2uM        // 5dlx.pdf (5D2) compound 2
5lz4  2.07  2016  Kd=2uM        // 5lyy.pdf (7BW) ligand is compound 13; ITC data available
4zgk  2.00  2016  Kd=3.1uM      // 4zfi.pdf (4NX) compound 2a; MST assay
5cks  2.12  2016  Kd=3.1uM      // 5cks.pdf (52L) ligand is DAHP Oxime
5avf  1.95  2016  Kd=3.2uM      // 5ave.pdf (TAU) ligand is taurine
5aqz  1.65  2016  Kd=3.3uM      // 5aqz.pdf (SGV) ligand is compound sangivamycin 10
5hrw  1.80  2016  Kd=3.3uM      // 5hrv.pdf (64E) compound 11, according to structure in RCSB PDB
4y4j  1.03  2016  Kd=3.4mM      // 4y38.pdf (LNR) fragment compound 97
5ave  1.80  2016  Kd=3.6uM      // 5ave.pdf (SER) ligand is L-serine
5e3a  2.05  2016  Kd=3.6uM      // 5e2q.pdf (5-mer) ligand is opioid peptide leu-enkephalin
5f2u  1.85  2016  Kd=3.7nM      // 5f2u.pdf (4-mer) ligand is 4-mer fully modified farnesylated INPP5E Peptide
5i9x  1.43  2016  Kd=30nM       // 5i9v.pdf (DB8) ligand is bosutinib (SKI-606); Kinobeads binding assay
4yxi   .96  2016  Kd=318.8nM    // 4yx4.pdf (4J8) compound 2
5fnd  2.00  2016  Kd=320uM      // 5fnd.pdf (IQ5) compound 2
5eh7  1.43  2016  Kd=330uM      // 5eh5.pdf (5O5) compound 37
5fut  1.60  2016  Kd=352nM      // 5fut.pdf (PQ7) ligand is compound BR25
5jox  1.80  2016  Kd=35uM       // 5jov.pdf (EDG) ligand is AraDNJ
5d6j  2.25  2016  Kd=36uM       // 5d6j.pdf (ATP)
5f2p  1.80  2016  Kd=37.5uM     // 5eu1.pdf (5TY) compound 3
5g4o  1.48  2016  Kd=37uM       // 5g4m.pdf (O80) compound 6
5ihh  1.35  2016  Kd=390nM      // 5en3.pdf (6B5) ligand is 7-MeO-Lut; MST assay
4xoc  1.42  2016  Kd=3nM        // 4xo8.pdf (KGM) FimHL F18 .HM
5f08  1.92  2016  Kd=3uM        // 5eyr.pdf (5TG) compound 14
5tef  1.95  2016  Kd=4.0uM      // 5tef.pdf (GTG) kd=4.0+/-0.5uM; ligand is m7GpppG.
5chk  2.20  2016  Kd=4.12uM     // 5chk.pdf (55R) avidin-HABA, MST assay
4y3y  1.35  2016  Kd=4.5mM      // 4y38.pdf (DCL) fragment compound 42
5edl  1.95  2016  Kd=4.5nM      // 5edl.pdf (VIB) ligand is thiamine
5l4m  1.58  2016  Kd=4.6uM      // 5jid.pdf (SBK) ligand is 3,5,6-Trichloro-2-pyridinyloxyacetic acid (Triclopyr)
5czm  1.30  2016  Kd=4.8nM      // 5cxa.pdf (R47) compound 1; delta G=-11.6 kcal/mol
5d3c  1.31  2016  Kd=40pM       // 5cxa.pdf (56O) compound 2; delta G=-14.2 kcal/mol
5igm  1.60  2016  Kd=41.7nM     // 5igk.pdf (BMF) ligand is bromosporine (BSP)
4yyt  1.07  2016  Kd=418.3nM    // 4yx4.pdf (S2O) compound 5
5d3x  1.69  2016  Kd=440nM      // 5d3v.pdf (4IP) ITC Kd=391nM in figure S2, but 440nM in page 5
5ia3  1.79  2016  Kd=46nM       // 5i9v.pdf (P17) ligand is PD173955
4zcs  2.45  2016  Kd=47uM       // 4zcp.pdf (CDC) Kd = 47 +/ -5 uM. ligand is CDPCho
5h8g  2.00  2016  Kd=48.2pM     // 5h8b.pdf (5Y4) compound 7b
5meh  0.95  2016  Kd=481nM      // 5meh.pdf (DMJ) ligand is DMJ
5fe7  2.08  2016  Kd=488uM      // 5fdz.pdf (5WU) fragment ZB2216 (fragment 11)
5ep7  1.20  2016  Kd=4uM        // 5eic.pdf (5QR) ligand is compound 3
5eqp  2.35  2016  Kd=4uM        // 5eqe.pdf (5R9) compound 37
5fns  1.79  2016  Kd=4uM        // 5fnq.pdf (XYY) compound 5
5l9o  1.84  2016  Kd=4uM        // 5l9g.pdf (GOP) ligand is glucopine
5hrv  1.70  2016  Kd=5.1uM      // 5hrv.pdf (64C) compound 10, according to structure in RCSB PDB
5hrx  1.73  2016  Kd=5.1uM      // 5hrv.pdf (64F) compound 12, according to structure in RCSB PDB
5ect  1.30  2016  Kd=5.2uM      // 5ect.pdf (DUP) ligand is dUPNPP; assay by near-UV CD titration
5hwu  2.10  2016  Kd=5.35uM     // 5hva.pdf (DUP) ligand is dUMPNPP
5gs9  2.50  2016  Kd=5.5uM      // 5gs9.pdf (ARG) ligand is arginine
4zv1  1.52  2016  Kd=5.73uM     // 4zv1.pdf (ARG) ligand is L-argnine
5d3j  1.70  2016  Kd=5.7uM      // 5d24.pdf (L33) compound 6
5edd  1.97  2016  Kd=5.7uM      // 5ect.pdf (DUP) ligand is dUPNPP; assay by near-UV CD titration
5d24  1.65  2016  Kd=5.8uM      // 5d24.pdf (L26) compound 14
5g45  2.07  2016  Kd=500uM      // 5g42.pdf (A7W) ligand is CT24
5ewy  1.40  2016  Kd=50uM       // 5ewk.pdf (5TQ) inhibitor P6E
5duw  1.70  2016  Kd=510uM      // 5duw.pdf (5GO) ligand is lactose-3'-sulfate
4r06  2.22  2016  Kd=513nM      // 4r06.pdf (3E7) ligand is SR2067
5i7y  1.45  2016  Kd=52nM       // 5i1q.pdf (69G) compound 4; BROMOscan bromodomain selectivity data
5ia4  1.80  2016  Kd=52nM       // 5i9v.pdf (88Z) ligand is foretinib (XL880)
5f2r  2.15  2016  Kd=52uM       // 5evz.pdf (ACP) ligand is AMPPCP
5l4j  1.62  2016  Kd=52uM       // 5jid.pdf (6JD) ligand is 4,4'-Dihydroxydiphenyl sulfone (Bisphenol S, BPS)
5ia1  2.04  2016  Kd=530nM      // 5i9v.pdf (ZZL) ligand is MLN8054
5i7x  1.18  2016  Kd=53nM       // 5i1q.pdf (67B) compound 2; BROMOscan bromodomain selectivity data
5f9b  2.25  2016  Kd=54.82uM    // 5f9b.pdf (5VN) compound 19 (caulophyllogenin)
5ei3  1.71  2016  Kd=56.5uM     // 5ehc.pdf (5O8) compound 7a
5b2d  2.18  2016  Kd=56uM       // 5b2d.pdf (SLT) ligand is 3-sialyllactose
5f8y  1.70  2016  Kd=57uM       // 5f8y.pdf (X6X) ligand is galactosamine; BLI assay
5ad1  1.32  2016  Kd=58nM       // 5a5d.pdf (8LC) ligand is CFe-8-Lic
5csp  1.50  2016  Kd=58uM       // 5csp.pdf (54G) compound 5
5fnr  1.89  2016  Kd=59uM       // 5fnq.pdf (XMS) compound 4
5eyr  1.57  2016  Kd=5uM        // 5eyr.pdf (5T0) compound 5
5h8e  2.15  2016  Kd=6.33pM     // 5h8b.pdf (5Y3) compound 7h
4y3j  1.31  2016  Kd=6.8mM      // 4y38.pdf (HIC) compound 30
5kh3  1.60  2016  Kd=60uM       // 5b8d.pdf (6U6) Kd = 60 +/- 3 uM. ligand is compound 3
5dyo  2.36  2016  Kd=61pM       // 5dyo.pdf (FLU) ligand is flourescein
5en3  1.25  2016  Kd=620nM      // 5en3.pdf (7LU) ligand is compound 7-Cl-Lut; MST assay
5i80  1.45  2016  Kd=62nM       // 5i1q.pdf (67B) compound 2; BROMOscan bromodomain selectivity data
5cs6  1.88  2016  Kd=630uM      // 5cs6.pdf (K82) compound 3
5ha1  1.35  2016  Kd=64.1nM     // 5h8t.pdf (RNE) ligand is retinylamine
5fox  1.30  2016  Kd=675uM      // 5fot.pdf (6-mer) [Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHAA TETRAPEPTIDE
5ito  2.35  2016  Kd=68.9uM     // 5ito.pdf (6DB) ligand is octopine
5fot  1.19  2016  Kd=680uM      // 5fot.pdf (6-mer) [Nonstandard assay: pH 6.0, 100 mM NaCl] ligand is FHTU TETRAPEPTIDE
5bw4  2.10  2016  Kd=68uM       // 5bw4.pdf (SAM) ligand is SAM
5fe6  1.77  2016  Kd=6910uM     // 5fdz.pdf (5WZ) fragment ZB1916 (fragment 10)
5k8s  1.15  2016  Kd=6nM        // 5k8s.pdf (CMP) ligand is cAMP
5kva  1.83  2016  Kd=7.32uM     // 5kva.pdf (SAM) ITC Kd=8.6uM in Fig. 4a, but 7.32uM in table 2; mad author
5d3p  1.95  2016  Kd=7.4uM      // 5d24.pdf (57E) compound 10
5f74  2.35  2016  Kd=7.6uM      // 5f74.pdf (AMP)
5d3h  1.70  2016  Kd=7.9uM      // 5d24.pdf (57G) compound 4
5fnf  2.10  2016  Kd=700uM      // 5fnf.pdf (TQL) compound 3
5flo  1.66  2016  Kd=709uM      // 5eh5.pdf (J4K) compound 6
5ehr  1.70  2016  Kd=73nM       // 5ehr.pdf (5OD) Allosteric Inhibitor SHP099
5lvq  2.05  2016  Kd=73uM       // 5luu.pdf (2LX) Kd=73+/-1uM; PCAF/CPD-D
5lom  1.50  2016  Kd=74.1nM     // 5l9g.pdf (SNW) ligand is Deoxyfructosylglutamine (DFG)
5ey4  1.86  2016  Kd=750uM      // 5evz.pdf (DTP) ligand is 2'-deoxyATP
5e6o  1.80  2016  Kd=76.9uM     // 5e6o.pdf (4-mer) peptide Trp-Glu-Glu-Leu (WEEL)
5dnu  1.20  2016  Kd=77.6uM     // 5dnu.pdf (KKN) ligand is karrikin (KAR1)
5fnc  2.20  2016  Kd=77uM       // 5fnc.pdf (IEE) compound 1
5kat  2.10  2016  Kd=78.7uM     // 5kat.pdf (P4P) ligand is tetraphenylphosphonium (TPP)
5f1x  1.90  2016  Kd=780nM      // 5evz.pdf (ATP) ligand is ATP
5l9l  1.80  2016  Kd=79.4nM     // 5l9g.pdf (GOP) ligand is glucopine
5eh8  1.38  2016  Kd=791uM      // 5eh5.pdf (5O6) compound 19
5hwv  1.65  2016  Kd=8.5uM      // 5hwv.pdf (MBN) ligand is toluene;
5ehv  1.21  2016  Kd=826uM      // 5eh5.pdf (5ON) compound 35
5l2s  2.27  2016  Kd=83nM       // 5l2i.pdf (6ZV) ligand is compound Abemaciclib
5i3x  1.85  2016  Kd=8nM        // 5i3v.pdf (68J) ligand is compound 6
5f25  1.68  2016  Kd=9.1uM      // 5eu1.pdf (5TU) compound 4
5d3n  2.15  2016  Kd=9.2uM      // 5d24.pdf (L40) compound 7
4xoe  2.40  2016  Kd=9.9uM      // 4xo8.pdf (KGM)
5itp  1.85  2016  Kd=9.9uM      // 5ito.pdf (6DB) ligand is octopine
5fls  1.67  2016  Kd=905uM      // 5eh5.pdf (6ZX) compound 2
5lli  2.40  2016  Kd=90nM       // 5lli.pdf (6Z3) ligand is VH298; SPR Kd=10nM; FP Kd=80nM
5e2l  2.50  2016  Kd=93uM       // 5e2l.pdf (DPN) ligand is D-Phe
5l9i  1.90  2016  Kd=99nM       // 5l9g.pdf (SNW) ligand is DFG
5cxa  1.30  2016  Kd=9nM        // 5cxa.pdf (55L) compound 3; delta G=-11.2 kcal/mol
5i9z  1.70  2016  Kd=9nM        // 5i9v.pdf (627) ligand is danusertib (PHA739358)
5ld8  2.13  2016  Kd=9nM        // 5ld8.pdf (6U5) ligand is GSK3011724A; chemoproteomic affinities, also has SPR Kd in the 10-20nM range
5i3a  2.20  2016  Kd=9uM        // 5i38.pdf (HQE) ligand is hydroquinone (HQ) in configuration A
5hz6  1.14  2016  Ki=0.016uM    // 5hz6.pdf (65Y) compound 11
5edc  1.29  2016  Ki=0.022uM    // 5edb.pdf (5M7) compound 13
5hct  1.36  2016  Ki=0.0254uM   // 5hct.pdf (61P) compound 13; +/-0.0002
5d48  1.81  2016  Ki=0.03uM     // 5d45.pdf (L96) compound 1
5b25  1.90  2016  Ki=0.058nM    // 5b25.pdf (4QJ) compound 3
4zx3  2.00  2016  Ki=0.065uM    // 4zw3.pdf (4TK) pfa-m1, compound10b
4zx4  1.90  2016  Ki=0.078uM    // 4zw3.pdf (4TL) pfa-m1, compound 10o
5k0h  2.20  2016  Ki=0.081uM    // 5k0h.pdf (6PK) ligand is compound 2
5hz9  2.30  2016  Ki=0.093uM    // 5hz6.pdf (5M8) compound 6
5d47  1.70  2016  Ki=0.10uM     // 5d45.pdf (L19) compound 2; author gives wrong compound 3
5d45  1.65  2016  Ki=0.12uM     // 5d45.pdf (57P) compound 3; author gives wrong compound 2
5ayt  1.40  2016  Ki=0.17uM     // 5ayt.pdf (L6Y)
5edb  1.18  2016  Ki=0.1uM      // 5edb.pdf (5M8) compound 10
5fho  2.30  2016  Ki=0.213uM    // 5fhm.pdf (5XN) compound 7
5dh5  2.00  2016  Ki=0.23nM     // 5dh4.pdf (5AY) ligand is Pyp-1
5l7e  1.86  2016  Ki=0.25uM     // 5l7e.pdf (6Q0) ligand is compound 1; pKi=6.6, pIC50=5.9
5ew0  1.30  2016  Ki=0.26uM     // 5ev8.pdf (3C7) compound 1a (L-CS319)
5dxt  2.25  2016  Ki=0.2nM      // 5dxh.pdf (5H5) compound 4
5sz4  1.60  2016  Ki=0.2nM      // 5sz0.pdf (72D) ligand is compound 4a
5sz7  1.78  2016  Ki=0.2nM      // 5sz0.pdf (72H) ligand is compound 4p
5kr1  1.60  2016  Ki=0.32nM     // 5kqx.pdf (017) ligand is DRV
5iwg  1.66  2016  Ki=0.346uM    // 5iwg.pdf (IWX) ligand is compound  BRD4884
5jfp  1.49  2016  Ki=0.48nM     // 5jfp.pdf (6KK) ligand is compound 15d
5hz8  1.12  2016  Ki=0.4uM      // 5hz6.pdf (65Z) compound 9
5ix0  1.72  2016  Ki=0.519uM    // 5iwg.pdf (6EZ) ligand is compound  BRD7232
5kqy  1.65  2016  Ki=0.51nM     // 5kqx.pdf (017) ligand is DRV
5dhu  2.33  2016  Ki=0.5uM      // 5dhp.pdf (5A8) compound 11q
5eei  1.32  2016  Ki=0.6nM      // 5edu.pdf (SHH) ligand is SAHA
5kr0  1.80  2016  Ki=0.71nM     // 5kqx.pdf (478) ligand is APV
5l30  1.73  2016  Ki=0.72nM     // 5l2y.pdf (70A) ligand is compound 59
5eek  1.59  2016  Ki=0.8nM      // 5edu.pdf (TSN) ligand is trichostatin A(TSA)
5sz0  1.63  2016  Ki=0.8nM      // 5sz0.pdf (72D) ligand is compound 4a
5e2s  1.50  2016  Ki=0.98nM     // 5e28.pdf (5CX) compound 4c
4uja  1.93  2016  Ki=0.9nM      // 4uj1.pdf (4L7) compound 1p
5een  1.86  2016  Ki=1.1nM      // 5edu.pdf (5OG) ligand is Belinostat
4zw8  2.00  2016  Ki=1.1uM      // 4zw3.pdf (4T2) pfa-m1,compound 9r
5fhn  1.60  2016  Ki=1.27uM     // 5fhm.pdf (5XO) compound 8
5hcy  2.46  2016  Ki=1.2nM      // 5hcx.pdf (60D) compound 13
5sz1  1.55  2016  Ki=1.2nM      // 5sz0.pdf (72E) ligand is compound 4b
5kby  2.24  2016  Ki=1.5nM      // 5kby.pdf (6RL) ligand is trelagliptin (SYR-472)
5d2r  1.90  2016  Ki=1.5uM      // 5d2r.pdf (56W) ligand is inhibitor 1
5jg1  1.16  2016  Ki=1.9nM      // 5jfp.pdf (6KR) ligand is compound 15i
4zw6  1.90  2016  Ki=1.9uM      // 4zw3.pdf (4SY) compound 9q
4ujb  1.95  2016  Ki=10nM       // 4uj1.pdf (8BQ) compound 1b
5evb  1.84  2016  Ki=10uM       // 5ev8.pdf (3R9) compound 1b (D-CS319)
5evd  1.80  2016  Ki=10uM       // 5ev8.pdf (VC2) compound 2b (D-VC26)
5e28  1.30  2016  Ki=12.3nM     // 5e28.pdf (BC5) compound 4h
5jy3  2.40  2016  Ki=12nM       // 5jy3.pdf (6OX) ligand is compound 15 (BMS-852927)
5evk  1.63  2016  Ki=12uM       // 5ev8.pdf (3C7) compound 1a (L-CS319)
5j7w  2.50  2016  Ki=13uM       // 4o7u.pdf (MTX) ligand is methotrexate
5f1v  2.20  2016  Ki=140nM      // 5f1u.pdf (3VN) potent allosteric inhibitor bislysine
5elw  1.40  2016  Ki=14nM       // 5dnl.pdf (5LD) ligand is (R)-C348
5hi7  2.15  2016  Ki=14nM       // 5hi7.pdf (62X) ligand is GSK2807
5ewa  2.30  2016  Ki=15uM       // 5ev8.pdf (9BZ) compound 2a (L-VC26)
5l7g  2.01  2016  Ki=16nM       // 5l7e.pdf (6QE) ligand is compound 25d; pKi=7.8, pIC50=6.3
5fdi  1.85  2016  Ki=18.5nM     // 5fdc.pdf (5WM) compound 4
5j41  1.19  2016  Ki=199uM      // 5j41.pdf (2-mer) ligand is 3LF-GSH, hydrolyzed Piperlongumine (hPL)
4zw7  1.95  2016  Ki=19uM       // 4zw3.pdf (4SZ) pfa-m1;compound 9m
5ef7  1.90  2016  Ki=1nM        // 5edu.pdf (5OJ) ligand is HPOB
5cj6  2.07  2016  Ki=2.03nM     // 5cj6.pdf (51Y) compound 6
5sz2  1.63  2016  Ki=2.0nM      // 5sz0.pdf (72G) ligand is compound 4e
5htz  1.95  2016  Ki=2.4nM      // 5htz.pdf (66J) compound 9
5sz3  1.69  2016  Ki=2.5nM      // 5sz0.pdf (72H) ligand is compound 4p
5sz5  1.27  2016  Ki=20nM       // 5sz0.pdf (72E) ligand is compound 4b
5jsq  1.50  2016  Ki=21.3uM     // 5jsq.pdf (6MS) ligand is compound 3
5dex  2.40  2016  Ki=22.6nM     // 5dex.pdf (5E0) ligand is FRA-19
5dfp  2.20  2016  Ki=22nM       // 5dey.pdf (59U) compound 1 (FRAX1036)
5kz0  2.30  2016  Ki=22nM       // 5kz0.pdf (6YL) ligand is compound 6f
5el9  1.10  2016  Ki=23.0nM     // 5dnl.pdf (5DL) ligand is (S)-C348
5exn  1.49  2016  Ki=23nM       // 5exl.pdf (5SU) ligand is compound (S)-24
5j7q  2.05  2016  Ki=26.6uM     // 5j7p.pdf (6H2) ligand is compound 14
5sym  1.55  2016  Ki=280nM      // 5sym.pdf (71Q) ligand is ML348
5hcv  2.50  2016  Ki=2nM        // 5hcv.pdf (60R) compound 21
5kr2  1.78  2016  Ki=3.3nM      // 5kqx.pdf (ROC) ligand is SQV
5drr  1.59  2016  Ki=3.5pM      // 5dro.pdf (5EN) ligand is LPC-058
5kqx  2.40  2016  Ki=3.6nM      // 5kqx.pdf (ROC) ligand is SQV
5dey  2.10  2016  Ki=3.7nM      // 5dey.pdf (59T) compound 12 (G-5555)
5exl  2.30  2016  Ki=3.7nM      // 5exl.pdf (5SS) ligand is compound (S)-10
4uj1  1.77  2016  Ki=300nM      // 4uj1.pdf (NVX) compound 1c
5ehq  2.50  2016  Ki=33pM       // 5ehn.pdf (5O2) ligand is anti-TZ2PA5
5fdc  1.75  2016  Ki=34.8nM     // 5fdc.pdf (5WN) compound 1
5efj  1.73  2016  Ki=350nM      // 5edu.pdf (4-mer) ligand is HC toxin, a peptide-like inhibitor
4zw5  1.80  2016  Ki=37uM       // 4zw3.pdf (4SA) pfa-m1; compoud 9f
5ime  2.22  2016  Ki=4.6nM      // 5ime.pdf (6BZ) ligand is compound 9
5dqc  2.47  2016  Ki=45.6nM     // 5dqc.pdf (5E7) compound 2
5eij  1.99  2016  Ki=4860nM     // 5eij.pdf (5OT) ligand is compound 3
5j8z  1.70  2016  Ki=5.0nM      // 5j8z.pdf (FC4) ligand is racemic compound D; ligand codes are FC4 and 6KE
5l7h  1.84  2016  Ki=50nM       // 5l7e.pdf (6QG) ligand is compound 44; pKi=7.3, pIC50=6.6
5dh4  2.20  2016  Ki=58nM       // 5dh4.pdf (5AV) compound 6
5khm  1.48  2016  Ki=5nM        // 5khm.pdf (XNH) ligand is compound 13; pKi=8.3
5fto  2.22  2016  Ki=6.2nM      // 5fto.pdf (YMX) compound 2, Entrectinib; Ki calculated from IC50
5exm  2.09  2016  Ki=6.3nM      // 5exl.pdf (5ST) ligand is compound (S)-17
5aa9  1.93  2016  Ki=6.4nM      // 5a9u.pdf (5P8) ligand is loratinib
5fcz  2.45  2016  Ki=63uM       // 5fcz.pdf (TNX) ligand is NTA-glucal
5etj  2.30  2016  Ki=66pM       // 5etj.pdf (IM5) ligand is DADMe-ImmG; inhibition assay, should be Ki data, not Kd data
5ev8  2.30  2016  Ki=6uM        // 5ev8.pdf (3R9) compound 1b (D-CS319)
5jxq  1.20  2016  Ki=7nM        // 5jxq.pdf (6OK) ligand is compound 6b
5fhm  1.55  2016  Ki=8.15uM     // 5fhm.pdf (5XP) compound 6
5jfu  1.70  2016  Ki=8.5nM      // 5jfp.pdf (6KQ) ligand is compound 15h
5efh  2.16  2016  Ki=800nM      // 5edu.pdf (FKS) ligand is trifluoroketone inhibitor
4uj2  2.02  2016  Ki=80nM       // 4uj1.pdf (NVV) compound 1e
5e2k  1.40  2016  Ki=9.3nM      // 5e28.pdf (BX4) compound 4g
5sz6  1.15  2016  Ki=99nM       // 5sz0.pdf (72G) ligand is compound 4e
5ufr  2.07  2017  Kd=0.002uM    // 5ufo.pdf (88J) ligand is compound S-12, TF binding assay
5org  1.99  2017  Kd=0.004uM    // 5org.pdf (6DB) +/-0.0001, octopine
5n1z  1.81  2017  Kd=0.0065uM   // 5n1v.pdf (8GQ) ligand is compound 11
5llg  1.12  2017  Kd=0.0074nM   // 5llc.pdf (VD9) ligand is compound 1
5lyr  1.14  2017  Kd=0.013uM    // 5lyr.pdf (2-mer) +/-0.002, ligand is compound 9
6euw  1.00  2017  Kd=0.017uM    // 6euv.pdf (BYB) A/H5N1 PB2 cap-binding/ VX-787N;+/- 0.004
5lle  1.90  2017  Kd=0.060nM    // 5llc.pdf (V51) ligand is compound 2
5kly  1.30  2017  Kd=0.061uM    // 5kly.pdf (6UR)
5llh  1.90  2017  Kd=0.067nM    // 5llc.pdf (V49) ligand is compound 4
5vr8  2.00  2017  Kd=0.135uM    // 5vr8.pdf (UDX) ligand is UDX
5h1t  1.95  2017  Kd=0.16mM     // 5h1t.pdf (7FF) [Nonstandard assay: PH=8] ligand is compound 1
5wa9  1.15  2017  Kd=0.175uM    // 5kly.pdf (9ZD)
5h1v  2.00  2017  Kd=0.1mM      // 5h1t.pdf (7FU) ligand is compound 6
6ayi  2.09  2017  Kd=0.21uM     // 6ayh.pdf (C3G) EcGusR/PNPG
5wyx  2.40  2017  Kd=0.22uM     // 5wyx.pdf (CU8) [Nonstandard assay: PH=5.5] CU-CPT8m
5mxf  1.90  2017  Kd=0.26mM     // 5mxf.pdf (MFU) +/-0.6, n=4 Me-alpha-L-Fuc
5g1a  1.42  2017  Kd=0.27uM     // 5g17.pdf (7H1) [Nonstandard assay: Temp 30, PH=8] PFSAHA bound to HDAHbo
5g17  1.51  2017  Kd=0.2uM      // 5g17.pdf (6DK) [Nonstandard assay: Temp 30, PH=8] HDAHbo T101A - SATFMK.
5h1u  1.90  2017  Kd=0.31mM     // 5h1t.pdf (6KT) ligand is compound 2
5xg5  1.54  2017  Kd=0.33mM     // 5xg5.pdf (A2G) N-acetyl-D-galactosamine
5mes  2.24  2017  Kd=0.34uM     // 5ku9.pdf (7LT) ligand is compound 29
5vb5  2.23  2017  Kd=0.35uM     // 5vb5.pdf (92A) Kd=0.35+/-0.22uM, ligand is compound 2
5jop  1.75  2017  Kd=0.39nM     // 5jop.pdf (4-mer) ligand is tetrasaccharide, TS14 glycan; ITC Kd=51nM
5v79  2.25  2017  Kd=0.39uM     // 5u0v.pdf (8Y4) Kd=2.05+/-0.02uM, ligand is compound 62
5llc  1.10  2017  Kd=0.3nM      // 5llc.pdf (V26) ligand is compound 13
5g60  1.99  2017  Kd=0.3uM      // 5g5z.pdf (NYT) complex is FusA/nystose
5lsh  1.06  2017  Kd=0.41mM     // 5lsh.pdf (KTS)
5v7a  2.35  2017  Kd=0.42uM     // 5u0v.pdf (8Y7) Kd=0.42+/-0.04uM, ligand is compound 61
5vb6  2.04  2017  Kd=0.43uM     // 5vb5.pdf (927) Kd=0.43+/-0.18uM, ligand is compound 2
5m04  1.85  2017  Kd=0.46uM     // 5m04.pdf (GDP)
5u4d  1.55  2017  Kd=0.47uM     // 5u48.pdf (XLO) Kd=0.47+/-0.01uM, ligand is compound 7
5llo  1.60  2017  Kd=0.4nM      // 5llc.pdf (5EF) ligand is compound 12
5g61  2.40  2017  Kd=0.4uM      // 5g5z.pdf (FNY) complex is FusA/fructofuranosyl-nystose
5uk8  2.50  2017  Kd=0.4uM      // 5uk8.pdf (8DV) ligand is compound 5
5oku  2.07  2017  Kd=0.55uM     // 5oei.pdf (0L1) +/-0.49; adipate
5wa8  1.30  2017  Kd=0.587uM    // 5kly.pdf (9ZA)
5llp  1.48  2017  Kd=0.58nM     // 5llc.pdf (6Z9) ligand is compound 16
5u0z  2.29  2017  Kd=0.65uM     // 5u0v.pdf (7PM) Kd=0.65+/-0.03uM, ligand is compound 59
5wl0  2.40  2017  Kd=0.67nM     // 5wl0.pdf (21G) PB2LONG-VX787
5nwi  2.35  2017  Kd=0.69uM     // 5nwi.pdf (5-mer) +/-0.05, CPP, -FC
5j20  1.76  2017  Kd=0.72nM     // 5j20.pdf (6FJ) ligand is compound 20
5u49  2.22  2017  Kd=0.73uM     // 5u48.pdf (S2L) Kd=0.73+/-0.02uM, ligand is compound 3
5nkb  1.50  2017  Kd=0.76nM     // 5njz.pdf (8ZT) ligand is compound 4a
5wxh  1.30  2017  Kd=0.7uM      // 5wxg.pdf (7-mer)
5fso  1.67  2017  Kd=0.81uM     // 5fsi.pdf (S76) ligand is compound 7
5u0y  1.88  2017  Kd=0.83uM     // 5u0v.pdf (7PJ) Kd=0.83+/-0.01uM, ligand is compound 58
5n0f  1.69  2017  Kd=0.90uM     // 5m77.pdf (7K2) +/-0.03, ManSIFG 2
5mmg  1.23  2017  Kd=0.970uM    // 5eic.pdf (UT0) ligand is compound 10
5tbe  2.44  2017  Kd=1.06nM     // 5tbe.pdf (78L) ligand is compound 3, Kd=(1.06+-4.40)nM
5ttw  1.74  2017  Kd=1.1uM      // 5ttw.pdf (5-mer) [Nonstandard assay: PH=8] Kd=1.1+/-0.27uM, ligand is compound 3
6eqp  2.35  2017  Kd=1.1uM      // 6ep4.pdf (BUW) ethropropazine/hBChE; +/-0.1
6eux  2.05  2017  Kd=1.2uM      // 6euv.pdf (BYB) B/Memphis PB2 cap-midlink/VX-787N; +/-0.2
5ngz  2.40  2017  Kd=1.3mM      // 5ngz.pdf (2BG)
5mme  1.35  2017  Kd=1.4uM      // 5eic.pdf (8Q6) ligand is compound 9
5k0m  1.83  2017  Kd=1.5nM      // 5k0m.pdf (6PU) Kd = 1.5 +/- 0.1 nM. ligand is A395(5)
5oei  1.78  2017  Kd=1.60uM     // 5oei.pdf (OOG) +/-0.67; 2-oxoadipate
5n31  1.37  2017  Kd=1.61uM     // 5mnr.pdf (8LB) [Nonstandard assay: buffer is Cacodylate] +/-0.22, compd 5
5mo8  1.82  2017  Kd=1.64uM     // 5ct0.pdf (C98) [Nonstandard assay: PH=8] ligand is compound 21
5ota  2.10  2017  Kd=1.8uM      // 5org.pdf (AQQ) +/-0.3, octopinic acid
5u4b  1.45  2017  Kd=1.8uM      // 5u48.pdf (XOS) Kd=1.8+/-0.1uM, ligand is compound 5
5gj9  2.10  2017  Kd=10.2uM     // 5gj9.pdf (VGL) Kd=10.2+/-0.5uM, ligand is POA
5j82  2.17  2017  Kd=1000nM     // 5j20.pdf (6GV) Kd = 1000 +/- 40 nM, ligand is compound 8
5mgk  2.30  2017  Kd=100uM      // 5mge.pdf (7MW) ligand is compound 2
5x54  2.30  2017  Kd=10uM       // 5x54.pdf (5-mer) EWWW
5vcw  2.25  2017  Kd=1105nM     // 5v5y.pdf (93J) Kd=1105+/-82.9nM, ligand is Pelitinib
5m5d  1.07  2017  Kd=111uM      // 5lyr.pdf (2-mer) +/-11, ligand is compound 7
5n84  2.30  2017  Kd=11nM       // 5n7v.pdf (8Q5) Mps-BAY2b
5ta2  1.48  2017  Kd=11nM       // 5t9u.pdf (78X) ligand is compound 7
5ioz  2.02  2017  Kd=11uM       // 5ioy.pdf (6C4) amide 4 bound to subpocket II of EthR.
6b7b  1.98  2017  Kd=1280uM     // 6b7a.pdf (CWJ) CoaD in complex with compound 2; +/-402
5orv  1.88  2017  Kd=1297uM     // 5orl.pdf (A65) ligand is compound 8
5f63  1.45  2017  Kd=12nM       // 5f5z.pdf (5W2) ligand is compound 5
5ldm  2.46  2017  Kd=139uM      // 5ldk.pdf (2AM) LigT/2'-AMP
5j6l  1.75  2017  Kd=13nM       // 5j20.pdf (6GC) ligand is compound 16
5ipc  1.30  2017  Kd=13uM       // 5ipc.pdf (6CE) complex (ES1) of H112N-3
5jsg  2.50  2017  Kd=14.2uM     // 5jsg.pdf (6P9) Spindlin1 bound to compound EML405(2)
5j64  1.38  2017  Kd=140nM      // 5j20.pdf (6G7) Kd = 140 +/- 17 nM, ligand is compound 1
5wuk  2.03  2017  Kd=14nM       // 5wuk.pdf (73K) EED226; +/-8
5vcv  1.92  2017  Kd=150nM      // 5v5y.pdf (1N1) Kd=150+/-9.1nM, ligand is Dasatinib
5nk6  1.27  2017  Kd=158nM      // 5njz.pdf (90W) ligand is compound 2d
5j8m  1.90  2017  Kd=160nM      // 5j20.pdf (6DL) ligand is compound 6
5os4  1.88  2017  Kd=1665uM     // 5orl.pdf (A8H) ligand is compound 17
5njz  1.77  2017  Kd=16nM       // 5njz.pdf (8ZH) ligand is compound 1g
5j3l  1.66  2017  Kd=16uM       // 5ioy.pdf (6FR) ligand is compound 5
5jzi  2.50  2017  Kd=16uM       // 5jzi.pdf (10-mer) HCV1406-NS3/A2 complex
5nvw  2.20  2017  Kd=170nM      // 5nvv.pdf (9BW) +/-30, ligand is compound 6
5j6n  1.90  2017  Kd=17nM       // 5j20.pdf (6FF) ligand is compound 14
5j9x  1.80  2017  Kd=17nM       // 5j20.pdf (6GC) Kd = 17 +/- 1.8 nM, ligand is compound 16
5j6a  2.05  2017  Kd=17nM       // 5j6a.pdf (P46) PDK2 + 17
5mg2  1.75  2017  Kd=17nM       // 5mg2.pdf (7M8) compound 5/ TAF1 BD2
5iyy  1.60  2017  Kd=17uM       // 5ijr.pdf (R40) Kd = 17 +/- 1 uM, ligand is R7
5gmn  1.80  2017  Kd=18.8uM     // 5gmm.pdf (949) protein is CA II, ligand is Polmacoxib
5j27  1.70  2017  Kd=180nM      // 5j20.pdf (6FF) Kd = 180 +/- 61 nM, ligand is compound 14
5os2  1.92  2017  Kd=1821uM     // 5orl.pdf (A7K) compound 15
5nk2  1.65  2017  Kd=182nM      // 5njz.pdf (8ZZ) compound 2b
5j2x  1.22  2017  Kd=18nM       // 5j20.pdf (6DL) Kd = 18 +/- 4.2 nM, ligand is compound 6
5otc  2.20  2017  Kd=19.3uM     // 5org.pdf (AQK) +/-1.37,noroctipinic acid
5kma  1.55  2017  Kd=19.6uM     // 5kly.pdf (777)
5o58  1.55  2017  Kd=191nM      // 5o1u.pdf (2-mer) +/-36, 5'-pApG, 2-mer RNA
5nki  1.68  2017  Kd=19nM       // 5njz.pdf (8ZW) ligand is compound 4b
5nkc  1.45  2017  Kd=19nM       // 5njz.pdf (90T) ligand is compound 2h
5nk4  1.45  2017  Kd=2.0nM      // 5njz.pdf (90E) ligand is compound 2c
5mro  1.80  2017  Kd=2.0uM      // 5mrm.pdf (Q9P) +/-0.1, compound 1
5ouh  2.50  2017  Kd=2.14uM     // 5oug.pdf (L0B) +/-1.06, alpha-lobeline
5n18  1.45  2017  Kd=2.1uM      // 5n16.pdf (8HZ) +/-0.2, compound 1
5o2d  1.60  2017  Kd=2.1uM      // 5o2d.pdf (9HH) MnK2-13
5n93  2.10  2017  Kd=2.2nM      // 5n7v.pdf (8QE) TC-Mps1-12
5g5z  2.01  2017  Kd=2.2uM      // 5g5z.pdf (DQR) complex is FusA/kestose
5x74  2.25  2017  Kd=2.3nM      // 5x72.pdf (JAY) complex with 2c; +/-0.8
5lvd  1.25  2017  Kd=2.4mM      // 5lvd.pdf (79F) TLN-5
5nbw  2.40  2017  Kd=2.6nM      // 5nbw.pdf (8SK) Benzo[a]pyrene
5n9r  2.23  2017  Kd=2.6uM      // 5n9r.pdf (8RN) +/-0.1, compound 2
5j6m  1.64  2017  Kd=2.7nM      // 5j20.pdf (6FJ) ligand is compound 20
5gja  2.10  2017  Kd=2.8uM      // 5gja.pdf (6PC) Kd=2.8+/-0.2uM, ligand is 2-PA
5nvv  2.10  2017  Kd=200nM      // 5nvv.pdf (9BT) +/-30, compound 3
5h85  1.70  2017  Kd=20uM       // 5eic.pdf (5XS) ligand is compound 20
5wbm  2.16  2017  Kd=20uM       // 5wbm.pdf (A4G) ligand is compound 3
5nkg  1.10  2017  Kd=21nM       // 5njz.pdf (8ZK) ligand is compound 3d
5wyz  2.30  2017  Kd=21nM       // 5wyx.pdf (7VF) [Nonstandard assay: PH=5.5] CU-CPT9b
5yjm  1.90  2017  Kd=21nM       // 5yjm.pdf (8W3) human chymase/O-phenylamidoxime 5f
5kab  1.97  2017  Kd=21uM       // 5k9w.pdf (OTA) PTP1B delta7 P185G:TCS401
5m17  1.03  2017  Kd=221uM      // 5lyr.pdf (2-mer) +/-11, ligand is compound 5
5nk8  1.76  2017  Kd=229nM      // 5njz.pdf (90Z) ligand is compound 2f
5tcy  1.90  2017  Kd=22nM       // 5a5d.pdf (5LC) ligand is H227L-5-Lic
5j1r  1.92  2017  Kd=22uM       // 5ioy.pdf (6FG) ligand is compound 8
6ezq  2.39  2017  Kd=22uM       // 6ezq.pdf (C7K) ligand is compound 3f; +/- 3
5n34  1.22  2017  Kd=23.27uM    // 5mnr.pdf (8JQ) [Nonstandard assay: buffer is Cacodylate] +/-1.74, compound 3
5jq5  1.94  2017  Kd=2341nM     // 5jq5.pdf (I74) CDK2/ICEC0942
5jhk  1.80  2017  Kd=23uM       // 5ijr.pdf (6K8) Kd = 23 +/- 1 uM, ligand is R8
5ulp  1.55  2017  Kd=24.3uM     // 5ulp.pdf (KB1) ligand is MS2042
5m77  1.46  2017  Kd=24.7nM     // 5m77.pdf (2-mer) +/-7.9, (ManS)2IFG 3
5lud  1.25  2017  Kd=248uM      // 5lud.pdf (76X)
5ta4  1.50  2017  Kd=24nM       // 5t9u.pdf (838) ligand is compound 8
5jgq  1.60  2017  Kd=24uM       // 5ijr.pdf (6JY) Kd = 24 +/- 0 uM, ligand is R6
5nw1  2.10  2017  Kd=250nM      // 5nvv.pdf (9BH) +/-50, ligand is compound 18
5t9u  2.30  2017  Kd=25nM       // 5t9u.pdf (7HG) ligand is compound 3
5u0g  1.54  2017  Kd=26.2uM     // 5txy.pdf (7QY) ligand is compound 17
5t9w  2.00  2017  Kd=2600nM     // 5t9u.pdf (78E) ligand is compound 5
5nkh  1.29  2017  Kd=26nM       // 5njz.pdf (8ZQ) compound 3e
5nkd  1.41  2017  Kd=26nM       // 5njz.pdf (91K) compound 2i
5k9w  2.01  2017  Kd=26uM       // 5k9w.pdf (OTA) PTP1B:TCS401
5ovr  2.15  2017  Kd=27.2uM     // 5ovr.pdf (AXK) +/-0.6, compound 2
5vcy  1.56  2017  Kd=270nM      // 5v5y.pdf (DB8) Kd=270+/-17.2nM, ligand is Bosutinib
5ko5  1.36  2017  Kd=27uM       // 5ko5.pdf (CYT) Kd = 27 +/- 3 uM. ligand is cytosine
5u0d  1.59  2017  Kd=28.6uM     // 5txy.pdf (7R7) ligand is compound 14
5tpx  2.10  2017  Kd=280nM      // 5tpx.pdf (7H7) ligand is L-45
5vd3  1.80  2017  Kd=2817nM     // 5v5y.pdf (H8H) Kd=2817+/-144.4nM, ligand is Saracatinib
5mrp  1.90  2017  Kd=3.0uM      // 5mrm.pdf (6BC) +/-0.3, compound 2
5nn6  2.00  2017  Kd=3.0uM      // 5nn4.pdf (MIG) NHE-DNJ
5mn1  0.79  2017  Kd=3.3mM      // 5mn1.pdf (2AP) +/-1.0
5mnr  1.25  2017  Kd=3.44uM     // 5mnr.pdf (JC2) [Nonstandard assay: buffer is Cacodylate] +/-1.26, compound 7
5u0f  1.21  2017  Kd=3.4uM      // 5txy.pdf (7R1) ligand is compound 25
5nka  1.38  2017  Kd=3.5uM      // 5njz.pdf (91H) ligand is compound 2g
5txy  1.21  2017  Kd=3.5uM      // 5txy.pdf (7Q1) ligand is compound 10
5u13  1.95  2017  Kd=3.9uM      // 5u0v.pdf (YH5) Kd=3.9+/-0.2uM, ligand is compound 36
5nw0  2.30  2017  Kd=300nM      // 5nvv.pdf (9BK) +/-40, compound 17
5mod  2.08  2017  Kd=300uM      // 5ct0.pdf (86L) [Nonstandard assay: PH=8] ligand is compound 3
5ovx  2.10  2017  Kd=31.4uM     // 5ovr.pdf (AY5) [Nonstandard assay: Temp 30] +/-0.8, compound 3
5tya  1.50  2017  Kd=32.9uM     // 5txy.pdf (7QS) ligand is compound 13
5nw2  2.20  2017  Kd=320nM      // 5nvv.pdf (9B8) +/-20, compound 19
5vd0  2.13  2017  Kd=324nM      // 5v5y.pdf (8X7) Kd=324+/-27.3nM, ligand is MK1775
5isz  2.06  2017  Kd=32uM       // 5isz.pdf (9-mer) ligand is peptide LS01
6b7a  1.99  2017  Kd=32uM       // 6b7a.pdf (CWM) CoaD in complex with compound 1; +/-4
5ma7  1.30  2017  Kd=336uM      // 5lvd.pdf (7K0) TLN-6
5ka1  1.84  2017  Kd=33uM       // 5k9w.pdf (OTA) PTP1B delta 7:TCS401
5j8u  1.75  2017  Kd=340nM      // 5j20.pdf (6DL) ligand is compound 1
5f61  1.45  2017  Kd=35nM       // 5f5z.pdf (5W0) ligand is compound 3
5h5f  1.70  2017  Kd=37.2uM     // 5h5d.pdf (SAM) Kd=37.2+/-3.59uM, Sfm1-SAM
5x62  2.20  2017  Kd=379nM      // 5x62.pdf (SAH) SAH-bound YNL092W
5kad  1.90  2017  Kd=37uM       // 5k9w.pdf (OTA) PTP1B N193A :TCS401
5nk3  1.59  2017  Kd=38nM       // 5njz.pdf (92Q) ligand is compound 1l
5ne5  1.05  2017  Kd=39nM       // 5ne5.pdf (KIF) Kifunensine (compound 1)
5ka9  2.07  2017  Kd=39uM       // 5k9w.pdf (OTA) PTP1B L192A:TCS401
5vi6  1.24  2017  Kd=3nM        // 5vi6.pdf (4-mer) Kd=3+/-1nM, ligand is Trapoxin A
5j1x  2.10  2017  Kd=3uM        // 5ijr.pdf (AR5) Kd = 3 +/- 1 uM, ligand is R5
5mek  1.74  2017  Kd=4.2uM      // 5mek.pdf (A3P) +/-2.6, PAP
5fsc  1.95  2017  Kd=4.4mM      // 5fsb.pdf (G8Z) Kd = 4.4 +/- 1.5 mM, ligand is All4MeMan
5u11  1.99  2017  Kd=4.5uM      // 5u0v.pdf (7PS) Kd=4.5+/-0.1uM, ligand is compound 41
5u14  1.95  2017  Kd=4.6uM      // 5u0v.pdf (7PV) Kd=4.6+/-0.1uM, ligand is compound 60
5wp5  1.50  2017  Kd=4.6uM      // 5wp4.pdf (SAH) AtPMT2/SAH
5n17  1.60  2017  Kd=4.8uM      // 5n16.pdf (8FK) +/-1.0, compound 1
5mz8  2.20  2017  Kd=4.9mM      // 5mz8.pdf (SIN) +/-0.7, succinate, by MST
5n2z  1.37  2017  Kd=4.9uM      // 5mnr.pdf (8JH) [Nonstandard assay: buffer is Cacodylate] +/-0.32, compound 1
5tuz  1.95  2017  Kd=40nM       // 5tuy.pdf (7L6) [Nonstandard assay: PH=8] Kd=40+/-5nM, ligand is compound 4.
5os5  1.74  2017  Kd=410uM      // 5orl.pdf (A8K) compound 18
5ufp  1.90  2017  Kd=42.5nM     // 5t0t.pdf (86D) ligand is PT2399
5lny  1.88  2017  Kd=42nM       // 5lny.pdf (70K) Kd = 42 +/- 5.7 nM. ligand is compound 3b
5tcj  2.40  2017  Kd=42nM       // 5tcf.pdf (79V) ligand is BRD4592
5vc4  2.10  2017  Kd=43.7nM     // 5v5y.pdf (XZN) [Nonstandard assay: Temp 15] Kd=43.7+/-10nM, ligand is Bos.isomer
5f60  1.35  2017  Kd=43nM       // 5f5z.pdf (5VZ) ligand is compound 2
5vcz  1.50  2017  Kd=444nM      // 5v5y.pdf (XZN) Kd=444+/-41.0nM, ligand is Bos. isomer
5n3v  1.12  2017  Kd=45.24uM    // 5mnr.pdf (8L5) [Nonstandard assay: buffer is Cacodylate] +/-3.41, compound 4
5ka7  2.06  2017  Kd=45uM       // 5k9w.pdf (OTA) PTP1B T178A:TCS401
5nk7  1.89  2017  Kd=468nM      // 5njz.pdf (8ZZ) compound 2a
5mrb  2.20  2017  Kd=471nM      // 5mrb.pdf (C5N) +/-50, compound 5/Mps1 C604Y
5m28  1.08  2017  Kd=48uM       // 5m28.pdf (MLR) +/-1.9, maltotriose
5jsj  2.35  2017  Kd=4uM        // 5jsg.pdf (6PD) Spindlin1 bound to compound EML631(6)
5lsg  2.00  2017  Kd=4uM        // 5lsg.pdf (QZQ) PPAR gamma /BA
5mqe  1.65  2017  Kd=4uM        // 5mpz.pdf (PKU) ligand is compound 1
5g5f  2.30  2017  Kd=5.2uM      // 5g5f.pdf (GSH) GSH-MiGSTU
5ltn  1.88  2017  Kd=5.38uM     // 5ltn.pdf (XI7) [Nonstandard assay: with ions] Kd = 5.38 +/- 2.06 uM. ligand is DPBA
5irr  2.04  2017  Kd=5.4uM      // 5irr.pdf (GSP)
5twj  2.30  2017  Kd=5.58uM     // 5twj.pdf (SAM) Kd=5.58+/-0.31uM, ligand is SAM
5j86  1.87  2017  Kd=5.5nM      // 5j20.pdf (6GW) Kd = 5.5 +/- 3.2 nM, ligand is compound 18
5b5f  1.20  2017  Kd=5.6uM      // 5b5f.pdf (6F3) ligand is compound ALiS3
5b5g  1.50  2017  Kd=5.6uM      // 5b5f.pdf (6FX) ligand is compound ALiS4
5m9w  1.21  2017  Kd=5.7mM      // 5lvd.pdf (7GR) TLN-1
5w1e  2.06  2017  Kd=5.8uM      // 5w1e.pdf (PHB) +/-0.5uM
5jgi  1.38  2017  Kd=50uM       // 5ijr.pdf (AAG) Kd = 50 +/- 3 uM, ligand is R4
5mgj  2.10  2017  Kd=51uM       // 5mge.pdf (7MX) ligand is compound 1
5mgf  1.90  2017  Kd=54uM       // 5mge.pdf (7MW) ligand is compound 2
5km9  1.45  2017  Kd=55.9uM     // 5kly.pdf (ADN) complex with hHint2
5uff  2.14  2017  Kd=57.1uM     // 5ufc.pdf (8B7) ligand is 2'-Fucosyllactose
5ut6  1.65  2017  Kd=57.3uM     // 5ut4.pdf (8MY) Kd=57.3+/-2.8uM, ligand is compound 8
5u0w  1.97  2017  Kd=58uM       // 5u0v.pdf (9MG) Kd=58+/-8uM, ligand is compound 7
5ty9  1.53  2017  Kd=6.1uM      // 5txy.pdf (7QV) ligand is compound 11
5f62  1.35  2017  Kd=6.8nM      // 5f5z.pdf (5W1) ligand is compound 4
5ufc  1.89  2017  Kd=6.9uM      // 5ufc.pdf (3-mer) ligand is H-trisaccharide
5n99  1.50  2017  Kd=61.3uM     // 5n7x.pdf (5-mer) [Nonstandard assay: pH=5.0] NQpWQ
5wbo  2.25  2017  Kd=62uM       // 5wbm.pdf (A1Y) ligand is compound 4
5ot8  2.35  2017  Kd=63.8uM     // 5org.pdf (6DB) +/-13.8, octopine
5ijr  1.52  2017  Kd=637uM      // 5ijr.pdf (HRG) Kd = 637 +/- 70 uM, ligand is R9
5t9z  1.40  2017  Kd=64nM       // 5t9u.pdf (78R) ligand is compound 6
5vgy  1.39  2017  Kd=65.5uM     // 5txy.pdf (9AA) ligand is compound 27'
5u28  1.80  2017  Kd=67nM       // 5u28.pdf (82V) Kd=67+/-7nM, ligand is SF2523
5ldp  1.80  2017  Kd=67uM       // 5ldk.pdf (ATP) LigT/ATP
5ose  1.90  2017  Kd=681uM      // 5orl.pdf (A98) compound 21
5fyx  1.80  2017  Kd=69.6uM     // 5aan.pdf (FD6) dNCS-1 bound to penothiazine FD16
5ja0  1.90  2017  Kd=6uM        // 5ja0.pdf (FPP) ligand is FPP, titrated in presence of Mg2+
5u0e  1.27  2017  Kd=7.7uM      // 5txy.pdf (7R4) ligand is compound 24
5kej  2.35  2017  Kd=7.8uM      // 5g5f.pdf (GTX) GSX-MiGSTU
5aan  1.60  2017  Kd=71uM       // 5aan.pdf (XOC) dNCS-1 bound to penothiazine FD44
5nk9  1.59  2017  Kd=724nM      // 5njz.pdf (912) compound 2e
5my8  1.70  2017  Kd=72nM       // 5mxx.pdf (RXZ) +/-5, SPHINX31
5vc3  1.97  2017  Kd=77.5nM     // 5v5y.pdf (DB8) [Nonstandard assay: Temp 15] Kd=77.5+/-6.0nM, ligand is Bosutinib
5vd2  2.05  2017  Kd=78.7nM     // 5v5y.pdf (34W) [Nonstandard assay: Temp 15] Kd=78.7+/-8.3nM, ligand is PF-03814735
5orw  2.00  2017  Kd=796uM      // 5orl.pdf (A6E) compound 9
5t7s  1.90  2017  Kd=79uM       // 5t7s.pdf (LBT) ligand is lactose
5n2t  1.38  2017  Kd=8.40uM     // 5mnr.pdf (8KK) [Nonstandard assay: buffer is Cacodylate] +/-0.35, compound 2
5u12  1.84  2017  Kd=8.5uM      // 5u0v.pdf (5RU) Kd=8.5+/-2.1uM, ligand is compound 13
5gsa  2.49  2017  Kd=82nM       // 5gsa.pdf (73K) EED226 compound bound EED
5ot9  2.45  2017  Kd=84.4uM     // 5org.pdf (AOZ) +/-6.7, histopine
5mpz  1.40  2017  Kd=85uM       // 5mpz.pdf (4I8) compound 3
5f5z  1.76  2017  Kd=86nM       // 5f5z.pdf (5VY) ligand is compound 1
5jhb  2.48  2017  Kd=873nM      // 5jha.pdf (6K5) p110 gamma PIKiN3
5uxf  1.50  2017  Kd=87nM       // 5uxf.pdf (2BA) ligand is c-di-AMP
5mge  1.95  2017  Kd=87uM       // 5mge.pdf (7MX) ligand is compound 1
5lyn  2.00  2017  Kd=9.04uM     // 5lyn.pdf (7-mer) +/-0.05, PTVEEVD
5n3y  1.34  2017  Kd=9.32uM     // 5mnr.pdf (8L2) [Nonstandard assay: buffer is Cacodylate] +/-0.28, compound 8
5mrm  1.80  2017  Kd=9.3uM      // 5mrm.pdf (Q9T) +/-0.6, compound 4
5gof  1.60  2017  Kd=90.1uM     // 5goe.pdf (GTP) GTP-bound MFN1IMC(T109A)
5nvx  2.20  2017  Kd=90nM       // 5nvv.pdf (4YY) +/-10, compound 10
5vsf  1.70  2017  Kd=94nM       // 5vsc.pdf (9HG) GLP-SAM-17; +/- 14
5vd1  1.70  2017  Kd=990nM      // 5v5y.pdf (P48) Kd=990+/-55.2nM, ligand is PHA-848125
5wal  2.45  2017  Ki=0.0017uM   // 5wal.pdf (9ZS) ligand is compound 6-TYK2
5vo1  2.45  2017  Ki=0.007uM    // 5vo1.pdf (9FS) 10 bound to the DLK kinase domain
5ult  1.53  2017  Ki=0.014nM    // 5ult.pdf (8FM) ligand is compound 25
5wlo  1.27  2017  Ki=0.015nM    // 5wlo.pdf (GR7) ligand is inhibitor 5j
5uov  1.33  2017  Ki=0.025nM    // 5uov.pdf (8FP) ligand is compound 4b
5oot  2.10  2017  Ki=0.0285uM   // 5oop.pdf (4K4) ligand is compound 2
5nee  1.70  2017  Ki=0.02nM     // 5nea.pdf (8V5) ligand is compound 8
5nea  1.30  2017  Ki=0.05nM     // 5nea.pdf (8V8) ligand is compound 7
5we9  1.80  2017  Ki=0.06uM     // 5w3i.pdf (GY7) 7b (SRI-29731); +/-0.01
5v82  1.89  2017  Ki=0.07nM     // 5v82.pdf (96Y) ligand is compound 19
5hz5  1.40  2017  Ki=0.086uM    // 5hz5.pdf (65X) human FABP5 with compound 12
5op4  2.00  2017  Ki=0.194uM    // 5oop.pdf (A0T) ligand is compound 4a
5vb7  2.34  2017  Ki=0.19uM     // 5vb5.pdf (921) ligand is compound 3
5op5  1.90  2017  Ki=0.216uM    // 5oop.pdf (3FE) ligand is compound 5
6b97  1.76  2017  Ki=0.237uM    // 6b96.pdf (CZY) ligand is compound 9
5mby  1.55  2017  Ki=0.31mM     // 5mby.pdf (PRO) Ki=0.31+/-0.04 mM
5t8o  2.41  2017  Ki=0.31uM     // 5t8f.pdf (76Z) Ki=0.31+/-0.11uM, ligand is compound 3
6b4l  2.25  2017  Ki=0.34uM     // 5vkc.pdf (CJY) ligand is compound 5
5upz  1.27  2017  Ki=0.63nM     // 5uov.pdf (8HD) ligand is compound 3b
5m7s  2.40  2017  Ki=0.9nM      // 5m7s.pdf (NHT) Thiamet-G
5vp9  1.86  2017  Ki=1.03nM     // 5voj.pdf (9H7) 18f/WT NS3 4A; +/- 0.13
5wqc  1.96  2017  Ki=1.1nM      // 5wqc.pdf (7MA) OX2R-EMPA (cryocooled crystal structur/Synchrotron)
5m23  1.97  2017  Ki=1.25nM     // 5m23.pdf (7DC) +/-0.36, peptidomimetic 7 trans
5t8p  2.32  2017  Ki=1.28uM     // 5t8f.pdf (774) Ki=1.28+/-0.3uM, ligand is compound 2
5ljt  1.00  2017  Ki=1.2nM      // 5ljq.pdf (A6N) hCAII/compound13
5n24  1.50  2017  Ki=1.2nM      // 5n24.pdf (8HE) ligand is compound 1
5oq8  2.00  2017  Ki=1.41uM     // 5oop.pdf (A0Q) ligand is compound 3b
5mlj  1.80  2017  Ki=1.4nM      // 5mkx.pdf (9ST) complex is GCN5 / (R,R)-32
5uoo  1.69  2017  Ki=1.4nM      // 5uoo.pdf (8FV) Ki=1.4+/-0.4nM,  ligand is compound 31
5ndf  2.30  2017  Ki=1.4uM      // 5ndf.pdf (LU2) +/-0.05 Luteolin
5vkc  2.31  2017  Ki=1.8nM      // 5vkc.pdf (9EA) ligand is compound 33
5n1s  1.30  2017  Ki=10.2nM     // 5n1s.pdf (8GE) lgiand is compound 4
5g2b  1.83  2017  Ki=100nM      // 5g2b.pdf (LQY) pKi = 7, ligand is compound NPD-008(8)
5wcm  1.20  2017  Ki=100uM      // 3m8t.pdf (4NZ)
5n1r  1.30  2017  Ki=11.1nM     // 5n1r.pdf (8GH) lgiand is compound 2
6en5  1.75  2017  Ki=11.45nM    // 6en5.pdf (BJ2) N-domain of ACE bound to 16; Ki=11.45+/-1.37nM
5l8a  1.57  2017  Ki=12.3uM     // 5l87.pdf (6RB) PEX14-3
5nih  1.30  2017  Ki=134nM      // 5neb.pdf (8VE) +/-43, LM-12b
5uln  1.35  2017  Ki=14.2nM     // 5uln.pdf (8JS) ligand is compound 22(S)
6b96  1.88  2017  Ki=14.3nM     // 6b96.pdf (CZV) ligand is compound 16
5th4  1.47  2017  Ki=1420uM     // 5th4.pdf (BEW) Ki=1420+/-30uM, ligand is 1,2-HOPTO.
5k1f  1.94  2017  Ki=16.2uM     // 5k1d.pdf (IMP) ligand is IMP
5n25  1.40  2017  Ki=16.6nM     // 5n25.pdf (8HK) ligand is compound 3
5ueu  2.26  2017  Ki=16.7nM     // 5ueu.pdf (0S6) ligand is compound 2a
5uf0  1.35  2017  Ki=160uM      // 5ueu.pdf (89J) ligand is fragment 1
5neb  2.05  2017  Ki=17nM       // 5neb.pdf (8VE) +/-5, LM-12b
5mkr  1.87  2017  Ki=17uM       // 5mkr.pdf (TI8) ligand is compound 8
5mks  1.99  2017  Ki=17uM       // 5mkr.pdf (TI8) ligand is compound 8
5tt3  2.20  2017  Ki=193nM      // 5tt3.pdf (EZL) ligand is EZA
5ljq  1.05  2017  Ki=1nM        // 5ljq.pdf (ANV) hCAII/compound3
5upf  1.69  2017  Ki=2.5nM      // 5upe.pdf (8HV) ligand is compound 53
5mjn  1.17  2017  Ki=2.9nM      // 5mjn.pdf (7O8) ligand is compound 17
5k1d  1.94  2017  Ki=20.8uM     // 5k1d.pdf (5GP) ligand is GMP
5o4f  2.10  2017  Ki=208nM      // 5neb.pdf (8VE) +/-55, LM-12b
6b4u  1.95  2017  Ki=21nM       // 5vkc.pdf (CN7) ligand is compound 14; Ki=21+/-7.9nM
6b98  1.97  2017  Ki=22.4uM     // 6b96.pdf (D07) ligand is compound 1
5u6j  2.30  2017  Ki=23nM       // 5u6j.pdf (82J) ligand is compound 14
5vij  2.11  2017  Ki=24.3nM     // 5dex.pdf (5DX) ligand is ST1
6b4n  1.30  2017  Ki=27.9pM     // 6b4n.pdf (G53) inhibitor 3g (GRL-5311) with wild-type HIV-1 protease
5u8c  1.60  2017  Ki=29.58nM    // 5u8c.pdf (84J) Ki=29.58+/-0.24nM; ligand is NVP-AAM077
5ufs  2.12  2017  Ki=3.2nM      // 5ufs.pdf (1TA) ligand is TA
5n0d  1.70  2017  Ki=3.3nM      // 5n0d.pdf (8F2) ligand is compound 30a
5nn5  2.00  2017  Ki=3.4uM      // 5nn4.pdf (NOJ) DNJ
5tp0  1.25  2017  Ki=3.66uM     // 5tp0.pdf (BRN) Ki=3.66+/-0.08uM; ligand is diminazene
5n0e  1.75  2017  Ki=3.6nM      // 5n0d.pdf (8F3) compound 30b
5voj  1.80  2017  Ki=3.6nM      // 5voj.pdf (9H4) 19b/WT NS3 4A; +/- 0.04
5g57  1.73  2017  Ki=3.98nM     // 5g2b.pdf (6M5) pKi = 8.4, ligand is compound NPD-001(1)
5vih  2.40  2017  Ki=32.2nM     // 5dex.pdf (5DZ) ligand is ST6
5tuo  2.50  2017  Ki=323nM      // 5tt3.pdf (1SA) ligand is compound 1
5t19  2.10  2017  Ki=32uM       // 5t19.pdf (73U) ligand is compound 5b
5o07  1.80  2017  Ki=33.8nM     // 5o07.pdf (1VQ) ligand is compound 3
5dpx  1.85  2017  Ki=35uM       // 5dpx.pdf (L3B)
5uv2  2.20  2017  Ki=39.5uM     // 5uv1.pdf (LA6) Ki=39.5+/-5.2uM; ligand is FNPP
6ep4  2.30  2017  Ki=4.5uM      // 6ep4.pdf (DME) decamethonium/hBChE; +/-0.2uM
5g1z  1.50  2017  Ki=4.74uM     // 5g1z.pdf (U53) quinoline 1 in a ternary complex with P. vivax NMT and S-(2- oxo)pentadecylCoA (NHM)
6equ  1.65  2017  Ki=419nM      // 6equ.pdf (BVE) hCA II/2
5m25  2.43  2017  Ki=6.50nM     // 5m23.pdf (7DU) +/-0.36, peptidomimetic 7 cis
5tfx  1.50  2017  Ki=60.9nM     // 5tfx.pdf (7B1) ligand is compound 13
5ti0  1.42  2017  Ki=61uM       // 5th4.pdf (7CZ) Ki=61+/-5uM, ligand is Thiotropolone.
5wex  1.26  2017  Ki=66.3nM     // 5uln.pdf (8JS) ligand is compound 10(Se)
5v0n  2.16  2017  Ki=67.1nM     // 5v0n.pdf (8W4) ligand is compound 5g
5ula  1.50  2017  Ki=77nM       // 5ula.pdf (5MJ) ligand is MS402
5n6s  2.10  2017  Ki=8.2nM      // 5n6s.pdf (8P5) ligand is compound 5
5m7u  2.30  2017  Ki=8nM        // 5m7s.pdf (XHA) ligand is VV347
5vsj  2.46  2017  Ki=95uM       // 5vsj.pdf (9HV) ligand is compound 6; +/-16
5uez  1.51  2017  Ki=970nM      // 5ueu.pdf (89G) Ki=970+/-200nM; ligand is compound 11
5upe  1.93  2017  Ki=9nM        // 5upe.pdf (8HY) ligand is compound 5
6fs0  2.25  2018  Kd=0.00017uM  // 6fs0.pdf (E4W) ligand is compound (Ra)-7
5mpk  1.90  2018  Kd=0.003uM    // 5eic.pdf (0BC) ligand is compound 13
6ma3  2.00  2018  Kd=0.005uM    // 6ma1.pdf (JAJ) ligand is compound 2a; Kd = 0.005 +/- 0.001uM
6ma5  2.00  2018  Kd=0.008uM    // 6ma1.pdf (J9V) ligand is compound 4a; Kd = 0.008 +/- 0.001uM
6d56  1.68  2018  Kd=0.009uM    // 6d55.pdf (FVM) ligand is compound 65; Binding assay: FPA; Kd = 0.009+/-0.0017uM
6eq8  2.19  2018  Kd=0.010uM    // 6epy.pdf (BQZ) Kd = 0.010+/-0.001uM
6cks  1.72  2018  Kd=0.015uM    // 6ckr.pdf (F5Y) ligand is compound 35
5nlk  1.80  2018  Kd=0.035uM    // 5nlk.pdf (92E) ligand is compound 16
6eol  1.50  2018  Kd=0.037uM    // 6eog.pdf (BKH) ligand is compound 2h; Kd=0.037+/-0.0010 uM
6fyz  2.15  2018  Kd=0.039uM    // 6fyz.pdf (EBE) ligand is compound 16
6d55  1.68  2018  Kd=0.044uM    // 6d55.pdf (FWA) ligand is compound 64; binding assay: FPA; Kd = 0.044+/-0.0067uM
6ma4  2.00  2018  Kd=0.045uM    // 6ma1.pdf (JA7) ligand is compound 3a; Kd = 0.045 +/- 0.02uM
6fa4  2.02  2018  Kd=0.051uM    // 5ocg.pdf (D1W) ligand is Abd-7
6ckr  1.62  2018  Kd=0.05uM     // 6ckr.pdf (F5V) ligand is compound 32
6epz  1.80  2018  Kd=0.072uM    // 6epy.pdf (MLB) Kd = 0.072+/-0.004uM
6chp  1.94  2018  Kd=0.075nM    // 6chl.pdf (F0Y) ligand is compound 11
6ht1  2.10  2018  Kd=0.077uM    // 6ht0.pdf (GQ5) ligand is compound 92
5mpn  1.23  2018  Kd=0.085uM    // 5eic.pdf (YE5) ligand is compound 19
6as8  2.10  2018  Kd=0.089uM    // 6aox.pdf (BTG) bio-layer interferometry experiment, Kd=0.089+/-0.4uM
6fs1  1.60  2018  Kd=0.098uM    // 6fs0.pdf (E4Q) ligand is compound 4
5yj8  1.76  2018  Kd=0.104mM    // 5yj8.pdf (8W9) ligand is compound 1,Kd=0.104+/-0.002mM
5ymx  1.35  2018  Kd=0.12uM     // 5ymx.pdf (GDP) Kd=0.12+/-0.03uM
6d5h  1.80  2018  Kd=0.12uM     // 6d55.pdf (FV7) ligand is compound 38; binding assay: FPA; Kd = 0.12+/-0.034uM
6d5e  1.75  2018  Kd=0.14uM     // 6d55.pdf (FVG) ligand is compound 47; binding assay: FPA; Kd = 0.14+/-0.009uM
6ghh  1.90  2018  Kd=0.193uM    // 6ge7.pdf (TDA) ligand is C13, Kd = 0.193 +/- 0.031 uM
5ya5  1.89  2018  Kd=0.19uM     // 5ya5.pdf (6TD) ligand is HL-11
6fo5   .95  2018  Kd=0.19uM     // 6fnx.pdf (DZH) ligand is compound 17; Kd = 0.19 +/- 0.07 uM
6msy  2.00  2018  Kd=0.1uM      // 1zls.pdf (4-mer)
6mub  2.50  2018  Kd=0.1uM      // 1zls.pdf (5-mer)
6eq7  1.50  2018  Kd=0.1uM      // 6eq2.pdf (BS8) compound 11
6b1k  1.17  2018  Kd=0.213uM    // 6b1c.pdf (C9G) ligand is 3a,Ki=0.363uM
6fsy  1.34  2018  Kd=0.247uM    // 6fsy.pdf (E5Q) Kd(ITC)=0.247+/-0.08uM
5z7j  1.98  2018  Kd=0.25uM     // 5z7j.pdf (36J) ligand is alpha-ZOL
6d5g  1.92  2018  Kd=0.25uM     // 6d55.pdf (FVD) ligand is compound 43; binding assay: FPA; Kd = 0.25+/-0.057uM
6gfs  2.00  2018  Kd=0.291uM    // 6ge7.pdf (F15) ligand is C15, Kd = 0.291 +/- 0.117 uM
5yyf  1.90  2018  Kd=0.33uM     // 5yyf.pdf (7-mer) ligand is XL-07i
6epy  2.04  2018  Kd=0.347uM    // 6epy.pdf (RAF) Kd = 0.347+/-0.42uM
5uc4  2.05  2018  Kd=0.35uM     // 5uc4.pdf (83S) Kd = 0.35 +/- 0.13 uM. ligand is compound 4
6gf9  2.10  2018  Kd=0.411uM    // 6ge7.pdf (X90) ligand is C17, Kd = 0.411 +/- 0.129 uM
5ucj  1.69  2018  Kd=0.44uM     // 5uc4.pdf (KU3) Kd = 0.44 +/- 0.56 uM. ligand is compound 6b
5xo7  1.88  2018  Kd=0.44uM     // 5xo7.pdf (36J) ligand is alpha-ZOL
6cvf  2.30  2018  Kd=0.45uM     // 6cvf.pdf (CDP) Kd = 0.45+/-0.05uM; ligand is cytidine diphosphate
6d5j  1.75  2018  Kd=0.46uM     // 6d55.pdf (FV4) ligand is compound 29; binding assay: FPA; Kd = 0.46+/-0.078uM
6gvz  1.54  2018  Kd=0.4uM      // 6gvz.pdf (CHO) ligand is GCDCA
5vyy  1.79  2018  Kd=0.62uM     // 5vyy.pdf (9QY) Kd = 0.62 +/- 0.13 uM. ligand is compound 1
6gjn  1.70  2018  Kd=0.6uM      // 6gjn.pdf (F0Q) ligand is compound 15; Kd = 0.6 +/- 0.4 uM
6fmj  2.45  2018  Kd=0.76uM     // 6fmi.pdf (DV5) ligand is compound 3; Kd = 0.76 +/- 0.02 uM (ITC)
6mu3  2.33  2018  Kd=0.7uM      // 1zls.pdf (4-mer) ligand is synthetic oligomannoses 7
6eq3  1.80  2018  Kd=0.7uM      // 6eq2.pdf (BU5) compound 9
6ckw  2.06  2018  Kd=0.83nM     // 6chl.pdf (F6D) ligand is compound 51
6ge7  2.30  2018  Kd=0.867uM    // 6ge7.pdf (EW8) ligand is C19, Kd = 0.867 +/- 0.184 uM
5oht  1.87  2018  Kd=0.96uM     // 5ohs.pdf (9VH) Kd=0.96+/-0.12uM
6cdo  2.10  2018  Kd=1.06nM     // 5tkj.pdf (8-mer) protein is vFP16.02, ligand is Fusion peptide
6epa  1.82  2018  Kd=1.13uM     // 6epa.pdf (BNQ) ligand is compound IGS-1.76; Kd = 1.13 +/- 0.35uM
5ovc  1.55  2018  Kd=1.1uM      // 5ovc.pdf (7-mer) Kd = 1.1 +/- 0.05 uM, ligand is CKAP
5umx  1.59  2018  Kd=1.1uM      // 5umw.pdf (RBF) Kd = 59.5 +/- 8.6 uM, ligand is riboflavin, protein is TnmS3
6ey9  2.00  2018  Kd=1.24uM     // 6ei5.pdf (C4N) ligand is compound 40; Kd = 1.24+/-0.14uM
6fv4  1.97  2018  Kd=1.2mM      // 6fv4.pdf (16G) ligand is GlcNAc6P; Kd = 1.2 +/- 0.05 mM
6gw4  2.30  2018  Kd=1.2uM      // 6gvz.pdf (CHO) ligand is GCDCA
6fmc   .90  2018  Kd=1.32uM     // 6fmc.pdf (DUE) ligand is compound 1; Kd = 1.32 +/- 0.08 uM
6eq2  1.80  2018  Kd=1.3uM      // 6eq2.pdf (BU8) compound 6
6bm5  1.50  2018  Kd=1.43uM     // 6bdy.pdf (SAM) ligand is compound AdoMet; Kd = 1.43+/-0.05uM
6ey8  2.16  2018  Kd=1.55uM     // 6ei5.pdf (C4T) ligand is compound 38; Kd = 1.55+/-0.052uM
6mj7  1.41  2018  Kd=1.5mM      // 6mj7.pdf (ARG)
6ftp  1.80  2018  Kd=1.5uM      // 5om2.pdf (DM2) ligand is doxorubicin, Kd for S-conformation
6ced  1.70  2018  Kd=1.5uM      // 6ce6.pdf (EYA) ligand is compound 31
5vm0  1.79  2018  Kd=1.60nM     // 5vl2.pdf (9EG) [Multiple sites: site 1: Kd = 1.60 nM, site 2: Kd = 1.10 nM.] ligand is TCC
6eog  1.20  2018  Kd=1.60uM     // 6eog.pdf (BKK) ligand is compound 1c; Kd=1.60+/-0.078 uM
6cdp  2.46  2018  Kd=1.64nM     // 5tkj.pdf (8-mer) protein is vFP20.01, ligand is Fusion peptide
6czf  1.95  2018  Kd=1.6uM      // 6czf.pdf (G4P) [Nonstandard assay: Mg2+]
5mwh  1.65  2018  Kd=1.8uM      // 5mwg.pdf (UWX) ligand is compound 21
5om7  1.73  2018  Kd=1.8uM      // 5om2.pdf (DM2) ligand is doxorubicin, Kd for S-conformation
6eyt  2.21  2018  Kd=1.9uM      // 6eyt.pdf (UDP) [Uncommon element] Kd = 1.9 +/- 0.5 uM; the ligand contains a Mn atom
6gnw  1.75  2018  Kd=10.20uM    // 6gnm.pdf (F52) ligand is compound 2,4,5-T
6arm  1.50  2018  Kd=10.6uM     // 6aox.pdf (145) bio-layer interferometry experiment, Kd=10.6+/-4.6uM
6ftz  1.67  2018  Kd=1000uM     // 6fty.pdf (E7E) ligand is compound 6
5os8  1.55  2018  Kd=105uM      // 5oqu.pdf (J27) ligand is compound 11
5umy  1.78  2018  Kd=108nM      // 5umw.pdf (TNN) Kd = 108 +/- 13 nM, ligand is TNM A, protein is TnmS3
5zw6  2.05  2018  Kd=10nM       // 5zw6.pdf (6-mer) Kd=10+/-2.2nM
5yft  2.21  2018  Kd=10uM       // 5yfj.pdf (RI2) [Nonstandard assay: PH=8] ligand is R15P,protein is D204N mutant
5nap  2.17  2018  Kd=11.12nM    // 5nap.pdf (DZ7) Kd = 11.12 +/- 2.88 nM. Ki = dissociation constant in lecture
5yz2  1.75  2018  Kd=11.3uM     // 5yz2.pdf (AMP) [Nonstandard assay: pH 8.0] ligand is AMP,Kd=13.2uM in SPR
6hmg  1.27  2018  Kd=11.5uM     // 6hmg.pdf (2-mer) ligand is compound 4; Kd = 11.5 +/- 0.9 uM
6hai  2.20  2018  Kd=11.6nM     // 6h96.pdf (FWW) ligand is compound 3
5yqx  1.82  2018  Kd=110nM      // 5yqx.pdf (E0K)
6g9i  2.19  2018  Kd=118uM      // 6g95.pdf (CXX) ligand is clomipramine; Kd = 118 +/- 40 uM
6glb  2.00  2018  Kd=129nM      // 6gl9.pdf (F48) ligand is compound 20; IC50 = 129 +/- 13 nM
5otr  1.52  2018  Kd=12uM       // 5oqu.pdf (AU8) ligand is compound 14
6dq4  1.39  2018  Kd=12uM       // 6dq4.pdf (K0I) ligand is compound GSK-J1; Kd = 12+/-2 uM
5o9o  1.90  2018  Kd=13.00uM    // 5o9o.pdf (9PB) Kd = 13.00 +/- 0.01 uM. ligand is compound 7
5yfs  2.30  2018  Kd=13.8uM     // 5yfj.pdf (RI2) [Nonstandard assay: PH=8] ligand is R15P, protein is C135S mutant
5nwe  2.00  2018  Kd=13200nM    // 5nwe.pdf (G39) Kd = 13200 +/- 600 nM, ligand is oseltamivir carboxylate
5z99  1.49  2018  Kd=133nM      // 5yyb.pdf (SLB) [Nonstandard assay: pH 8.0] ligand is Neu5Ac,Kd=133+/-22nM
6el5  1.67  2018  Kd=133nM      // 6ei5.pdf (PU1) ligand is compound 68; Kd = 133+/-4.1nM
6gl9  1.70  2018  Kd=135nM      // 6gl9.pdf (F3W) ligand is compound 10; IC50 = 135 +/- 3 nM
6gji  1.60  2018  Kd=135uM      // 6gji.pdf (F1E) ligand is compound 8; Kd = 135 +/ -6 uM
6gjl  1.16  2018  Kd=139uM      // 6gjl.pdf (F1Q) ligand is compound 10; Kd = 139 +/- 4 uM
6fnf  1.56  2018  Kd=13nM       // 6fnf.pdf (DXH) ligand is NVP
5oha  1.55  2018  Kd=13uM       // 5oha.pdf (9UW) Ki = 13 +/- 1.3 uM, ligand is 2-Thiohydantoin
5z7b  2.10  2018  Kd=13uM       // 5z7b.pdf (VNL) [Nonstandard assay: pH 8.0 ] ligand is vanillate,Kd=13+/-1uM
6fnj  1.24  2018  Kd=142nM      // 6fnf.pdf (DWT) ligand is NVPiso
5mnn   .86  2018  Kd=143uM      // 5mng.pdf (MRZ) Kd = 143 +/- 11 uM. ligand is N-amidinopiperidine, direct ITC, X-ray diffraction (100K)
6csr  1.62  2018  Kd=144nM      // 6csp.pdf (BHO) ligand is compound 1
5o1h  1.32  2018  Kd=14uM       // 5o1a.pdf (9GN) ligand is compound 60
6h2t  1.67  2018  Kd=15.2uM     // 6h1u.pdf (GLU) ligand is GLU; Kd = 15.2 +/- 5.7 uM
6aox  2.10  2018  Kd=15uM       // 6aox.pdf (TF0) bio-layer interferometry experiment, Kd=15+/-0.8uM
6g36  1.46  2018  Kd=16.3nM     // 6g33.pdf (EKH) ligand is 5-chlorotubercidin; Kd = 16.3 +/ - 0.9 nM
6czc  2.30  2018  Kd=16.5uM     // 6czc.pdf (TTP) ligand is TTP; Kd = 16.5+/-0.7uM
5y94  2.00  2018  Kd=164nM      // 5y8c.pdf (8QC) ligand is 6j
5yh8  2.12  2018  Kd=167.8nM    // 5yh8.pdf (8UX) [Uncommon element] ligand is Staphylopine.containing Ni2+
6g35  1.55  2018  Kd=17.5nM     // 6g33.pdf (EKK) ligand is 5-bromotubercidin; Kd = 17.5 +/- 1.3 nM
5qa8  2.50  2018  Kd=170uM      // 5qa4.pdf (JSX) ligand is compound 4c
6fuh  1.37  2018  Kd=170uM      // 6fty.pdf (E88) ligand is compound 8
6faa  1.97  2018  Kd=179nM      // 6fa5.pdf (ADP) ligand is ADP
5o5a  1.60  2018  Kd=17uM       // 5mwg.pdf (9LN) ligand is compound 2
5orj  1.99  2018  Kd=17uM       // 5oqu.pdf (A4Q) ligand is compound 3
6fgg  1.10  2018  Kd=17uM       // 6fg6.pdf (D9B) ligand is compound 5
5nyh  1.65  2018  Kd=18.7nM     // 5lny.pdf (9EK) Kd = 18.7 +/- 0.5 nM. ligand is compound 2b
6i8y  1.52  2018  Kd=180nM      // 6i8b.pdf (2OD) ligand is 35
6gjr  1.69  2018  Kd=184uM      // 6gjr.pdf (F0W) ligand is compound 9; Kd = 184 +/- 13 uM
5ov8  1.80  2018  Kd=18uM       // 5mwg.pdf (AXN) ligand is compound 13
6eq5  1.80  2018  Kd=18uM       // 6eq2.pdf (AX7) compound 4
6evn  1.48  2018  Kd=19.7uM     // 6evm.pdf (9-mer) Ligand is peptide PPG-PAG-PPG; Kd = 19.7+/-0.7uM
6fba  2.00  2018  Kd=19.9uM     // 6fba.pdf (D48) ligand is 2,3-naphthalenediol; Kd = 19.9+/- 4.7 uM; Binding assay: Microscale Thermophoresis
5wa5  1.17  2018  Kd=192nM      // 5wa5.pdf (4K4) Kd(XMD11-50)=192+/-28nM
5odx  1.82  2018  Kd=195nM      // 5lny.pdf (9RZ) Kd = 195 +/- 78 nM. ligand is compound 3b
6bdy  1.51  2018  Kd=2.04uM     // 6bdy.pdf (SFG) ligand is compound sinefungin; Kd = 2.04+/-0.07uM
6gon  1.65  2018  Kd=2.16uM     // 6gnm.pdf (8PF) ligand is compound PFOA
6fhu  2.00  2018  Kd=2.3mM      // 6fap.pdf (3-mer) ligand is compound H3 3-mer
6gl8  1.40  2018  Kd=2.47nM     // 6gl8.pdf (F3Q) ligand is S55746
5zvw  2.29  2018  Kd=2.4nM      // 5zvw.pdf (6-mer) Kd=2.4+/-0.3nM
5xsr  2.30  2018  Kd=20.3nM     // 5xsr.pdf (8EC) ligand is compound 13,Kd=20.3+/-3.0nM,IC50=17nM
6bm6  1.50  2018  Kd=20.8uM     // 6bdy.pdf (SAH) ligand is compound AdoHcy; Kd = 20.8+/-0.2uM
6gjj  1.38  2018  Kd=200uM      // 6gjj.pdf (L36) ligand is compound 2; Kd = 200 +/- 5 uM
5yhe  2.47  2018  Kd=203.3nM    // 5yh8.pdf (8UX) ligand is Staphylopine,containing Co2+
5os7  1.66  2018  Kd=205uM      // 5oqu.pdf (A8Q) ligand is compound 4
6cfc  2.04  2018  Kd=210uM      // 6cfc.pdf (BLG) Kd = 210 +/-28uM;ligand is Cj0843
6bbx  2.20  2018  Kd=215nM      // 5umw.pdf (D77) Kd = 215 +/- 27 nM, ligand is TNM C, protein is TnmS3
6hke  2.11  2018  Kd=21nM       // 6hke.pdf (MLT) ligand is D-malate; Kd = 21 +/- 2 nM
6cwn  1.53  2018  Kd=226nM      // 6cwf.pdf (6LA) Ligand is compound 4,6-Pyr-beta-D-ManNAcOMe
5o1d  1.36  2018  Kd=22uM       // 5o1a.pdf (9GW) ligand is compound 50
5ork  2.14  2018  Kd=234uM      // 5oqu.pdf (A4T) ligand is compound 6
6elp  1.85  2018  Kd=236nM      // 6ei5.pdf (BA8) ligand is compound 14; Kd = 236+/-19nM
6g38  1.47  2018  Kd=239.2nM    // 6g33.pdf (TBN) ligand is tubercidin; kd is 239.2 +/- 10.0 nM
6eq1  2.10  2018  Kd=24.6uM     // 6epy.pdf (STW) Kd = 24.6+/-2.4uM
5oqu  2.32  2018  Kd=244uM      // 5oqu.pdf (A4B) ligand is compound 5
5o87  2.20  2018  Kd=245nM      // 5o87.pdf (NCT) Kd=245+/-20nM
6f1j  1.25  2018  Kd=24uM       // 6f1j.pdf (EDG)  ligand is AraDNJ; Kd = 24+/-0.4 uM
6css  1.70  2018  Kd=25nM       // 6csp.pdf (FBJ) ligand is compound 4
6guc  2.00  2018  Kd=25nM       // 6gu2.pdf (SU9) Kd = 25 +/- 5 nM; ligand is compound SU9516
6gjm  1.35  2018  Kd=266uM      // 6gjm.pdf (L36) ligand is compound 4; Kd = 266 +/- 3 uM
6guh  1.50  2018  Kd=26nM       // 6gu2.pdf (FB8) Kd = 26 +/- 3 nM; ligand is compound AZD5438
6fnq  1.75  2018  Kd=26uM       // 6fnq.pdf (AVJ) ligand is TMH; Kd = 26 +/- 4 uM
5ost  2.10  2018  Kd=27.3uM     // 5oss.pdf (AEZ) [Nonstandard assay: pH=6.8] Kd = 27.3 +/- 0.4 uM, ligand is compound 6
5oaj  2.47  2018  Kd=275nM      // 5o87.pdf (TKT) Kd=275+/-15nM, T53F, Q74R, Y110A, I135S, G162E mutant
6gla  1.92  2018  Kd=27nM       // 6gl9.pdf (F4B) ligand is compound 11; IC50 = 27 +/- 1 nM
5oss  1.70  2018  Kd=28.3uM     // 5oss.pdf (AEZ) [Nonstandard assay: pH=6.8] Kd = 28.3 +/- 6.9 uM, ligand is compound 6
6gnp  2.02  2018  Kd=28.41uM    // 6gnm.pdf (F4Z) ligand is compound TC2P
6hsh  1.55  2018  Kd=28.4nM     // 6hqy.pdf (GOK) ligand is Quisinostat(QSN); Kd = 28.4 +/- 3.3 nM
5nau  2.25  2018  Kd=29.86nM    // 5nap.pdf (DZ0) Kd = 29.86 +/- 1.12 nM. Ki = dissociation constant in lecture
6cwh  2.00  2018  Kd=29nM       // 6cwf.pdf (6LA) Ligand is compound 4,6-Pyr-beta-D-ManNAcOMe; Solving co-crystal structure in P1 space group
6f9g  2.39  2018  Kd=2uM        // 6f9g.pdf (PUT) ligand is putrescine; Kd = 2 +/- 1 uM
6hd6  2.30  2018  Kd=2uM        // 6hd4.pdf (FYH) ligand is compound 6;
5oa6  1.94  2018  Kd=3.10uM     // 5o9o.pdf (9PT) Kd = 3.10 +/- 0.02uM. ligand is compound 12
6g14  1.80  2018  Kd=3.26uM     // 6g0z.pdf (G4P) ligand is compound ppGpp
6fe1  1.95  2018  Kd=3.3nM      // 6fe0.pdf (V14) ligand is VD11-4-2
6fhq  1.95  2018  Kd=3.4mM      // 6fap.pdf (DE5) ligand is compound Fr21; Kd = 3.4 +/- 0.5 mM
6ekq  1.65  2018  Kd=3.5uM      // 5mwg.pdf (B0H) ligand is compound 42
6gnr  1.40  2018  Kd=3.61uM     // 6gnm.pdf (6J3) ligand is compound Clonixin
5vl2  1.90  2018  Kd=3.77nM     // 5vl2.pdf (9EG) [Multiple sites: site 1: Kd = 3.77 nM, site 2: Kd = 0.98 nM.] ligand is TCC
6gfz  2.30  2018  Kd=3080nM     // 6gfx.pdf (EXE) ligand is compound 13b; Kd = 3080 +/- 10 nM
5o1f  1.38  2018  Kd=30uM       // 5o1a.pdf (9GQ) ligand is compound 52
5vh0  2.06  2018  Kd=30uM       // 5vh0.pdf (8P0) Kd(pyrene)=30+/-2.0uM
6fhk  1.66  2018  Kd=31.15nM    // 6fhk.pdf (ADP)
5yl2  2.09  2018  Kd=31.69uM    // 5xiw.pdf (8WU) ligand is SKLB028, Kd=31.69+/-5.26uM
6fe0  1.91  2018  Kd=330nM      // 6fe0.pdf (V90) ligand is VD12-09
6eya  2.10  2018  Kd=33nM       // 6ei5.pdf (C4K) ligand is compound 35; Kd = 33+/-3.1nM
5ovv  1.40  2018  Kd=33uM       // 5ovc.pdf (7-mer) Kd = 33 +/- 2.0 uM, ligand is ProSAPiP1
5ogb  1.80  2018  Kd=34nM       // 5ogb.pdf (9U5) Kd(DC360)=34+/-2.5nM
6q3q  2.00  2018  Kd=35.2uM     // 6hpg.pdf (8-mer) ligand is Hsp90; Kd = 35.2 +/- 6.85 uM
5qal  1.95  2018  Kd=350uM      // 5qa4.pdf (TVZ) ligand is compound 11b
5msb  1.30  2018  Kd=35nM       // 5llc.pdf (V13) ligand is compound 10
6fui  1.38  2018  Kd=35uM       // 6fty.pdf (E7W) ligand is compound 9
6hqy  2.50  2018  Kd=367nM      // 6hqy.pdf (GKW) ligand is PCI-34051; Kd = 367 +/- 40.7 nM
6h8s  1.77  2018  Kd=37.7uM     // 6h8r.pdf (FSZ)
6g9u  1.75  2018  Kd=370nM      // 6fe0.pdf (ETK) ligand is VR16-10
5osl  1.95  2018  Kd=375uM      // 5oqu.pdf (A9K) ligand is compound 7
6ei5  2.20  2018  Kd=38.3nM     // 6ei5.pdf (B5Q) ligand is compound 62; Kd = 38.3+/-9.4nM
6csp  1.24  2018  Kd=3nM        // 6csp.pdf (FBM) ligand is compound 2
5o9r  1.70  2018  Kd=4.09uM     // 5o9o.pdf (9PK) Kd = 4.09 +/- 0.04 uM. ligand is compound 9
6ma2  2.10  2018  Kd=4.1uM      // 6ma1.pdf (J9S) ligand is compound ent-1a; Kd = 4.1 +/- 3.0uM
6eyb  1.90  2018  Kd=4.22uM     // 6ei5.pdf (C3Z) ligand is compound 41; Kd = 4.22+/-0.097uM
6g3a  1.43  2018  Kd=4.2nM      // 6g33.pdf (5ID) ligand is 5-iTU; Kd = 4.2 +/- 0.4 nM
5o9y  1.57  2018  Kd=4.60uM     // 5o9o.pdf (9PN) Kd = 4.60 +/- 0.03 uM. ligand is compound 11
6g39  1.45  2018  Kd=4.6nM      // 6g33.pdf (5ID) ligand is 5-iTU; Kd = 4.6 +/- 0.3 nM
6g0z  2.15  2018  Kd=4.84uM     // 6g0z.pdf (GDP)
6h1u  1.68  2018  Kd=4.8uM      // 6h1u.pdf (ASP) ligand is ASP; Kd = 4.8 +/- 0.6 uM
5nze  1.69  2018  Kd=410nM      // 5nwe.pdf (G39) Kd = 410 +/- 20 nM, ligand is oseltamivir carboxylate
6csq  2.03  2018  Kd=410nM      // 6csp.pdf (F9P) ligand is compound 3
5orh  1.75  2018  Kd=41uM       // 5oqu.pdf (A4N) ligand is compound 2
6g37  1.48  2018  Kd=42.7nM     // 6g33.pdf (FTU) ligand is 5-fluorotubercidin; Kd = 42.7 +/- 2.8 nM
6e4a  1.26  2018  Kd=44nM       // 6e4a.pdf (HRY) Ligand is compound 48(CN750); Binding assay: BROMOscan assay
6h77  2.10  2018  Kd=46.3nM     // 6h77.pdf (ATP)
5w2s  2.40  2018  Kd=46.5nM     // 5w2o.pdf (KMG) Kd(5g)=46.5+/-18.7nM
6hly  1.40  2018  Kd=47nM       // 6hly.pdf (G9Z) ligand is agropinic acid; Kd = 47 +/- 5.6 nM (fluorescence)
6exj  1.80  2018  Kd=47uM       // 5ovc.pdf (7-mer) Kd = 47 +/- 2.5 uM, ligand is SSRL2
6czb  2.40  2018  Kd=47uM       // 6czb.pdf (UTP) ligand is UTP; Kd = 47+/-1uM
5wij  2.04  2018  Kd=488nM      // 5wij.pdf (AQG) Kd(NU6140)=488+/-26nM
6f20  2.00  2018  Kd=49.5uM     // 6f1x.pdf (C9E) ligand is compound 1
6gue  1.99  2018  Kd=4nM        // 6gu2.pdf (FB8) Kd = 4 +/- 1 nM; ligand is compound AZD5438
5tkk  1.55  2018  Kd=5.29nM     // 5tkj.pdf (8-mer) protein is vFP5.01, ligand is Fusion peptide
5xpi  2.20  2018  Kd=5.2uM      // 5xpi.pdf (8C3) ligand is NV01, Kd=5.2+/-1.2uM
6gzm  1.59  2018  Kd=5.5nM      // 6gzd.pdf (LCI) ligand is compound A86
6cpw  1.85  2018  Kd=5.6nM      // 6cpw.pdf (F8V) ligand is compound 27
6b5q  2.16  2018  Kd=5.7nM      // 6b5q.pdf (5-mer) [Nonstandard assay: Temp 30] ligand is compound 38,Kd=5.7+/-2.0nM
6g34  1.76  2018  Kd=5.7nM      // 6g33.pdf (5ID) ligand is 5-ITU; Kd = 5.7 +/- 0.5 nM
6bhv  2.30  2018  Kd=5.87uM     // 6bhv.pdf (DQV) ligand is compound BAD; Kd=5.87+/-0.62uM
6fuj  2.25  2018  Kd=50uM       // 6fty.pdf (E8B) ligand is compound 10
6elo  1.80  2018  Kd=514nM      // 6ei5.pdf (BAW) ligand is compound 7; Kd =514+/-6nM
5nz4  1.36  2018  Kd=520nM      // 5nwe.pdf (G39) Kd = 520 +/- 30 nM, ligand is oseltamivir carboxylate
6gnm  2.24  2018  Kd=54.61uM    // 6gnm.pdf (27M) ligand is compound BP2
6f1n  2.09  2018  Kd=547nM      // 6ei5.pdf (C8W) ligand is compound 6; Kd = 547+/-7.3 nM
5xmx  2.00  2018  Kd=57nM       // 5xmx.pdf (89L) ligand is compound 18, Kd=57+/-1nM
5qay  1.70  2018  Kd=590uM      // 5qa4.pdf (X6P) ligand is compound 32
5wmg  1.19  2018  Kd=6.1nM      // 5wma.pdf (6JF)
5o9q  1.40  2018  Kd=6.2uM      // 5o9o.pdf (9PH) Kd = 6.2 +/- 0.1 uM. ligand is compound 6
5zo8  2.20  2018  Kd=6.3nM      // 5zo8.pdf (4C5) ligand is PVEI0021,Kd=6.3+/-1.8nM
5zkc  2.30  2018  Kd=6.4nM      // 5yc8.pdf (3C0) ligand is NMS; Kd=6.4+/-0.1nM
5otz  1.46  2018  Kd=6.5uM      // 5oqu.pdf (AUT) ligand is compound 15
6arn  1.25  2018  Kd=6.5uM      // 6aox.pdf (BQY) bio-layer interferometry experiment, Kd=6.5+/-1.4uM
5oxk  2.38  2018  Kd=6.82mM     // 5oxk.pdf (2-mer) Kd = 6.82 + 1.33 mM, ligand is Ala-Gln
6mjf  2.20  2018  Kd=6.88uM     // 6mjf.pdf (SAH) Kd = 6.88 +/- 1.13 uM; ligand is compound SAH
6ghj  2.26  2018  Kd=6.89mM     // 6ghj.pdf (3-mer) Kd = 6.89 +/- 1.35 mM
5ohy  1.77  2018  Kd=6.8uM      // 5ohs.pdf (9VH) Kd=6.8+/-0.2uM
6hlx  1.65  2018  Kd=67nM       // 6hlx.pdf (G9Z) ligand is agropinic acid; Kd = 67 +/- 10.6 nM (fluorescence)
6htg  1.94  2018  Kd=67nM       // 6hqy.pdf (T61) ligand is compound 4; IC50 = 67 +/- 10 nM
6fni  1.47  2018  Kd=6nM        // 6fnf.pdf (DXH) ligand is NVP
5tkj  2.12  2018  Kd=7.15nM     // 5tkj.pdf (8-mer) protein is vFP1.01, ligand is Fusion peptide
6aro  1.20  2018  Kd=7.1uM      // 6aox.pdf (BS7) bio-layer interferometry experiment, Kd=7.1+/-2.3uM
6gwr  2.07  2018  Kd=7.9nM      // 6gwr.pdf (FEW) ligand is compound 5n
6g98  2.47  2018  Kd=710nM      // 6fe0.pdf (ER5) ligand is VR16-09
6guk  1.30  2018  Kd=715nM      // 6gu2.pdf (FC8) Kd = 715 +/- 15 nM; ligand is compound CGP74514A
6fng  1.04  2018  Kd=73nM       // 6fnf.pdf (DWT) ligand is NVPiso
5obg  2.00  2018  Kd=74.1nM     // 5o87.pdf (SY9) Kd=74.1+/-22.6nM
6cvv  2.41  2018  Kd=75uM       // 6cvv.pdf (ATP) ligand is ATP; Kd = 75+/-3uM
5om3  2.00  2018  Kd=79.2uM     // 5om2.pdf (DXT) ligand is doxycycline, Kd for S-conformation
5o9p  1.75  2018  Kd=8.06uM     // 5o9o.pdf (9P8) Kd = 8.06 +/- 0.07 uM. ligand is compound 10
6hpw  1.90  2018  Kd=807nM      // 6hpw.pdf (GKT) ligand is compound 20
6hrq  1.85  2018  Kd=81.7nM     // 6hqy.pdf (GM5) ligand is NCC-149; Kd = 81.7 +/- 7.0 nM
5var  1.83  2018  Kd=81.7uM     // 5var.pdf (92Y) Kd = 81.7 +/- 7.1 uM. ligand is compound 1a.
5y8y  1.87  2018  Kd=82nM       // 5y8c.pdf (8PX) ligand is 6i
5om2  1.47  2018  Kd=86.7uM     // 5om2.pdf (DXT) ligand is doxycycline, Kd for S-conformation
6ce6  1.60  2018  Kd=8uM        // 6ce6.pdf (EYP) ligand is compound 1
5ovp  1.50  2018  Kd=9.1uM      // 5ovc.pdf (7-mer) Kd = 9.1 +/- 0.5 uM, ligand is CIRL
5oa2  2.15  2018  Kd=9.80uM     // 5o9o.pdf (9PW) Kd = 9.80 +/- 0.07 uM. ligand is compound 8
6gzd  2.28  2018  Kd=9.8nM      // 6gzd.pdf (LCI) ligand is compound A86
6eln  1.60  2018  Kd=900nM      // 6ei5.pdf (P4A) ligand is compound 10; Kd = 900+/-17nM
6cze  2.30  2018  Kd=93uM       // 6cze.pdf (ITT) ligand is Inosine triphosphate; Kd = 93+/-8 uM
5win  2.38  2018  Kd=94nM       // 5wij.pdf (SKE) Kd(JNJ7706621)=94+/-1nM
5yhg  2.03  2018  Kd=952.3nM    // 5yh8.pdf (8UX) [Uncommon element] ligand is Staphylopine.containing Zn2+
6d50  2.50  2018  Kd=9uM        // 6d41.pdf (GCB) Kd = 9+/-2uM
6exi  1.92  2018  Kd=9uM        // 6exi.pdf (ADN) ligand is Ado
6e9a  1.22  2018  Ki=0.0012nM   // 6e7j.pdf (J0S) binding assay: Continuous Fluorometric Assay; ligand is compound 4a
6cdj  1.13  2018  Ki=0.002nM    // 6cdj.pdf (GR8) ligand is compound 5d
5xvg  2.10  2018  Ki=0.009uM    // 5xva.pdf (8FX) [Nonstandard assay: Tem 22 C] ligand is compound 31,Ki=0.009uM
6cdl  1.25  2018  Ki=0.012nM    // 6cdj.pdf (GR5) ligand is compound 5c
6h5x  1.80  2018  Ki=0.015nM    // 6h5w.pdf (FT8) ligand is Omapatrilat; Ki = 0.015 +/- 0.001 nM
6dif  1.20  2018  Ki=0.019nM    // 6dif.pdf (TPV) ligand is compound 3
6cn5  2.30  2018  Ki=0.02uM     // 6cn5.pdf (F7M) Ligand is compound 8b
6dj1  1.26  2018  Ki=0.031nM    // 6dif.pdf (AB1) ligand is compound 2
5xva  1.85  2018  Ki=0.051uM    // 5xva.pdf (8FU) [Nonstandard assay: Tem 22 C] ligand is compound 30,Ki=0.051uM
6ebe  1.88  2018  Ki=0.20uM     // 6ebe.pdf (J3V) ligand is compound 15; binding assay: Stopped Flow CO2 Hydrase Assay
6dar  1.88  2018  Ki=0.219uM    // 6d9x.pdf (G2J) ligand is compound 4q
5vja  2.46  2018  Ki=0.260uM    // 5vja.pdf (DUK) ligand is HS38
6ecz  2.21  2018  Ki=0.27uM     // 6ebe.pdf (J4D) ligand is compound 17; binding assay: Stopped Flow CO2 Hydrase Assay
6e7j  1.30  2018  Ki=0.33nM     // 6e7j.pdf (HWY) binding assay: Continuous Fluorometric Assay; ligand is compound 4e
5w44  2.10  2018  Ki=0.36uM     // 5w44.pdf (GY6) Ki = 0.36 +/- 0.03 uM, ligand is compound 7a
6eeo  1.72  2018  Ki=0.37uM     // 6ebe.pdf (J6V) ligand is compound 16; binding assay: Stopped Flow CO2 Hydrase Assay
6h36  1.85  2018  Ki=0.45nM     // 6h2z.pdf (FKE) ligand is compound 7a
6got  1.56  2018  Ki=0.4nM      // 6got.pdf (F6W) ligand is compound 5b
6f92  1.90  2018  Ki=0.4uM      // 6f90.pdf (MVL) ligand is Manl
6hh3  1.82  2018  Ki=0.58uM     // 6g1p.pdf (A1R) Ki = 0.58 +/- 0.12 uM; ligand is compound ADP-HPD
5y12  1.75  2018  Ki=0.59uM     // 5y0f.pdf (8JX) [Nonstandard assay: Temp 30] ligand is 16d,Ki=0.59+/-0.03uM
6h2z  1.94  2018  Ki=0.5nM      // 6h2z.pdf (FKE) ligand is compound 7a
6h34  1.55  2018  Ki=0.5nM      // 6h2z.pdf (FKK) ligand is compound 8b
5laq  2.40  2018  Ki=0.63nM     // 5g2b.pdf (6M5) pKi = 9.2, ligand is compound NPD-001(1)
6ays  1.70  2018  Ki=0.65nM     // 6ays.pdf (HT6) kinetic inhibition assay,  Ki=0.65+/-0.17nM (calculated from the time-equilibrated rates)
6h33  1.58  2018  Ki=0.6nM      // 6h2z.pdf (FKQ) ligand is compound 7b
6eiz  1.85  2018  Ki=0.6uM      // 6eiz.pdf (FOH) ligand is compound 6; Ki = 0.6+/-0.2uM
6b4d  1.20  2018  Ki=0.78uM     // 6b4d.pdf (53X) ligand is 1d,Ki=0.78+/-0.009uM
6c7q  1.51  2018  Ki=0.7nM      // 6c7q.pdf (EO1) ligand is compound 12; Ki = 0.7+/-0.3nM
6f90  2.40  2018  Ki=1.0uM      // 6f90.pdf (MVL) ligand is Manl
5y13  1.75  2018  Ki=1.16uM     // 5y0f.pdf (8K0) [Nonstandard assay: Temp 30] ligand is 16c,Ki=1.16+/-0.07uM
5od1  1.34  2018  Ki=1.1uM      // 5od1.pdf (9RQ) Ki=1.1+/-0.1uM
5owl  2.23  2018  Ki=1.2uM      // 5owh.pdf (B0K) ligand is compound 8b, the crystallization conditions are different
6dpx  1.90  2018  Ki=1.3uM      // 6dpt.pdf (H7G) enzyme inhibition assay
6ayt  1.85  2018  Ki=1.4nM      // 6ays.pdf (4EH) kinetic inhibition assay,  Ki=1.4+/-0.2nM (calculated from the time-equilibrated rates)
5nw7  1.85  2018  Ki=1.7uM      // 5nw7.pdf (9C2) ligand is 5PAHz
6dj7  1.31  2018  Ki=1.9nM      // 6dif.pdf (G10) ligand is compound 5; Ki = 1.9+/-0.7nM
5nxp  1.25  2018  Ki=10.2nM     // 5nxg.pdf (9DH) Ki = 10.2 +/- 1.0 nM. ligand is compound 5
5l8c  2.01  2018  Ki=100nM      // 5g2b.pdf (908) pKi = 7, ligand is compound NPD-039(9)
5mwy  1.75  2018  Ki=100nM      // 5mwp.pdf (YNU) pKi = 7.0 +/- 0.1, ligand is eplerenone
6eif  2.22  2018  Ki=104nM      // 6eif.pdf (B5T) ligand is compound AC12
5zag  1.95  2018  Ki=108nM      // 5za7.pdf (94I) ligand is compound 25,Ki=108+/-17nM
6cbg  2.00  2018  Ki=113uM      // 6cb5.pdf (EWG) ligand is compound 5
6dh6  1.97  2018  Ki=117.2pM    // 6dgx.pdf (017) ligand is compound DRV; Ki = 117.2+/-5.8 pM
6ej3  1.94  2018  Ki=1179nM     // 6ej2.pdf (B7T) ligand is compound 23; Ki = 1179+/-374nM
6iiu  2.50  2018  Ki=11nM       // 6iiu.pdf (A8X) ligand is Ramatroban; Ki = 11 +/- 4nM
6dh2  1.98  2018  Ki=12.8pM     // 6dgx.pdf (A60) ligand is compound UMass6; Ki = 12.8+/-3.1 pM
6dh7  2.00  2018  Ki=131.3pM    // 6dgx.pdf (K13) ligand is compound UMass1; Ki = 131.3+/-8.2 pM
5za7  1.70  2018  Ki=1356nM     // 5za7.pdf (HMX) ligand is compound 5,Ki=1356+/-183nM
5oh3  2.10  2018  Ki=136uM      // 5oh3.pdf (9V2) Ki = 136 +/- 11.6 uM, ligand is Ethosuximide
5oh9  1.65  2018  Ki=137uM      // 5oh9.pdf (9UT) Ki = 137 +/- 15.9 uM, ligand is Thiazolidine-2,4-dione
6dh8  1.95  2018  Ki=146.2pM    // 6dgx.pdf (A60) ligand is compound UMass6; Ki = 146.2+/-10.7 pM
6g2m  1.37  2018  Ki=15.1nM     // 6g2m.pdf (O84) ligand is compound 6; Ki = 15.1 +/- 5.6 nM
5zae  1.73  2018  Ki=156nM      // 5za7.pdf (EAU) ligand is compound 22,Ki=156+/-20nM
5zaf  1.65  2018  Ki=166nM      // 5za7.pdf (28I) ligand is compound 23,Ki=166+/-34nM
6eij  2.42  2018  Ki=1680nM     // 6eif.pdf (B5Z) ligand is compound AC20
6euc  2.22  2018  Ki=168uM      // 6euc.pdf (RM0) reverse inhibition assay, Ki(17)=168+/-23uM
6ej2  1.46  2018  Ki=16nM       // 6ej2.pdf (B7E) ligand is compound 28; Ki = 16+/-7.6nM
6f9v  1.69  2018  Ki=171.9nM    // 6f9r.pdf (D0Z) ligand is compound Sampatrilat; Ki = 171.9 +/- 32.2 nM
5za9  1.62  2018  Ki=183nM      // 5za7.pdf (50I) ligand is compound 18,Ki=183+/-10nM
5g5v  1.80  2018  Ki=199nM      // 5g2b.pdf (8Z4) pKi = 6.7, ligand is compound NPD-038(22)
6f28  2.40  2018  Ki=2.15uM     // 6f28.pdf (CG8) ligand is compound 5c; Ki = 2.15 +/- 0.10 uM
6h29  1.46  2018  Ki=2.4uM      // 6h29.pdf (FK8) ligand is compound 1
6h37  1.90  2018  Ki=2.6nM      // 6h2z.pdf (FKQ) ligand is compound 7b
6fnr  1.83  2018  Ki=2.6uM      // 6fnq.pdf (DYT) ligand is compound 8; Ki = 2.6 +/- 0.4 uM
5nxg  1.20  2018  Ki=2.8nM      // 5nxg.pdf (RA1) Ki = 2.8 +/- 0.3 nM. ligand is compound 6
6gg4  2.46  2018  Ki=205uM      // 6gg4.pdf (PHE) ligand is PHE
5nxi  1.16  2018  Ki=217.4nM    // 5nxg.pdf (9DE) Ki = 217.4 +/- 15.7 nM. ligand is compound 4
6eqw  1.99  2018  Ki=22.4pM     // 6eqv.pdf (5-mer) ligand is compound I3
5nzn  1.73  2018  Ki=220000nM   // 5nwe.pdf (G39) Kd = 220000 +/- 4000 nM, ligand is oseltamivir carboxylate
6cjv  1.55  2018  Ki=2200nM     // 6cjv.pdf (G2Y) ligand is Sucralose
5yum  2.43  2018  Ki=223uM      // 5ypp.pdf (ILE)
6eqv  1.90  2018  Ki=238nM      // 6eqv.pdf (5-mer) ligand is compound I2
5wgp  1.53  2018  Ki=2400nM     // 5wg7.pdf (AUD) CA IX (mimic) in complex with Ace K
6eis  2.36  2018  Ki=252nM      // 6eif.pdf (B6N) ligand is compound AC27
6fag  1.79  2018  Ki=255.1nM    // 6fag.pdf (EON) in vitro enzyme assay
6dpz  1.50  2018  Ki=259uM      // 6dpt.pdf (H7D) enzyme inhibition assay
6dh1  1.97  2018  Ki=26.1pM     // 6dgx.pdf (K13) ligand is compound UMass1; Ki = 26.1+/-3.7 pM
6f3b  1.40  2018  Ki=273.3nM    // 6f3b.pdf (CJK) ligand is compound 5
6edr  2.40  2018  Ki=28.5uM     // 6edr.pdf (ZNA) ligand is compound S-NAD+; Ki=28.5+/-3.1uM
6aqs  1.57  2018  Ki=28nM       // 6aqs.pdf (IM5) ligand is DADMe-ImmG,Ki=28+/-1nM
5oh4  2.30  2018  Ki=28uM       // 5oh4.pdf (9UZ) Ki = 28 +/- 5.0 uM, ligand is Glutarimide
6faf  1.99  2018  Ki=306.1nM    // 6f3b.pdf (D3B) ligand is compound 15
5mwp  1.82  2018  Ki=31.6nM     // 5mwp.pdf (ECV) pKi = 7.5 +/- 0.1, ligand is AZD9977
6d9x  1.83  2018  Ki=323uM      // 6d9x.pdf (FZM) ligand is compound F-1
6eqx  1.99  2018  Ki=33.7pM     // 6eqv.pdf (6-mer) ligand is compound I1
5ny3  1.40  2018  Ki=33.9nM     // 5nxg.pdf (9E8) Ki = 33.9 +/- 2.7 nM. ligand is compound 9
6c7w  1.28  2018  Ki=3410nM     // 6c7w.pdf (LMS) ligand is compound 1
6f05  2.20  2018  Ki=34uM       // 6ezy.pdf (GTS) ligand is GSO3
6exs  2.50  2018  Ki=362uM      // 6exs.pdf (C3H) IC50 = 362 +/- 21.8 uM
5ny1  1.10  2018  Ki=366.7nM    // 5nxg.pdf (9E5) Ki = 366.7 +/- 46.5 nM. ligand is compound 10
6eiq  2.30  2018  Ki=383nM      // 6eif.pdf (B6Z) ligand is compound AC24
5l8y  2.14  2018  Ki=398nM      // 5g2b.pdf (CVA) pKi = 6.4, ligand is compound NPD-937(16)
6ayr  1.95  2018  Ki=4.1nM      // 6ayo.pdf (BIG) ligand is BTDIA,Ki=4.1+/-1.0nM,Ki*=0.75+/-0.20nM
5nxo  1.20  2018  Ki=4.9nM      // 5nxg.pdf (9HK) Ki = 4.9 +/- 0.6 nM. ligand is compound 2
5nya  1.20  2018  Ki=415.6nM    // 5nxg.pdf (FB2) Ki = 415.6 +/- 56.5 nM. ligand is compound 1
5zaj  1.65  2018  Ki=42nM       // 5za7.pdf (32I) ligand is compound 27,Ki=42+/-2nM
5oh7  1.85  2018  Ki=43uM       // 5oh7.pdf (HYN) Ki = 43 +/- 10.7 uM, ligand is Hydantoin
6ex1  1.60  2018  Ki=49.4nM     // 6evr.pdf (N19) ligand is compound (S)-12; Ki(hCA IX) = 83.7nM
6ayo  1.67  2018  Ki=5.1nM      // 6ayo.pdf (C1Y) ligand is PDIA,Ki=5.1+/-0.6nM,Ki*=1.4+/-0.1nM. Ki = determined from the initial rates
5za8  1.90  2018  Ki=508nM      // 5za7.pdf (27I) ligand is compound 14,Ki=508+/-9nM
6hh5  1.95  2018  Ki=54.2uM     // 6g1p.pdf (A3R) Ki = 54.2 +/- 4uM; ligand is compound ADP-HPM
5nxw  1.10  2018  Ki=57.4nM     // 5nxg.pdf (RA9) Ki = 57.4 +/- 7.7 nM. ligand is compound 8
6g3q  1.01  2018  Ki=57.9nM     // 6g3q.pdf (FO9) ligand is famotidine
6eir  2.40  2018  Ki=575nM      // 6eif.pdf (B6H) ligand is compound AC25
5oh2  1.90  2018  Ki=57uM       // 5oh2.pdf (BAQ) Ki = 57 +/-11.6, ligand is gamma-Butyrolactam
6d2o  1.90  2018  Ki=5uM        // 6d2o.pdf (4MZ) ligand is compound 4MI; An Applied Photophysics stopped-flow instrument was used for binding assay
6ayq  1.42  2018  Ki=6.5nM      // 6ayo.pdf (TDI) ligand is MTDIA,Ki=6.5+/-0.6nM,Ki*=2.9+/-0.1nM. Ki = determined from the initial rates
5z5f  2.10  2018  Ki=6.8mM      // 5z5f.pdf (FUB) ligand is arabinose,Ki=6.8+/-0.6mM
6cbf  2.30  2018  Ki=6.8uM      // 6cb5.pdf (EWD) ligand is compound 8a
6c7x  1.50  2018  Ki=65.2nM     // 6c7w.pdf (EO7) ligand is compound 2
6g2l  1.48  2018  Ki=68nM       // 6g2l.pdf (EJ8) ligand is compound 5; Ki=68+/-22nM
6dak  1.60  2018  Ki=7.21uM     // 6d9x.pdf (G1Y) ligand is compound 4a
6dj5  1.75  2018  Ki=7.2nM      // 6dif.pdf (G52) ligand is compound 4; Ki=7.2+/-1.4nM
6f9u  1.90  2018  Ki=7.4uM      // 6f9r.pdf (D0W) ligand is compound SamAsp; Ki = 7.4 +/- 0.3 uM
6dj2  1.36  2018  Ki=7.6nM      // 6dif.pdf (AB1) ligand is compound 3; Ki = 7.6+/-0.3nM
6dil  1.48  2018  Ki=7.6nM      // 6dif.pdf (TPV) ligand is compound 3; Ki = 7.6+/-0.3nM
6h38  1.70  2018  Ki=7.8nM      // 6h2z.pdf (FKK) ligand is compound 8b
6dpt  1.79  2018  Ki=77nM       // 6dpt.pdf (H7M) enzyme inhibition assay
6b59  1.64  2018  Ki=8.2nM      // 6b59.pdf (CQS) ligand is compound 29
6evr  1.50  2018  Ki=8.8nM      // 6evr.pdf (BZW) ligand is compound (S)-17; Ki(hCA IX) = 104nM
6dpy  1.91  2018  Ki=80uM       // 6dpt.pdf (H7A) enzyme inhibition assay
6eed  1.50  2018  Ki=812nM      // 6eed.pdf (J6A) ligand is compound 6o; Ki=812+/-64nM
6dai  1.63  2018  Ki=85.2uM     // 6d9x.pdf (G2V) ligand is compound 3h
5zc5  1.90  2018  Ki=88nM       // 5za7.pdf (09I) ligand is compound 19,Ki=88+/-33nM
6c0s  2.35  2018  Ki=89nM       // 6c0s.pdf (EEJ) ligand is compound 17
6g3v  1.69  2018  Ki=922.4nM    // 6g3q.pdf (FO9) ligand is famotidine
5nzf  1.75  2018  Ki=94000nM    // 5nwe.pdf (G39) Ki = 94000 +/- 7000 nM, ligand is oseltamivir carboxylate
6mqe  2.46  2019  Kd=0.0051nM   // 6mqc.pdf (8-mer)
6r8o  1.36  2019  Kd=0.006uM    // 6r8l.pdf (JV2) ligand is compound 14
6i8m  2.10  2019  Kd=0.016uM    // 6i8m.pdf (H7W) ligand is (S)-13
6dyv  1.62  2019  Kd=0.026nM    // 6dyu.pdf (OS3) Kd(HpMTAN, 16)=0.026+/-0.006nM
6dyy  1.61  2019  Kd=0.028nM    // 6dyu.pdf (OS6) Kd(HpMTAN, 30)=0.028+/-0.010nM
6maj  2.14  2019  Kd=0.034uM    // 6maj.pdf (JAV) ligand is WM-3835
6qmk  1.72  2019  Kd=0.035uM    // 6qmc.pdf (J8H) ligand is compound 21; has ITC Kd data
6dyw  1.45  2019  Kd=0.036nM    // 6dyu.pdf (OS5) Kd(HpMTAN, 32)=0.036+/-0.010nM
6qmj  1.86  2019  Kd=0.044uM    // 6qmc.pdf (J6K) ligand is compound 20; has ITC Kd data
6dyu  1.60  2019  Kd=0.055nM    // 6dyu.pdf (OS2) Kd(HpMTAN, 15)=0.055+/-0.025nM
6jb0  1.63  2019  Kd=0.058uM    // 6j9w.pdf (TRE)
6u5y  1.53  2019  Kd=0.069uM    // 6u5m.pdf (Q0M) ligand is compound 7k; Kd = 0.069 +/- 0.034 uM; Binding assay is FPA
6nfh  1.40  2019  Kd=0.07uM     // 6nfh.pdf (KLM) ligand is compound 1; binding assay is ThermoFluor
5zyl  1.80  2019  Kd=0.088uM    // 5zyl.pdf (9MC) Kd=0.088+/-0.002uM, kon=1.63E+5, koff=1.43E-2, E25A(1S,2R)
6p83  1.70  2019  Kd=0.08uM     // 6p83.pdf (O3Y) ligand is compound 1o
6pi5  1.67  2019  Kd=0.11uM     // 6pi5.pdf (GUN) ligand is guanine; Kd = 0.11 +/- 0.02 uM
6qr0  1.59  2019  Kd=0.12uM     // 6qr0.pdf (JFB) ligand is compound 26l; Kd = 0.12+/-0.02uM
6np2  1.20  2019  Kd=0.16uM     // 6np2.pdf (SIS) ligand is compound sisomicin; Kd = 0.16 +/- 0.01 uM
6qqz  1.70  2019  Kd=0.18uM     // 6qqz.pdf (JEB) ligand is compound 26g; Kd = 0.18 +/- 0.06 uM
5zhl  2.25  2019  Kd=0.19uM     // 5zhj.pdf (9D0) compound 15, koff=0.12, kon=6.45E+5
6e23  1.66  2019  Kd=0.1nM      // 6dy7.pdf (HLJ) compound is C6
6idg  2.00  2019  Kd=0.22uM     // 6idg.pdf (2-mer) ligand is dT(6-4)T
6i17  1.56  2019  Kd=0.25uM     // 6i0z.pdf (GZW) ligand is 24
6u8o  1.60  2019  Kd=0.289uM    // 6u5m.pdf (Q1G) ligand is compound 5n; Kd = 0.289 +/- 0.19 uM; Binding assay is FPA
6oja  1.55  2019  Kd=0.2nM      // 6dzx.pdf (MET) L-methionine
6n9l  2.01  2019  Kd=0.2uM      // 6n9l.pdf (ADP)
6if0  1.80  2019  Kd=0.31uM     // 6if0.pdf (A59) ligand is D16
6np3  1.15  2019  Kd=0.34uM     // 6np2.pdf (LLL) ligand is compound gentamicin; Kd = 0.34 +/- 0.01 uM
6g2r  2.10  2019  Kd=0.35nM     // 6g2r.pdf (EJK) compound 6
6qi7  2.50  2019  Kd=0.35uM     // 6qi7.pdf (PLM) ligand is palmitic acid; Kd = 0.35 +/- 0.09 uM
6qr3  1.61  2019  Kd=0.36uM     // 6qr3.pdf (JE8) ligand is compound 26o; Kd = 0.36+/-0.05uM
6n7d  1.78  2019  Kd=0.3nM      // 6n7d.pdf (KF4) ligand is 54
6iez  1.90  2019  Kd=0.3uM      // 6iez.pdf (A50) ligand is B16
6u8b  1.26  2019  Kd=0.431uM    // 6u5m.pdf (Q1M) ligand is compound 6b; Kd = 0.431 +/- 0.08 uM; Binding assay is FPA
6idb  2.50  2019  Kd=0.4uM      // 6icw.pdf (3-mer) ligand is alpha 2-6
6qr4  1.52  2019  Kd=0.59uM     // 6qr4.pdf (JD8) ligand is compound 26n; Kd = 0.59+/-0.23uM
6dyz  1.62  2019  Kd=0.63nM     // 6dyu.pdf (OS2) Kd(HsMTAP, 15)=0.63+/-0.08nM
6r8l  1.64  2019  Kd=0.670uM    // 6r8l.pdf (JUZ) ligand is compound 16
6hgi  1.52  2019  Kd=0.6uM      // 6hgd.pdf (C0R) ligand is Corticosterone
6j72  2.20  2019  Kd=0.74uM     // 6j72.pdf (GTP)
6hq7  2.46  2019  Kd=0.769uM    // 6hq3.pdf (PCG) dimer has two active binding site(positive co-operativity)
6a87  2.41  2019  Kd=0.7mM      // 6a86.pdf (2-mer) fucose(alpha1-6)GlcNAc, Kd=0.7+/-0.14mM
6dsp  1.37  2019  Kd=0.81uM     // 6dsp.pdf (PAV) Kd=0.81+/-0.13uM
6qz5  2.00  2019  Kd=0.83uM     // 6qxj.pdf (JLE) ligand is compound 8a
6mlo  1.72  2019  Kd=0.8uM      // 6mku.pdf (ARG)
6hm1  1.54  2019  Kd=0.91uM     // 6hm1.pdf (AO3) ligand is Allosamidin
6dz0  1.62  2019  Kd=0.94nM     // 6dyu.pdf (OS3) Kd(HsMTAP, 16)=0.94+/-0.12nM
6jbb  1.95  2019  Kd=1.03uM     // 6j9w.pdf (SUC)
6jb4  1.63  2019  Kd=1.04uM     // 6j9w.pdf (MAL)
6mle  1.86  2019  Kd=1.0nM      // 6mku.pdf (ARG)
6qgf  1.34  2019  Kd=1.0uM      // 6qgf.pdf (J0T) Ligand is compound R; Kd = 1.0+/-0.03 uM
6r9x  1.66  2019  Kd=1.1mM      // 6r8l.pdf (JW2) ligand is compound 8
6d9s  2.11  2019  Kd=1.1uM      // 6d9r.pdf (G4P) compound is (p)ppGpp
6md0  1.95  2019  Kd=1.27uM     // 5ugm.pdf (OLA)
6mh1  1.60  2019  Kd=1.2uM      // 6mh1.pdf (JQP) ligand is compound V
6r8w  1.40  2019  Kd=1.2uM      // 6r8l.pdf (JVH) ligand is compound 40
6gj8  1.65  2019  Kd=1.36uM     // 6gj5.pdf (F0K) ligand is BI2852
6e22  1.60  2019  Kd=1.3nM      // 6dy7.pdf (HLS) compound is C3
6dz3  1.91  2019  Kd=1.3nM      // 6dyu.pdf (OS6) Kd(HsMTAP, 30)=1.3+/-0.1nM
6dz2  1.99  2019  Kd=1.4nM      // 6dyu.pdf (OS5) Kd(HsMTAP, 32)=1.4+/-0.1nM
6n3w  1.75  2019  Kd=1.56uM     // 6n3v.pdf (KBJ) ligand is 2
6bs3  2.30  2019  Kd=1.5uM      // 6bs3.pdf (ADP) Kd(BagAB, ADP)=1.5uM
6i14  1.73  2019  Kd=1.5uM      // 6i0z.pdf (GZN) ligand is 9
6jan  1.77  2019  Kd=1.61uM     // 6j9w.pdf (MAL)
6stl  1.30  2019  Kd=1.6nM      // 6ssy.pdf (TAU) ligand is taurine
6mnc  2.40  2019  Kd=1.6uM      // 6mnc.pdf (J3Z) ligand is E1
6i8t  2.10  2019  Kd=1.76uM     // 6i8m.pdf (H7Z) ligand is (R)-13
5zdb  1.97  2019  Kd=1.78uM     // 5zdb.pdf (AR6) Kd=1.78+/-0.05uM, crystal P21
5zym  1.90  2019  Kd=1.7uM      // 5zym.pdf (9M6) Kd=1.7+/-0.6uM, kon=1.01E+5, koff=1.68E-1, E25B(1R,2S)
6d78  2.35  2019  Kd=1.8nM      // 6d78.pdf (9-mer) alpha-D26Y, beta-L98W, Kd=1.8+/-0.3nM
6mh7  1.74  2019  Kd=1.8uM      // 6mh1.pdf (JQY) ligand is compound IV
6p85  1.90  2019  Kd=10.3uM     // 6p83.pdf (O4V) ligand is compound 3
6jof  2.20  2019  Kd=10.4uM     // 5zhj.pdf (BWR) AZ51, koff=0.21, kon=2.01E+4
6haz  1.31  2019  Kd=100nM      // 6hax.pdf (FX5)
6j3p  1.60  2019  Kd=105nM      // 6j3o.pdf (B8O) ligand is (R,R)-36n
6rih  2.15  2019  Kd=105uM      // 6rih.pdf (K4T) ligand is compound 9
6pia  1.75  2019  Kd=11.0uM     // 6phr.pdf (XS6) ligand is compound 6
6j0o  1.80  2019  Kd=11.9uM     // 6j0o.pdf (XAF) ligand is SC1(this code is belong to literature 6iez)
6jaq  1.95  2019  Kd=111.23uM   // 6j9w.pdf (GLC)
6gjw  1.90  2019  Kd=11uM       // 6gjw.pdf (F2H) ligand is 5a
6pg5  1.99  2019  Kd=11uM       // 6pg3.pdf (OHV) ligand is compound 35; Kd = 11 +/- 1 uM
6nv7  2.13  2019  Kd=12.1nM     // 6nv7.pdf (L3J) ligand is inhibitor 2; Kd = 12.1 +/- 5.8 nM
6dgr  2.15  2019  Kd=12.3uM     // 6dgl.pdf (GDY) compound is CAY10638
6e7u  2.27  2019  Kd=121nM      // 6e7u.pdf (HX7) [Nonstandard assay: PH=7.6] Kd(PH=7.6)=121+/-5.1nM, Kd(PH=6.5)=78+/-3.0nM, chain BD: 363
6e7t  2.31  2019  Kd=129nM      // 6e7t.pdf (HYY) [Nonstandard assay: PH=7.6] Kd(PH=7.6)=129+/-9.3nM, Kd(PH=6.5)+116+/-2.2nM, Chain BD: 363
6pg9  1.75  2019  Kd=12uM       // 6pg3.pdf (OH1) ligand is compound 30; Kd = 12 +/- 1 uM
6qqv  1.71  2019  Kd=12uM       // 6qqv.pdf (JEW) ligand is compound 24d; Kd = 12 +/- 2 uM
6jon  2.34  2019  Kd=13.2uM     // 6jon.pdf (DTP) ligand is dATP
6jao  1.77  2019  Kd=13.8uM     // 6j9w.pdf (2-mer) ligand is Z9N-GLC
6jdl  2.25  2019  Kd=13uM       // 6j7e.pdf (AGS) ligand is ATPgS
6qrc  1.73  2019  Kd=13uM       // 6qrc.pdf (JFE) ligand is compound 24b; Kd = 13 +/- 2 uM
6mja  2.35  2019  Kd=14.1nM     // 6miv.pdf (JTJ) ligand is 15o
6gga  1.55  2019  Kd=14.2uM     // 6gga.pdf (EY2) ligand is PK9284
6jfk  2.00  2019  Kd=14.4uM     // 6jfk.pdf (GDP)
6pg8  1.67  2019  Kd=140uM      // 6pg3.pdf (OGY) ligand is compound 16; Kd = 140 +/- 30 uM
6e7r  2.10  2019  Kd=147nM      // 6e7r.pdf (HYS) [Nonstandard assay: PH=7.6] Kd(PH=7.6)=147+/-5.0nM, Kd(PH=6.5)=170+/-4.8nM, chain BD: 363
6p84  1.70  2019  Kd=15.6uM     // 6p83.pdf (O3V) ligand is compound 2o
6nsv  1.31  2019  Kd=15.8nM     // 6efk.pdf (6-mer) Ac-LWWPD, pKd=7.8
6e1z  1.10  2019  Kd=150uM      // 6dy7.pdf (HLP) compound is C4
6i62  1.65  2019  Kd=157.5nM    // 6i61.pdf (27N) ligand is Hydroxychlor (HPTE)
6qlr  0.97  2019  Kd=15uM       // 6qln.pdf (J4N) ligand is compound 6; Kd = 15+/-0.3 uM; Binding assay is fluorescence polarization
6jap  1.77  2019  Kd=16.02uM    // 6j9w.pdf (SUC)
6g2b  1.61  2019  Kd=160uM      // 6g24.pdf (EH8) Kd(compd 8)=160+/-26uM
6g7a  1.42  2019  Kd=167nM      // 6g5l.pdf (EOQ) Kd(9, FTSA)=167nM
6nfy  2.17  2019  Kd=16nM       // 6nfy.pdf (B49) ligand is compound sunitinib; Protein in crystal is at inactive state
6t1l  2.00  2019  Kd=17.1uM     // 6t1i.pdf (M7N) ligand is compound 3
6g24  2.10  2019  Kd=1700uM     // 6g24.pdf (EH2) Kd(compd 3)=1700+/-700uM
6g2o  1.81  2019  Kd=170nM      // 6g24.pdf (EJE) Kd(compd BI-9321)=170+/-3nM
6ql2  1.30  2019  Kd=17nM       // 6ql1.pdf (EZL) ligand is EZA
6mkw  2.32  2019  Kd=17uM       // 6mku.pdf (HIS)
6qas  1.75  2019  Kd=18.1nM     // 6qas.pdf (34W) Ligand is compound PF-03814735
6t1j  1.97  2019  Kd=18.1uM     // 6t1i.pdf (M7T) ligand is compound 2
6i66  1.60  2019  Kd=182.5nM    // 6i61.pdf (H4Q) ligand is 4-sec-butylphenol
6iou  2.10  2019  Kd=184.2uM    // 6iop.pdf (SER) ligand is L-serine
6mj4  2.00  2019  Kd=19.1nM     // 6miv.pdf (JTG) ligand is 15w
6ueg  2.00  2019  Kd=19.5uM     // 6uec.pdf (Q5G) ligand is compound 2
6jbe  1.75  2019  Kd=19.80uM    // 6j9w.pdf (GLC)
6qr9  2.42  2019  Kd=190nM      // 6qr9.pdf (JEE) ligand is compound 29c; Kd = 190 +/- 23nM
6qqw  1.80  2019  Kd=19uM       // 6qqw.pdf (JDQ) ligand is compound 24c; Kd = 19+/-1uM
6quv  1.48  2019  Kd=1mM        // 6quu.pdf (JJN) ligand is compound 15R
6n8x  1.49  2019  Kd=2.0uM      // 6n8x.pdf (KFY) ligand is PU-11-trans
6qge  1.16  2019  Kd=2.1uM      // 6qge.pdf (J1E) ligand is compound S; Kd = 2.1+/-0.1uM
6pi6  1.65  2019  Kd=2.2uM      // 6pi5.pdf (OKM) ligand is 2-Hydroxyatrazine; Kd =2.2 +/- 0.2 uM
6j0g  1.60  2019  Kd=2.3uM      // 5zxk.pdf (H6P) HMBPP, R351H, structure 1
6ets  1.33  2019  Kd=2.3uM      // 6etg.pdf (I1L) compound 1, Kd=2.3+/-0.9uM
6n3v  1.45  2019  Kd=2.45uM     // 6n3v.pdf (KB7) ligand is 1
6j3o  2.11  2019  Kd=2.4uM      // 6j3o.pdf (B4L) ligand is 12
6h1d  1.94  2019  Kd=2.5uM      // 6h1d.pdf (SAH) ligand is SAH complex with TRMT112
6t1o  1.90  2019  Kd=2.6uM      // 6t1i.pdf (M82) ligand is compound 6
6i12  1.65  2019  Kd=2.7uM      // 6i0z.pdf (H08) ligand is 5
6hk4  2.50  2019  Kd=2.81nM     // 6hk3.pdf (G8E) ligand is 4
6bs4  2.50  2019  Kd=2.8uM      // 6bs3.pdf (AGS) Kd(BagAB, ATPgammaS)=2.8uM
6mg5  1.80  2019  Kd=20.3uM     // 6mg5.pdf (6ZW) ligand is 1
6mlp  1.49  2019  Kd=200uM      // 6mku.pdf (HIS)
6pg6  1.68  2019  Kd=200uM      // 6pg3.pdf (OH7) ligand is compound 29; Kd = 200 +/- 10 uM
6i67  1.75  2019  Kd=201.4nM    // 6i61.pdf (H42) ligand is tetrahydro-2-naphtol
5z66  1.80  2019  Kd=206nM      // 5z66.pdf (VDM) microscale thermophoresis, Kd=206+/10nM
6g6t  1.12  2019  Kd=20nM       // 6g5l.pdf (ENN) Kd(9, FTSA)=20nM
6gj6  1.76  2019  Kd=20uM       // 6gj5.pdf (EZZ) ligand is 18
6p86  1.80  2019  Kd=20uM       // 6p83.pdf (O4S) ligand is compound 4.1
6dyr  2.45  2019  Kd=218.6uM    // 6dyr.pdf (HJD)
6cq1  1.70  2019  Kd=219uM      // 6c3l.pdf (F8J) Kd(15a, NMR)=219+/-32uM
6ift  1.90  2019  Kd=21uM       // 6ift.pdf (SAM)
6nw3  2.35  2019  Kd=22.1nM     // 6nv7.pdf (L4J) ligand is inhibitor 1; Kd = 22.1 +/- 9.5 nM
6pl1  2.03  2019  Kd=22.2nM     // 6pl1.pdf (OOJ) ligand is compound 1b; SPR assay
6e1y  1.22  2019  Kd=22nM       // 6dy7.pdf (HLM) compound is C2
6g2c  1.76  2019  Kd=22uM       // 6g24.pdf (EHT) Kd(compd 9)=22+/-2.2uM
6ooy  2.50  2019  Kd=22uM       // 6ooy.pdf (A7M) ligand is UCB-6876
6pg7  2.45  2019  Kd=22uM       // 6pg3.pdf (OH4) ligand is compound 17; Kd = 22 +/- 6 uM
6qln  1.00  2019  Kd=22uM       // 6qln.pdf (J5Q) ligand is compound 3; Kd = 22+/-0.7 uM; Binding assay is fluorescence polarization
6qlu  1.10  2019  Kd=23uM       // 6qln.pdf (J62) ligand is compound 7; Kd = 23+/-1.0 uM; Binding assay is fluorescence polarization
6pge  1.76  2019  Kd=240uM      // 6pg3.pdf (OJM) ligand is compound 24; Kd = 240 +/- 10 uM
6g5l  1.21  2019  Kd=24nM       // 6g5l.pdf (EM5) Kd(7a, ITC)=24nM
6p87  1.90  2019  Kd=25.4uM     // 6p83.pdf (O4P) ligand is compound 5
6p8a  1.80  2019  Kd=255uM      // 6p83.pdf (O4D) ligand is compound 8.1
6n5x  2.05  2019  Kd=25uM       // 6n5x.pdf (JEF) ligand is CI-MPR
6pgb  1.73  2019  Kd=25uM       // 6pg3.pdf (OJG) ligand is compound 31; Kd = 25 +/- 3 uM
6qe0  1.39  2019  Kd=25uM       // 6qdx.pdf (HZ2) ligand is BA2; Kd = 25+/-3uM
6pg4  1.60  2019  Kd=260uM      // 6pg3.pdf (OHG) ligand is compound 2; Kd = 260 +/- 20 uM
6np5  1.35  2019  Kd=27uM       // 6np2.pdf (9CS) ligand is compound kanamycin B; Kd = 27 +/- 0.5uM
6o9c  2.45  2019  Kd=28.5nM     // 6o9b.pdf (9-mer) ligand is S45F beta-catenin peptide
6pga  2.45  2019  Kd=28.9uM     // 6pg3.pdf (OGM) ligand is compound 32; Kd = 28.9 +/- 0.5 uM
6pid  1.55  2019  Kd=29.0uM     // 6phr.pdf (OKS) ligand is compound 5
6i11  1.67  2019  Kd=29.3uM     // 6i0z.pdf (H0H) ligand is 3
5znc  1.66  2019  Kd=29.9nM     // 5znc.pdf (QI9)
6mln  1.72  2019  Kd=29nM       // 6mku.pdf (ARG)
6o5g  1.89  2019  Kd=2uM        // 6eeb.pdf (LMJ) Kd(isomalbrancheamide D )=2+/-1uM
6dgl  1.95  2019  Kd=3.05uM     // 6dgl.pdf (GEV) compound is darglitazone
6dgq  2.45  2019  Kd=3.09uM     // 6dgl.pdf (GBV) compound is CAY10506
6qr2  1.55  2019  Kd=3.2uM      // 6qr2.pdf (JQB) ligand is compound 26j: Kd = 3.2+/-0.3uM
6dzx  1.68  2019  Kd=3.5uM      // 6dzx.pdf (MED) D-methionine
6gdy  2.04  2019  Kd=3.5uM      // 6gdy.pdf (AKG) [Nonstandard assay: in presence of Fe2+] Kd(2OG)=3.5+/-2.1uM
6t1n  1.95  2019  Kd=3.5uM      // 6t1i.pdf (M7Z) ligand is compound 5
6n3y  1.80  2019  Kd=3.65uM     // 6n3v.pdf (HHJ) ligand is TrpGc
6r1b  2.27  2019  Kd=3.6uM      // 6r1b.pdf (CH5) ligand is compound GPC; Kd = 3.6 +/- 0.5 uM
6mli  1.88  2019  Kd=3.7mM      // 6mku.pdf (HIS)
6hgg  1.79  2019  Kd=3.8uM      // 6hgd.pdf (HCY) ligand is cortisol
6mm2  1.04  2019  Kd=3.92uM     // 6mm2.pdf (ATP) [Uncommon element] ligand is ATP
6p88  1.70  2019  Kd=30.2uM     // 6p83.pdf (O4G) ligand is compound 6
6sge  1.50  2019  Kd=30.8nM     // 6hxu.pdf (GTP) RHOB-GTP in complex with nanobody B6
6g25  1.43  2019  Kd=300uM      // 6g24.pdf (EHQ) Kd(compd 4)=300+/-21uM
6nco  1.71  2019  Kd=30uM       // 6ncn.pdf (KQP) ligand is 3
6nu1  2.25  2019  Kd=31.2uM     // 6nu1.pdf (CYS) ligand is cysteine; assay in presence of FBP ligand
6hk3  2.35  2019  Kd=31.4nM     // 6hk3.pdf (G8B) ligand is 5
6jag  1.85  2019  Kd=31.5uM     // 6j9w.pdf (SUC)
6nyv  2.43  2019  Kd=312nM      // 6nyv.pdf (LBD) ligand is compound 1; Kd = 312+/-300nM
6qlq  1.08  2019  Kd=31uM       // 6qln.pdf (J4E) ligand is compound 4; Kd = 31+/-1.3 uM; Binding assay is fluorescence polarization
6qau  2.48  2019  Kd=32.9nM     // 6qas.pdf (1FV) Ligand is compound MRT67307
6poi  1.77  2019  Kd=326uM      // 6pmf.pdf (OVS) ligand is compound 25; Kd = 326 +/- 65 uM
6ql1  1.42  2019  Kd=330nM      // 6ql1.pdf (V50) ligand is compound 14; Kd = 330 +/- 140 nM
6pvz  1.99  2019  Kd=341uM      // 6pmf.pdf (OZM) ligand is compound 28; Kd = 341 +/- 47 uM
6q4e  1.06  2019  Kd=350uM      // 6q3b.pdf (HH5) ligand is compound 33
6np4  1.15  2019  Kd=36uM       // 6np2.pdf (TOY) ligand is compound tobramycin; Kd = 36 +/- 0.3 uM
6m8q  2.49  2019  Kd=370nM      // 6m8q.pdf (JBG) ligand is 2; binding assay method is SEC CTID
6rtw  1.90  2019  Kd=370nM      // 6rtw.pdf (Y01) ligand is cholesterol-hemisuccinate(HS)
6j1l  2.30  2019  Kd=380nM      // 6j1l.pdf (B6L) ligand is 27
6py0  2.20  2019  Kd=386nM      // 6pxz.pdf (RTL) ligand is retinol, Kd = 386 +/- 143 nM
6i65  1.50  2019  Kd=390.4nM    // 6i61.pdf (H3Z) ligand is  4-iso-propylphenol
6g5u  1.70  2019  Kd=395nM      // 6g5l.pdf (ENN) Kd(9, FTSA)=395nM
6g2s  2.20  2019  Kd=4.01nM     // 6g2r.pdf (EJN) compound 5
6ggb  1.32  2019  Kd=4.1uM      // 6ggb.pdf (EXQ) ligand is PK9318
6ggf  1.32  2019  Kd=4.1uM      // 6ggf.pdf (EXQ) ligand is PK9318
6olx  1.44  2019  Kd=4.2uM      // 6n8x.pdf (KFY) ligand is PU-11-trans
6n0j  1.79  2019  Kd=4.3uM      // 6n0j.pdf (K8S) ligand is CCG-222740
6pgc  1.81  2019  Kd=4.5uM      // 6pg3.pdf (OJJ) ligand is compound 37; Kd = 4.5 +/- 0.3 uM
6qls  1.05  2019  Kd=4.5uM      // 6qln.pdf (HRK) ligand is compound 9; Kd = 4.5+/-0.2 uM; Binding assay is fluorescence polarization
6u6w  1.20  2019  Kd=4.71uM     // 6u5m.pdf (Q0Y) ligand is compound 1; Kd = 4.71 +/- 1.59 uM; Binding assay is FPA
6qav  2.05  2019  Kd=4.9nM      // 6qas.pdf (HVH) Ligand is compound MRT68921
5zni  2.30  2019  Kd=40.3uM     // 5znc.pdf (YMZ)
6im4  1.93  2019  Kd=40nM       // 6im4.pdf (6-mer) ligand is AimP
6hgj  1.83  2019  Kd=41.6uM     // 6hgd.pdf (AS4) ligand is Aldosterone
6mla  1.58  2019  Kd=42uM       // 6mku.pdf (ARG)
6o5u  1.40  2019  Kd=42uM       // 6np2.pdf (KAN) ligand is compound kanamycin A; Kd = 42 +/- 0.2uM
6qi4  1.78  2019  Kd=43uM       // 6qi4.pdf (FKW) ligand is compound 3b; Kd = 43 +/- 6 uM
6q3z  2.00  2019  Kd=44nM       // 6q3y.pdf (HG8) ligand is compound 16k
6ajz  1.30  2019  Kd=46uM       // 6ajv.pdf (LOC)
6phx  2.00  2019  Kd=478.6uM    // 6phx.pdf (3-mer) ligand is raffinose
6g29  1.70  2019  Kd=47uM       // 6g24.pdf (EHK) Kd(compd 6)=47+/-11uM
6jad  1.90  2019  Kd=48.3uM     // 6j9w.pdf (2-mer) ligand is Z9N-GLC 
6ajr  1.34  2019  Kd=48.5uM     // 6ajo.pdf (URA) compound is uracil
6i64  1.91  2019  Kd=48.7nM     // 6i61.pdf (H48) ligand is bisphenol-E
6pg3  2.04  2019  Kd=480uM      // 6pg3.pdf (OHJ) ligand is compound 1; Kd = 480 +/- 30 uM
6ior  2.50  2019  Kd=49.5uM     // 6iop.pdf (ASN) ligand is L-Asparagine
6qqu  1.59  2019  Kd=5.0uM      // 6qqu.pdf (JF8) ligand is compound 25; Kd = 5.0+/-2.1 uM
6mqc  1.99  2019  Kd=5.22nM     // 6mqc.pdf (8-mer)
6qlp  1.08  2019  Kd=5.2uM      // 6qln.pdf (J3Q) ligand is compound 8; Kd = 5.2+/-0.3 uM; Binding assay is fluorescence polarization
6ajy  1.60  2019  Kd=5.3uM      // 6ajv.pdf (A0R) Kd(ISL 4-methyl ester)=5.3uM, ligand structure is inconsistent with the literature
6t1i  1.80  2019  Kd=5.5uM      // 6t1i.pdf (M7W) ligand is compound 1
6gxg  1.60  2019  Kd=5.7uM      // 6gxg.pdf (FFN) 
6pu3  1.80  2019  Kd=5.85uM     // 6ofq.pdf (4-mer) ligand is peptide STSA; Kd = 5.85 +/- 0.56 uM
6jam  1.63  2019  Kd=5.95uM     // 6j9w.pdf (TRE)
6q4g  0.98  2019  Kd=50uM       // 6q3b.pdf (HJK) ligand is compound 37
6mji  2.30  2019  Kd=51.5nM     // 6miv.pdf (JTD) ligand is 15s
6q3y  1.20  2019  Kd=54nM       // 6q3y.pdf (HG5) ligand is compound 16i
6mlj  1.60  2019  Kd=55nM       // 6mku.pdf (ARG)
6dys  2.30  2019  Kd=56.4uM     // 6dys.pdf (HJ1)
6i61  1.65  2019  Kd=569.0nM    // 6i61.pdf (H3W) ligand is Bisphenol-B
6eeb  1.96  2019  Kd=5uM        // 6eeb.pdf (J6P) Kd(malbrancheamide)=5+/-1uM
6ml9  1.69  2019  Kd=5uM        // 6mku.pdf (ARG)
6t1m  1.85  2019  Kd=6.1uM      // 6t1i.pdf (M8K) ligand is compound 4
5zyg  1.80  2019  Kd=6.2uM      // 5zyg.pdf (9N3) Kd=6.2+/-2.7uM, kon=5.45E+4, koff=3.0E-1
6iht  1.57  2019  Kd=6.2uM      // 6iht.pdf (3-mer) ligand is His12
6nv9  2.13  2019  Kd=6.4nM      // 6nv7.pdf (L3M) ligand is inhibitor 3; Kd = 6.4 +/- 2.9 nM
6qqq  1.85  2019  Kd=6.7uM      // 6qqq.pdf (JDE) ligand is compound 14; Kd = 6.7 +/- 0.6 uM
6g2f  1.74  2019  Kd=6.8uM      // 6g24.pdf (EHW) Kd(compd 16)=6.8+/-2.6uM
6k3l  2.09  2019  Kd=60.1nM     // 6k3l.pdf (3NG)
6dyn  2.10  2019  Kd=638.9uM    // 6dyn.pdf (HSM)
6ssy  1.62  2019  Kd=649uM      // 6ssy.pdf (P7I) ligand is 2-AEP
6dy7  1.90  2019  Kd=66.2uM     // 6dy7.pdf (HH7) compound is C1
6p9e  2.00  2019  Kd=67.6nM     // 6p9e.pdf (O6D) kd = 67.6+/-5.98 nM; ligand is compound A-552
6det  1.75  2019  Kd=6nM        // 6det.pdf (ARG)
6nu5  1.60  2019  Kd=7.04uM     // 6nu1.pdf (CYS) ligand is cysteine; Kd = 7.04 +/- 1.83 uM
6j9w  1.80  2019  Kd=7.46uM     // 6j9w.pdf (TRE)
6r9u  1.26  2019  Kd=7.5mM      // 6r8l.pdf (JVQ) ligand is compound 4
6qe5  1.61  2019  Kd=7.5uM      // 6qdx.pdf (SAH) ligand is SAH; Kd = 7.5+/-0.9uM
6i13  1.79  2019  Kd=7.6uM      // 6i0z.pdf (H0Q) ligand is 7
6jdi  1.95  2019  Kd=7.8uM      // 6j7e.pdf (AGS) ligand is ATPgS
6mku  1.73  2019  Kd=70nM       // 6mku.pdf (ARG)
6qr7  2.03  2019  Kd=70nM       // 6qr7.pdf (JEK) ligand is compound 29b; Kd = 70 +/- 29 nM
6fcj  2.49  2019  Kd=71.1nM     // 6fcj.pdf (D4W) Kd=71.1+/-4.33nM, kon=4.79E+5,  koff=3.38E-2
6g27  1.65  2019  Kd=731uM      // 6g24.pdf (EHE) Kd(compd 5)=731+/-308uM
6st0  1.50  2019  Kd=7463nM     // 6ssy.pdf (LUQ) ligand is ACES
6gxq  1.96  2019  Kd=79.4nM     // 6gxq.pdf (FFZ) ligand is 37
6ios  2.35  2019  Kd=79.4uM     // 6iop.pdf (PRO) ligand is L-proline
6n3x  1.10  2019  Kd=8.09uM     // 6n3v.pdf (KBD) ligand is 3
6j9y  1.63  2019  Kd=8.54uM     // 6j9w.pdf (MAL)
6qr1  1.67  2019  Kd=8.5uM      // 6qr1.pdf (JFT) ligand is compound 27g; Kd = 8.5 +/- 1.0 uM
6n0k  1.46  2019  Kd=8.6uM      // 6n0k.pdf (K8M) ligand is CCG-257081
6qlo  1.18  2019  Kd=8.8uM      // 6qln.pdf (J5E) ligand is compound 5; Kd = 8.8+/-0.3 uM; Binding assay is fluorescence polarization
6kjd  2.30  2019  Kd=8.9uM      // 6kjd.pdf (LVA) ligand is lovastatin
6fh3  1.85  2019  Kd=850uM      // 6fh2.pdf (RPI) Kd(pArg)=850+/-400uM
6i18  1.49  2019  Kd=85uM       // 6i0z.pdf (H0N) ligand is BDP-13176
6ftf  1.09  2019  Kd=8nM        // 6ftf.pdf (7CI) Kd(7-CN-7-C-Ino)=8+/-2nM
6md6  1.68  2019  Kd=8uM        // 6md6.pdf (JSV) ligand is G6SG-OMe
6s57  1.82  2019  Kd=8uM        // 6s55.pdf (KVT) ligand is compound 15; SPR pKd=5.1
6s56  2.01  2019  Kd=8uM        // 6s55.pdf (KVZ) ligand is compound 9; SPR pKd=5.1
6ajv  1.45  2019  Kd=9.1uM      // 6ajv.pdf (HCC) Kd(ISL)=9.1uM, +DMSO in crystal structure
6j7e  2.40  2019  Kd=9.2uM      // 6j7e.pdf (AGS) ligand is ATPgS
6hgf  1.65  2019  Kd=9.6uM      // 6hgd.pdf (HCY) ligand is cortisol
6p89  1.40  2019  Kd=9.77uM     // 6p83.pdf (O4A) ligand is compound 7
6g2e  1.85  2019  Kd=9.7uM      // 6g24.pdf (EHH) Kd(compd 13)=9.7+/-2.3uM
6ncn  1.82  2019  Kd=900uM      // 6ncn.pdf (KJM) ligand is 1
6qpl  1.60  2019  Kd=91nM       // 6qpl.pdf (JC5) ligand is compound 3; Kd = 91 +/- 4 nM
6i0z  1.77  2019  Kd=92uM       // 6i0z.pdf (GZQ) ligand is 1
6qlt  1.15  2019  Kd=92uM       // 6qln.pdf (J5W) ligand is compound 2; Kd = 92+/-5 uM; Binding assay is fluorescence polarization
6hni  1.35  2019  Kd=94uM       // 6hni.pdf (TYR)
6i63  2.23  2019  Kd=98.6nM     // 6i61.pdf (2OH) ligand is bisphenol-A
6hay  2.24  2019  Kd=98nM       // 6hax.pdf (FX8) ligand is PROTAC 1, ternary complex VHL and PROTAC 1 with SMARCA2
6hhr  2.00  2019  Kd=98nM       // 6hhr.pdf (G5E) ligand is 7
6mlg  1.89  2019  Kd=9uM        // 6mku.pdf (ARG)
6qgh  2.00  2019  Ki=0.007uM    // 6qfi.pdf (1XJ) ligand is compound 13, ABT-263; FP Ki data
6o0k  1.62  2019  Ki=0.018nM    // 6o0k.pdf (LBM) ligand is venetoclax; Ki = 0.018+/-0.014 nM
5zg1  1.32  2019  Ki=0.019uM    // 5zg0.pdf (9C0)
6ne5  1.85  2019  Ki=0.03nM     // 6ne5.pdf (KJP) ligand is compound 42; Ki = 0.030+/-0.02nM
6no9  1.71  2019  Ki=0.03nM     // 6no9.pdf (KUV) ligand is compound 16
6p3t  2.50  2019  Ki=0.048uM    // 6p3t.pdf (NRS) ligand is compound 1, inhibitor SGT449; Ki = 0.048 +/- 0.003 uM
6oqc  1.80  2019  Ki=0.04nM     // 6o6f.pdf (N0S) ligand is compound 9
6udv  1.35  2019  Ki=0.051nM    // 6ud2.pdf (Q51) ligand is compound 3
6oqb  1.60  2019  Ki=0.05nM     // 6o6f.pdf (N0J) ligand is compound 10 (AM-8621); Some data are Ki, some are IC50
5zg3  1.65  2019  Ki=0.061uM    // 5zg0.pdf (9C6)
6ud2  1.70  2019  Ki=0.062nM    // 6ud2.pdf (Q4D) ligand is compound 1
6ndl  2.00  2019  Ki=0.065uM    // 6ndl.pdf (BQX) ligand is compound 7; Ki = 0.065 +/- 0.03 nM
6nzv  1.55  2019  Ki=0.067nM    // 6nzt.pdf (L9J) ligand is compound 12
5zg0  1.58  2019  Ki=0.082uM    // 5zg0.pdf (9C3)
6p3v  2.50  2019  Ki=0.096uM    // 6p3t.pdf (NRV) ligand is compound 3; Ki = 0.096 +/- 0.010 uM
6udi  1.94  2019  Ki=0.10nM     // 6ud2.pdf (Q4S) ligand is compound 20; Ki = 0.10 +/- 0.01 nM
6o0p  1.80  2019  Ki=0.11nM     // 6o0k.pdf (LBM) ligand is venetoclax; Ki = 0.11 +/- 0.03 nM
6oqd  1.48  2019  Ki=0.14nM     // 6o6f.pdf (N0M) ligand is compound 8
6sbt  2.30  2019  Ki=0.166uM    // 6sbt.pdf (L5H) Ligand is compound 11; Ki = 0.166+/-0.011uM
6ixd  1.00  2019  Ki=0.16nM     // 6ixd.pdf (B0F) ligand is 2
6udt  1.50  2019  Ki=0.1nM      // 6ud2.pdf (Q4V) ligand is compound 10
6cjs  1.90  2019  Ki=0.20nM     // 6cjj.pdf (2GJ) AUY922
6n78  1.83  2019  Ki=0.21nM     // 6n78.pdf (KEP) ligand is 21
6n79  2.27  2019  Ki=0.21nM     // 6n79.pdf (KES) ligand is 20
6d19  1.45  2019  Ki=0.246uM    // 6d15.pdf (YKG) compound 9, Ki=0.246+/-0.047uM
6cjr  1.80  2019  Ki=0.30nM     // 6cjj.pdf (E0G) SNX-2112
6o5t  2.10  2019  Ki=0.316uM    // 6d15.pdf (L8J) compound 16, Ki=0.316+/-0.015uM
6ftw  2.16  2019  Ki=0.32uM     // 6ftw.pdf (E6Z) pKi(8b)=6.5+/-0.2
6q54  1.40  2019  Ki=0.32uM     // 6q54.pdf (HJ8) ligand is compound 6b; Ki = 0.32+/-0.03uM
6hoq  1.55  2019  Ki=0.41uM     // 6hop.pdf (FER) ligand is ferulic acid
6o0m  1.75  2019  Ki=0.46nM     // 6o0k.pdf (LBM) ligand is venetoclax; Ki = 0.46 +/- 0.12 nM
6pvw  1.60  2019  Ki=0.48uM     // 6pvu.pdf (OZV) ligand is compound cp4pA; Ki = 0.48 +/- 0.03 uM
6hza  1.90  2019  Ki=0.504nM    // 6hlb.pdf (5-mer) ligand is 2
6orr  2.25  2019  Ki=0.5nM      // 6orr.pdf (N37) ligand is compound 10, Inhibitor NS1; pKi = 9.30 +/- 0.07
6udu  1.75  2019  Ki=0.5nM      // 6ud2.pdf (Q4Y) ligand is compound 8
6qgg  1.50  2019  Ki=0.5uM      // 6qfi.pdf (J1H) ligand is compound 1; FP Ki data
6n7b  1.81  2019  Ki=0.6nM      // 6n7b.pdf (KEY) ligand is 38
6odz  1.30  2019  Ki=0.7nM      // 6odz.pdf (M8J) ligand is compound 5a; Binding assay is stopped flow CO2 hydrase assay
6c2r  1.96  2019  Ki=0.8nM      // 6c2r.pdf (EG7)
6hzb  1.90  2019  Ki=1.05nM     // 6hlb.pdf (5-mer) ligand is 3
6fz4  1.85  2019  Ki=1.12uM     // 6fz4.pdf (EC8) Ki(37)=1.12+/-0.14uM
6oe0  1.30  2019  Ki=1.2nM      // 6odz.pdf (M8S) ligand is compound 5c; Binding assay is stopped flow CO2 hydrase assay
6d18  1.35  2019  Ki=1.4uM      // 6d15.pdf (GTV) compound 6, Ki=1.4+/-0.2uM
6pvv  1.65  2019  Ki=1.4uM      // 6pvu.pdf (5FA) ligand is compound p5A; Ki = 1.4 +/- 0.06 uM
6jav  1.44  2019  Ki=1.72uM     // 6jav.pdf (BC0) ligand is PT
6o94  1.98  2019  Ki=1.8nM      // 6o8u.pdf (LRS) ligand is compound 17; Ki = 1.8+/-0.9nM
6q60  1.55  2019  Ki=1.97uM     // 6q54.pdf (HJH) ligand is compound 7a; Ki = 1.97+/-0.17uM
6jay  1.50  2019  Ki=1.99uM     // 6jav.pdf (JUK) ligand is DP
6hr2  1.76  2019  Ki=100nM      // 6hax.pdf (FWZ) ligand is PROTAC 2, ternary complex VHL and PROTAC 2 with SMARCA4
6s4t  2.00  2019  Ki=11.2nM     // 6s4n.pdf (KVB) ligand is WAY-254011; pKi=7.95
6r0v  1.60  2019  Ki=11uM       // 6r0q.pdf (JO2) ligand is compound 4b; Ki = 11+/-1.8 uM
6c9v  1.70  2019  Ki=120.2nM    // 6c67.pdf (ERS) enzymic inhibition assay, compound 7, Ki=120.2+/-0.9nM
6g9x  2.30  2019  Ki=120uM      // 6g9x.pdf (JKE) Microscale thermophoresis binding assay, compound is TSA
6hzy  1.70  2019  Ki=121uM      // 6hzy.pdf (GYZ) ligand is 39
6d1b  1.25  2019  Ki=123.7uM    // 6d15.pdf (FUJ) compound 2, Ki=123.7+/-3.6uM
6c85  2.40  2019  Ki=126uM      // 6c85.pdf (PLQ) enzyme assay, Ki=126+/-14uM
6r11  1.75  2019  Ki=12uM       // 6r0q.pdf (JOB) ligand is compound 5b; Ki = 12 +/- 0.7 uM
6r18  1.35  2019  Ki=12uM       // 6r0q.pdf (JOQ) ligand is compound 11a; Ki = 12 +/- 1.7 uM
6i5g  2.00  2019  Ki=13.03uM    // 6i5g.pdf (PTG) ligand is 15d-PGJ2
6d17  1.45  2019  Ki=15.3uM     // 6d15.pdf (VKE) compound 3, Ki=15.3+/-2.5uM
6s4n  1.90  2019  Ki=162nM      // 6s4n.pdf (KUW) ligand is AZ6; pKi=6.79
6hgs  1.55  2019  Ki=170uM      // 6hgq.pdf (5GP) ligand is GMP
6e6m  1.55  2019  Ki=1786.5nM   // 6e5l.pdf (8CB) compound CBDO at 350nm
6szp  1.76  2019  Ki=18uM       // 6szp.pdf (M3B) ligand is compound 8a; Ki = 18 +/- 6 uM;
6ugz  1.31  2019  Ki=19.1nM     // 6ugn.pdf (Q71) ligand is compound 2h, SB4-208
6d1h  1.25  2019  Ki=190.2uM    // 6d15.pdf (KED) compound 11, Ki=190.2+/-22.6uM
6rfn  2.29  2019  Ki=199.5nM    // 6gxq.pdf (K3W) ligand is 40
6nmb  2.30  2019  Ki=2.01mM     // 6nmb.pdf (AMH) ligand is compound TXA;Ki = 2.01+/-0.09mM
6jaw  1.98  2019  Ki=2.18uM     // 6jav.pdf (BBO) ligand is NI
6prf  1.21  2019  Ki=2.5nM      // 6prf.pdf (7OA) ligand is compound 2, GRL-14213A; Ki = 2.5 +/- 0.5 nM
6mxc  1.99  2019  Ki=2.73uM     // 6mxb.pdf (5GP)
6ouv  1.94  2019  Ki=2.8uM      // 6ouv.pdf (TDK) ligand is MAP; Ki = 2.8 +/- 0.2 uM
6nwk  1.65  2019  Ki=20nM       // 6nwk.pdf (DEX) ligand is DEX
6r13  1.65  2019  Ki=20uM       // 6r0q.pdf (JOK) ligand is compound 7f; Ki = 20+/-2.6uM
6plf  1.70  2019  Ki=214nM      // 6plf.pdf (ONV) ligand is compound 1; Ki = 214 +/- 26 nM
6o5x  1.70  2019  Ki=22nM       // 6o48.pdf (0Q4) ligand is CA-p2; Ki = 22+/-3.4nM
6mll  1.86  2019  Ki=239uM      // 6efj.pdf (N1G) Ki(compound 7)=239+/-23uM,   -Lactamase Inhibition Assay
6hax  2.35  2019  Ki=26nM       // 6hax.pdf (FWZ) ligand is PROTAC 2, ternary complex VHL and PROTAC 2 with SMARCA2
6p5o  1.49  2019  Ki=28.6uM     // 6p5o.pdf (O2Y) ligand is compound CMP; Ki = 28.6 +/- 8.8 uM
6e5t  1.55  2019  Ki=285nM      // 6e5l.pdf (HVJ) compound abn-CBDO, at 350nm
6gvf  2.50  2019  Ki=28nM       // 6gvf.pdf (FE5) ligand is 1
6oe1  1.45  2019  Ki=3.1nM      // 6odz.pdf (M8V) ligand is compound 5b; Binding assay is stopped flow CO2 hydrase assay
6dd0  1.50  2019  Ki=3.3uM      // 6d15.pdf (P9T) compound 8, Ki=3.3+/-0.1uM
5qtt  2.23  2019  Ki=3.4nM      // 5qtt.pdf (QEY) compound is 17
6d3q  2.24  2019  Ki=3.4nM      // 6d3q.pdf (4NG) compound is SF2312
6nxz  1.75  2019  Ki=3.5uM      // 6nxz.pdf (D49) ligand is compound 3; Ki = 3.5+/-1.7 uM
6otg  1.50  2019  Ki=31.4nM     // 6otg.pdf (4UY) ligand is compound 1; Ki = 31.4 +/- 3.9nM
6rfw  2.18  2019  Ki=316nM      // 6gxq.pdf (K1Q) ligand is 41
6d15  1.30  2019  Ki=32.9uM     // 6d15.pdf (TWB) compound 1, Ki=32.9+/-3.3uM
6d1d  1.40  2019  Ki=33.8uM     // 6d15.pdf (GTV) compound 6, Ki=33.8+/-3.8uM
6dl2  1.47  2019  Ki=33nM       // 6dl2.pdf (GUJ) Ki(FP, 3)=33+/-4nM
6d1g  1.15  2019  Ki=34.2uM     // 6d15.pdf (YKG) compound 9, Ki=34.2+/-8.0uM
6hgr  1.52  2019  Ki=350uM      // 6hgq.pdf (IMP) ligand is IMP
6gxb  1.35  2019  Ki=35nM       // 6gxb.pdf (FF5) ligand is compound 1
6o0o  2.00  2019  Ki=36nM       // 6o0k.pdf (F3Q) ligand is S55746; Ki = 36 +/- 12 nM
6ppy  2.00  2019  Ki=36uM       // 6ppw.pdf (OVY) ligand is compound NeuNAC oxime; Ki = 36 +/- 12 uM
6ny0  1.40  2019  Ki=4.0uM      // 6nxz.pdf (LBA) ligand is compound 1; Ki = 3.5+/-1.7 uM
6n7a  1.33  2019  Ki=4.3nM      // 6n7a.pdf (KEV) ligand is 39
6of5  2.30  2019  Ki=4.5uM      // 6of5.pdf (MFJ) ligand is compound 1; Ki = 4.5 +/- 1.9 uM
6md8  1.40  2019  Ki=4200uM     // 6efj.pdf (J84) Ki(compound 3)=4200+/-300uM,   -Lactamase Inhibition Assay
6mnv  1.65  2019  Ki=428uM      // 6mlf.pdf (JVS) ligand is 3
6gwe  2.30  2019  Ki=42nM       // 6gwe.pdf (FE8) ligand is P2
6nwl  1.60  2019  Ki=43nM       // 6nwk.pdf (HCY) ligand is HCY
6pve  2.30  2019  Ki=43nM       // 6pve.pdf (OZP) ligand is compound 1a, inhibitor LL319; Ki = 43 +/- 5.0 nM
6d1a  1.25  2019  Ki=44.3uM     // 6d15.pdf (TWB) compound 1, Ki=44.3+/-7.3uM
6r1a  1.54  2019  Ki=45uM       // 6r0q.pdf (JP8) ligand is compound 20b; Ki = 45 +/- 15.7 uM
6s5k  1.60  2019  Ki=47.9nM     // 6s4n.pdf (KWE) ligand is AZ8; pKi=7.32
6efj  1.65  2019  Ki=477uM      // 6efj.pdf (O5E) Ki(compound 9)=477+/-40uM,   -Lactamase Inhibition Assay
6rot  1.34  2019  Ki=483.63nM   // 5jfd.pdf (KDQ) compound 4
6c9s  2.23  2019  Ki=48nM       // 6c67.pdf (ERP) enzymic inhibition assay, compound 17, Ki=48+/-0.6nM
6r1d  1.10  2019  Ki=4uM        // 6r0q.pdf (JP5) ligand is compound 7d; Ki = 4 +/- 0.4 uM
6r1w  1.35  2019  Ki=5.0uM      // 6r0q.pdf (JPW) ligand is compound 16b; Ki = 5.0 +/- 0.5 uM
6o95  1.77  2019  Ki=5.1nM      // 6o8u.pdf (LSV) ligand is compound 41; Ki = 5.1+/-1.2nM
5qqp  2.08  2019  Ki=5.3nM      // 5qqo.pdf (NR7) compound 13
6ibk  1.99  2019  Ki=509uM      // 6ibk.pdf (YTW) ligand is 4
6o5a  1.67  2019  Ki=514nM      // 6o48.pdf (2NC) ligand is compound p2-NC; crystal in space group P61
6ugr  1.31  2019  Ki=533.6nM    // 6ugn.pdf (Q71) ligand is compound 2h, SB4-208
6d1j  1.15  2019  Ki=56.2uM     // 6d15.pdf (7SX) compound 13, Ki=56.2+/-4.3uM
6mdu  1.15  2019  Ki=56uM       // 6efj.pdf (N1G) Ki(compound 7)=56+/-8uM,   -Lactamase Inhibition Assay
6om8  2.45  2019  Ki=6.9uM      // 6om8.pdf (UDX) ligand is compound UDP-xyl; Ki = 6.9 +/- 0.6 uM
6e5l  1.17  2019  Ki=66.7nM     // 6e5l.pdf (HVD) compound abn-CBD, at 350nm
6ugp  1.31  2019  Ki=685.5nM    // 6ugn.pdf (Q7A) ligand is compound 2i, SB4-206
6abx  1.70  2019  Ki=7.19mM     // 6abx.pdf (FLC) citrate
6n95  1.80  2019  Ki=7.5uM      // 6n95.pdf (YXS) ligand is 4
6d1k  1.20  2019  Ki=741.3uM    // 6d15.pdf (M3Q) compound 14, Ki=741.3+/-53.1uM
6o48  1.46  2019  Ki=75nM       // 6o48.pdf (0Q4) ligand is CA-p2
6ugn  1.41  2019  Ki=763.5nM    // 6ugn.pdf (Q77) ligand is compound 2d, SB4-205
6jtc  2.39  2019  Ki=8.45uM     // 6jtb.pdf (C8O)
6d16  1.40  2019  Ki=8.4uM      // 6d15.pdf (FUJ) compound 2, Ki=8.4+/-0.4uM
6r4k  2.13  2019  Ki=8.5uM      // 6qwi.pdf (JSK) ligand is compound 10
6d1i  1.10  2019  Ki=81uM       // 6d15.pdf (T6Z) compound 12, Ki=81+/-12.8uM
6uh0  1.31  2019  Ki=853.1nM    // 6ugn.pdf (PX7) ligand is compound 2o, SB4-202
6k04  1.25  2019  Ki=9.1nM      // 6k04.pdf (CQF) ligand is 40
6ic2  1.15  2019  Ki=917.4nM    // 6ic2.pdf (BBJ) ligand is EPA
6gxe  1.30  2019  Ki=9nM        // 6gxe.pdf (FFH) ligand is compound 2
